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 ABSTRACT 
 
Studies investigating exposure to disinfection by-products (DBPs) via chlorinated waters during 
pregnancy and adverse fetal growth outcomes have been limited by potential exposure measurement 
error, lack of exposure assessment validation and potential residual confounding.  Factors driving 
DBP exposure are poorly understood, making it difficult to target resources appropriately in order to 
improve exposure assessment.  These issues were investigated through DBP exposure assessment 
and validation for a new investigation of DBPs and fetal growth within the Born in Bradford (BiB) 
cohort study. 
 
Analysis of individual water use in the BiB cohort found that water consumption, showering, 
bathing and swimming varied by demographic and lifestyle factors.  Sampling, analysis, and 
modelling of trihalomethanes (THMs) in tap water showed that THM concentrations exhibited clear 
seasonal variation, but spatial variability was limited across the study area.  Various metrics of 
exposure to THMs during pregnancy were created, including ‘personalised’ semi-individual 
metrics.  Analysis of these metrics revealed individual water use to be the main driver of THM 
exposure in this cohort, with spatial and temporal variability having little influence.  Compared with 
a fully integrated THM exposure metric (incorporating ingestion, showering/bathing and 
swimming), metrics based only on THM concentrations or THM ingestion misclassified over 50% 
of women.  A nested validation study was conducted using a 7-day water diary and urinary 
trichloroacetic acid (TCAA) biomarker.  This found error in self-reported water use and TCAA 
ingestion estimates to vary by employment status - error being greater for employed women.  
Urinary TCAA was not correlated with TCAA in tap water, reinforcing that individual water use is 
the most influential driver of DBP exposure in this cohort. 
 
Recommendations for future research include improved individual water use assessment covering 
more activities and time-points in pregnancy, stratified analysis of questionnaire validation studies, 
and use of urinary TCAA as a main exposure measure in epidemiological studies. 
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 CHAPTER 1: INTRODUCTION & LITERATURE REVIEW 
 
 
1.1. INTRODUCTION 
Disinfection of public drinking water supplies by chlorination is widely practiced throughout the 
world, serving as the principal barrier to microbial contaminants in drinking water.1  Since its 
introduction in the early 20th century, disinfection of drinking water has led to major improvements 
in public health, reducing morbidity and mortality from water-borne infectious diseases.2   
 
Over 30 years ago it was discovered that by-products are formed during the disinfection process3;4 
and since then there has been concern about the potential health risks that chlorination disinfection 
by-products (DBPs) pose.  As a result, alternative disinfection processes have been introduced, e.g. 
chloramination and ozonation, but each has been subsequently shown to form DBPs.  
 
Various studies have investigated potential associations between DBPs and risk of cancers and 
adverse reproductive outcomes.1  Since 1989 there have been over 40 epidemiological studies 
examining a range of reproductive endpoints in humans, including stillbirth, spontaneous abortion, 
congenital anomalies, preterm birth, birth weight, fetal growth, and semen quality.5   
 
Birth weight is of interest because it reflects fetal growth and well-being and is recognised globally 
as an indicator of perinatal and infant health.  Low birth weight (LBW) is strongly associated with 
increased infant mortality and morbidity, and an increased risk of developing various diseases, such 
as cardiovascular disease and diabetes, in later life.6;7  Epidemiological studies have suggested that 
exposure to DBPs in drinking water during pregnancy may have a small, but significant, effect on 
fetal growth.  However, because exposure assessment is difficult, and the effects seen are likely to 
be small, the epidemiological evidence is somewhat inconsistent and inconclusive.  Nonetheless, 
given the large number of people potentially exposed to DBPs through tap water via drinking, 
showering and bathing, the population effect may be considerable.  It is therefore important to 
continue to investigate this problem, improving upon exposure assessment in previous studies. 
 
This chapter begins with an introduction to DBPs, their determinants, and routes of human exposure 
to DBPs, before reviewing the epidemiological and toxicological evidence for a relationship 
between DBPs and adverse fetal growth outcomes, and possible mechanistic pathways by which 
such a relationship might act.  This review of the literature has contributed to two published 
papers,5;8 which are shown in Appendices A and B. 
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 1.2. CHLORINATION DISINFECTION BY-PRODUCTS 
1.2.1 Formation 
Chlorination disinfection by-products (DBPs) were first discovered in 1974.3;4  They are formed as 
a side reaction of water chlorination when chlorine reacts with natural organic matter and/or 
bromide ions in the water.1  Natural organic matter (NOM) is an organic precursor of chlorination 
by-product formation, and consists of a mixture of substances including humic and fulvic acids.  
Total organic carbon (TOC) is commonly used as a good measure of the levels of NOM present in 
water.9  Bromide ion is an inorganic precursor.  When chlorine gas or sodium hypochlorite is added 
to the water, it is hydrolysed to form hypochlorous acid (HOCl) and hypochlorite ion (OClˉ).  
Hypochlorous acid and hypochlorite ion oxidise bromide ion to form hypobromous acid (HOBr) 
and hypobromite ion (OBrˉ).  Both hypochlorous acid and hypobromous acid react with NOM to 
form DBPs.  The species distribution of DBPs is determined by the relative concentrations of NOM, 
chlorine and bromide in the water.1  Chlorinated species tend to dominate over brominated species, 
but this may not be the case in high bromide concentration source waters.10  However, brominated 
species are generally more toxic than their chlorinated analogs (and iodinated DBPs even more 
toxic).11 
 
1.2.2 Types of DBP 
There are several classes of DBP, including trihalomethanes (THMs), haloacetic acids (HAAs), 
haloacetonitriles (HANs), haloketones (HKs), and aldehydes, among others. 
 
THMs are the most common class/fraction followed by HAAs.10  There are four species of THMs: 
chloroform, bromodichloromethane (DCBM), chlorodibromomethane (DBCM) and bromoform.  
Chloroform is the most common, followed by DCBM, DBCM and then bromoform.12  The sum of 
these four species is referred to as total THM (TTHM).  There are nine species of HAA, the most 
common being dichloroacetic acid (DCAA) and trichloroacetic acid (TCAA) in low-bromide source 
waters.1  The sum of di-, tri-, mono- chloroacetic acids and mono- and di- bromoacetic acids 
(DCAA, TCAA, MCAA, MBAA and DBAA) is often referred to as HAA5. 
 
However, although 600 DBPs have been identified, a large proportion (>50%) of total organic 
halogen (TOX) formed during chlorination of drinking water has not been chemically identified, 
and TOX represents only a portion of the types of DBPs that can be formed.11 
 
1.2.3 Monitoring of DBPs in drinking water 
Strict regulatory standards have been set for the maximum acceptable concentrations of DBPs in 
drinking water.  These standards are shown in Table 1.1. 
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 In the UK, the maximum allowable contaminant level for TTHM is 100 μg/l for any three monthly 
average, and since the end of 2008, this has been an absolute standard of 100 μg/l in any sample.13  
There are currently no standards for any other DBPs in the UK.  Standards set by the United States 
Environmental Protection Agency (US EPA) are more stringent, with a maximum contaminant level 
for locational running annual averages of 80 μg/l for TTHM and 60 μg/l for HAA5.14 
 
It is important to note that current drinking water regulatory standards for DBPs have been 
developed largely on the basis of risk of cancer, not risk of adverse reproductive outcomes.14;15  The 
World Health Organisation established guideline values for THMs associated with an upper-bound 
excess lifetime cancer risk of 10-5.15 The US EPA uses long term toxicology studies that show a 
dose response to derive maximum contaminant level goals (MCLGs) and cancer potency factors.14  
MCLGs established by the US EPA are set at concentration levels at which no known or anticipated 
adverse health effects occur, allowing for an adequate margin of safety.14  Establishment of an 
MCLG for each specific contaminant is based on the available evidence of carcinogenicity or 
noncancer adverse health effects from drinking water exposure using the US EPA’s guidelines for 
risk assessment.14  However, relevant DBP concentrations in drinking water potentially associated 
with adverse fetal growth and other reproductive outcomes may differ from (and possibly be lower 
than) those associated with cancer risk.  
 
UK water companies are required to monitor levels of THMs in each water supply zone 
(WSZ)/distribution system at least 4 times per year.  The running annual average of these samples 
must not exceed the limits set out in Table 1.1.  Monitoring of non-THMs has not been statutorily 
required in the past and thus less is known about the behaviour of non-THM DBPs. 
 
1.2.4 Determinants of the composition and concentration of DBPs in water 
DBP formation is influenced by water quality and conditions during treatment and distribution, as 
discussed below. 
 
1.2.4.1 Source water quality 
The type and quality of raw water entering the treatment plant plays a major role in DBP formation.  
DBP formation is influenced by the concentrations of its precursors, NOM and bromide ion, in the 
raw water source.  NOM will tend to influence overall concentration of DBPs, whilst the ratio of 
bromide to TOC will have a significant influence on speciation of those DBPs.9 
 
Precursor content is influenced by the type of water source.  In the UK around 70% of drinking 
water comes from surface water sources (e.g. upland reservoirs, and lowland rivers and reservoirs) 
and 30% from groundwater sources.12  The amount of NOM in surface water sources can be 
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 variable, but in groundwater it tends to be low.12  This is because groundwater is protected from 
run-off NOM.16  Agricultural drainage, particularly from land that is high in peat soil, is a major 
source of TOC and DBP precursors.17  Wetland areas can also contribute to TOC, both from 
vegetative biomass and from leaching of underlying peat soils.17  In general, one would expect 
higher DBP concentrations to be produced when the raw water comes from surface water sources 
compared to groundwater sources. 
 
DBP formation shifts towards brominated species of THMs, HAAs and haloacetonitriles (HANs) 
when bromide levels in raw water are high.10  High bromide levels may be found in groundwater as 
a result of saltwater intrusion, and in lowland surface waters they may result from industrial and 
agricultural chemicals, however bromide levels tend to be low in upland surface waters.12  
Groundwater has been shown to produce a higher proportion of brominated THMs relative to 
surface and mixed waters.12  Mixed waters are likely to produce higher  levels of DCBM and 
DBCM (the two THMs that incorporate both chlorine and bromine) compared to surface or ground 
waters.12 
 
1.2.4.2 During the treatment process 
Factors affecting DBP formation during treatment are treatment practice, pH, temperature, type and 
dose of disinfectant, reaction time, and the point in the treatment process when disinfectant is 
added. 
 
Treatment processes, such as coagulation, flocculation, sedimentation and filtration, may be used to 
remove organic matter from the raw water prior to disinfection, which has proven to be effective for 
reducing the potential for DBP formation.16  The use of pre-ozonation, prior to chlorination, has 
been shown to reduce formation of THMs, HAAs, dihaloacetonitriles and TOX, but to increase 
formation of haloketones and chloropicrin (CP).18  Pre-ozonation has been shown to shift the 
species distribution towards more brominated species.18 
 
Increasing chlorine dose increases the potential for DBP formation.16  pH has been noted to have a 
significant effect upon DBP formation.  TTHM concentration increases with increasing pH.19  High 
pH is associated with lower concentrations of HAAs, HANs, haloketones and chloral hydrate, 
possibly because of a formation-decay competing reaction, in which high pH favours degradation of 
these substances.1;19  Increasing temperature has a positive effect on formation rates of DBPs.20 
 
THM and HAA concentrations have been shown to increase with increasing reaction time.19  
Chloral hydrate and DCAN concentrations increase with reaction time at low pH, but this pattern 
reverses as pH increases.19 
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Alternative disinfectants may be employed in drinking water treatment.  Chloramination has been 
shown to minimise formation of THMs compared to chlorination.20 Treatment works using 
chloramination are better able to THM regulatory standards.21  There is currently a trend in the 
water industry to switch to chloramination in order to meet standards for regulated DBPs, however, 
chloramination may increase the formation of some of the emerging by-products, e.g. iodinated 
DBPs and nitrogen-containing DBPs such as nitrosodimethylamine (NDMA).11;22  
 
1.2.4.3 During distribution 
The concentration of DBPs can vary throughout a water distribution system.  Factors affecting DBP 
formation in the distribution system are level of free residual chlorine, residence time, pH and 
temperature. 
 
A chlorine residual tends to be maintained throughout the distribution system to prevent the 
regrowth of microbial pathogens.  This residual can allow DBP formation to occur as the water 
travels through the distribution system if there are also DBP precursors in the water available for 
reaction.  Generally, THM concentrations tend to increase with increasing residence time.23-25  
Longer residence time leads to higher consumption of residual chlorine and results in greater 
formation of THMs - this is the major reason for higher THM concentrations observed at the 
extremities of water distribution systems.25  However, concentrations of HANs, HKs, CP and HAAs 
have been shown to decrease with increasing residence time.23  HAAs have been shown to degrade 
as they approach the system extremities.25 
 
As in the treatment works, DBP levels generally increase with increasing temperature.23  Increasing 
pH tends to favour further THM formation, but the opposite effect may be observed for other DBPs, 
such as HAAs.19 
 
1.2.4.4 Spatial variation within the distribution system. 
Spatial variation of DBPs within a distribution system is the result of the continuing reaction 
between residual chlorine and DBP precursors and is determined by the residence time of water in 
the system.24 
 
Concentrations of THMs tend to increase as the water flows through the distribution system, with 
the highest concentrations typically observed at the system extremities, whilst HAAs appear to 
degrade as they travel through the distribution system, so concentrations of HAAs tend to be highest 
on leaving the treatment works and lowest at the system extremities.25 
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 1.2.4.5 Temporal and seasonal variation in DBP concentrations 
Distinct seasonal variation has been observed in DBP levels.  THM levels in the treatment works 
and distribution system tend to peak during the summer and autumn and decrease in the 
winter.10;12;23  This is likely to be explained by seasonal changes in temperature and raw water 
quality.  Higher temperatures in the summer will favour THM and other DBP formation, leading to 
more rapid depletion of chlorine residual, therefore in order to maintain an adequate level of 
residual chlorine in the distribution system, higher chlorine doses must be applied in summer.16  
Increased biological activity in summer and leaf fall in autumn will contribute to higher NOM in 
raw water in summer and autumn, thus favouring increased THM formation.12 
 
Temporal variation on a shorter timescale (e.g. from month-to-month) has been shown to be 
considerable for chloroform, but more stable for brominated THMs.12;24 
 
1.2.4.6 Natural events 
Run-off is an important source of NOM.  Increased rainfall generates greater run-off thus increasing 
NOM in raw water sources and DBP formation potential.  THM levels are higher during wet 
weather events compared to during dry weather, with the impact of wet weather on THM formation 
potential extending beyond the wet period.26  Flooding will result in greater NOM being washed 
into water sources, and therefore may also be associated with higher DBP formation potential. 
 
Conversely, at times of drought, reduced run-off may result in lower concentrations of NOM in raw 
water sources and thus lower overall DBP formation potential.  However, in such a situation, the 
relative contribution of brominated species might increase due to increased levels of bromide in 
source water, e.g. due to saltwater intrusion.17 
 
1.3. ROUTES OF EXPOSURE TO DBPs 
There are three routes by which DBPs can commonly enter the body:  ingestion, inhalation and 
dermal absorption.  The chemical properties of individual DBPs determine the exposure pathways 
for each DBP.27  DBPs can be divided into volatile and non-volatile compounds, and this is one of 
the major determinants of exposure pathway. 
 
1.3.1 Ingestion 
Consuming tap water, or beverages and foods prepared using tap water, allows for potential 
ingestion of DBPs contained in tap water.  Estimates of average tap water consumption amongst 
pregnant women range from 0.6 l/day to 3.4 l/day.28-34  Estimates for average total water intake (all 
sources) for pregnant women range from 2 l/day to 2.7 l/day.29-31  Pregnancy is associated with 
significant increases in water intake.31;34  Forssen et al.33 have shown tap water intake in pregnant 
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 women to differ by ethnicity, and a recent report commissioned by the UK Drinking Water 
Inspectorate (DWI) has shown that tap water consumption increases with age.35   
 
The concentrations of DBPs in the water, beverages or foods consumed, may be modified prior to 
ingestion (due to filtering, boiling, and storage of the water), which may affect the ingested dose of 
DBPs.  Water filters (either a tap-mounted filter or a filter jug) have demonstrated THM removal 
ranging from 31% to 100%, HAA removal ranging from 40% to 95%, and MX removal from 60% 
to 99%, depending upon the filter capacity and age.28;36-40  Filters have been shown to be more 
effective at removing bromine containing DBPs, probably due to their lower solubility and polarity, 
compared to their non-bromine containing counterparts.36 
 
Boiling tap water reduces THM concentrations by between 34% and 98%, depending upon boiling 
time,36;37;40-43 with boiling for 2 minutes reducing TTHM by 92% on average.40;41    This reduction is 
due to the volatilization of THMs.  THMs should, therefore, exist only at low concentrations in 
drinks and food prepared with boiled water.  However, THMs can be formed by reactions between 
free chlorine and organic matter present in foods and beverages, e.g. tea.44  Boiling decreases 
TCAA concentration whilst increasing DCAA concentration.37;41  Concentrations of total HKs, 
HANs and haloaldehydes have been shown to be reduced by boiling.41  In areas where 
microbiological water quality is poor, people may consume very little non-boiled water, and thus 
their exposure to THMs through ingestion should be low.28 
 
Storage of water, especially if the container is uncovered, has been shown to reduce THM 
concentrations.  An average THM reduction of 61% has been shown after 48 hours storage, but no 
effect of storage was observed upon HAA concentrations, presumably because they are not volatile, 
unlike THMs.37 
 
Of course, many people drink bottled water and this may act as a substitute for some or all tap water 
consumption.  In 2008 46% of households surveyed in the UK reported using bottled water for 
drinking, but it is unclear if this is instead of drinking tap water or in addition to drinking it.35   Kaur 
et al.29 found ~80% of pregnant women in a UK sample reported drinking some bottled water, and 
estimates of bottled water consumption amongst pregnant women vary from 0.6 L/day to 0.9 
L/day.29;33  A recent study45 in the US detected no THMs in any of 35 different types of bottled 
water sampled and it is generally assumed that bottled water contains no DBPs. 
 
DBPs may also be ingested via food.  Washing or cooking meat and vegetables using THM-
containing drinking water has been shown to result in adsorption of THMs into these foodstuffs.46  
In the domestic setting, the level of DBPs adsorbed by food during food preparation may be 
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 determined in part by DBP concentrations in the domestic drinking water supply.    THMs may also 
occur in foodstuffs due to use of chlorine in industrial food processing practices, for example, use of 
chlorinated rinses during poultry processing can result in high levels of chloroform in chicken.47 
 
1.3.2 Inhalation and Dermal Absorption 
DBPs may be inhaled and absorbed through the skin during activities such as showering, bathing 
and swimming, and also through various household tasks that involve water. 
 
1.3.2.1 Showering and bathing 
There are various factors which may influence inhalation and dermal uptake of DBPs during 
showering and bathing. 
 
Water temperature is an important determinant of DBP concentrations in tap water.  Heating of 
water, e.g. in a domestic boiler, accelerates formation of some DBPs if chlorine residual is present.  
Weisel & Chen observed that THM concentrations doubled in water heated to 65°C over a period of 
8 hours, DCAN and TCP concentrations decreased with heating, whilst DCP initially increased then 
decreased with heating.48 
 
In order to be inhaled, DBPs must be in vapour or aerosol form.  Differences in volatility between 
DBP species will determine the extent to which DBPs are vaporized, and thus influence exposure 
via inhalation.  For example, a higher percentage of chloroform is released from shower water to air 
compared with haloketones, due to the higher volatility of chloroform.49  At typical shower water 
temperatures HAAs are expected to be non-volatile, therefore inhalation exposure to HAAs during 
showering will occur predominantly through respiratory uptake of shower generated aerosols.50 
 
Dermal uptake of DBPs is influenced by their permeability across human skin.  In a study of dermal 
absorption during bathing, Xu et al. found that of the THMs, bromoform was the most permeable 
across human skin, followed by DBCM, DCBM and finally chloroform.  Permeability of 
haloketones was approximately one order of magnitude lower than that for THMs, and for HAAs 
two orders of magnitude lower than for THMs.51  The authors calculate that the dermal dose from 
daily bathing activities would be between 40% and 70% of the daily THM ingestion dose, and 10% 
of the daily haloketone ingestion dose, however it would represent an insignificant proportion of 
daily HAA ingestion. As such, exposure assessment should include the dermal route for THMs and 
HKs, but not for HAAs.51  Weisel et al. suggest that dermal exposure during showering contributes 
as much as inhalation to the body burden of chloroform.52 
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 Water flow rate and bathroom ventilation (e.g. a bathroom window being open or shut, an extractor 
fan being on or off) may also influence exposure during showering, as these factors have been 
shown to influence THM levels in the air.48;53;54 
 
Potential for DBP exposure increases as duration of showering and bathing increases.  Longer 
bathing duration has been associated with higher dermal chloroform dose, as measured in breath 
samples.52  THM airborne concentrations are higher for a typical shower (12 minutes) compared to 
a bath (20 minutes), however shorter shower and bath durations have been associated with higher 
average airborne THM concentrations and greater variability in THM concentrations between 
events54 – this suggests exposure assessment based purely on event duration may not fully reflect 
variation in exposure.  Estimates of daily duration of showering for pregnant women range from 
13.1 to 15.5 minutes.28;30  Time spent showering and bathing has been shown to differ by 
ethnicity,33;55 smoking status,33 and socio-economic status (SES),33 and to decrease with age.33;35 
 
Concentrations of DBPs in bathroom air can remain high for some time after getting out of the 
shower/bath.56  The half-life of shower aerosols was found to range from ~5-15 minutes after the 
shower was turned off, depending on aerosol size.50  Inhalation exposure will be influenced by time 
spent in the bathroom after bathing and showering. 
 
Hand-washing may potentially contribute to DBP exposure.  A study by Nuckols et al. observed  4 
to 11-fold increases in ambient air TTHM concentration following hand-washing activity.57  
However, increases in THM biomarkers (breath or blood) due to hand-washing were relatively 
modest compared to increases in THM biomarkers resulting from showering or bathing.57  This may 
reflect the relatively short duration of hand-washing events compared to showering and bathing.  
However, if hand-washing is frequent (perhaps related to specific occupations, e.g. food preparation 
or nursing) it may potentially play a more significant role in DBP exposure. 
 
1.3.2.2 Swimming 
Swimming pools in London (UK) have been found to have TTHM concentrations ranging from 57-
222.5 μg/l,58 whilst chloroform concentrations in swimming pools in northern Italy ranged from 9-
179 μg/l.59;60  Chloroform contributes most to TTHM concentrations in water and air at swimming 
pools.60 
 
Concentrations of chloroform in ambient air at the swimming pool are positively correlated with 
chloroform in the pool water.60  Ambient air levels of chloroform in indoor swimming pools have 
been reported in the range 16-853 μg/m3.59;60 
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 THM concentrations in swimming pool water and air have been found to be influenced by the 
number of swimmers in the water, as turbulence produced by swimming can induce the release of 
THMs from water to air.58-60  In addition, the number of swimmers in the pool is significantly 
positively correlated with TOC levels,58 suggesting that the potential for DBP formation increases 
as the number of swimmers increases. 
 
Individual behaviour can also influence DBP uptake at the swimming pool.  Biomonitoring has 
shown that duration in the pool is significantly positively correlated with plasma chloroform levels, 
and that increased physical activity in the pool gives rise to higher levels of chloroform in  plasma 
and alveolar air, reflecting increasing uptake with increasing physical activity.60  A study 
investigating water ingestion during swimming found that adult swimmers swallowed on average 
16 ml (range 0-53 ml) of swimming pool water during 45 minutes of active swimming.61 
 
1.3.2.3 Other household activities 
Household water activities, such as washing dishes by hand, running a dishwasher, and washing 
clothes with bleach have been shown to significantly increase chloroform levels in indoor air.57;62 
The use of blood and breath biomarkers to measure uptake has shown these tasks to be associated 
with increases in blood and breath THM levels.57  After showering and bathing, hand dish-washing 
has been shown to produce the greatest average increases in blood and exhaled breath THM levels, 
compared to other household water use activities and tap water consumption, although a high 
degree of interparticipant variation has been observed.57;63 
 
1.3.3 Relative importance of various routes of exposure 
The relative importance of the different exposure routes depends upon the class and physical 
properties of the DBPs in question.  For THMs, and chloroform in particular, exposure via 
showering and bathing has been shown to play a very influential role in determining total dose via 
dermal exposure and inhalation, whilst ingestion plays a relatively minor role.57;62;64;65   For 
haloketones, inhalation exposure during showering plays a more moderate role than that for 
THMs.49  Inhalation and dermal routes are expected to contribute very little to HAA uptake,50;51 
suggesting ingestion is the most important route for HAA exposure. 
 
1.4. DEFINING FETAL GROWTH OUTCOMES 
Various approaches are used to define adverse fetal growth outcomes.  Low birth weight (LBW) is 
defined as a birth weight below 2,500g.  It is the product of preterm birth and/or fetal growth 
restriction.  Thus, LBW can include babies who are appropriately sized but small because they are 
born preterm and those who are small due to fetal growth restriction, and this is an important 
distinction because the etiologies may differ.  Term low birth weight (tLBW) is defined as a birth 
26
 weight below 2,500g on or after 37 weeks of gestation, and thus excludes preterm births.   However, 
LBW  and tLBW are crude definitions and take no account of population-specific birth weight 
distributions.66 
 
Babies with birth weights less than the 10th percentile of a population birth-weight-for-gestational-
age curve are defined as small-for-gestational-age (SGA).  This statistical definition will include 
constitutionally small but normally grown babies, in addition to pathologically small babies.  An 
issue with using a population birth-weight-for-gestational-age reference curves is that birth weights 
at preterm gestations are not representative of weights in utero of fetuses that go on to deliver at 
term.67   
 
From a clinical viewpoint, intrauterine growth restriction (IUGR) or fetal growth restriction (FGR) 
should represent fetuses that have failed to reach their growth potential due to an insult in utero.68  
Confusingly, however, the term IUGR has often been used interchangeably with SGA, even though 
two clinical concepts are not the same.68   A fetus is commonly defined as IUGR when the 
estimated-fetal-weight from multiple biometric measurements (measured by ultrasound) falls below 
the 10th percentile of either a birth-weight-for-gestational-age curve or estimated-fetal-weight-for-
gestational-age curve.69   
 
In defining IUGR, there is debate as to whether to use birth-weight-for-gestational-age curves or 
fetal-weight-for-gestational-age curves.70  Birth-weight-for-gestational-age reference curves are 
commonly used in epidemiological research.71 Preterm birth makes developing appropriate growth 
curves challenging as infants who are born preterm are more likely to be growth restricted thus their 
birth-weight does not represent all fetuses in utero at a given gestational week.71  Birth-weight-for-
gestational-age curves will significantly underestimate the incidence of IUGR in a premature 
infant.70  
 
Definitions of SGA and IUGR tend to use the 10th percentile as a threshold, although the 5th and 3rd 
percentiles are sometimes used.69    
 
The choice of growth curve may influence the extent to which infants and fetuses are correctly 
defined as being normally or poorly grown.  A population reference curve is often established from 
of a study population that includes both normal and abnormal perinatal outcomes, whilst a standard 
is usually based on low-risk pregnancies with a normal outcome.71  A standard may have greater 
clinical utility than a population reference for correctly identifying abnormal growth in utero.71 
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 The various measures of adverse fetal growth discussed above may fail (to varying degrees) to 
distinguish those babies whom are constitutionally small from those whom are pathologically small 
(i.e. growth restricted).   Some small but normally grown babies will fall below the threshold, and 
some growth restricted babies will reach a weight above the threshold.  A proportion of infants may 
therefore be misclassified as to their true underlying disease status,72;73 and in epidemiological 
studies this may bias any association towards the null.  In addition, ascertainment of gestational age 
can be challenging and any error in dating will lead to misclassification of babies/fetuses when 
using gestational-age-specific curves.69 
 
The field of fetal growth assessment has been improved with the introduction of customised fetal 
growth curves72;74, which measure fetal growth against a genetic potential for growth which has 
been customised to the particular individual fetus on the basis of factors such as maternal height and 
ethnicity.  It is well-established that normal fetal size at birth varies significantly by race/ethnicity, 
sex, parity, maternal size, and other genetic and physiologic factors, for example, a given fetal size 
may be considered normal for a short, thin woman but may reflect FGR for a tall, large woman.71  
There is evidence to suggest that the use of customised fetal growth curves significantly reduces the 
proportion of false-positive and false-negative diagnoses of fetal growth restriction, compared to 
using a traditional population growth curve.75 
 
1.5. EPIDEMIOLOGICAL STUDIES INVESTIGATING DBPs AND FETAL GROWTH 
Over the past 18 years, 20 studies have been carried out which have looked at the relationship 
between fetal growth and DBPs, focussing on outcomes such as term LBW and small-for-
gestational-age (SGA).  There have been 3 population-based case-control studies,76-78 2 hospital-
based case-control studies,79;80 14 retrospective cohort studies,81-94 and 1 prospective cohort study.95  
In addition, there have been 2 studies examining the relationship between swimming and fetal 
growth outcomes.96;97 
 
1.5.1 Exposure assessment 
The studies can be grouped according to the method of exposure assessment used.  Five studies 
used a qualitative measure of exposure assessment, simply comparing those supplied with 
chlorinated water with those supplied with non-chlorinated water.78;83;84;86;87 
 
The remainder generated quantitative estimates of exposure, with varying degrees of sophistication.  
Seven studies were able to quantify levels of DBP exposure for each WSZ by using routinely 
collected DBP data.  In general, maternal residence at birth was assigned to a WSZ and its 
corresponding THM level at that time was used as a measure of exposure.76;81;85;88;89;92;94  Four 
studies have attempted to improve upon these exposure measures by modelling DBP levels in order 
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 to achieve more robust exposure estimates, particularly for times and places where data were 
sparse.82;90;91;93  Two studies combined routinely collected THM estimates with individual water-use 
information in order to create a personalised exposure estimate for each study participant.77;80  One 
study performed weekly area-level THM and HAA sampling, then incorporated individual water 
use data to estimate total TTHM uptake via ingestion/showering and bathing, and HAA intake.95  
One study took water samples direct from participants’ homes to give individual level THM 
measurements for each participant.79 
 
There are two studies investigating the relationship between swimming and fetal growth 
outcomes96;97 which cannot be grouped with any of the other studies in terms of exposure 
assessment because they do not relate to drinking water, but should be included in this review 
because swimmers can be exposed to high levels of THMs and other DBPs from the chlorinated 
water in swimming pools. 
 
Each of these epidemiological studies and their findings are described in Table 1.2.  They have been 
ordered and grouped according to the methods of exposure assessment set out above. 
 
1.5.2 Summary of the epidemiological findings 
1.5.2.1 Chlorination 
Of 5 studies which simply compared exposure to chlorinated water vs. non-chlorinated water, 2 
observed some elevated risks of LBW associated with chlorinated water supply,78;84 whilst the other 
3 studies did not.83;86;87  Two studies observed significant associations between chlorination 
increased risk of short body length and small head circumference.78;84  Risk of SGA was not 
significantly associated with chlorination.83;84 
 
1.5.2.2 Trihalomethanes 
In those studies which quantified THM exposure, an increased risk of LBW or term LBW was 
significantly positively associated with exposure to high levels of total trihalomethane (TTHM) in 
four studies.81;85;90;91  Three studies showed increasing exposure to TTHM or chloroform to be 
significantly associated with reductions in term birth weight.81;88;89  Six studies showed exposure to 
high levels of TTHM, chloroform or DCBM to be associated with elevated risk of intrauterine 
growth retardation (IUGR) or SGA, the majority reaching statistical significance.76;81;88;89;93;95 
 
Five studies failed to find any consistent or statisically significant associations, or evidence of dose-
response relationships, between either TTHM or individual THMs and any of the outcomes term 
LBW, IUGR or SGA.77;79;82;92;94 
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 Carriers of the CYP2E1*5 polymorphism (a variant of the CYP2E1 gene which is involved in 
chloroform metabolism) were found to be at a greatly increased risk of IUGR when exposed to high 
TTHM levels compared to non-carriers.80 
 
Whilst there have been several reviews, there has been only one meta-analysis on exposure to 
THMs and fetal growth, published very recently by Grellier et al.8  It examined four adverse birth 
outcomes: LBW, term LBW, preterm delivery and SGA.  It found little or no evidence for 
associations between 3rd trimester THM exposure and LBW, term LBW or preterm delivery, but 
some evidence suggesting an association with SGA.  This meta-analysis found no evidence of 
publication bias, however the very small number of studies available meant that assessment of 
publication bias was limited.8 
 
1.5.2.3 Haloacetic acids 
Two studies report significant associations between HAAs and IUGR and term LBW,92;93 but two 
find no evidence of such associations.89;95  The evidence for an association between HAAs and fetal 
growth is inconclusive. 
 
1.5.3 Interpreting the epidemiological evidence 
Before assuming a causal explanation for any of the associations observed between DBPs and fetal 
growth, it is necessary to explore the limitations of the epidemiological evidence, and rule out other 
possible explanations such as bias, confounding and chance. 
 
1.5.3.1 Exposure measurement error and misclassification 
One of the greatest challenges in environmental epidemiology is accurately assessing exposure to 
the environmental factor of interest.  Due to time, budgetary and practical constraints, it is often 
necessary to make simplifying assumptions or to use proxy measures when assessing exposure.  
However, these assumptions and proxies may lead to exposure measurement error and 
misclassification, which  can influence the risk estimates for health effects.  In the epidemiological 
studies reviewed, exposure measurement error and misclassification in the epidemiological studies 
reviewed could have arisen for a number of reasons, as discussed below. 
 
Lack of information on DBP concentrations 
Qualitative studies use the very simplest proxies for DBP exposure, comparing groups supplied 
with different water types.78;83;84;86;87  Scope for exposure misclassification is large in these studies 
because they ignore temporal, seasonal and spatial variation in DBP levels, and they ignore the 
possibility that individuals get their water supply from other sources, e.g. bottled water. 
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 Temporal variation 
Most of the epidemiological studies have relied upon THM data routinely collected by water 
suppliers for regulatory monitoring purposes in order to quantify DBP/THM exposure.76;77;80-82;85;88-
93  The statutory requirement for routine THM monitoring tends to be quarterly sampling.  With a 
low number of measurements per zone/distribution system per year, the accuracy of any water zone 
estimates generated from this data is likely to be low.  In only 4 studies were more frequent routine 
sampling data available at either monthly or weekly resolution.85;92;93;95 
 
Quarterly measurements should at least reflect seasonal variation, but only if they have been evenly 
spaced throughout the year.  If fewer than four measurements are collected per year, then seasonal 
variation is unlikely to be captured and depending on the seasons in which samples have been taken, 
infrequent measures may overestimate or underestimate potential exposure. 
 
THMs measured once per quarter at a few points in the distribution system may provide an 
incomplete assessment of exposure because sampling may not reflect the extent of spatial and 
temporal variation in THM levels within a distribution system.  Limitations of quarterly sampling 
data may have been ameliorated in 4 studies82;90;91;93 that performed statistical modelling of the data 
in order to achieve more robust estimates, 3 of which report statistically significant positive 
associations between adverse fetal growth outcomes and THM or HAA exposure.90;91;93 
 
The potential exposure window for reproductive outcomes is relatively short (~9 months) and the 
critical window for adverse fetal growth outcomes in relation to DBPs may be even shorter than 
this, e.g. one particular trimester of pregnancy.  Temporal and seasonal variation in DBP 
concentrations may be important in driving exposure relevant to these outcomes over such a short 
time period, and if temporal and seasonal variation is not reflected in exposure estimates, exposure 
measurement error/misclassification may occur.  All 4 studies which had DBP data available at a 
higher than quarterly temporal resolution report some elevated risk of SGA/IUGR or term LBW 
associated with high THM exposure or HAA exposure, but these findings are not always 
statistically significant. 85;92;93;95 
 
Some of the studies have completely ignored temporal variation in DBP concentrations during 
pregnancy.  Aggazzotti et al. collected water samples at mothers’ homes to reduce exposure 
misclassification due to spatial variability in the water distribution system, but because only one 
sample was collected at each subject’s home, temporal/seasonal variability in DBP concentrations 
over the course of pregnancy was not taken into account.79  Savitz et al.77 applied the quarterly 
average THM value recorded nearest in time to the 28th week of gestation, thus ignoring any 
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 temporal or seasonal variation during pregnancy.  Neither study reports any significant association 
between DBP exposure and fetal growth outcomes. 
 
Some studies have used sampling data that was not collected during the exposure period of interest.  
Aggazzotti et al. took water samples from mothers’ homes a few days after delivery.79  Although 
water sampling was not very distant in time from the exposure period of interest (i.e. pregnancy) 
there is still scope for exposure measurement error, should DBP concentrations vary within season, 
e.g. from week-to-week.  A more extreme example is the study by Kramer et al. in which exposure 
estimates were calculated from sampling data that occurred 2 years prior to the births of interest.76  
Sampling data was collected during a drought period, which may have resulted in lower absolute 
concentrations of THMs than might have been present in the non-drought years from which the 
birth outcome data was taken.  Such an approach assumes that general patterns of seasonal variation 
do not vary from year-to-year, however a study of year-to-year DBP occurrence suggests that this 
assumption may be invalid.12 
 
Area-level estimates and spatial variation 
Area-level exposure estimates, often based on just one sample from that area for each quarter, do 
not represent the magnitude of spatial variability in DBP levels across the distribution system, and 
this carries the risk of exposure  misclassification when area-level estimates are assigned to an 
individual within the WSZ.  Most of the epidemiological studies which used area-level THM 
sampling data assume that THM levels at the sampling points apply to all customers of that 
particular area/WSZ.  In contrast, Gallagher et al. incorporated hydraulic modelling of each water 
treatment facility to estimate TTHM (total trihalomethane) levels within the distribution system, and 
thus provide better estimates for individual participants.91  Their ability to reduce error by taking 
into account spatial variability within the distribution system may explain the strong effect estimates 
they observed, despite the relatively low levels of TTHMs observed in Colorado.91  However, water 
distribution networks are not operated the same way every day (for example, storage tanks operate 
at different levels, hydrants are flushed, water sources are blended) so even with incorporation of 
hydraulic modelling into THM estimation, it may not be possible to fully reflect spatial variability 
of THMs within the distribution system. 
 
However, Keegan et al98 have shown between-zone variability to be greater than within-zone 
variability for chloroform and DCBM (the main THMs) and to explain most of the total variation in 
their concentrations (across one company with 288 WSZs supplied by 194 treatment works, 
supplying 6.8 million customers).  This suggests that exposure misclassification arising from the use 
of area-level estimates may not be severe. 
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 Lack of information on mobility during pregnancy 
If area-level exposure estimates, e.g. at the level of WSZs, are used for exposure assessment, then 
ignoring mobility between these zones during pregnancy may lead to exposure misclassification. 
 
Mother’s residence at birth has been used as a proxy for location during pregnancy, and has been 
used to assign area-level exposure estimates in virtually all the epidemiological studies reviewed.76-
78;81-94  This approach ignores any exposure in other areas due to mobility between WSZs/areas 
during pregnancy, which may arise from living and working in two different WSZs or from 
residential mobility between WSZs during pregnancy.  The extent of exposure misclassification will 
depend upon between-WSZ variation in the study area, and for workplace exposure, the extent of 
water consumption/use at work.  Residential history during pregnancy appears to have been taken 
into account in only one study.80   
 
There is little information on residential mobility during pregnancy in the UK.  The only published 
study estimates this to be 9% in the north of England, however this may not be representative of the 
rest of the UK.99  Studies in the US, Canada and Norway find residential mobility during pregnancy 
to range from 12% to 33%, and have found residential mobility to be associated with younger age, 
lower income, SES, smoking, alcohol consumption, low parity, ethnicity, lower education, 
unmarried status, low BMI and unplanned pregnancy.100-106  Given that some these factors, e.g. 
smoking, are risk factors for adverse fetal growth outcomes, this suggests that exposure 
misclassification due to residential mobility could potentially be differential by outcome, thus 
complicating the interpretation of health risk estimates.  However, if mobility is within the zone 
then this should have no effect on exposure estimates, in studies using area-level exposure 
estimates, and thus introduce no exposure misclassification.   
 
Individual behaviour 
Sixteen studies had no information on individual water contact and consumption.76;78;81-94  
Considerable misclassification can result from not incorporating individual water-use information 
into exposure assessment.107  It is expected that any exposure misclassification arising from this 
would be non-differential with regard to fetal growth outcomes (and thus bias risk estimates 
towards the null), because outcome is unknown during pregnancy therefore this could not influence 
water use during pregnancy.  However, should women choose to avoid tap water due to poor taste, 
perhaps switching to bottled water, and this coincides with times or locations for which THM levels 
are high, this could result in a nonlinear dose-response pattern and a reduction in the estimated 
effect at the highest exposure level.85  Studies without data on individual water use may 
overestimate ingestion of THMs for women who drink bottled water.  If this error is not distributed 
uniformly across the study population, e.g. if bottled water consumption differs by SES, or by 
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 geography if water tastes unpleasant in some areas, the effect of this error on risk estimates becomes 
more difficult to predict. 
 
Individual water consumption/use was combined with DBP concentrations at the tap in 4 studies, 
and this should provide more accurate estimates of exposure dose, and thus reduce the potential for 
exposure misclassification.77;79;80;95   In these 4 studies findings for such “personalised” exposure 
metrics and fetal growth outcomes were generally null, with only Hoffman et al. observing an 
elevated risk of SGA (RR = 1.6, 95% CI: 1.0-2.1) in association with the highest category for 
TTHM uptake via showering and bathing, and similar results for total TTHM exposure through tap 
water ingestion and showering and bathing.95 
 
Whilst the study by Savitz et al.77 used a measure of individual water ingestion, exposure 
assessment lacked information on inhalation and dermal exposure from activities such as 
showering, bathing and washing - exposure assessment was thus incomplete, leaving potential for 
exposure measurement error.  
 
Exposure misclassification is estimated to be between 29% and 62% when exposure estimates are 
based on THM/DBP concentration in tap water alone.64;107;108 
 
In studies where data on individual water use have been collected retrospectively,77;79;80 these data 
may be subject to recall error.  Three studies using individual water use data measured behaviour 
only once during pregnancy, and asked for “usual” or “average” behaviour during pregnancy.77;79;80  
Within-subject variation in water use and consumption (e.g. on a day-to-day or week-to-week basis) 
may also give rise to exposure measurement error.  If women are required to self-report an average 
value for the entire pregnancy, this may differ from true consumption/use in the critical time 
window for exposure.  In this situation, error would follow the classical error model (in which the 
average of many replicate measurements would equal the true exposure), which may result in the 
attenuation of health risk estimates.109;110  A few studies have examined validity of self-reported 
questionnaires/interview as a method of assessing tap water use during pregnancy by comparing 
these with a water-use diary.29;30;32;111  However, only one epidemiological study of DBPs and fetal 
growth used a questionnaire which had previously been validated.32  All 4 validation studies report 
overestimation of tap water intakes by questionnaire/interview but generally report good agreement 
between questionnaire and diary for tap water intakes, with the exception of Maskiell et al.111  
Agreement tended to be weaker for tap water intakes at work compared to home, where these were 
both measured.29;32  Agreement between questionnaire and diary reported to be good for showering 
and bathing.29;30;32;111  Whilst a diary is not feasible as a method of exposure assessment for a large 
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 cohort study, it could be used in a nested sub-sample to assess validity of individual water use data, 
and to improve understanding of any exposure measure arising from water use data. 
 
Use of TTHM as an exposure measure 
Nine of the epidemiological studies reviewed used only TTHM as an exposure 
measure.77;79;81;82;85;88;90;91;94    TTHM may not be a good proxy for either individual THM species, or 
non-THM species.  The major constituent of TTHM is chloroform, and the correlation between 
TTHM and brominated THMs or HAAs can be poor (or even inverse depending on species), and 
correlations vary widely by location.12;107;112  Consequently, TTHM is unlikely to be a good marker 
for brominated THMs and other DBPs.  Epidemiological studies using only TTHM for exposure 
assessment may only have been able to detect an association between chloroform and fetal growth.  
True underlying associations existing between other THMs and fetal growth outcomes may have 
gone undetected.  Some studies which have examined individual THMs/HAAs/other DBPs report 
elevated risk of adverse fetal growth outcomes to be significantly associated with exposure to 
DCBM, DCAA, TCAA, DBAA, and HAA5.89;92;93 
 
Until there is a study which performs comprehensive exposure assessment for a wide range of 
individual DBP species, it will not be possible to fully understand the potential harmful effects of 
DBPs on fetal development, or to discern the most important exposure agent. 
 
1.5.3.2 Implications of exposure measurement error and misclassification 
Five studies measured exposure on a qualitative basis (comparing those supplied with chlorinated 
water with those supplied with non-chlorinated water).78;83;84;86;87  Exposure misclassification in 
these studies would be expected to be non-differential with regard to outcome, the effect of which is 
to bias effect estimates towards the null.110  
 
Eleven studies used area-level THM/HAA concentrations to estimate exposure for each 
mother.76;81;82;85;88-94  In these studies exposure measurement error would follow the Berkson error 
model.  This type of error arises when the same approximate measure (proxy) is used for many 
subjects, whilst the true exposures vary randomly about this proxy, with their mean equal to it.110  
Berkson error causes loss of study power and loss of precision in effect estimates, but rarely causes 
bias.110 
 
In the study by Aggazzotti et al.79 exposure assessment was carried out at the individual level for 
each mother.  In this study exposure measurement error would follow the classical error model.  
This type of error occurs when the average of many replicate measurements of the same true 
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 exposure would equal the true exposure.110  Classical error biases effect estimates towards the 
null.110 
 
In the three studies that have generated personalised exposure estimates by combining area-level 
THM or HAA concentration estimates with individual information on water use,77;80;95 exposure 
measurement error may combine elements of both Berkson and classical error models.  This may 
make the health risk estimates more difficult to interpret if a clear understanding is not achieved as 
to the contribution of the various exposure errors.109 
 
1.5.3.3 Limitations of study design 
In the study by Dodds et al.82 only 2.7% of the cohort lived in areas where TTHM levels were under 
25µg/l, therefore the study did not have a truly unexposed (or minimally exposed) group.  The 
exposure categories 0-25 μg/L and 25-49 μg/L were merged to form a referent category.  If TTHM 
exposure in the range of 25-49µg/l was truly associated with increased risks of adverse birth 
outcomes compared with negligible TTHM exposures, the effect estimates reported for exposure 
levels over 50µg/l would be underestimated.82 
 
In some studies relatively low levels of THMs were observed, with mean TTHM far below 
regulatory cut-points.  For example, Aggazzotti et al.79 observed a median TTHM level of 1.1 μg/l, 
with only 0.5% of samples exceeding 30 μg/l TTHM, and in the study by Infante-Rivard80 mean 
TTHM was 18.74 μg/l (SD 19.76) for cases, and almost identical for controls.  If there is a threshold 
level over which DBPs exhibit an adverse effect upon fetal growth, it may be difficult to detect any 
association between DBPs and fetal growth in studies with such low levels of THM exposure. 
 
In study populations/areas which exhibit a lack of variability in DBP concentrations,76;94 there may 
be insufficient contrast between low and high exposure categories,  e.g. in the study by Kramer et 
al. chloroform exposure levels were categorized as undetectable, low (1-9 μg/l) and high (≥ 10 
μg/l).76  Any true underlying differences in health risk due to chloroform between such exposure 
levels are likely to be small, and the study may not have sufficient power to detect these differences. 
 
1.5.3.4 Limitations of outcome definitions used 
The epidemiological studies may be limited by errors in outcome definition.  Dichotomous 
definitions such as LBW, SGA and IUGR used in the epidemiological studies reviewed earlier,  
may fail to distinguish between those babies whom are constitutionally small and those whom are 
pathologically small (i.e. growth restricted) - a proportion of infants may therefore be misclassified 
as to whether they are truly growth restricted in utero or not.72;73  Outcome misclassification can 
cause bias in health-risk estimates (in addition to loss of study power).110  If misclassification of 
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 fetal growth restriction is non-differential with regard to exposure status/level, effect estimates are 
biased towards the null.110  Improved classification of fetal growth restriction is required in 
epidemiological studies to reduce the potential for misclassification bias.  Where a continuous 
outcome measure has been used, e.g. birth weight or head circumference, random measurement 
error would cause loss of study power, but would not bias risk estimates.110  
 
1.5.3.5 Confounding 
The epidemiological studies included in this literature review have differed in their ability to control 
for potential confounding.  Those studies which involve an interview/questionnaire are likely to 
have more extensive information on potential confounders than those based on birth certificate data, 
and are therefore less likely to be at risk of residual confounding. 
 
In studies where gestational age is unknown78;90 it is impossible to distinguish between babies who 
are small due to preterm birth and those who are small due to growth restriction.  In these studies, 
and also those which have simply not adjusted for gestational age in analyses of LBW,77;86 two 
aetiological pathways may be being treated as one.  However, the epidemiological evidence 
suggests that DBPs are not associated with preterm delivery,8;113 implying that confounding by 
gestational age  may not be a problem in these studies. 
 
There are numerous risk factors for adverse fetal growth and developmental outcomes, and studies 
have varied in their ability account for these in analysis due to study design.  For example, some 
studies were missing information on maternal smoking, which is a known risk factor, or do not 
report having adjusted for smoking in the analysis.81;83;86;87;90;94;95  If, at the individual level, these 
risk factors are also associated with exposure to DBPs, e.g. if associated with tap water 
consumption, failure to adjust for these risk factors in the analysis leaves these studies open to 
residual confounding.  It is plausible that ethnicity is linked to water use behaviour, and thus may be 
a possible confounder in studies which did not adjust for this factor.76-79;81-84;86;87;90;91;94;97 
 
1.5.3.6 Chance 
The role of chance needs to be borne in mind when interpreting study results.  A study should be 
sufficiently powered to avoid Type II errors, i.e. be sufficiently powered to reduce to acceptable 
levels the chance sampling variation that would lead to a conclusion of no association when one 
truly exists. Large numbers are also needed to detect small to moderate effects on growth, e.g. on 
birth weight or body length.  Power can be increased by increasing sample size or increasing 
precision of measurements.114  Power should not be a problem for large studies such as Toledano et 
al.90 which included almost 1 million births. 
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 In some of the epidemiological studies a large number of statistical tests were carried out examining 
various exposure indices, at various time windows during pregnancy, in relation to various outcome 
measures.77;82;83;85;88;89;92;93;95  This gives rise to the multiple testing problem:  the greater the number 
of statistical tests carried out on a dataset, the greater the probability of a Type I error (i.e. falsely 
rejecting the null hypothesis due to chance).  Even if there is no true underlying association between 
the exposure and outcome variables, 1 in 20 comparisons are expected to be statistically significant 
at the 5% level.114  The multiple testing problem means that, in effect, such studies are operating at a 
significance level which is different to that reported.  None of these studies report any adjustment 
(e.g. Bonferroni correction) for this multiple testing problem, therefore interpretation of associations 
reported should be cautious. 
 
1.6. TOXICOLOGICAL EVIDENCE 
1.6.1 Summary of the toxicological findings 
Several reviews of the animal toxicology literature suggest that high doses of chloroform and 
various HAAs and HANs may cause retarded fetal development, measured as reduced fetal weight 
and length.113;115;116  Table 1.3 briefly describes each of the toxicological studies of DBPs which 
have included fetal growth as a reproductive endpoint, with studies ordered by DBP class and 
species.  The main findings from these studies are set out below.     
 
1.6.1.1 Trihalomethanes 
All 6 studies investigating the effects of chloroform on reproductive endpoints in rats, rabbits and 
mice have found evidence of retarded fetal development in terms of reduced fetal weight at high 
doses, and some also found reduced fetal length.117-121  However, these adverse fetal growth 
outcomes occurred in conjunction with maternal toxicity.  Other adverse effects observed were fetal 
resorption, fetotoxicity, skeletal malformations, cleft palate, increased fetal mortality and decreased 
pregnancy incidence.117;119;121 Out of all these studies, the lowest observed adverse effect level 
(LOAEL) was 20 mg/kg/day.118 
 
Of 6 studies investigating the effect of DCBM on fetal growth in rats or rabbits, none found any 
adverse effect of DCBM upon fetal growth.117;122-126  However, other adverse reproductive effects 
have been observed in association with DCBM:  minor skeletal defects, delayed sexual maturation, 
and fetal resorption.122-124  In addition, the effects of DCBM on human cytotrophoblast cells have 
been observed in vitro, and it is reported that DCBM reduces the secretion of chorionic 
gonadotrophin, and disrupts the formation of placental synctiotrophoblast cells in a dose dependent 
manner.127;128  The lowest observed adverse effect level in vitro was 0.2 nM (≈ 0.0321 μg). 
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 Borzelleca et al. found DBCM to be associated with a slight reduction in fetal weight, and 
decreased litter size and pup viability at high doses of DBCM in mice.129  Using lower doses 
Ruddick et al. found no adverse reproductive effects of DBCM in rats.117 
 
There is no evidence to suggest that bromoform has an effect upon fetal growth, or other 
reproductive outcomes, with no adverse effects observed at doses up to 200 mg/kg/day in rats117 or 
mice.130 
 
1.6.1.2 Haloacetic acids 
One study has investigated DCAA in relation to fetal growth in rats, reporting a dose response 
relationship between DCAA and reduced fetal weight and length,  and also evidence of an 
association with fetal resorption and cardiovascular malformations.131  The no observed adverse 
effect level (NOAEL) was 14 mg/kg/day. 
 
One study has investigated the effect of TCAA on reproductive endpoints in rats, finding a dose 
response relationship between TCAA and reduced fetal weight and length, and associations with 
embryolethality, fetal resorption, cardiovascular, soft tissue and skeletal malformations.132  The 
LOAEL was 330 mg/kg/day. 
 
No adverse effects of DBAA on fetal growth have been reported at doses up to 50 mg/L in 
rats.133;134 
 
1.6.1.3 Haloacetonitriles 
Exposure to chloroacetonitrile (CAN) at a dose of 55 mg/kg/day was found to be associated with 
reduced fetal weight in rats135 and mice.136  The LOAEL was 12.5 mg/kg/day. 
 
Two studies found exposure to dichloroacetonitrile (DCAN) to be associated with reduced fetal 
weight, and also fetal resorption and various malformations in rats.135;137  The highest reported 
NOAEL was 15 mg/kg/day. 
 
Three studies which investigated trichloracetonitrile (TCAN) and fetal growth in rats all found 
TCAN to be associated with reduced fetal weight,135;138;139 and one found evidence for an 
association with reduced fetal length.138  Other adverse reproductive endpoints observed in 
association with exposure to TCAN were fetal resorption, decreased litter size, and various 
malformations.135;138;139   
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 Two studies found that BCAN was associated with reduced fetal weight in rats135;140 and also an 
association with reduced fetal length.140  The LOAEL was 5 mg/kg/day.  DBAN was associated 
with reduced fetal weight in rats.135 
 
1.6.1.4 Chlorophenols 
No adverse effects upon fetal growth and development in rats are reported for any of 2-CP, 2,4-
DCP and 2,4,6-TCP by Exon et al.141 nor for 2,4-DCP in mice by Borzelleca et al.142  Exon et al. 
observed decreased litter size in rats associated with 2-CP, 2,4-DCP and 2,4,6-TCP, and decreased 
pup survival, increased conception rate and increased stillbirth rate associated with 2-CP.141 
 
1.6.1.5 Chloral hydrate 
Kallman et al. report that chloral hydrate has no adverse effects upon fetal growth and development 
in mice.143  The NOAEL was 205 mg/kg/day. 
 
1.6.1.6 MX (or 3-chloro-4-(dichloromethyl)-5-hydroxy-5H-furan-2-one) 
No in vivo study of MX toxicity upon fetal growth or other reproductive endpoints has been 
reported to date.  However, in vitro studies suggest that MX might have teratogenic potential and 
may cause cell apoptosis.144;145 
 
1.6.2 Interpreting the toxicological evidence 
There are a number of issues which make it difficult to interpret the toxicological evidence.  
Retarded fetal development and other adverse reproductive effects have often been observed at 
doses that also produce maternal toxicity, therefore it is difficult to determine whether the observed 
effect is a result of the toxicant acting directly on the fetus, or a indirect result of maternal systemic 
toxicity. 
 
One must take into consideration the methods of exposure used in animal studies.  Gavage is the 
most common method, but it is the least representative of any human exposure pathway, compared 
with those studies which used dosed drinking water and inhalation as exposure methods.  Gavage 
studies tended to use corn oil or Tricaprylin as the medium in which the dose was delivered.  In 
some studies there was evidence of these vehicles causing toxicity, or vehicle-dose interactions, 
consequently it is difficult to be certain of the true effect of the DBP in question. 124;137;138;146  No 
toxicological study in which dosed drinking water was the route of exposure found any evidence of 
retarded fetal development, although those that used inhalation as the route of exposure did report 
reductions in fetal measurements.119-121 
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 A major problem for interpretation is that the exposure doses at which adverse effects have been 
observed, are rarely, if ever, doses which fall within the normal human range of exposure.  Doses 
are often several orders of magnitude greater than any feasible human exposure from drinking 
water.  For example, given that the maximum allowable level for TTHM/chloroform in tap water is 
100 μg/L, then even the smallest LOAEL reported for chloroform of 20 mg/kg/day (equivalent to 
20,000 μg/L) is 200 times greater than the maximum concentrations in tap water that humans in the 
UK are likely to be exposed to.  In this respect the NOAELs and LOAELs bear little relevance to 
human exposure.  Additionally, toxicological studies examine only one substance at a time, whereas 
in reality humans are exposed to a mixture of DBPs.  In this respect, the studies do not accurately 
represent human exposure, making it difficult to apply the findings to humans. 
 
To conclude, there is some toxicological evidence to suggest that chloroform, DBCM, DCAA, 
TCAA, and HANs, have an adverse effect on fetal growth and development in experimental 
animals, but it is difficult to extrapolate these findings to humans. 
 
1.7. POSSIBLE MECHANISTIC PATHWAYS 
Various possible mechanistic pathways by which DBPs may exert an adverse effect upon the fetus 
are reviewed below. 
 
1.7.1 Transplacental passage of chloroform 
Chloroform (and other volatile organic compounds) can cross the human placenta.147  Chloroform 
metabolites have been shown to accumulate in the fetoplacental unit, and in particular in the 
amniotic fluid, of pregnant mice.148  It is plausible therefore that chloroform has a direct effect upon 
the fetus rather than an indirect effect mediated via the mother. 
 
1.7.2 Disruption of chorionic gonadotrophin 
Chen et al. have demonstrated that exposure to DCBM is associated with a dose-dependent decrease 
in the secretion of both immunoreactive and bioreactive chorionic gonadotrophin in human 
placental trophoblast cultures and disruption of placental syncytiotrophoblast formation in a dose-
dependent manner.127;128  Chen et al. conclude from their findings that the placenta is a likely target 
of DCBM toxicity in humans.  Trophoblasts are the sole source of chorionic gonadotrophin during 
normal human pregnancy and are important in the maintenance of the conceptus, therefore a 
decrease in the amount of this hormone could have adverse effects on pregnancy outcome.128  
 
1.7.3 Oxidative stress 
There is evidence to suggest that maternal oxidative stress during pregnancy may be an important 
factor in adverse fetal growth.149-153  Increased concentrations of oxidative stress biomarkers (8-
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 hydroxy-2’-deoxyguanosine (8-OH-dG) and malondialdehyde (MDA)) observed in urine of 
pregnant women have been associated with decreased birth weight.149;153  In late gestation, an 
increase in oxidative stress is observed in pregnancies complicated by IUGR, pre-eclampsia and 
diabetes, and this is associated with increased trophoblast apoptosis and alterations to placental 
vascular reactivity.150  Levels of oxidative stress biomarkers (MDA, Schiff bases, conjugated dienes 
and lipid peroxides) measured in maternal blood were reported to be higher for those mothers with 
an IUGR pregnancy compared to a normal pregnancy.151 
 
In vitro studies find evidence that exposure to DBPs results in oxidative stress in human cells.  An 
in vitro study on human hepatoma (HepG2) cells reported that increasing chloroform dose resulted 
in decreasing glutathione (GSH), which induces oxidative stress.154  Another in vitro study on 
human HepG2 cells found that when exposed to chlorinated drinking water, MDA increased and 
GSH decreased in a dose-dependent manner, indicating oxidative stress.155  Decreased GSH and 
increased oxygen radicals were also observed in HepG2 cells exposed to water with high 
trihalomethane levels.156 
 
Gao et al. observed that GSH is an important protective factor in the toxicity associated with 
DCBM in rats, suggesting that oxidative stress may be the mechanism of action by which DCBM 
toxicity occurs.157   
 
DCAA and TCAA have been found to induce cellular death and oxidative stress in macrophage 
cells in vitro,158 and in vivo they induce lipid peroxidation, which is a biomarker of oxidative stress, 
in mouse and rat livers.159 
 
Maternal exposure to CAN induced oxidative stress in mouse fetal livers, as marked by decreased 
GSH, increased oxidised glutathione, MDA and 8-OHdG in genomic DNA.160 
 
Given the observed associations between exposure to DBPs and markers of oxidative stress, and the 
observed associations between markers of oxidative stress and adverse fetal growth outcomes,  the 
evidence suggests that oxidative stress may be a mechanism by which DBPs could have an effect on 
fetal growth. 
 
1.7.4 Chloroform metabolism 
Chloroform is both oxidatively and reductively metabolized.  The oxidative pathway generates 
reactive metabolites, including phosgene, whilst the reductive pathway generates free radicals.161  
Oxidative and reductive chloroform metabolism both proceed through a cytochrome P450 (CYP)-
dependent enzymatic activation step, and cytochrome P-450E1 (CYP2E1) is the primary enzyme 
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 involved in the metabolism of low concentrations of chloroform.161  An in vitro study on human 
liver cells has demonstrated that at low doses, typical of actual human exposure through exposure to 
chlorinated waters, chloroform is metabolized primarily to phosgene by CYP2E1, a high affinity-
low capacity enzyme.162  Electrophilic phosgene is highly reactive and binds covalently to cell 
components containing nucleophilic groups, such as proteins, phospholipid polar heads and reduced 
glutathione (GSH).162 
 
A study by Infante-Rivard suggests that certain individuals are characterised by greater 
susceptibility to chloroform toxicity. Carriers of the CYP2E1*5 polymorphism, a variant of the 
CYP2E1 gene, were shown to be at greatly increased risk of IUGR when exposed to high TTHM 
levels (OR=13.2; 95% CI: 1.19-146.72) and high levels of chloroform (OR=5.62; 95% CI: 0.82-
38.39), when compared to non-carriers.80  This might be due to increased metabolism of THMs 
resulting in increased production of activated metabolites in carriers.80 
 
1.7.5 Folate metabolism 
Folate deficiency is associated with increased risk of LBW and fetal growth retardation163 and is a 
probable risk factor for placental-mediated diseases such as pre-eclampsia, spontaneous abortion 
and placental abruption.164  Vitamin B12 deficiency has been shown to be associated with IUGR in 
humans.165 Mouse studies have shown IUGR to be associated with 5,10-methylenetetrahydrofolate 
reductase (MTHFR) deficiency and folate deficiency.166;167  Both chloroform and TCAA have been 
found to inhibit the vitamin B12-dependent methionine biosynthesis pathway.168;169  Inhibition of 
this pathway can lead to vitamin B12 deficiency and, as a consequence, folate deficiency.169   
 
The enzyme MTHFR is involved in the vitamin B12-dependent methionine biosynthesis pathway 
(transformation of homocysteine to methionine) and in carriers of the common MTHFR C677T 
polymorphism, this pathway is less efficient, and it is possible that exposure to chloroform or other 
DBPs could further inhibit this pathway.80  Thus, it has been suggested that carriers of the MTHFR 
C677T polymorphism could be at higher risk for the effects of chloroform and DBPs in drinking 
water.170  However, a study by Infante-Rivard has demonstrated no difference in risk of IUGR when 
exposed to high levels of TTHM and chloroform, between carriers of the MTHFR C677T 
polymorphism and non-carriers.80 
 
1.8. CRITICAL WINDOW FOR EXPOSURE 
During the third trimester of pregnancy, the rate of fetal growth and weight gain increases 
dramatically and reaches its peak at about week 33.171;172  Average weight gain may reach almost 
250g per week during this period.172  On this basis, it has generally been assumed that the third 
trimester is the critical exposure window for fetal growth outcomes, and that maternal exposure to 
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 high levels of THMs during the third trimester may have an adverse effect upon fetal growth.  
However, there is little hard evidence upon which to base this assumption, and there is evidence to 
suggest that adverse fetal growth outcomes may have their origins earlier in pregnancy.173  
Brzezinski et al. report that in the human fetus, between days 50 and 113 of gestation, fetal brain 
CYP2E1 mRNA is expressed at relatively high levels.174  Exposure to chloroform during this stage 
of development might be of interest in relation to risk of adverse reproductive outcomes in humans 
exposed to chloroform via drinking water, given the role of CYP2E1 in the metabolism of 
chloroform. 
 
Only 5 studies have looked at time periods other than the 3rd trimester or whole pregnancy in their 
epidemiological analyses.  Wright et al.88 observed significant associations between the highest 
TTHM exposure in the 2nd trimester and increased risk of SGA and reduced term birth weight.  
Porter et al.92 did not find any significant associations for exposure to THMs/HAAs during the 1st or 
2nd trimesters.  Lewis et al.85 found increased risk of term LBW associated with exposure to TTHM 
in the 2nd trimester, but not for the 1st and 3rd trimesters.  Hinckley et al.93 observed elevated risk of 
IUGR associated with the highest categories of exposure to TTHM, TCAA and DCAA in the 3rd 
trimester, and also for specific 3 week time windows from week 25 of gestation onwards.  Hoffman 
et al.95 observed increased risk of SGA associated with residential TTHM concentrations for the 3rd 
trimester and elevated risk of SGA associated with highest quartile of personal TTHM exposure 
across all 3 trimesters, although only reaching significance for the 3rd trimester. 
 
Given that LOAELs from the toxicology studies are much greater than any reasonably expected 
human exposure, it is unlikely that toxicology studies would be able to investigate the effect of 
timing of exposure whilst also looking at doses relevant to humans.  The answer to the critical 
window question probably lies with epidemiology, if exposure assessment can be carried out with 
sufficient temporal resolution in order to allow the examination of more specific and shorter time 
windows during pregnancy in any epidemiological analysis.  Of course, it is not clear which factors 
are most important in driving exposure to DBPs in humans, e.g. spatial, temporal or seasonal 
variation in DBPs at the tap, or variation in individual water use, and until this is better understood 
it will be difficult to target resources for exposure assessment appropriately in order to achieve these 
objectives. 
 
1.9. CONCLUSION 
Having reviewed the epidemiological studies, the author concludes that the current weight of 
evidence is suggestive of positive associations between exposure to THMs and increased risk of the 
following adverse fetal growth outcomes: term LBW, SGA, and reductions in term birth weight.  
There is, as yet, insufficient epidemiological evidence on HAAs to draw any conclusion as to their 
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 possible effects on fetal growth.  The weight of evidence does not support associations between 
exposure to chlorinated water or THMs and increased risk of the reproductive outcomes LBW, very 
LBW (<1,500g) or preterm birth. 
 
The findings from the epidemiological studies have been somewhat inconsistent.  Inconsistency 
could be due to differences in exposure and exposure assessment between the various studies.  In 
some studies the concentrations of THMs were very low79;86;87;94 and this should be taken into 
account when comparing studies.  Also, it is important to remember that DBPs do not occur in 
isolation, but instead in complex mixtures, and associations observed may be the result of a 
particular mixture of DBPs at a specific study location and time.  The composition of DBPs in water 
and the levels of organic precursors may vary between different study sites, which might explain 
why one study finds a positive result whilst another observes no association.   
 
1.10. GAPS IN THE LITERATURE & RESEARCH NEEDS 
The main gaps in the current body of literature relate to:  
• research on the effects of the non-THM DBPs; 
• research on the effects of 1st and 2nd trimester DBP exposure;  
• the need for more sophisticated exposure assessment, including statistical modelling of exposure 
and validation of exposure assessment; and  
• the need for improved identification of adverse fetal growth outcomes. 
 
On the whole, the epidemiological studies have examined only THMs, however this may not 
necessarily be a good proxy measure for other DBPs.  The  metabolism of different DBP species 
varies,1 so it might be insufficient to analyse DBPs as a whole, or to use TTHM as a proxy.  There is 
little epidemiological evidence on non-THMs in relation to fetal growth, and this is certainly 
insufficient to draw any firm conclusions as to their effects.  Investigation of the relationships 
between non-THM by-products and fetal growth is required in order to understand which, if any, 
specific DBPs are driving the associations observed. 
 
Most epidemiological studies to date have focussed on the third trimester.  In-depth analyses 
comparing exposure metrics for the different trimesters of pregnancy are required to discover the 
critical window in which DBP exposure affects fetal growth.  
 
Clearly, improved exposure assessment, and validation of exposure assessment, is required for 
future studies.  In order to be able to target exposure assessment resources appropriately an 
improved understanding of the factors driving exposure to DBPs is required.  Although biomarkers 
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 for DBPs exist, they have not been used as part of exposure assessment in any of the 
epidemiological studies on fetal growth to date.  Whilst their expense might prohibit their use as the 
main form of exposure assessment in a large cohort study, biomarkers could be usefully employed 
in smaller nested validation studies. 
 
Finally, there is also a need for the use of improved measures of adverse fetal growth in order to 
reduce potential outcome misclassification bias.  There is evidence to suggest that the use of 
customised fetal growth charts, which take into account factors such as maternal height and 
ethnicity, significantly reduces the proportion of false-positive and false-negative diagnoses of fetal 
growth restriction, compared to using a standard population growth chart.75  By reducing scope for 
error and misclassification in both exposure estimates and outcome definitions this should increase 
confidence in, and improve interpretation of, health risk estimates generated in future 
epidemiological studies.  
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 Table 1.1  Standards for DBP concentrations (μg/L) in drinking water 
 
DBP UK USEPA 
TTHM 100 80* 
Chloroform - 70** 
DCBM - zero** 
DBCM - 60** 
Bromoform - zero** 
   
HAA5 - 60* 
* Maximum contaminant level 
**Maximum contaminant level goals (MCLG) 
- indicates no standard mandated for individual 
THM species or HAAs. 
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 Table 1.2   Summary of epidemiological studies examining fetal growth outcomes and DBPs, grouped according to method of exposure assessment 
(continues on following pages) 
Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
       
Kanitz et al.78 Liguria, Italy. 
 
Cross-sectional 
case control study 
 
676 births at 2 
hospitals  
 
Cases from 
Galliera hospital in 
Genoa 1988-1989 
 
Controls from 
Chiavari Hospital – 
community where 
drinking water not 
disinfected. 
 
Total sample size = 
676 
 
20 LBW 
288 Small body 
length 
370 Small cranial 
circumference 
50 Preterm 
 
Total 548 births in 
“exposed” area  
 
(not clear whether 
LBW comprises of 
just term births or if 
it includes preterm 
births) 
Maternal address at birth 
assigned one of 4 
“disinfection treatment types” 
 
1.None 
2.Chlorine dioxide 
3.Sodium hypochlorite 
4.Chlorine dioxide + sodium 
hypochlorite 
Maternal age 
Education level 
Smoking 
Alcohol consumption 
Gender of child 
LBW 
Disinfection type  OR 
None   1.0 
Chlorine dioxide  5.9 (0.8-14.9) 
Sodium hypochlorite 6.0 (0.6-12.6) 
Both   6.6 (0.9-14.6) 
 
 
Body Length ≤  49.5 cm  
Disinfection type  OR 
None   1.0 
Chlorine dioxide  2.0 (1.2-3.3) 
Sodium hypochlorite 2.3 (1.3-4.2) 
Both   1.4 (0.8-2.5) 
 
 
Cranial Circumference ≤  35 cm  
Disinfection type  OR 
None   1.0 
Chlorine dioxide  2.2 (1.4-3.9) 
Sodium hypochlorite 3.5 (2.1-8.5) 
Both   2.4 (1.6-5.3) 
 
Preterm 
Disinfection type  OR 
None   1.0 
Chlorine dioxide  1.8 (0.7-4.7) 
Sodium hypochlorite 1.1 (0.3-3.7) 
Both   1.8 (0.6-5.0) 
 
In general, risk of 
adverse fetal growth 
(LBW, small body 
length and small 
head circumference) 
showed strong 
positive associations 
with exposure to 
disinfected water. 
 
 
These associations 
were statistically 
significant for risk of 
body length ≤  49.5 
cm and cranial 
circumference ≤  35 
cm. 
 
 
 
 
 
Risk of preterm birth 
appeared to be 
elevated with 
exposure to 
disinfected water, but 
these associations 
did not reach 
statistical 
significance. 
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 Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
Kallen et al.84 Swedish Birth 
Registry 1985-1994 
 
Retrospective 
cohort study 
 
Total sample size:  
114,484  
 
Exposure cohort 
sizes: 
 
74,324 No 
disinfection 
 
15,429 Chlorine 
dioxide 
 
24,731Sodium 
hypochlorite 
Gestational 
duration 
Birth weight 
IUGR 
Body length 
Head 
circumference 
BMI 
 
Maternal address at birth 
assigned one of 3 
“disinfection treatment types” 
according to municipality.   
 
1.No disinfection 
2.Chlorine dioxide 
3.Sodium hypochlorite 
 
Year of birth 
Maternal age 
Parity 
Maternal education 
Maternal smoking 
 
No disinfection – vs – Chlorine dioxide 
Outcome   OR 
Preterm <32 wks  0.95 (0.75-1.09) 
Preterm <37wks  0.96 (0.88-1.04) 
vLBW <1500g  0.84 (0.65-1.09) 
LBW <2500g  0.93 (0.84-1.03) 
SGA <-2SD  0.95 (0.84-1.07) 
SGA<-3SD  1.07 (0.81-1.43) 
<43 cm length  0.91 (0.63-1.33) 
<47 cm length  0.84 (0.74-0.96) 
BMI <12kg/m2  0.88 (0.82-0.95) 
BMI >16kg/m2  1.06 (0.97-1.15) 
<31cm head circumference 1.29 (0.93-1.79) 
<33cm head circumference 1.08 (0.96-1.22) 
 
 
 
No disinfection –vs- Sodium hypochlorite 
Outcome   OR 
LBW <2500g  1.15 (1.05-1.26) 
vLBW <1500g  1.11 (0.90-1.36) 
SGA <-2SD  1.07 (0.96-1.19) 
SGA<-3SD  0.87 (0.65-1.15) 
<43 cm length  1.97 (1.30-2.97) 
<47 cm length  1.25 (1.10-1.43) 
<31cm head circumference 1.46 (1.07-1.98) 
<33cm head circumference 1.07 (0.96-1.20) 
BMI <12kg/m2  1.02 (0.96-1.09) 
BMI >16kg/m2  1.27 (1.19-1.37) 
Preterm <32 wks  1.22 (1.00-1.48) 
Preterm <37wks  1.09 (1.01-1.17) 
 
 
No significantly 
increased risks 
associated with 
exposure to drinking 
water disinfected with 
chlorine dioxide. 
 
Statistically 
significant decreased 
risk of body 
length<47 cm and of 
BMI <12kg/m2  
associated with 
exposure to drinking 
water disinfected with 
chlorine. 
 
In general, exposure 
to drinking water 
disinfected with 
sodium hypochlorite 
associated with 
increased risk of 
adverse fetal growth 
outcomes.  These 
associations are 
statistically significant 
for LBW, short body 
length, small head 
circumference. 
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 Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
Jaakkola et 
al.83 
Norwegian Birth 
Registry 
1993-1995 
 
Retrospective 
cohort. 
 
Total sample size:  
137,145 
 
Sample size for 
which gestational 
age known: 
123,747 
 
Birth weight 
6249 LBW 
SGA 
7886 Preterm 
Maternal residence 
Waterworks divided by use of 
chlorination, and water colour 
(as a measure of organic 
matter) – to give 4 categories: 
 
1. No chlorination, low colour 
2. No chlorination, high colour 
3. Chlorination, low colour 
4. Chlorination, high colour 
 
These categories represent: 
1. = no THM 
2. = no THM 
3. = low THM 
4. = high THM 
 
Maternal age 
Parity 
Place of birth 
Centrality 
Population density 
Industrial profile 
 
(No data on maternal 
occupation, smoking, 
alcohol consumption - 
analysis not adjusted 
for these risk factors) 
 
LBW 
Exposure   OR 
No chlorination, low colour 1.00  
No chlorination, high colour 1.02 (0.91-1.14) 
Chlorination, low colour 0.99 (0.90-1.09) 
Chlorination, high colour 0.97 (0.89-1.06) 
 
SGA 
Exposure   OR 
No chlorination, low colour 1.00  
No chlorination, high colour 1.02 (0.89-1.14) 
Chlorination, low colour 1.00 (0.91-1.11) 
Chlorination, high colour 1.00 (0.91-1.10) 
 
Preterm 
Exposure   OR 
No chlorination, low colour 1.00  
No chlorination, high colour 0.92 (0.83-1.03) 
Chlorination, low colour 0.95 (0.88-1.03) 
Chlorination, high colour 0.91 (0.84-0.99) 
 
 
No associations were 
found between LBW 
or SGA and any of 
the exposure 
categories 
 
 
 
 
 
 
 
 
 
An inverse 
association was 
found between 
preterm birth and the 
exposure category: 
chlorination, high 
colour, which 
represents high THM 
concentration. 
Yang et al.87 Taiwan 
 
Retrospective 
cohort study. 
 
18,025 first parity 
singleton births 
1994-1996 in 28 
municipalities 
 
14 chlorinated 
municipalities: 
10,007 births 
 
14 non-chlorinated 
municipalities: 
8,018 births 
 
 
Term LBW 
Preterm 
 
 
Chlorinated municipalities 
(>90% population served by 
chlorinated water) matched to 
a non-chlorinated municipality 
(<5% population served by 
chlorinated water). 
Maternal age 
Marital status 
Maternal education 
Sex of baby 
 
(No data on maternal 
occupation, smoking, 
alcohol consumption - 
analysis not adjusted 
for these risk factors) 
 
Chlorination –vs- No Chlorination (reference) 
 
Outcome   OR 
Term LBW   0.90 (0.75-1.09) 
Preterm    1.34 (1.15-1.56) 
 
No significant 
association was 
found between term 
LBW and living in a 
chlorinated 
municipality. 
 
Risk of preterm birth 
was found to be 
positively associated 
with living in a 
chlorinated 
municipality.  This 
finding was 
statistically 
significant. 
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 Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
Yang et al.86 Taiwan 
 
310 municipalities 
1994-1996 
 
Sample size: 
182,796 
primiparous births 
 
Retrospective 
cohort study. 
 
 
 
 
 
 
 
 
 
8,251 LBW 
80,030 preterm 
Exposure categories defined 
as living in either a 
chlorinated municipality 
(>95% popn served by 
chlorinated water) or a non-
chlorinated municipality (<5% 
popn served by chlorinated 
water) 
 
Maternal age 
Marital status 
Maternal education 
Sex of baby 
Urbanisation level 
 
(No data on maternal 
occupation, smoking, 
alcohol consumption - 
analysis not adjusted 
for these risk factors) 
 
Chlorination –vs- No Chlorination (reference) 
 
Outcome   OR 
LBW    1.05 (0.94-1.18) 
Preterm    1.37 (1.20-1.56) 
 
No significant 
association was 
found between LBW 
and living in a 
chlorinated 
municipality. 
 
Risk of preterm birth 
was found to be 
positively associated 
with living in a 
chlorinated 
municipality.  This 
finding was 
statistically 
significant. 
Kramer et 
al.76 
Iowa, US. 
1989-1990 
 
Population-based 
case-control study 
 
5 controls per case 
 
159 LBW 
342 Preterm 
187 IUGR 
 
688 cases in total 
THM levels from 1987 water 
survey assigned to maternal 
residence at birth. 
 
(chloroform, DCBM, DBCM, 
bromoform) 
 
Stratified by water source. 
Maternal Age 
Parity 
Education 
Marital status 
Smoking 
Adequacy of prenatal 
care 
 
LBW 
Chloroform (μg/l)  OR 
Nondetectable  1.0 
1-9   1.1 (0.7-1.6) 
≥10   1.3 (0.8-2.2) 
 
IUGR 
Chloroform (μg/l)  OR 
Nondetectable  1.0 
1-9   1.3 (0.9-1.8) 
≥10   1.8 (1.1-2.9) 
 
DCBM (μg/l)   OR 
Nondetectable  1.0 
1-9   1.2 (0.8-1.7) 
≥10   1.7 (0.9-2.9) 
 
Preterm – no statistically significant associations with any THMs 
 
Bromoform and DBCM not associated with increased risk for any 
outcome. 
 
Risk of LBW 
positively associated 
with increased 
chloroform 
concentrations, but 
not statistically 
significant. 
 
Risk of IUGR 
positively associated 
with increased 
concentration of 
chloroform and 
DCBM in  water, but 
only significantly so 
for chloroform: 80% 
increased risk in 
those exposed to 
water with ≥10 μg/l 
chloroform. 
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Bove et al.81 New Jersey, US. 
1985-1988 
 
Retrospective 
cohort  
study of 80938 live 
births and 594 fetal 
deaths 
 
1853 term LBW 
905 term vLBW 
4082 SGA 
7167 Preterm 
 
Monthly estimates of TTHM 
assigned to each gestational 
month of each live birth and 
fetal death, and exposure 
averaged over whole 
pregnancy. 
Maternal age 
Maternal race 
Maternal education 
Primipara 
Previous stillbirth or 
miscarriage 
Gender of child 
Adequacy of prenatal 
care 
(A-280 contaminants) 
 
(No data on maternal 
occupation, smoking, 
alcohol consumption - 
analysis not adjusted 
for these risk factors) 
 
Term Birth Weight 
TTHM (ppb) Weight difference (g)  90% CI 
0-20 (reference level) 
20-40  +34.8  (+49.8, +19.8) 
40-60  -51.2  (-43.1, -59.3) 
60-80  -26.6  (-17.2, -36) 
80-100  -54.9  (-40.9, -68.9) 
>100  -70.4  (-40.6, -100.2) 
 
 
Term LBW 
OR=1.42 (50%CI = 1.22-1.65) for TTHM>100ppb 
 
SGA 
OR=1.50 (90%CI = 1.19-1.86) for TTHM>100ppb 
 
Trend supported for both term LBW and SGA 
 
vLBW – no significant associations with TTHM 
 
 
A-280 contaminants 
carbon tetrachloride >1ppb vs ≤  1ppb 
 
Outcome   OR 
Term LBW   2.26 (1.52-3.36) 
SGA   1.75 (1.31-2.32) 
Term vLBW  1.66 (0.78-3.51) 
In general, birth 
weight at term 
inversely related to 
TTHM levels in 
water. 
 
 
 
 
 
Risk of term LBW 
and SGA positively 
associated with 
exposure to high 
levels of TTHM. 
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Wright et al.88 Massachusetts, 
USA.  1990 
 
Cross-sectional 
analysis, semi-
individual study 
design 
 
Sample size: 
56,513 singleton 
infants 
 
 
 
 
Term Birth weight 
1325 term LBW 
5310 SGA 
3173 Preterm 
Gestational age 
Maternal THM exposure for 
each trimester estimated from 
the quarterly or annual 
average TTHM concentration 
for the town of residence. 
 
Based on maternal residence 
recorded on birth certificate. 
 
Average maternal pregnancy 
exposure calculated from 
trimester-specific values. 
Previous preterm 
delivery 
Previous birth of 
infant>4000 g 
Gestational age 
Adequacy of prenatal 
care 
Maternal race 
Parity 
Maternal education 
Smoking 
Household income 
Maternal medical 
history 
 
Results shown below are for TTHM exposure averaged over 
whole pregnancy. 
 
Term Birth Weight Reductions 
TTHM conc. (μg/l) Birth weight difference (g) 
0-60  Reference 
60-80  -1 (-12, 11) 
>80  -32  (-47, -0.2) 
 
Per 20 μg/l inc -2.8 (-5.5, -0.2) 
 
Term LBW 
TTHM conc. (μg/l)  OR 
0-60   1.0 
60-80   0.97 (0.81-1.26) 
>80   1.05 (0.85-1.29) 
 
SGA 
TTHM conc. (μg/l)  OR 
0-60   1.0 
60-80   1.0 (0.92-1.09) 
>80   1.14 (1.02-1.26) 
 
Gestational Age 
TTHM conc. (μg/l) Gestational age difference (wks) 
0-60 
60-80   0.04 (-0.01, 0.09) 
>80   0.08 (0.01, 0.14) 
 
Per 20 μg/l inc  0.02 (0.01, 0.03) 
 
Preterm 
TTHM conc. (μg/l)  OR 
0-60   1.0 
60-80   1.0 (0.89-1.12) 
>80   0.90 (0.77-1.04) 
 
 
Significant decrease 
in term birth weight 
associated with 
increasing pregnancy 
average TTHM 
exposure. 
 
Exposure to highest 
category of exposure 
(>80 μg/l) associated 
with significantly 
increased risk of 
SGA compared to 
those in the 0-60 μg/l 
exposure category. 
 
Trimester specific 
results (not shown) 
found no significant 
associations between 
exposure in 3rd 
trimester and 
adverse fetal growth 
outcomes, but 2nd 
trimester results 
yielded significant 
associations between 
the highest exposure 
categories and 
increased risk of 
SGA and reduced 
term birth weight. 
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Wright et al.89 Massachusetts, 
USA 
1995-1998 
 
Sample size: 
196,000 singleton 
births 
 
Retrospective 
cohort study. 
 
 
 
 
 
 
Term BW 
17,359 term SGA 
Gestational age 
11,580 preterm 
delivery 
Very Preterm 
delivery 
Exposures of interest: 
 
- TTHM 
- Individual THMs 
(chloroform, DCBM) 
- Total HAAs 
- Individual HAAs 
(dichloroacetic acid, 
trichloroacetic acid) 
- MX 
- Mutagenic activity 
 
Town-specific aggregate data 
based on quarterly samples.  
Maternal ZIP code and infant 
month of birth used to assign 
3rd-trimester-specific 
exposure data. 
 
Exposure also averaged over 
whole pregnancy. 
Maternal education 
Parity 
Prenatal care 
Smoking 
Maternal age 
Maternal race 
Infant sex* 
Household income 
Weight gain during 
pregnancy 
 
And maternal risk 
factors: 
Diabetes 
Lung disease 
Renal disease 
Chronic hypertension 
Marital status 
Previous preterm 
delivery 
Previous birth to 
infant > 4,000 g 
 
 
 
*not adjusted for in 
SGA analysis 
Term Birth Weight 
TTHM (μg/l) BW diff (g)  95% CI 
0-33 
>33-74  -12  (-16, -7) 
>74-163  -18   (-26, -10) 
Per 66 μg/l -18    (-23, -13) 
 
chloroform (μg/l) BW diff (g)  95% CI 
0-26 
>26-63  -14  (-19, -9) 
>63-135  -18   (-26, -10) 
Per 59 μg/l -19    (-25, -14) 
 
DCBM (μg/l) BW diff (g)  95% CI 
0-5 
>5-13  -12  (-17, -8) 
>13-46  -12   (-20, -3) 
Per 11 μg/l -9    (-13, -4) 
 
SGA 
TTHM (μg/l) OR  95% CI 
0-33  1.0 
>33-74  1.06 (1.02, 1.10) 
>74-163  1.13 (1.07, 1.20) 
 
chloroform (μg/l) OR  95% CI 
0-26  1.0 
>26-63  1.05 (1.02, 1.09) 
>63-135  1.11  (1.04, 1.17) 
 
DCBM (μg/l) OR  95% CI 
0-5  1.0 
>5-13  1.1 (1.07, 1.14) 
>13-46  1.15 (1.08, 1.22) 
 
No significant associations observed between SGA and total or 
individual HAAs, or MX. 
 
Risk of preterm birth (results not shown) demonstrated significant 
inverse associations with TTHM, chloroform and DCBM. 
 
Significant 
associations were 
observed between 
term BW reductions 
and exposure to 
TTHM, chloroform 
and DCBM. 
 
  
 
 
 
 
 
 
 
 
 
 
A small but 
significantly 
increased risk of term 
SGA was associated 
with exposure to 
TTHM, chloroform, 
DCBM and 
mutagenicity. 
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Porter et al.92 Maryland, USA 
1998-2002 
 
Sample size: 
15,135 singleton 
births 
 
Information from 
birth certificates 
 
Retrospective 
cohort 
 
IUGR Averaged biweekly 
measurements for each of 
the 4 Maryland regions were 
used to compute: 
 
Whole pregnancy average 
exposures and trimester-
specific exposures to: 
TTHM and individual THMs 
HAA5 and individual HAAs 
 
 - based on maternal ZIP 
code. 
Maternal age 
Maternal weight gain 
Race/ethnicity of child 
Adequacy of prenatal 
care 
Marital status 
Tobacco/cigarette use 
Alcohol consumption 
3rd trimester results shown below: 
 
TTHM 
Exposure quintile  OR 
1  1.00 
2  1.18 (0.97-1.44) 
3  1.20 (0.99-1.46) 
4  1.05 (0.86-1.29) 
5  1.17 (0.96-1.42) 
 
HAA5 
Exposure quintile  OR 
1  1.00 
2  1.29 (1.01-1.66) 
3  1.41 (1.11-1.81) 
4  1.15 (0.89-1.49) 
5  1.34 (1.04-1.71) 
 
 
Significantly 
increased risk of 
IUGR for HAA5 
exposures at 2nd 
quintile or above 
during the 3rd 
trimester. 
 
A similar pattern of 
increased risk 
observed for TTHM 
exposures at 2nd 
quintile or above 
during 3rd trimester, 
however these 
results do not reach 
significance. 
 
No consistent, 
statistically significant 
findings for any 
individual THMs or 
HAAs, nor for 1st or 
2nd trimesters, nor for 
whole pregnancy 
average exposures.  
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Lewis et al.85 Massachusetts, 
USA. 
 
1999-2001 
 
Sample size: 
36,529 births 
 
Retrospective 
cohort study 
 
 
 
 
 
 
780 Term LBW Weekly TTHM sampling data 
used to calculate mother’s 
trimester-specific and whole 
pregnancy average exposure. 
 
Assigned according to 
maternal residence at birth. 
Gestational age 
Infant’s sex 
Marital status 
Kessner Index 
Maternal age 
Maternal 
race/ethnicity 
Maternal Education 
Parity 
Maternal smoking 
Previous infant 
>4000g 
 
Previous 
preterm/SGA 
 
Prenatal care source 
of payment 
 
Conception season 
Birth Season 
Average income of 
community 
 
Various maternal 
diseases 
 
Adjusted for previous 
trimester exposure 
 
Specific trimesters: 
 
Term LBW in the 2nd trimester 
TTHM (μg/l)  OR 
< 40   1.0 
40-<50   1.10 (0.81-1.49) 
50-<60   1.08 (0.79-1.49) 
60-<70   1.24 (0.92-1.67) 
≥70   1.50 (1.07-2.10) 
Per 10 μg/l increase 1.08 (1.00-1.17) 
 
 
Caucasians only 
≥70 vs <40 μg/l TTHM 1.37 (0.80-2.36) 
Per 10 μg/l increase 1.06 (0.95 -1.20) 
 
Non-Caucasians (African American, Hispanic, Asian) 
≥70 vs <40 μg/l TTHM 1.60 (1.03-2.47) 
Per 10 μg/l increase 1.10 (1.00 -1.22) 
 
 
1st and 3rd trimester 
No significant associations were found for 1st and 3rd trimester 
exposures. 
 
Whole pregnancy 
No significant associations observed. 
Increased risk of term 
LBW associated with 
exposure to TTHM in 
the 2nd trimester, 
although this is 
statistically significant 
only for the highest 
exposure category 
(≥70 μg/l). 
 
 
 
 
 
 
When the analysis 
was stratified by 
race, it is found that 
non-Caucasians 
were at greater risk 
of term LBW 
associated with 
exposure to high 
TTHM levels, 
compared with 
Caucasians. 
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Yang et al. 94 Taiwan 
 
2000-2002 
 
65 municipalities 
each served by one 
waterworks 
 
Sample size: 
90,848 births  
 
Retrospective 
cohort study. 
2766 Term LBW 
8938 SGA 
2818 Preterm 
Average of TTHM over years 
2000-2002 used as TTHM 
concentration for each 
municipality. 
 
Assigned according to 
municipality in which mother 
was resident at birth. 
 
Categorised into: 
Low   <4.93 µg/l 
Medium 4.93-13.11µg/l 
High    >13.11 µg/l 
 
On the whole TTHM levels 
were low, mean TTHM = 8.42 
µg/l 
Maternal age 
Marital status 
Maternal education 
Infant’s gender 
 
(No data on maternal 
occupation, smoking, 
alcohol consumption - 
analysis not adjusted 
for these risk factors) 
 
Term LBW 
TTHM category OR 
Low  1.00 
Medium  0.99 (0.90-1.08) 
High  1.00 (0.91-1.10)  
 
SGA 
TTHM category OR 
Low  1.00 
Medium  1.00 (0.94-1.04) 
High  0.96 (0.91-1.02) 
 
Preterm 
TTHM category OR 
Low  1.00 
Medium  1.03 (0.94-1.13) 
High  1.08 (0.98-1.18) 
 
No significant 
associations 
observed for any 
outcome. 
Gallagher et 
al.91 
Colorado, US.  
 
Retrospective 
cohort study of  
1990-1993 birth 
records 
 
1893 eligible births 
in 28 census blocks 
served by either of 
2 municipal water 
districts. 
 
In total 1244 births 
for which THM data 
available. 
72 LBW 
29 Term LBW 
68 Preterm  
 
 
THM levels from routine 
sampling combined with 
hydraulic modelling. 
 
Hydraulic modelling of each 
water treatment facility to 
estimate TTHM levels within 
distribution system, rather 
than assuming that TTHM 
level at the sampling point 
applies to all customers of a 
facility – thus reducing 
exposure misclassification. 
 
Exposure score assigned to 
mother’s address for 3rd 
trimester, based on maternal 
residence at birth. 
 
Exposure also categorised 
as: 
High = ≥50 ppb 
Low = 0-49 ppb 
 
 
Maternal Age 
Parity 
Education 
Marital status 
Smoking 
Employment during 
pregnancy 
Adequacy of prenatal 
care 
 
LBW 
TTHM (ppb)   OR 
≤ 20   1.0 
21-40   1.0 (0.6-1.8) 
41-60   0.8 (0.3-1.7) 
≥61   2.1 (1.0-4.8) 
High -vs- Low  1.5 (0.8-3.0) 
 
 
Term LBW 
TTHM (ppb)   OR 
≤ 20   1.0 
21-40   1.3 (0.5-3.3) 
41-60   1.2 (0.4-4.0) 
≥61   5.9 (2.0-17.0) 
High -vs- Low  2.6 (1.1-6.1) 
 
 
Preterm 
TTHM (ppb)   OR 
≤ 20   1.0 
21-40   1.0 (0.6-1.7) 
41-60   0.7 (0.3-1.6) 
≥61   1.0 (0.3-2.8) 
High -vs- Low  0.9 (0.4-2.0) 
 
 
 
 
 
 
 
 
 
 
 
A statistically 
significant and highly 
elevated risk of term 
LBW was associated 
with the highest 
category of TTHM 
exposure (≥61 ppb). 
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Dodds et al.82 Nova Scotia, 
Canada. 
 
Retrospective 
cohort study of 
singleton births 
1988-1995 
 
Total sample size: 
50,755 
4673 SGA 
2392 LBW 
342 vLBW 
2689 Preterm 
Routine sampling data was 
modelled using linear 
regression.  This allowed 
estimation of TTHM for time 
periods with no samples. 
 
TTHM level for 3rd trimester 
assigned to maternal address 
at birth 
Maternal Age 
Parity 
Smoking 
Neighbourhood 
Family income 
Attendance at 
prenatal classes 
Gender of baby 
Prepregnancy weight 
Predelivery weight 
 
SGA 
TTHM (μg/l)  RR 
0-49   1.00 
50-74   1.04 (0.97-1.11) 
75-99   1.01 (0.92-1.11) 
≥100   1.08 (0.99-1.18) 
 
LBW 
TTHM (μg/l)  RR 
0-49   1.00 
50-74   1.07 (0.97-1.19) 
75-99   1.11 (0.97-1.26) 
≥100   1.04 (0.92-1.18) 
 
vLBW 
TTHM (μg/l)  RR 
0-49   1.00 
50-74   1.03 (0.80-1.33) 
75-99   0.93 (0.65-1.32) 
≥100   0.89 (0.64-1.23) 
 
Preterm 
TTHM (μg/l)  RR 
0-49   1.00 
50-74   0.96 (0.88-1.06) 
75-99   0.99 (0.88-1.12) 
≥100   0.97 (0.87-1.09) 
 
No significant 
associations for any 
of the outcomes, 
SGA, LBW, vLBW or 
preterm birth. 
 
All RRs close to 
unity. 
 
No evidence of trend 
of increasing risk with 
increasing TTHM 
level. 
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Toledano et 
al.90 
England 
 
3 water companies:  
Northumbrian, 
United Utilities, 
Severn Trent.   
 
1992 – 1998 
 
Sample size: 
Approx 1 m birth 
and stillbirths. 
 
LBW 
vLBW  
Stillbirth 
 
Weighted average of 
modelled quarterly TTHM 
estimates for last 93 days 
before birth, assigned 
according to maternal 
residence at birth. 
 
Categorised as: 
 
Low: <30 μg/l 
Medium: 30-59 μg/l 
High: ≥60 μg/l 
Maternal age 
Deprivation 
 
 
(No data on 
gestational age, or 
maternal occupation, 
smoking, alcohol 
consumption - 
analysis not adjusted 
for these factors) 
 
United Utilities area: 
 
LBW 
TTHM category OR 
Low  1.00 
Medium  1.11 (1.07-1.16) 
High  1.19 (1.14-1.24)  
 
vLBW 
TTHM category OR 
Low  1.00 
Medium  1.09 (0.98-1.21) 
High  1.20 (1.07-1.34) 
 
Stillbirth 
TTHM category OR 
Low  1.00 
Medium  1.16 (1.00-1.35) 
High  1.21 (1.03-1.42) 
 
Northumbrian and Severn Trent areas: 
No significant excess risks of LBW, vLBW or stillbirth observed in 
these areas. 
 
Statistically 
significant positive 
associations between 
risk of LBW, vLBW, 
stillbirth and 
residence in areas 
with medium to high 
TTHM levels were 
found in the United 
Utilities area. 
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Hinckley et 
al.93 
Arizona, USA 
 
Community served 
by 3 water 
treatment facilities. 
 
Retrospective 
cohort study 
 
Sample size: 
48,119 subjects 
(live births and fetal 
deaths) 
 
 
 
 
 
 
4,346 IUGR 
1,010 term LBW 
4,008 preterm 
568 v. preterm 
TTHMS and HAAs 
 
Monthly DBP exposures 
estimated from quarterly and 
monthly samples and some 
modelling to impute missing 
values. 
 
Assigned according to 
maternal residence at birth. 
 
Estimated monthly DBP 
exposures averaged over 3rd 
trimester, and averaged for 
specific time windows (25-28, 
29-32, 33-36, 37-40, 41-44 
wks). 
 
For IUGR and term LBW 
evaluated for both whole 3rd 
trimester and specific time 
windows. 
 
For preterm and v.preterm 
birth, exposure only 
evaluated for specific time 
windows. 
 
 
Maternal age 
Race 
Ethnicity 
Education 
Parity 
Smoking 
Adequacy of prenatal 
care 
3rd trimester 
 
IUGR 
Exposure   OR 
≥ 53  μg/l  TTHM  1.09 (1.00-1.18) 
≥ 5  μg/l  DCAA  1.28 (1.08-1.51) 
≥ 8  μg/l  TCAA  1.19 (1.01-1.41) 
 
Per unit increase DCAA 1.05 (1.02-1.09) 
Per unit increase TCAA 1.04 (1.02-1.07) 
 
Term LBW 
Exposure   OR  
≥ 5  μg/l DBAA  1.49 (1.09-2.04) 
Per unit increase DBAA 1.17 (1.03-1.32) 
 
 
Specific gestation time windows 
 
IUGR 
Week Exposure  OR  95% CI 
37-40 ≥8 μg/l  DCAA 1.27 (1.02-1.59) 
41-44 4-6 μg/l  TCAA 1.58 (1.02-2.46) 
 
Term LBW 
Week Exposure  OR 
33-36 ≥5 μg/l  DBAA 1.49 (1.10-2.02) 
37-40 3.5-5 μg/l  TCAA 1.38(1.02-1.86) 
 
Other significant elevated risks were found for specific gestation 
time windows but they were not as large as those shown here. 
 
Significantly 
increased risk of 
IUGR observed for 
highest category of 
exposure to DCAA 
and TCAA in the 3rd 
trimester. 
 
Increased risk of 
IUGR observed for 
highest category of 
exposure to TTHM in 
the 3rd trimester, 
although this was of 
borderline 
significance. 
 
Significantly 
increased risk fo term 
LBW associated with 
the highest exposure 
category for DBAA, 
during 3rd trimester. 
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Savitz et al.77 North Carolina, US. 
 
6 hospitals (Orange 
& Durham counties 
1988-1989, 
Alamance county 
1988-1991) 
 
Population-based 
case control study. 
 
1 term normal 
weight control 
matched to each 
case 
 
 
LBW 
Preterm  
 
(Overlap between 
LBW and preterm 
groups: 50% of 
cases were both 
LBW and preterm.  
34% were preterm 
but not LBW, 17% 
were LBW but not 
preterm.) 
 
 
Exposure to mother at 28th 
week estimated using the 
quarterly average TTHM 
value recorded nearest in 
time to that date by 
appropriate water supplier, 
based on maternal residence. 
 
TTHM dose also calculated 
by combining tap water 
TTHM concentration with 
glasses of water per day. 
Maternal Age 
Race 
Hospital 
Education 
Marital status 
Poverty 
Smoking 
Alcohol consumption 
Employment 
 
(LBW analysis not 
adjusted for gestation) 
 
LBW 
Water source – not significantly associated with LBW. 
 
TTHM (μg/l)  OR 
40.8-63.3   1.0 
63.4-82.7   1.5 (1.0-2.3) 
82.8-168.8  1.3 (0.8-2.1) 
 
Per 50ppb change  0.9 (0.6-1.4) 
 
TTHM dose (ppb x glasses/day) OR 
44.0-169.9   1.0 
170.0-330.8   1.0 (0.6-1.5) 
330.9-1171.0   0.8 (0.5-1.3) 
 
Per 250 unit change  1.0 (0.8-1.2) 
 
Preterm – not significantly associated with water source, TTHM 
concentration or dose. 
 
No significant 
associations or 
trends observed. 
 
Borderline positive 
association for LBW 
in one TTHM 
concentration 
category (63.4-82.7 
μg/l) 
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Infante-
Rivard80 
Montreal, Quebec, 
Canada. 
 
Hospital-based 
case-control study 
 
 
 
 
 
 
493 IUGR cases 
472 controls (not 
IUGR) 
Routine regulatory data on 
THMs by municipality gave 
average level at tap over 
pregnancy period. 
 
Based on maternal residence 
but residential history during 
pregnancy taken into 
account. 
 
This was categorised above 
or below 90th percentile of 
distribution, to give a 
dichotomous high –vs- low 
variable. 
 
Information on individual 
water use was combined with 
average THM levels to give 
exposure dose variables 
based on glasses of tap 
water per day and frequency 
of showering per week. 
 
Race 
Sex 
Gestational Age 
Weight gain during 
pregnancy 
Prepregnancy BMI 
Parity 
Preeclampsia history 
Prior history of IUGR 
Primiparity 
Smoking 
Risk of IUGR associated with exposure to >90th percentile of 
average tap water concentration compared with referent 
category (≤90th percentile): 
 
Exposure   OR 
CHCl3>23.7 μg/l  1.06 (0.63 - 1.79) 
CHBr3>1.22 μg/l  2.44 (0.19 - 31.10) 
DCBM>6.3 μg/l  0.84 (0.50 – 1.43) 
DCBM>3.9 μg/l  0.62 (0.27 – 1.44) 
TTHM>29.4 μg/l  0.97 (0.57 – 1.62) 
 
No increased risk observed for exposure indices incorporating tap 
water consumption or showering 
 
 
Analysis stratified according to genotype: 
 
CYP2E1*5 –vs- wild type 
   OR 
TTHM > 90th %ile  13.2 (1.19 – 146.72) 
chloroform  5.62 (0.82 – 38.39) 
 
 
MTHFR –vs- wild type 
   OR 
TTHM > 90th %ile  0.76 (0.38 – 1.54) 
chloroform  0.83 (0.38– 1.54) 
 
 
 
 
 
 
No increased risk of 
IUGR associated with 
high average tap 
water levels of any 
THM or TTHM. 
 
 
 
 
Risk of IUGR 
associated with 
exposure to TTHM 
shown to be different 
for carriers and non-
carriers of CYP2E1*5 
variant. 
 
This suggests 
increased genetic 
susceptibility to the 
effects of THMs in 
carriers of the 
CYP2E1*5 variant. 
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 Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
Hoffman et 
al. 95 
North Carolina, 
USA 
 
3 communities 
 
Sample size: 2,039 
pregnancies. 
 
Prospective cohort 
study – enrolled 
prior to conception 
or in early 
pregnancy (≤  12 
weeks gestation). 
 
SGA (n = 113) 
Term BW 
 
Weekly or fortnightly THM4, 
HAA9 and TOX sampling at  
representative location in 
distribution system for each 
of 3 sites:  chlorinated site, 
brominated site and low DBP 
site. 
 
All women in a given study 
area were assigned the same 
DBP concentrations for any 
given week, which were then 
averaged to give trimester-
specific residential DBP 
concentrations. 
 
Residential concentrations 
combined with individual 
water use information to give 
personal estimates of 
exposure for each trimester: 
 
- average daily THM uptake 
via showering/bathing 
- total TTHM exposure via tap 
water ingestion and 
showering/bathing 
 
- average daily HAA intake 
via ingestion 
 
Maternal age 
Race/ethnicity 
Education 
Marital status 
Maternal caffeine 
consumption 
Income 
Pre-pregnancy BMI 
Live birth history 
Employment status 
Parity 
 
(analyses not 
adjusted for smoking 
or alcohol 
consumption – not 
considered to be 
potential confounders) 
3rd trimester exposures: 
 
Residential    mean birth 
TTHM  RR of SGA  weight difference (g) 
≥80 vs <80 μg/L 2.0 (1.1-3.6)  -56 (-144, 32) 
 
 
TTHM (μg/d) via   mean 
showering and   birth weight 
bathing  RR of SGA difference (g) 
0.02 - 0.09 1.0   0 
0.1 - 0.8  1.2 (0.7-2.2)  -39 (-99, 22) 
0.9 - 1.5  1.0 (0.5-1.8)  7 (-52, 66) 
1.6 - 27.1  1.6 (1.0-2.7)  5 (-57, 67) 
 
Results for estimated total TTHM exposure through tap water 
ingestion and showering and bathing were similar to results for 
estimated exposure through showering and bathing alone. 
 
No evidence of association between HAA exposure, either 
residential concentrations or exposure via tap water consumption 
and SGA or term BW. 
 
No evidence of dose response relationship between birth weight 
and TTHM, HAA5, or TOX. 
A large excess risk of 
SGA was significantly 
associated with 
residential 
concentration of ≥  80 
μg/L TTHM 
compared to < 80 
μg/L during the 3rd 
trimester. 
 
The highest quartile 
of personal TTHM 
exposure was 
consistently 
associated with 
increased risk of 
SGA across all 3 
trimesters. 
 
The same cohort 
study in a different 
paper175 suggests 
overall trend of 
decreasing 
probability of PTD 
with increasing levels 
of residential TTHM 
and HAA5 
concentration during 
2nd trimester. 
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 Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
Aggazzotti79 Italy 
 
Case-control study 
in 9 Italian cities. 
 
1999-2000 
239 term SGA 
343 preterm 
 
Questionnaire on individual 
water habits during 
pregnancy. 
 
Water sampling for THMs at 
mothers’ homes (few days 
after delivery). 
 
Two composite 3rd trimester 
exposure variables created:  
one based on DBP levels and 
tap water consumption, the 
other based on DBP levels 
and inhalation exposure. 
 
High THM exposure 
categorised as a combination 
of THM concentration >10 
μg/l, being a tap water 
consumer, and high 
inhalation exposure. 
 
Education 
Smoking 
Sex of child 
Type of drinking water 
Tap water based 
beverages intake 
High THM exposure  -vs- low THM exposure (reference) 
 
Outcome   OR 
Term SGA  0.63 (0.31-1.28) 
Preterm   0.73 (0.56-1.35) 
 
Overall exposure to high levels of DBPs in drinking water (THMs 
≥  30μg/l, chlorites  ≥  200μg/l  or chlorates ≥  200μg/l) produced 
an OR of 1.38 (0.92-2.07) for risk of term SGA. 
 
Very low THM concentrations were observed in this study. 
 
THM exposure was 
not significantly 
associated with either 
term SGA or preterm 
birth. 
 
 
Nieuwenhuijs
-en et al.96 
 
Avon, UK 
 
Prospective cohort 
study 
 
11,462 pregnant 
women – part of 
ALSPAC study in 
1991-1992 
 
 
Birth weight 
 
Hours per week of swimming 
during first 18-20 weeks of 
pregnancy – assessed by 
questionnaire. 
 
Never 
Up to 1 hr per week 
2-6 hrs per week 
7+ hrs per week 
Maternal age 
Parity 
Maternal ethnicity 
Maternal Education 
Housing tenure 
Smoking 
Alcohol consumption 
Illicit drug use 
Gestational age 
Infant gender 
 
Birth Weight 
Hrs swimming Birth weight difference (g) 
Never 
<1 hr/wk   7.84 (-10.36, 26.05) 
2+ hrs/wk  16.74 (-11.40, 44.90) 
 
 
No association 
between duration of 
swimming and 
adverse effects on 
birth weight. 
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 Author Study details and 
design 
Outcomes of 
interest 
and no. of cases 
Exposure measure Analyses adjusted 
for: 
Main findings 
(Confidence intervals shown are at 95% unless otherwise 
indicated, statistically significant findings are shown in bold) 
General direction of 
finding 
Juhl et al. 97 Denmark 
 
Prospective cohort 
study 
 
74,486 singleton 
pregnancies - 
Danish National 
Birth Cohort – 
1996-2002 
Birth weight 
6756 SGA 
3673 PTD 
Swimming/exercise and 
duration of activity assessed 
by interview twice during 
pregnancy, at weeks 12-16 
and week 30 
 
Swimming (compared to 
bicyclists and non-exercisers) 
 
<90 vs 90+ minutes per week 
of swimming 
Maternal age 
Parity 
Occupational status 
Smoking 
Pre-pregnancy BMI 
Gestational age* 
Infant gender* 
Gravidity** 
Previous 
miscarriage** 
Maternal illnesses** 
Abdominal diseases** 
Subfecundity** 
Bleeding in early 
pregnancy** 
Coffee/alcohol 
consumption** 
Working hours** 
Working position** 
Physically strenuous 
work** 
Psycho-social 
jobstrain** 
 
* only included in 
analysis for birth 
weight 
**only included in 
analysis for PTD 
Swimming during pregnancy -vs- no exercise (reference) 
 
Outcome     
Birth weight difference (g)  7 (-3, 16) 
 
Outcome   HR 
SGA   0.97 (0.90 -1.04) 
PTD   0.80 (0.72 -0.88) 
 
 
Birth Weight 
Min swimming Birth weight difference (g) 
No exercise 0 
<90 min/wk  5 (-6, 15) 
90+ min/wk 20 (-3 , 42) 
 
SGA 
Min swimming HR 
No exercise 1.00 
<90 min/wk  0.92 (0.85, 0.99) 
90+ min/wk 0.95 (0.80, 1.13) 
 
PTD 
Min swimming HR 
No exercise 1.00 
<90 min/wk  0.80 (0.72, 0.89) 
90+ min/wk 0.78 (0.61, 1.00) 
 
No association 
between swimming in 
pool water during 
pregnancy and 
increased risk of 
adverse fetal growth 
outcomes. 
 
Slight reduction in 
risk of PTD for 
women who swam in 
early/mid pregnancy, 
compared with non-
exercisers. 
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 Table 1.3  Summary of toxicology studies 
(continues on following pages) 
Class DBP Author Animal Dose Exposure 
method 
Effects on fetal growth Other reproductive 
effects 
Malformations Effect level 
N=NOAEL 
L=LOAEL 
Maternal 
toxicity 
observed? 
THM Chloroform Dilley et al.120 Rat 0-20 g/m3 Inhalation Reduced fetal weight, 
length, size 
Increased fetal 
mortality 
No teratogenic 
effect 
Insufficient 
data 
 
THM Chloroform Murray et 
al.119 
Mouse 0-100 ppm for 7 
hrs per day for 7-
10 days 
Inhalation Reduced fetal weight, 
length 
Decreased pregnancy 
incidence 
Skeletal and cleft 
palate 
malformations 
NA Yes 
THM Chloroform Ruddick et 
al.117 
Rat 0-400 mg/kg for 10 
days 
Gavage (in corn 
oil) 
Reduced fetal body weight 
at highest dose 
Fetotoxicity No adverse effect L=100 
mg/kg/day 
Yes 
THM Chloroform Schwetz et 
al.121 
Rat 0-300 ppm for 7hrs 
per day for 10 
days 
Inhalation Retarded fetal 
development, reduced fetal 
body measurements 
Fetal resorption (at 
highest dose) 
Minor skeletal 
defects 
L=30 ppm Yes 
THM Chloroform Thompson et 
al.118 
Rat 0-126 mg/kg/day 
for 10 days 
Gavage (in oil) Reduced fetal weight No adverse effect No adverse effect N= 50 
mg/kg/day 
Yes 
THM Chloroform Thompson et 
al.118 
Rabbit 0-50 mg/kg/day for 
13 days 
Gavage (in oil) Reduced fetal weight No adverse effect No adverse effect L=20 
mg/kg/day 
Yes 
THM DCBM Christian et 
al.123 
Rat 0-82 mg/kg/day Orally in drinking 
water 
No adverse effect No adverse effect Minor skeletal 
defects 
N=45 
mg/kg/day 
Yes 
THM DCBM Christian et 
al.123 
Rabbit 0-55.3 mg/kg/day Orally in drinking 
water 
No adverse effect No adverse effect No adverse effect N≥  55.3 
mg/kg/day 
Yes 
THM DCBM Christian et 
al.122 
Rat 0-109 mg/kg/day Orally in drinking 
water 
No adverse effect Delayed sexual 
maturation 
No adverse effect N= 450 
ppm 
Yes 
THM DCBM Delaney et 
al.125 
Rat 5.8-40.3 
mg/kg/day 
Orally in drinking 
water 
No adverse effect No adverse effect No adverse effect   
THM DCBM Narotsky et 
al.124 
Rat 0-75 mg/kg for 10 
days 
Gavage (in oil or 
aqueous vehicle) 
No adverse effect Fetal resorption No adverse effect N=25 
mg/kg/day 
L=50 
mg/kg/day 
Yes 
THM DCBM NTP126 Rat 0-1300 ppm Orally in drinking 
water 
No adverse effect No adverse effect No adverse effect N=1300 
ppm 
Yes ≥  700 
ppm 
THM DCBM Ruddick et 
al.117 
Rat 0-200 mg/kg for 10 
days 
Gavage (in corn 
oil) 
No adverse effect No adverse effect No adverse effect N=200 
mg/kg/day 
Yes 
THM DBCM Borzelleca et 
al.129 
Mice 0-685 mg/kg  Slight reduction fetal weight Decreased litter 
size/pup viability 
No adverse effect   
THM DBCM Ruddick et 
al.117 
Rat 0-200 mg/kg for 10 
days 
Gavage (in corn 
oil) 
No adverse effect No adverse effect No adverse effect N=200 
mg/kg/day 
Yes 
THM Bromoform Gulati et al.130 Mice 0-200 mg/kg  No adverse effect No adverse effect No adverse effect   
THM Bromoform Ruddick et 
al.117 
Rat 0-200 mg/kg for 10 
days 
Gavage (in corn 
oil) 
No adverse effect No adverse effect No adverse effect N=200 
mg/kg/day 
No 
HAA DCAA Smith et al.131 Rat 0-2400 mg/kg/day 
for 10 days 
Gavage Reduced fetal weight and 
length (dose response) 
Fetal resorption (≥  
900mg/kg) 
Cardiovascular 
malformations 
(frequency is dose 
related) 
N=14 
mg/kg/day 
Yes 
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 Class DBP Author Animal Dose Exposure 
method 
Effects on fetal growth Other reproductive 
effects 
Malformations Effect level 
N=NOAEL 
L=LOAEL 
Maternal 
toxicity 
observed? 
HAA TCAA Smith et al.132 Rat 0-1800 mg/kg/day 
for 10 days 
Gavage Reduced fetal weight (dose 
response), reduced crown-
rump length (dose 
response) 
Embryolethality (dose 
response), fetal 
resorption 
Cardiovascular, 
soft tissue and 
skeletal 
malformations 
(frequency is dose 
related) 
L=330 
mg/kg/day 
Yes 
HAA DBAA Christian et 
al.133 
Rat 0-132.0 mg/kg/day Orally in drinking 
water 
No adverse effect Adverse sperm effects, 
changes in male 
reproductive organs. 
Not investigated N= 50 ppm Yes 
HAA DBAA Klinefelter et 
al.134 
Rat 0-76.3 mg/kg/day 
for 56 days 
Orally in drinking 
water 
No adverse effect Adverse sperm effects, 
delayed sexual 
maturation 
 N= 0.4 
mg/kg/day 
L=40 ppm 
 
HAN CAN Smith et al.135 Rat 0 and 55 
mg/kg/day for 15 
days 
Gavage (in oil) Reduced fetal weight No adverse effect No adverse effect NA Yes 
HAN CAN Ahmed et 
al.136 
Mice 0-50 mg/kg/day for 
13 days 
Orally (in corn 
oil) 
Reduced fetal weight Reduced fetal viability Skeletal anomalies L=12.5 
mg/kg/day 
Not 
reported 
HAN DCAN Smith et al.135 Rat 0 and 55 
mg/kg/day for 15 
days 
Gavage (in oil) Reduced fetal weight Fetal resorption (dose 
response) 
Cardio/skeletal/uro
genital 
malformations 
NA Yes 
HAN DCAN Smith et al.137 Rat 0-45 mg/kg/day for 
13 days 
Gavage (in oil) Reduced fetal weight (dose 
response) 
Fetal resorption (dose 
response) 
Cardiovascular, 
urogenital, skeletal 
malformations 
(frequency is dose 
related) 
N=15 
mg/kg/day 
Yes 
HAN TCAN Christ et al.138 Rat 0-75 mg/kg/day Gavage (in corn 
oil) 
Reduced fetal weight (dose 
response), reduced crown-
rump length 
Embryo lethality, fetal 
resorption, decreased 
litter size 
External, soft and 
skeletal 
malformations 
N=15 
mg/kg/day 
L=35mg/kg/
day 
Yes 
HAN TCAN Smith et al.135 Rat 0 and 55 
mg/kg/day for 15 
days 
Gavage (in oil) Reduced fetal weight Fetal resorption (dose 
response) 
Cardio/urogenital 
malformations 
NA Yes 
HAN TCAN Smith et al.139 Rat 0-55 mg/kg/day for 
13 days 
Gavage (in oil) Reduced fetal weight (dose 
response) 
Embryolethality (dose 
response), fetal 
resorption (dose 
response) 
Cardiovascular, 
urogenital 
malformations 
(frequency is dose 
related) 
N=1 
mg/kg/day 
Yes 
HAN BCAN Christ et al.140 Rat 0-65 mg/kg/day for 
13 days 
Gavage (in 
tricaprylin) 
Reduced fetal weight, 
reduced crown-rump length 
Embryotoxicity Cardiovascular, 
urogenital, skeletal 
malformations 
L=5 
mg/kg/day 
Yes 
HAN BCAN Smith et al.135 Rat 0 and 55 
mg/kg/day for 15 
days 
Gavage (in oil) Reduced fetal weight No adverse effect No adverse effect NA No 
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 Class DBP Author Animal Dose Exposure 
method 
Effects on fetal growth Other reproductive 
effects 
Malformations Effect level 
N=NOAEL 
L=LOAEL 
Maternal 
toxicity 
observed? 
HAN DBAN Smith et al.135 Rat 0 and 50 
mg/kg/day for 15 
days 
Gavage (in oil) Reduced fetal weight No adverse effect No adverse effect NA Yes 
Chloro-
phenols 
2-CP Exon et al.141 Rat 5-500 ppm for 84-
105 days 
Orally in drinking 
water 
No adverse effect Decreased pup 
survival, increased 
conception rate, 
decreased litter size (at 
highest dose), 
increased stillbirth (at 
highest dose) 
No adverse effect N=50 ppm 
L=500 ppm 
Not 
reported 
Chloro-
phenols 
2,4-DCP Borzelleca et 
al.142  
Mice 0-500 mg/kg/day 
for 108 days 
Orally in drinking 
water 
No adverse effect No adverse effects Not investigated N=500 
mg/kg/day 
No 
Chloro-
phenols 
2,4-DCP Exon et al.141 Rat 3-300 ppm for 84 - 
105 days 
Orally in drinking 
water 
No adverse effect Decreased litter size No adverse effect N=3 ppm 
L=30 ppm 
Not 
reported 
Chloro-
phenols 
2,4,6-TCP Exon et al.141 Rat 3-300 ppm for 84-
105 days 
Orally in drinking 
water 
No adverse effect Decreased litter size No adverse effect N=30 ppm 
L=300 ppm 
Not 
reported 
Chloral 
hydrate 
Chloral 
hydrate 
Kallman et 
al.143 
Mice 0-205 mg/kg/day Orally in drinking 
water 
No adverse effect No adverse effect No adverse effect N=205 
mg/kg/day 
No 
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 CHAPTER 2:  AIMS AND OBJECTIVES 
 
 
Aims 
The review of the literature in the previous chapter has shown that many previous epidemiological 
studies have been limited in their exposure assessment and/or their ability to control for 
confounding.  The aims of this study were to estimate exposure to DBPs during pregnancy for 
women in the Born in Bradford (BiB) birth cohort, improving upon methodology used in previous 
epidemiological studies, and whilst doing so to address some of the gaps in the literature with 
regard to DBP exposure assessment and potential confounding.  This exposure assessment will be 
used in, and will inform, an epidemiological analysis of DBP exposure and fetal growth outcomes 
in the BiB cohort, however this analysis is outside the scope of this study. 
 
The work required to achieve these aims can be split into four main themes as follows:  assessment 
of individual tap water use, measurement and modelling of area-level DBP concentrations, 
combining individual-level and area-level data, and validation of individual tap water use. 
 
Specific Objectives 
Assessment of individual tap water use 
• To describe patterns of individual water use amongst women in the BiB cohort. 
• To examine the demographic characteristics and lifestyle factors in the BiB cohort in 
relation to water use, in order to identify potential confounders for consideration in a future 
epidemiological analysis. 
 
Measurement and modelling of area-level DBP concentrations 
• To carry out systematic sampling of tap water, in order to provide data on DBP 
concentrations in the BiB study area for use in exposure assessment of the cohort and to 
contribute to a European database on DBP concentrations for the HiWATE study (see 
footnotea below). 
• To identify routinely collected data required for DBP exposure assessment, and to liaise 
with the local water company to access these data. 
                                                 
a HiWATE is an international study aiming to investigate potential human health risks associated with long-
term exposure to low levels of disinfectants and DBPs occurring in water for human consumption and use in 
the food industry.  The HiWATE study objectives include determining DBP composition and levels in 
drinking water in various regions in Europe, identifying determinants of DBPs and developing predictive 
models, assessing the risk of reproductive effects and risk of cancer in relation to disinfection practices and 
levels of DBPs, conducting risk-benefit analyses of microbial and chemical risks, and reviewing the water and 
health policies worldwide in relation to water disinfection.  Further details of the HiWATE study are available 
in Appendix E. 
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 • To model individual and total THM measurements to provide more robust area-level 
concentration estimates. 
 
Combining individual-level and area-level data 
• To link modelled area-level data on THM concentrations at the WSZ level with individual-
level data on water use for women in the BiB cohort. 
• To create THM exposure metrics for women in the BiB cohort, and to examine which are 
the most appropriate for use in future epidemiological analysis. 
• To assess the potential for exposure misclassification according to various exposure 
metrics, when compared with a gold-standard metric. 
• To identify the factors driving exposure to THMs for women in the BiB cohort. 
 
 Validation of individual tap water use 
• To validate individual water use data collected in the BiB study by conducting a more 
detailed nested validation study within a sub-sample of the BiB cohort. 
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 CHAPTER 3:  INDIVIDUAL WATER USE IN THE BiB COHORT 
 
 
3.1 INTRODUCTION 
This chapter describes the women in the study population and their patterns of water consumption, 
showering, bathing and swimming. 
 
3.2 METHODS 
3.2.1 Study population 
Born in Bradford (BiB) is a new prospective multi-ethnic birth cohort in the north of England.  The 
study population is drawn from the metropolitan district of Bradford.  Bradford is the eighth most 
deprived health community in the UK with an infant mortality rate which is significantly higher 
than the UK average.176  A greater proportion of babies born in Bradford are of low birth weight 
(9.7%) compared with England & Wales as a whole (7.5%).176  Nearly 50% of the 5,500 babies 
born each year in Bradford are to parents of South Asian origin.  The high prevalence of low birth 
weight and ethnicity in the Bradford community provides a unique setting in which to investigate 
the causes of adverse fetal growth and low birth weight.  Risk of infant mortality is higher amongst 
babies born to Pakistani mothers than white mothers in Bradford.177  In particular, cause of infant 
death varies by ethnicity, with infant mortality due to congenital anomalies being higher amongst 
babies born to Pakistani mothers compared to white mothers.177  Over 70% of marriages in the 
Bradford Pakistani community are cousin marriages, and some of Bradford’s excess infant mortality 
may be attributable to autosomal recessive inheritance, and thus consanguinity.177  However, whilst 
Bradford is not a typical UK community, there is no evidence that consanguinity should affect rates 
of low birth weight.  The BiB study was approved by the Bradford Research Ethics Committee. 
 
3.2.2 Recruitment 
Recruitment to the BiB study began in March 2007, and it is aimed to recruit between 10,000 and 
12,000 mother and baby pairs by the end of 2010.  All pregnant women booked for antenatal care at 
Bradford Royal Infirmary are invited to attend for a Glucose Tolerance Test (GTT) for gestational 
diabetes at approximately 26-28 weeks of gestation.  Those who attend the GTT clinic at Bradford 
Royal Infirmary are invited to participate in the BiB study.  Those who agree to participate 
complete a consent form and then answer a baseline questionnaire face-to-face with an interviewer.  
There are bilingual interviewers should women need to complete the recruitment, consent and 
questionnaire process in Urdu, Punjabi or Mirpuri.  Anthropometric measurements are taken by the 
interviewer at the same time.  Blood samples are collected as part of the GTT process and urine 
samples are also provided by the women.  The recruitment process is carried out by the BiB study 
team. 
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3.2.3 Data collection 
3.2.3.1 Collection of demographic and lifestyle data 
At recruitment a detailed baseline questionnaire is administered by bilingual researchers collecting a 
wide range of data on the womens’ lifestyle, environment, ethnicity, health and relation to the 
baby’s father.178  If the woman is related to the father of the baby other than by marriage, the nature 
of the relationship is recorded and a family tree is completed (one aim of the BiB study being to 
determine the prevalence of congenital anomalies in Bradford, and to describe their nature and 
association with consanguinity and other risk factors.178)  Two versions of the baseline 
questionnaire have been used: the pilot version used from March 2007 to August 2007, and the final 
version used from August 2007. 
 
3.2.3.2 Collection of water use data 
The baseline questionnaire includes a set of questions on water use to ascertain typical daily 
consumption of tap water, bottled water, tea, coffee, and squash (including any other drinks made 
with tap water) at home, work/study, or elsewhere; water filtering habits at home and work; and 
frequency and duration of showering, bathing and swimming whilst pregnant.  The water use 
section of the questionnaire is shown in Appendix C. 
 
3.2.4 Datasets for analysis 
3.2.4.1 Preliminary dataset 
A preliminary dataset of baseline questionnaire data for 39 women was made available in 
November 2008 in advance of the main dataset.  These women were selected as they had 
participated in a nested validation study, details of which are in Chapter 6. 
 
3.2.4.2 Main dataset 
A main dataset comprising all women recruited into the BiB study prior to end of May 2009 and 
who had completed the final version of the baseline questionnaire was made available in June 2009.  
It was not possible to include women who had completed the pilot version of the questionnaire, as 
datasets for the pilot and final versions of the questionnaire had not been integrated.  The main 
dataset was a flat file comprising one line of data for each of 4126 births to 4070 mothers.  The 
dataset contained 4015 singleton births, 54 sets of twins and 1 set of triplets, which meant that 55 
mothers were in the dataset more than once because they had multiple births.  Duplicated records 
for mothers of twins/triplets were excluded, so that their behaviour for each pregnancy was only 
counted once.   
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 A small number of women were represented in the dataset twice (n=22, 0.5%), under different ID 
numbers, because they had two pregnancies between August 2007 and May 2009.  These records 
were kept in the dataset, because overall this study is about exposure assessment for each 
pregnancy, and each time a woman was recruited to the study she completed a new baseline 
questionnaire. 
 
3.2.5 Data preparation for analysis 
3.2.5.1 Data cleaning and coding 
When the main dataset was received from BiB no data cleaning or checking had been performed, 
with the exception of residential address data.  Therefore, all variables required for this analysis 
were checked, cleaned and recoded as new variables where necessary.  The logical flow of some 
question sets, e.g. for smoking, meant that new variables had to be derived from a series of linked 
questions.  Overseas educational qualifications were recoded to the equivalent UK educational 
qualification, according to National Academic Recognition Information Centre (NARIC) guidelines 
on equivalency of educational qualifications.179 
 
3.2.5.2 Errors and extreme values 
Obvious errors in the dataset, and very extreme values in water use variables were queried directly 
with the BiB study team, with the request that the dataset be checked against the original paper 
questionnaire.  Where the dataset was found to be erroneous this was corrected.  Logistically, it was 
not possible to check all water use outliers against the original paper questionnaire.  Outliers were 
examined using boxplots, however this was not particularly successful, because even when the 
whiskers were increased from 1.5 IQR above the upper quartile to 3.0 IQR above, some plausible 
values were still classed as outliers.  In order not to exclude useful data, it was decided to not to rely 
on formal outlier testing but instead simply to make a judgement as to which values were 
implausibly high.  Values that were considered to be extreme were noted and new dummy variables 
were created to allow exclusion of extreme values from the analysis if necessary.  Conditions for 
coding these dummy variables were as follows:  if sum of all water intakes (including bottled water) 
across all locations exceeded 6 litres per day (i.e. 30 cups/glasses fluid per day), a dummy variable 
(extr_intake) was coded 1, otherwise coded 0.  If duration per shower exceeded 90 min, or 
showering per week exceeded 630 min (i.e. a 90 min shower 7 days a week) a dummy variable 
(extr_shwr) was coded 1, otherwise coded 0.  If duration per bath exceeded 120 min, or bathing per 
week exceeded 840 min (i.e. a 120 min bath 7 days a week) a dummy variable (extr_bath) was 
coded 1, otherwise coded 0.  If any of the previous showering/bathing conditions were met, or 
combined showering/bathing per week exceeded 840 min (i.e. 120 min of personal washing 7 days 
a week), a dummy variable (extr_wash) was coded 1, otherwise coded 0.  If duration per swim 
exceeded 120 min, or swimming per week exceeded 840 min (i.e. a 120 min swim 7 days a week), a 
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 dummy variable (extr_swim) was coded 1, otherwise coded 0.  If any of the above conditions 
applied, a dummy variable (extr_any) was coded 1, otherwise coded 0.   
 
3.2.5.3 Categorisation of population variables 
For analysis, women were categorised according to age, ethnicity, highest educational qualification, 
employment status, smoking, passive smoking, and household income.  Some ethnic categories 
contained very small numbers, e.g. Mixed ethnicity groups, so for analysis categories were 
collapsed to give 6 subgroups: White British, White Other, Black/Black British, Asian/Asian British 
– Pakistani, Asian/Asian British – Other, and All Other.  Pakistani women were categorised 
separately from other Asian/Asian British women, because there is a large distinct Pakistani 
community in Bradford, and birth weight has been shown to differ between Pakistani and other 
Asian groups in the UK.180  Educational qualifications which were equivalent (in terms of years of 
schooling or level of study required) were collapsed together to give 6 subgroups for analysis: No 
Qualifications, GCSE or equivalent, ‘A’ Level or equivalent, First degree or equivalent, Post-
graduate qualification, or Other.  Household income was split into 3 subgroups for analysis, 
representing approximate tertiles: <£11,000 per annum, £11,000-£25,000 per annum, and ≥ £25,000 
per annum.  However, a large proportion (n=840, 20.8%) responded that they did not know their 
household income and these women were disproportionately of Asian origin (76%).  Employment 
status was categorised as employed, employed but on maternity/sick leave, unemployed and full-
time student. 
 
3.2.5.4 Preparation of water use variables 
Individual water consumption was converted from glasses/cups to litres, to give volume per day.  
Each glass or cup represented 200ml of fluid.  Various new aggregate measures were created.  Total 
tap water consumption at home, work/study, and elsewhere were calculated by summing plain cold 
tap water, tea, coffee, and squash consumption at these respective locations.  Total tap water 
consumption at home, work/study, and elsewhere were then summed to give total tap water 
consumption across all locations.  Consumption at work/study was only allowed to contribute to 
total consumption across all locations, if the woman was employed, employed but on maternity/sick 
leave or a full-time student (because a few women (n=14) had clearly reported “past” consumption 
at work although they were not currently employed at the time of completing the questionnaire).   
Similarly, new aggregate variables for cold tap water-based beverages (summing plain cold tap 
water and squash) and hot tap water-based beverages (summing tea and coffee) were calculated for 
home, work/study, elsewhere, and then all locations.  For showering, bathing and swimming, 
frequency and duration were multiplied to give minutes spent showering, bathing and swimming 
per week.  Minutes of showering and bathing per week were summed to give a combined 
showering/bathing (min/week) variable. 
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3.2.5.5 Exclusions 
Women were excluded from the analysis if they had not answered all the questions on consumption 
of water, showering, bathing and swimming, leaving 4045 in the analysis.  Women who had 
answered all these questions but had not responded to one or both of the water filtering questions 
(n=10), were kept in the analysis as their quantitative data on water use was deemed valuable. 
 
3.2.6 Statistical analysis 
3.2.6.1 Analysis of population variables 
For continuous variables, i.e. maternal age and parity, normality was assessed by examining 
histograms and performing the Shapiro-Wilk test.  Relations between population characteristics 
were assessed using Cramer’s V statistic where one or both variables were categorical but not 
ranked, and Spearman’s correlation coefficient where one or both variables were ranked or 
continuous variables. 
 
3.2.6.2 Descriptive analysis of water exposure variables 
Normality of the water use variables was assessed by examining histograms, quantile-quantile (Q-
Q) plots and performing the Shapiro-Wilk test for normality.  Basic summary statistics were 
calculated for each water use variable, and 95% confidence intervals were calculated for means.   
Percentage contribution of tap water consumption at each location (home, work/study and 
elsewhere) to total tap water consumption was calculated for each woman (excluding those who 
reported no tap water consumption at all as their denominator would be zero), and then averaged to 
give the mean percentage contribution for each location.  Percentage contribution of each separate 
beverage to total tap water consumption at home, work/study, elsewhere and all locations was 
calculated for each woman, and then averaged to give the mean percentage contribution for all 
women.  Percentage contribution of hot vs. cold tap water-based beverages to total tap water 
consumption was calculated in a similar manner.  Percentages of women filtering tap water at home 
and at work were calculated. 
 
3.2.6.3 Variability in water use  
Variability in water use according to selected population variables was analysed in order to 
understand the potential for confounding in future epidemiological analyses.  The population 
variables selected were those highlighted by analysis of the preliminary dataset, and others known 
to be related to birth weight/fetal growth (i.e. likely to be potential confounders if also related to 
water use, and thus DBP exposure).  The variables selected were maternal age, ethnicity, smoking, 
passive smoking, employment status, and, as measures of SES, both educational qualification and 
household income. 
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Initially, boxplots of water use according to population variable subgroups were examined for 
differences or trends.  Scatter plots of water use against continuous age were plotted and examined.  
Basic statistics for each water use variable stratified by subgroup were calculated.  Univariate 
analysis using one-way ANOVA was used to assess differences in water use between population 
subgroups.  The data were not transformed because ANOVA is robust to deviations from normality 
for large samples.  Nonetheless, the non-parametric Kruskal-Wallis rank sum test was also used to 
assess differences in water use between population subgroups, in order to verify the conclusions 
drawn from the ANOVA analysis.  The percentage of total variability in a water use variable (e.g. 
showering per week) explained by variability due to a population variable (e.g. ethnicity), was 
calculated by dividing the sum of squares attributed to that population variable by the total sum of 
squares for the one-way ANOVA, and multiplying by 100.    This analysis was limited to the major 
water use variables that are likely to be influential in determining THM/DBP exposure, i.e. plain 
cold tap water consumption, cold tap water-based beverage consumption, hot tap water-based 
beverage consumption, total tap water consumption, and minutes per week of showering, bathing, 
combined showering/bathing and swimming.  The non-parametric Spearman’s correlation 
coefficient was used to assess correlation between continuous age and water use variables.  A 
sensitivity analysis was performed excluding individuals who had one or more extreme value in 
their water use variables, to assess their influence on mean water use values and ANOVA. 
 
To identify key predictors of water use, multivariate analysis was performed for each of the major 
water use variables, using automated stepwise model selection (stepAIC) in R statistical software 
version 2.4.1, based on minimising the AIC (Akaike information criterion).  Subjects with null 
values for any of the potential explanatory variables (age, ethnicity, smoking, passive smoking, 
employment status, education and household income) were excluded, leaving 3959 women in the 
analysis.  Linear regression models were used for all tap water consumption, showering and bathing 
variables.  Water use variables were log-transformed using the transformation log(x+1), with the 
exception of combined showering/bathing which was transformed using log(x) because it contained 
no zero values.  Natural logarithms were used.  Despite transformation, multivariate models for 
showering and bathing separately were a poor fit and failed to meet linear regression assumptions.  
Hence a final model was generated simply for combined showering/bathing, which did meet linear 
regression assumptions.  Final multivariate linear regression models were analysed using ANOVA, 
to assess the percentage of total variability in the water use explained by the variables in the model.  
For swimming, logistic regression was used, with a binary variable (swimming or not swimming 
during pregnancy).  Analysis was performed using R statistical software version 2.4.1.181 
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 The methods above describe the analysis of the main dataset.  For the preliminary dataset  
descriptive analysis was performed in a similar manner, with the exception that some population 
variables were collapsed into fewer categories due to the small numbers in cells.  ANOVA was not 
used, but differences between subgroups were assessed using the Kruskal-Wallis rank sum test for 
population variables with more than 2 categories and the Wilcoxon rank sum test for population 
variables which were dichotomous. 
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3.3 RESULTS 
This section presents results from the analysis of the main dataset (n=4045).  Results of the analysis 
of the preliminary dataset on 39 women were used to inform this analysis, and are shown in the 
published paper182 in Appendix D. 
 
3.3.1 Characteristics of the study population 
General characteristics of the study population are shown in Table 3.1.  The mean age of 
participants was 28 years.  The two main ethnic groups dominating the study population were White 
British (38.7%), and Pakistani (46.0%).    Just under half of the women were currently employed, 
and a small proportion were full-time students.  A large proportion of women reported that they did 
not know their household income (n = 840, 20.8%), and these women were disproportionately of 
Asian origin (n = 642, 76%).  13.8% of women reported being a current smoker, and only a small 
proportion of women reported consuming alcohol regularly during early pregnancy.  Most women 
completed the baseline questionnaire in English, but just under 20% completed it in Urdu, Mirpuri 
or Punjabi.  There were some differences in the percentage distribution of population variables 
according to ethnicity, in particular between White British and Asian Pakistani women.  Compared 
to White British women, a greater proportion of women of Asian Pakistani origin were 
unemployed, had no educational qualifications, had never smoked, did not consume alcohol during 
pregnancy and were married, as shown in Table 3.2. 
 
No strong correlations or associations were observed between any of these population variables, 
although there were moderate correlations between age and parity (Spearman’s correlation:  0.47, p 
< 0.0001), and age and income (Spearman’s correlation: 0.42, p < 0.0001), and weak inverse 
correlations between number of cigarettes smoked per day during early pregnancy and age (-0.21, 
p<0.0001), and income (-0.18, p<0.0001).  Weak to moderate associations (Cramer’s V: 0.3-0.5) 
were observed between ethnicity and employment status, marital status, smoking and alcohol 
consumption; between education and employment status; between employment status and income; 
between marital status and smoking; and between cohabiting status and income, age and smoking. 
 
 
3.3.2 Water consumption 
Water consumption variables were not normally distributed, but were right-skewed.  Descriptive 
statistics for water consumption for the 4045 women in the study population are shown in Table 3.3, 
and percentage contributions to total tap water consumption from individual beverages, and from 
cold vs. hot tap water-based beverages are shown in Table 3.4. 
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 3.3.2.1 Water consumption at home 
97.8% of women consumed tap water in some form at home, and mean total tap water consumption 
at home was 1.38 l/day (1.36, 1.41) (Table 3.3).  Only a small proportion of women (13.4%) 
reported drinking bottled water at home.  Overall, 70% of total tap water consumed at home was 
consumed cold, and 30% consumed as hot beverages, and the relative proportions were very similar 
for unemployed, employed and full-time students (Table 3.4).   
 
3.3.2.2 Water consumption at work or study 
Amongst those women who were employed or full-time students (n=1880), 54.8% reported 
consuming tap water in some form at work/study and mean total tap water consumption was 0.41 
l/day (0.39, 0.44).  44.3% reported drinking bottled water at work/study, a greater proportion than 
for any of the other individual beverages recorded (Table 3.3).   Overall, just over half (51.4%) of 
total tap water consumed by employed women at work was consumed cold (Table 3.4).  For full-
time students the majority of total tap water consumption at work/study was consumed cold, 
however the values shown in Table 3.4 are based on only a handful of full-time students (n=10) 
who reported consuming tap water at work/study. 
 
3.3.2.3 Water consumption elsewhere 
Only 4.2% of women reported consuming any tap water or tap-water based beverages elsewhere 
(i.e. locations other than home or work/study), and only 3.3% reported consuming bottled water 
elsewhere (Table 3.3).  The very small proportion of women reporting water consumption 
elsewhere may reflect the manner in which the question was asked in the questionnaire – it 
asked for typical consumption per day during pregnancy.  This may be difficult to estimate 
for water consumption elsewhere, which may not occur on a daily basis.  For example, 
women could go to the gym once or twice a week and do physical exercise requiring 
rehydration with water.  However the ‘typical’ day may be one on which the woman does 
not go to the gym, thus she reports zero water consumption elsewhere. 
 
3.3.2.4 Water consumption across all locations 
Overall, 98.5% of women consumed tap water in some form, and mean total tap water consumption 
across all locations was 1.60 l/day (1.57, 1.62) (Table 3.3).  On average, the largest component of 
total tap water consumption across all locations came from plain cold tap water (50.5%), followed 
by tea (24.7%), squash (18.2%) and then coffee (6.6%).  The majority (68.7%) of total tap water 
consumed across all locations was consumed cold, and this was similar for unemployed, employed 
and student subgroups (Table 3.4). 
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 3.3.2.5 Percentage contribution of consumption at different locations 
For unemployed women, 98.7% of tap water consumption occurred at home, whilst for employed 
women 76.0% of tap water consumption occurred at home, and 23.2% at work.   Full-time students 
were most similar to unemployed women in that almost all tap water consumption occurred at home 
(94.7%), with only a small proportion (4.2%) occurring at work/study.  Contribution of 
consumption elsewhere was negligible for all women (≤  1.3%). 
 
3.3.3 Water filtering habits 
Only 9.6% of women reported filtering the water they drink at home.  Amongst employed women 
and full-time students (n=1880), 45.1% reported filtering the water they drink at work. 
 
3.3.4 Showering, Bathing and Swimming 
Descriptive statistics for showering, bathing and swimming are shown in Table 3.5.  Showering and 
bathing activities were not normally distributed, but were right-skewed.  All women spent time 
showering and/or bathing.  70.2% women reported showering, amongst whom the mean duration 
per shower was 19 minutes (18, 20).  69.5% of women reported bathing, amongst whom the mean 
duration per bath was 36 minutes (36, 37).  On average women spent 155 minutes per week, i.e. 2 
hours 35 minutes, on combined showering/bathing.  The distribution for swimming was very right-
skewed.  Only 7.3% of women reported swimming at least once per week, amongst whom the mean 
duration per swimming session was 57 minutes (54, 61) (Table 3.5). 
 
3.3.5 Variability in water consumption 
One-way ANOVA showed that water consumption varied according to demographic characteristics 
and lifestyle factors (Table 3.6).  In summary, univariate analysis found statistically significant 
differences between group means for consumption of plain cold tap water (according to ethnicity, 
education, employment status, smoking, passive smoking and age), consumption of cold tap water-
based beverages (according to ethnicity, smoking and age), consumption of hot tap water-based 
beverages (according to ethnicity, education, employment, smoking, passive smoking, age and 
household income), and total tap water consumption (according to ethnicity, employment status, 
smoking, and passive smoking).  Results of the non-parametric Kruskal-Wallis rank sum test were 
largely in line with those from the one-way ANOVA. 
 
Of particular note, given the multi-ethnic composition of the BiB cohort, and likely differences in 
DBP concentrations in non-boiled and boiled water, was the finding that consumption of cold tap 
water (either plain or including squash) was greater for Asian Pakistani women compared to White 
British women.  However, consumption of hot tap water beverages (tea and coffee) by White 
British women was, on average, more than twice that of Asian Pakistani women.  On average, total 
80
 tap water consumption was ~20% greater for White British women compared to Asian Pakistani 
women. 
 
The differences between subgroups whilst statistically significant were generally quite small (~0.1 
to 0.4 L/day).  On the whole, as assessed by ANOVA, the demographic characteristics and lifestyle 
factors examined explained little (<11%) of the total variability in water consumption (Table 3.6).  
There must be other factors not accounted for in this analysis which explain more of the variability 
in tap water consumption – perhaps physiological and psychological determinants of thirst, and 
during pregnancy in particular, gestational diabetes may be an important determinant. 
 
In multivariate analysis, ethnicity, smoking, and household income were included in the model as 
predictors of plain cold tap water consumption, explaining 9.7%, 0.9%, and 0.3% respectively of 
total variability.  For consumption of cold beverages from tap water, ethnicity, smoking and age 
were selected as explanatory variables, explaining 3.1%, 0.5%, and 0.4% respectively of total 
variability.  For consumption of hot beverages from tap water, ethnicity, smoking, age, employment 
status and passive smoking were included in the model, with these variables explaining 12%, 3.2%, 
2.3%, 0.1% and 0.1% respectively of total variability.  Finally, ethnicity, smoking, age, and 
employment status were included in the multivariate model as predictors of total tap water 
consumption, with these factors explaining 2.5%, 0.6%, 0.5% and 0.2% respectively of total 
variability.  Whilst ethnicity was the most influential factor determining variability of tap water 
consumption in multivariate models, it still only explained a small proportion of total variability. 
 
3.3.6 Variability in water filtering 
The proportions of women filtering their drinking water at home appeared to increase slightly 
across increasing educational achievement, age and household income categories (data not shown).  
Fewer current smokers (5.9%) filtered water at home compared with previous (9.9%) or never 
smokers (10.3%).  However, in all population subgroups the frequency of water filtering at home 
was relatively small (≤  20.8%), and there were no large differences in behaviour between 
subgroups.  Amongst women who were employed or full-time students, proportions filtering tap 
water at work/study were generally in the range 40-50%, with the exception of those in the lowest 
categories for education (no qualifications: 29.4%), age (< 20 years: 22.2%) and income (<£11,000 
pa.: 28.6%), current smokers (35.4%), White Other (35.9%) or Black/Black British (33.3%).  A 
smaller proportion of employed women on maternity/sick leave (31.3%) reported filtering tap water 
at work compared with those not maternity/sick leave (46.2%).  Only 9.9% of full-time students 
reported filtering water at work and a large proportion answered “not applicable”.  This may reflect 
the fact that “study” was not specifically mentioned in the question “Do you filter the water you 
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 drink at work?” in contrast to the previous question “On a typical day how much of the following 
do you drink?...at work/study.” 
 
3.3.7 Variability in showering, bathing and swimming 
Variability in showering, bathing and swimming according to selected population variables is 
shown in Table 3.7.  One-way ANOVA revealed significant differences between group means for 
time per week spent showering (according to all variables except income), bathing (according to all 
variables), combined showering/bathing (according to all variables), and swimming (according to 
all variables except age and passive smoking).  Results of the non-parametric Kruskal-Wallis rank 
sum test were largely in line with those from the ANOVA analysis. 
 
Overall, Asian women spent approximately 45-60 minutes per week less on combined 
showering/bathing compared with any other ethnic group.  On average, current smokers spent 41 
minutes more per week than previous smokers, and 80 minutes more per week than never smokers 
on combined showering/bathing.  Similar patterns were observed in relation to passive smoking and 
this difference was still evident even when all current smokers had been excluded from the analysis 
(data not shown).  There was a clear pattern of decreasing time spent on combined 
showering/bathing across increasing age groups, with a difference of 114 min per week (almost 2 
hours) between the youngest and oldest age groups.  Women in the lowest income category spent 
approximately 35-40 minutes more per week on showering/bathing compared with women in the 
medium and high income categories.  These findings are particularly noteworthy given the known 
associations between fetal growth and ethnicity, smoking, maternal age and SES.   
 
Swimming was more common amongst White women compared with Black or Asian women, 
probably reflecting cultural differences.  The proportion of swimmers increased with increasing 
level of educational qualification, and income, perhaps reflecting ability to afford such leisure 
activities.  Swimming was approximately twice as common amongst previous smokers compared 
with current or never smokers, and this might reflect overall lifestyle changes towards more healthy 
behaviour associated with quitting smoking. 
 
Spearman’s correlation coefficients showed inverse correlations between age as a continuous 
variable and duration per shower (-0.25, p<0.0001), duration per bath (-0.19, p<0.0001), overall 
combined showering/bathing per week (-0.20, p<0.0001), and duration per swim (-0.25, p<0.0001). 
 
Overall, demographic characteristics and lifestyle factors explained little (<6%) of the total 
variability in showering, bathing and swimming behaviour (Table 3.7). 
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 In the multivariate model for time spent on combined showering/bathing per week, the explanatory 
variables included in the model were smoking, age, ethnicity, education, employment status, and 
passive smoking, and these variables explained 5.3%, 2.5%, 1.9%, 0.5%, 0.2%, and 0.2% 
respectively, of total variability.  Overall the model explained 10.5% of total variability in combined 
showering/bathing. 
 
In a multivariate logistic regression model for swimming during pregnancy as a binary dependent 
variable, the explanatory variables selected for model inclusion were ethnicity, education, income 
and smoking, although variability due to smoking was not significant (p=0.11) according to 
ANOVA. 
 
3.3.8 Sensitivity analysis 
Excluding extreme water use values from the analysis had little effect upon water consumption 
means (for a few variables these decreased by 0.01 l/day, and total tap water across all locations 
decreased by 0.02 l/day).  Mean values for time spent showering, bathing and swimming per week 
were decreased by only 2-3 minutes.  Results for one-way ANOVA analysis were not affected, with 
the exception that differences between employment status group means for cold tap water-based 
beverages became significant and those for age group means were no longer significant. 
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 Table 3.1  Study population characteristics 
n %
All 4045 100
<20 298 7.4
20-24 1082 26.8
25-29 1309 32.4
30-34 836 20.7
35-39 447 11.1
≥  40 72 1.8
Missing 1 0.02
White British 1565 38.7
White Other 96 2.4
Black or Black British 104 2.6
Asian or Asian British, Pakistani 1860 46.0
Asian or Asian British, Other 292 7.2
All others 126 3.1
Missing 2 0.05
Employed 1615 39.9
Employed but on Maternity/Sick leave 184 4.5
Unemployed 2165 53.5
Full-time student 81 2.0
No Qualifications 696 17.2
GCSE or equivalent* 1574 38.9
A' Level or equivalent** 561 13.9
First degree*** 622 15.4
Post-graduate 270 6.7
Other 262 6.5
Missing 60 1.5
<£11,000 1013 25.0
£11,000 - £24,999 1173 29.0
≥  £25,000 961 23.8
Missing 898 22.2
Current smoker 559 13.8
Past smoker 609 15.1
Never smoker 2877 71.1
Exposed >1 hour/day 513 12.7
Exposed < 1 hour/day 750 18.5
Not exposed 2757 68.2
Missing 25 0.6
Once per week or more 173 4.3
Occasionally 482 11.9
Not consumed 3373 83.4
Missing 17 0.4
0 1575 38.9
1 1194 29.5
2 654 16.2
3 308 7.6
4 136 3.4
≥  5 78 1.9
Missing 100 2.5
Married or Re-married 2811 69.5
Never married 1148 28.4
Separated, Divorced or Widowed 80 2.0
Missing 6 0.1
Living with baby's father 3407 84.2
Living with another partner 7 0.2
Not living with a partner 622 15.4
Missing 9 0.2
English 3288 81.3
Mirpuri or Punjabi 257 6.4
Urdu 468 11.6
Other 5 0.1
Missing 27 0.7
Language of 
questionnaire 
completion
Parity
Marital Status
Passive smoking 
during pregnancy
Alcohol consumption 
during 1st trimester
Cohabitation
Highest Educational 
Qualification
Household Income
Smoking
Characteristics
Age
Ethnicity
Employment status
 
† GCSE/NVQ Levels 1 or 2 / Foundation or Intermediate GNVQ, ‡'A' Level / NVQ Level 3 / Advanced GNVQ, §First 
university degree (e.g. Bachelors degree) / NVQ Levels 4 or 5 / HNC / HND 
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 Table 3.2  Percentage distribution of population characteristics by ethnicity 
White 
British
White 
Other
Black/ 
Black 
British
Asian/ 
Asian 
British, 
Pakistani
Asian/ 
Asian 
British, 
Other
All 
Others
<20 12.2 8.3 1.9 3.5 3.8 16.7
20-24 27.9 31.3 15.4 27.7 18.8 22.2
25-29 27.7 43.8 35.6 35.8 35.6 21.4
30-34 18.1 12.5 30.8 21.7 26.0 22.2
35-39 11.8 4.2 13.5 9.9 13.7 15.9
≥  40 2.2 0 2.9 1.5 2.1 1.6
Missing 0.1 0 0 0 0 0
Employed 61.0 57.3 51.0 20.2 42.8 40.5
Employed but on Maternity/Sick leave 5.4 8.3 9.6 3.5 4.8 1.6
Unemployed 31.4 33.3 36.5 74.8 49.0 54.0
Full-time student 2.2 1.0 2.9 1.5 3.4 4.0
No Qualifications 11.4 8.3 12.5 23.8 11.6 15.1
GCSE or equivalent† 43.6 17.7 27.9 39.5 27.1 26.2
A' Level or equivalent ‡ 16.4 18.8 6.7 12.5 12.0 9.5
First degree§ 13.2 10.4 26.9 13.9 26.4 32.5
Post-graduate 5.8 15.6 9.6 5.8 13.7 6.3
Other 8.5 24.0 14.4 3.2 7.5 7.1
Missing 1.2 5.2 1.9 1.4 1.7 3.2
<£11,000 26.4 22.9 34.6 23.5 21.6 33.3
£11,000 - £24,999 26.6 41.7 33.7 30.6 30.5 19.0
≥  £25,000 39.9 22.9 20.2 9.8 26.4 27.8
Missing 7.2 12.5 11.5 36.1 21.6 19.8
Current smoker 28.9 16.7 1.0 3.1 3.8 17.5
Past smoker 28.0 37.5 8.7 4.7 5.1 17.5
Never smoker 43.1 45.8 90.4 92.2 91.1 65.1
Exposed >1 hour/day 21.1 14.6 2.9 6.7 5.1 20.6
Exposed < 1 hour/day 59.0 68.8 78.8 73.7 80.1 62.7
Not exposed 19.4 16.7 17.3 18.8 14.7 15.9
Missing 0.5 0 1.0 0.8 0 0.8
Once per week or more 9.7 5.2 2.9 0 0.7 8.7
Occasionally 27.0 21.9 10.6 0 4.1 10.3
Not consumed 62.7 72.9 84.6 99.6 95.2 81.0
Missing 0.6 0 1.9 0.3 0 0
0 45.4 64.6 35.6 31.6 40.1 46.8
1 32.1 24.0 38.5 27.3 27.7 31.0
2 12.5 5.2 15.4 20.2 16.8 11.1
3 4.4 0.0 5.8 11.2 5.8 5.6
4 1.9 2.1 1.0 4.8 4.1 2.4
≥  5 1.3 1.0 1.0 2.8 1.4 0
Missing 2.5 3.1 2.9 2.1 4.1 3.2
Married or Re-married 33.4 46.9 64.4 97.8 98.3 54.0
Marital status Never married 63.4 51.0 30.8 0.9 1.0 43.7
Separated, Divorced or Widowed 3.1 1.0 4.8 1.2 0.7 1.6
Missing 0.1 1.0 0 0.1 0 0.8
Living with baby's father 72.7 88.5 70.2 93.8 95.9 67.5
Living with another partner 0.3 1.0 1.0 0 0 0.8
Not living with a partner 26.9 9.4 28.8 5.9 4.1 31.7
Missing 0.1 1.0 0 0.3 0 0
English 99.6 96.9 97.1 62.8 84.6 94.4
Mirpuri or Punjabi 0 1.0 2.9 13.0 3.4 1.6
Urdu 0.1 1.0 0 23.2 10.3 2.4
Other 0 1.0 0 0.1 1.0 0
Missing 0.4 0.0 0 0.9 0.7 1.6
Alcohol 
consumption 
during 1st 
trimester
Parity
Cohabiting 
status
Language of 
questionnaire 
completion
Highest 
Educational 
Qualification
Household 
Income
Smoking
Passive 
smoking during 
pregnancy
%
Age
Employment 
status
Characteristics
 
† GCSE/NVQ Levels 1 or 2 / Foundation or Intermediate GNVQ, ‡'A' Level / NVQ Level 3 / Advanced GNVQ, 
§First university degree (e.g. Bachelors degree) / NVQ Levels 4 or 5 / HNC / HND 
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 Table 3.3  Individual water consumption as measured by Questionnaire (n = 4045) 
       Percentile Distribution Consumed  
Variable Mean (95% CI) SD Min 25th %ile Median 75th %ile Max n % 
Consumption (l/day)           
at Home           
Plain cold tap water 0.72 (0.70, 0.74) 0.60 0 0.20 0.60 1.00 8.00 3290 81.3 
Tea 0.33 (0.31, 0.34) 0.44 0 0 0.20 0.40 12.00 2748 67.9 
Coffee 0.08 (0.07, 0.09) 0.26 0 0 0 0 4.00 644 15.9 
Squash 0.26 (0.25, 0.27) 0.37 0 0 0 0.40 4.00 1991 49.2 
Total tap water 1.38 (1.36, 1.41) 0.79 0 0.80 1.20 1.80 12.20 3956 97.8 
Bottled water 0.09 (0.08, 0.10) 0.30 0 0 0 0 4.00 542 13.4 
at Work/Study           
Plain cold tap water* 0.19 (0.17, 0.21) 0.39 0 0 0 0.20 4.00 513 27.3 
Tea* 0.11 (0.10, 0.13) 0.27 0 0 0 0 4.00 455 24.2 
Coffee* 0.06 (0.05, 0.07) 0.21 0 0 0 0 3.20 248 13.2 
Squash* 0.05 (0.04, 0.06) 0.18 0 0 0 0 2.00 193 10.3 
Total tap water* 0.41 (0.39, 0.44) 0.55 0 0 0.20 0.60 4.00 1031 54.8 
Bottled water* 0.34 (0.32, 0.36) 0.50 0 0 0 0.60 4.00 833 44.3 
Elsewhere           
Plain cold tap water 0.01 (0, 0.01) 0.06 0 0 0 0 1.00 70 1.7 
Tea 0.01 (0.01, 0.01) 0.09 0 0 0 0 3.00 80 2.0 
Coffee 0 (0, 0) 0.04 0 0 0 0 1.20 35 0.9 
Squash 0 (0, 0.01) 0.05 0 0 0 0 1.00 55 1.4 
Total tap water 0.02 (0.02, 0.03) 0.14 0 0 0 0 3.00 171 4.2 
Bottled water 0.01 (0.01, 0.02) 0.10 0 0 0 0 3.00 133 3.3 
Across all locations           
Plain cold tap water  0.81 (0.79, 0.83) 0.66 0 0.40 0.80 1.20 8.00 3353 82.9 
Tea  0.39 (0.37, 0.40) 0.51 0 0 0.20 0.40 12.80 2891 71.5 
Coffee  0.11 (0.10, 0.12) 0.33 0 0 0 0 4.00 782 19.3 
Squash  0.29 (0.27, 0.30) 0.41 0 0 0.20 0.40 4.00 2054 50.8 
Total tap water  1.60 (1.57, 1.62) 0.89 0 1.00 1.40 2.00 13.00 3986 98.5 
Bottled water  0.26 (0.25, 0.28) 0.50 0 0 0 0.40 5.80 1347 33.3 
*amongst those who were employed or full-time students (n = 1880) 
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 Table 3.4  Average percentage contribution to total tap water consumption at each location from 
a) individual beverages, and b) cold vs. hot water-based beverages 
   
  
Average % contribution to total tap water consumption at each location 
from: 
  
 
Individual beverages Cold vs Hot tap water 
based beverages 
   n* Plain tap water Tea Coffee Squash Cold Hot 
         
All women  Home 3956 50.9 23.9 5.7 19.4 70.4 29.6 
Work/Study - - - - - - - 
Elsewhere 171 31.7 34.6 13.9 19.8 51.5 48.5 
All Locations 3986 50.5 24.7 6.6 18.2 68.7 31.4 
         
Unemployed  Home 2140 56.5 23.4 4.6 15.4 71.9 28.1 
Work/Study - - - - - - - 
Elsewhere 100 32.6 32.1 13.1 22.2 54.9 45.2 
All Locations 2412 56.5 23.4 4.6 15.5 71.9 28.1 
         
Employed† 
 
Home 1738 43.9 24.5 7.2 24.4 68.3 31.7 
Work/Study 1021 39.5 32.1 16.3 12.1 51.6 48.4 
Elsewhere 69 30.6 37.9 15.5 16.1 46.7 53.3 
All Locations 1766 42.9 26.5 9.1 21.5 64.4 35.6 
         
Full-time 
student 
Home 78 54.5 21.7 5.2 18.6 73.1 26.9 
Work/Study 10 64.3 10.0 5.7 20.0 84.3 15.7 
Elsewhere 2 25.0 45.8 0.0 29.2 54.2 45.8 
All Locations 78 56.4 20.6 4.3 18.6 75.1 24.9 
†amongst all employed women (including those on maternity/sick leave) 
*excluding women who drank no tap water at all at each location, as their denominator was zero 
 
87
 Table 3.5  Individual showering, bathing and swimming as measured by Questionnaire (n = 
4045) 
     Percentile Distribution 
Performed 
activity  
Variable Mean (95% CI) SD Min 25th %ile Median 75th %ile Max n % 
Showering & Bathing           
No. showers per week 4 (4, 4) 3 0 0 3 7 28 2841 70.2 
Duration per shower (min) † 19 (18, 20) 14 2 10 15 20 240   
Showering (min/week) 66 (64, 69) 83 0 0 60 105 1890   
           
No. baths per week 3 (2, 3) 3 0 0 2 4 21 2812 69.5 
Duration per bath (min) ‡ 36 (36, 37) 23 3 20 30 45 180   
Bathing (min/week) 89 (85, 93) 124 0 0 60 120 2400   
           
Combined showering 
/bathing (min/week) 155 (151, 159) 137 5 70 120 200 2420 4045 100 
 
Swimming           
No. swims per week 0 (0, 0) 0 0 0 0 0 7 297 7.3 
Duration per swim (min) § 57 (54, 61) 30 2 30 60 60 240   
Swimming (min/week) 5 (5, 6) 24 0 0 0 0 420   
†amongst those who reported at least one shower per week (n = 2841), ‡amongst those who reported at least one bath per 
week (n = 2812), §amongst those who reported going swimming at least once per week 
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Table 3.6  Variability in water consumption according to population variables – univariate analysis 
 
  Plain cold tap water at All 
Locations (L/day) 
Cold beverages from tap water at 
All Locations (L/day) 
Hot beverages from tap water at All 
Locations (L/day) 
Total tap water consumption at 
All Locations (L/day) 
Variables n Mean (95% CI)    % var Mean (95% CI)   % var Mean (95% CI)   % var Mean (95% CI)   % var 
Ethnicity    *** 6.1 *** 1.3 *** 10.8 *** 3.0 
White British 1565 0.63 (0.59, 0.66)    1.05 (1.01, 1.09)    0.74 (0.70, 0.77)    1.79 (1.73, 1.84)    
White Other 96 0.52 (0.38, 0.67)    0.68 (0.52, 0.83)    0.62 (0.50, 0.74)    1.30 (1.10, 1.50)    
Black/Black British 104 0.87 (0.72, 1.01)    1.08 (0.93, 1.24)    0.33 (0.25,0.40)    1.41 (1.24, 1.58)    
Asian/Asian British, Pakistani 1860 0.95 (0.93, 0.98)    1.15 (1.12, 1.18)    0.33 (0.32, 0.35)    1.48 (1.45, 1.51)    
Asian/Asian British, Other 292 0.99 (0.90, 1.08)    1.18 (1.09, 1.27)    0.35 (0.31, 0.38)    1.53 (1.43, 1.62)    
All Others 126 0.74 (0.62, 0.87)    1.03 (0.91, 1.16)    0.42 (0.32, 0.53)    1.46 (1.31, 1.61)    
Highest Educational Qualification    *** 0.7    0.2   * 0.4    0.3 
None 696 0.87 (0.82, 0.91)    1.10 (1.05, 1.15)    0.48 (0.44, 0.52)    1.58 (1.52, 1.64)    
GCSE or equivalent† 1574 0.79 (0.76, 0.82)    1.12 (1.08, 1.15)    0.52 (0.49, 0.55)    1.63 (1.59, 1.68)    
A' Level or equivalent ‡ 561 0.76 (0.71, 0.82)    1.09 (1.03, 1.15)    0.50 (0.45, 0.55)    1.59 (1.52, 1.67)    
First degree§ 622 0.87 (0.82, 0.93)    1.10 (1.04,1.16)    0.45 (0.41, 0.49)    1.55 (1.48, 1.62)    
Post-graduate degree 270 0.82 (0.75, 0.90)    1.05 (0.97, 1.13)    0.43 (0.38, 0.48)    1.48 (1.39, 1.57)    
Other 262 0.67 (0.59, 0.74)    1.00 (0.91, 1.08)    0.56 (0.49, 0.62)    1.55 (1.45, 1.65)    
Employment status     *** 1.1    0.2   *** 1.2   * 0.3 
Employed 1615 0.73 (0.70, 0.77)    1.06 (1.02, 1.10)    0.56 (0.53, 0.59)    1.62 (1.58, 1.67)    
Employed - Maternity/Sick leave 184 0.76 (0.67, 0.86)    1.13 (1.01, 1.25)    0.63 (0.53, 0.73)    1.76 (1.61, 1.91)    
Unemployed 2165 0.87 (0.85, 0.90)    1.12 (1.09, 1.15)    0.44 (0.42, 0.47)    1.57 (1.53, 1.60)    
Full-time Student 81 0.80 (0.68, 0.93)    1.13 (0.97, 1.28)    0.39 (0.28, 0.51)    1.52 (1.32, 1.72)    
Smoking     *** 3.9   *** 0.8   *** 10.4   *** 2.2 
Current 559 0.58 (0.52, 0.63)    0.99 (0.92, 1.05)    0.93 (0.85, 1.01)    1.91 (1.81, 2.01)    
Previous 609 0.63 (0.58, 0.69)    1.01 (0.95, 1.07)    0.61 (0.57, 0.66)    1.62 (1.55, 1.70)    
Never 2877 0.89 (0.87, 0.92)    1.14 (1.11, 1.16)    0.39 (0.37, 0.40)    1.53 (1.50, 1.56)    
Passive smoking     *** 0.8    0.0   *** 1.7   *** 0.6 
Exposed >1 hour/day 513 0.68 (0.62, 0.74)    1.08 (1.01, 1.16)    0.67 (0.61, 0.73)    1.76 (1.67, 1.84)    
Exposed < 1 hour/day 750 0.77 (0.73, 0.81)    1.10 (1.05, 1.14)    0.55 (0.49, 0.61)    1.65 (1.58, 1.72)    
Not exposed 2757 0.85 (0.82, 0.87)    1.10 (1.08, 1.13)    0.45 (0.43, 0.47)    1.55 (1.52, 1.59)    
Age     *** 1.0   * 0.3   *** 0.7    0.2 
< 20 298 0.61 (0.54, 0.67)    1.08 (0.99, 1.16)    0.49 (0.42, 0.55)    1.56 (1.46, 1.67)    
20-24 1082 0.78 (0.74, 0.82)    1.12 (1.08, 1.17)    0.47 (0.43, 0.51)    1.59 (1.54, 1.65)    
25-29 1309 0.84 (0.81, 0.88)    1.12 (1.08, 1.16)    0.46 (0.43, 0.49)    1.58 (1.53, 1.62)    
30-34 836 0.85 (0.81, 0.90)    1.10 (1.05, 1.15)    0.54 (0.50, 0.58)    1.64 (1.58, 1.70)    
35-39 447 0.8 (0.75, 0.86)    0.99 (0.93, 1.05)    0.57 (0.50, 0.65)    1.57 (1.48, 1.65)    
≥ 40 72 0.98 (0.79, 1.16)    1.12 (0.94, 1.30)    0.70 (0.53, 0.87)    1.82 (1.58, 2.06)    
Household Income      0.0    0.1   ** 0.4    0.1 
< £11,000 1013 0.77 (0.73, 0.82)    1.12 (1.08, 1.17)    0.50 (0.47, 0.54)    1.62 (1.57, 1.68)    
£11,000 - £24,999 1173 0.78 (0.74, 0.81)    1.08 (1.03, 1.12)    0.50 (0.47, 0.54)    1.58 (1.53, 1.63)    
≥ £25,000 961 0.76 (0.72, 0.81)     1.06 (1.01, 1.11)     0.59 (0.55, 0.63)     1.65 (1.59, 1.71)     
% var:  % of total variability explained by differences according to population characteristics, e.g. ethnicity, * difference between group means according to one-way ANOVA test (p<0.05), ** difference between 
group means according to one-way ANOVA test (p<0.01), *** difference between group means according to one-way ANOVA test (p<0.001), † GCSE/NVQ Levels 1 or 2 / Foundation or Intermediate GNVQ, 
‡'A' Level / NVQ Level 3 / Advanced GNVQ, §First university degree (e.g. Bachelors degree) / NVQ Levels 4 or 5 / HNC / HND 
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 Table 3.7  Variability in showering, bathing and swimming according to population variables – univariate analysis 
  
  Showering (min/week) Bathing (min/week) Combined showering/bathing 
(min/week) 
Swimming (min/week) 
Variables n Mean (95% CI) % var Mean (95% CI) % var Mean (95% CI) % var % swimmers Mean (95% CI)   % var 
Ethnicity     *** 1.6 *** 5.0   *** 2.9 *** 2.9 
White British 1565 59 (55, 63)    121 (113, 128)   179 (171, 187)    13.8 10.3 (8.6, 11.9)    
White Other 96 109 (90, 128)    64 (44, 84)   173 (148, 199)    13.5 9.2 (2.6, 15.8)    
Black/Black British 104 74 (58, 90)    125 (96, 155)   199 (171, 228)    0.0 0.0 (0.0, 0.0)    
Asian/Asian British, Pakistani 1860 65 (61, 69)    68 (65, 72)   134 (128, 139)    2.3 1.8 (1.2, 2.4)    
Asian/Asian British, Other 292 88 (80, 96)    46 (38, 53)   134 (124, 143)    4.8 3.4 (1.5, 5.3)    
All Others 126 83 (67, 99)    90 (68, 112)   174 (149, 198)    9.5 4.8 (2.1, 7.4)    
Highest Educational Qualification       *** 1.0    *** 2.5     *** 1.3      ** 0.4 
None 696 51 (45, 56)    100 (90, 109)   150 (139, 161)    2.4 2.6 (1.2, 3.9)    
GCSE or equivalent† 1574 65 (60, 70)    102 (96, 108)   167 (160, 174)    6.0 5.2 (3.9, 6.5)    
A' Level or equivalent ‡ 561 73 (67, 79)    92 (83, 102)   166 (156, 176)    10.2 7.2 (5.1, 9.4)    
First degree§ 622 74 (68, 79)    62 (54, 71)   136 (127, 145)    10.3 6.6 (4.7, 8.6)    
Post-graduate degree 270 75 (68, 83)    43 (35, 52)   119 (109, 128)    13.3 7.5 (4.6, 10.4)    
Other 262 74 (64, 83)    75 (63, 87)   148 (135, 162)    11.1 6.3 (3.8, 8.8)    
Employment status      *** 0.5    * 0.3     *** 0.5      *** 1.4 
Employed 1615 69 (66, 73)    84 (78, 90)   153 (147, 160)    11.8 8.1 (6.8, 9.5)    
Employed - Maternity/Sick leave 184 66 (56, 75)    108 (90, 126)   173 (155, 192)    8.7 8.8 (3.0, 14.5)    
Unemployed 2165 63 (59, 66)    90 (85, 95)   153 (147, 159)    3.8 2.8 (2.1, 3.5)    
Full-time Student 81 101 (54, 148)    114 (83, 146)   215 (161, 269)    9.9 12.1 (1.9, 22.3)    
Smoking      ** 0.3    *** 5.8     *** 4.3      *** 1.0 
Current 559 59 (52, 66)    159 (144, 174)   218 (203, 233)    7.5 6.7 (4.3, 9.1)    
Previous 609 75 (67, 83)    102 (90, 113)   177 (164, 190)    14.6 10.8 (8.2, 13.4)    
Never 2877 66 (63, 69)    73 (69, 76)   138 (134, 143)    5.8 4.0 (3.3, 4.8)    
Passive smoking      ** 0.3    *** 2.7     *** 2.4       0.0 
Exposed >1 hour/day 513 65 (58, 73)    142 (125, 158)   207 (191, 223)    5.8 4.5 (2.3, 6.6)    
Exposed < 1 hour/day 750 76 (68, 83)    88 (80, 96)   164 (153, 174)    7.3 5.6 (4.0, 7.1)    
Not exposed 2757 64 (61, 67)    80 (76, 84)   144 (139, 148)    7.6 5.6 (4.7, 6.5)    
Age      *** 0.7    *** 2.7     *** 3.7       0.2 
< 20 298 86 (67, 105)    136 (118, 154)   222 (199, 246)    5.7 4.5 (1.8, 7.2)    
20-24 1082 67 (62, 72)    109 (100, 117)   176 (167, 184)    5.5 4.1 (3.0, 5.3)    
25-29 1309 68 (64, 72)    82 (75, 89)   150 (143, 157)    8.1 6.2 (4.7, 7.7)    
30-34 836 63 (58, 67)    71 (64, 78)   133 (126, 141)    7.9 5.4 (3.9, 6.9)    
35-39 447 56 (51, 61)    70 (61, 78)   125 (116, 134)    9.4 6.7 (4.2, 9.2)    
≥ 40 72 50 (40, 61)    58 (42, 74)   108 (91, 125)    9.7 6.0 (0.3, 11.7)    
Household Income       0.1    *** 1.8     *** 1.7      *** 1.1 
< £11,000 1013 70 (63, 77)    117 (108, 127)   187 (176, 198)    4.1 4.2 (2.6, 5.7)    
£11,000 - £24,999 1173 66 (62, 70)    86 (80, 93)   152 (145, 159)    6.2 4.6 (3.4, 5.8)    
≥ £25,000 961 70 (66, 74)     75 (68, 82)     145 (137, 152)     15.9 10.3 (8.4, 12.3)     
% var:  % of total variability explained by differences according to population characteristics, e.g. ethnicity, * difference between group means according to one-way ANOVA test (p<0.05), ** difference between 
group means according to one-way ANOVA test (p<0.01), *** difference between group means according to one-way ANOVA test (p<0.001), † GCSE/NVQ Levels 1 or 2 / Foundation or Intermediate GNVQ, ‡'A' 
Level / NVQ Level 3 / Advanced GNVQ, §First university degree (e.g. Bachelors degree) / NVQ Levels 4 or 5 / HNC / HND 
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 CHAPTER 4:  AREA-LEVEL EXPOSURE ASSESSMENT FOR THE BiB COHORT 
 
 
4.1 INTRODUCTION 
This chapter describes the methods of DBP exposure assessment at the area-level, including 
environmental sampling, use of routine THM monitoring data, predictive modelling of THM 
concentrations, and calculation of area-level estimates of THM exposure during pregnancy for 
women in the BiB cohort.  It also describes spatial and temporal variability in THM concentrations 
in the BiB study area and present descriptive analysis of area-level THM exposure estimates. 
 
4.2 METHODS 
4.2.1 Environmental sampling 
Routinely measured data on THM concentrations were available for the BiB study area.  However, 
to address the current knowledge gap on non-THM DBPs (see  section 1.10), additional water 
sampling was required in order to collect data on concentrations of some non-THM DBPs in the 
BiB study area, which could then be used in exposure assessment for the BiB cohort. 
 
4.2.1.1 Tap water sampling in Bradford 
Systematic sampling of tap water for a range of DBPs (THMs, HAAs, HANs, HKs, chloral hydrate, 
CP, MX and bromate) was carried out across the BiB study area.  This was undertaken in order to 
provide raw data on DBP concentrations and their determinants to be used in exposure assessment 
for the BiB cohort and to contribute to a European database on DBP occurrence for HiWATE.  This 
is described in the introductory paper to HiWATE183 shown in Appendix E. 
 
A sampling protocol (shown in Appendix F) was designed by the author in order to best utilise the 
quota of samples allocated by HiWATE to the BiB study area.  The aim was to determine DBP 
levels in drinking water for the WSZs which cover the BiB catchment area, and to capture temporal 
and spatial variation in DBP concentrations. 
 
A WSZ is a pre-defined area of supply serving not more than 100,000 customers (set at 100,000 
since 1 January 2004).   The WSZs that covered the BiB eligibility area (the Bradford and Airedale 
Primary Care Trust (PCT) area) were identified.  Figure 4.1 shows the extent of the PCT denoted by 
the dashed black line.  The PCT is served by maternity services at two hospitals, Bradford Royal 
Infirmary (BRI) and Airedale General Hospital (AGH), shown in Figure 4.1.  According to births 
data for 2003-2005, there were 7,100 births per annum within the PCT, on average, of which 5,470 
occurred at BRI and 1,630 at AGH.  However, women are recruited to the BiB study at the antenatal 
clinic at BRI only.  The area in which the majority of BiB mothers will reside was estimated using 
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 birth data according to location of birth (BRI or AGH) aggregated over calendar years 2003 to 2005 
and mapped onto Lower Super Output Areas as shown shaded green in Figure 4.1.  This area 
covered 9 WSZs: Bradford City, Peel Park/Laisterdyke 2004, Bradford SE 2004, Bradford SW 
2004, Shipley/Bingley 2004, Idle/Pudsey 2004, Airedale 2004, Keighley 2004, and Graincliffe 2004 
as shown in Figure 4.2.  Boundaries for these WSZs were set in 2004.  On 1st January 2008 a new 
WSZ, known as Bradford Central 2008 WSZ, was formed from two existing WSZs (Peel 
Park/Laisterdyke 2004 WSZ and Bradford City 2004 WSZ).  This was a merger of 2 adjacent WSZs 
with no change to the overall boundary for the merged area. 
 
Water to these WSZs is supplied by Yorkshire Water, largely from two water treatment works 
(WTWs), Chellow Heights WTW and Graincliffe WTW.  Chellow Heights WTW is routinely fed 
from three raw water sources.  Two raw water flows enter sand removal channels, pH is adjusted 
using lime if required, and dosed with aluminium sulphate.  The third raw water flow is dosed with 
sulphuric acid to adjust pH if required.  The combined ‘dosed’ water undergoes the following water 
treatment processes:  sedimentation (with activated carbon dosing if required) – coagulation – rapid 
gravity filters – dosing with lime, sodium hypochlorite and monosodium phosphate – manganese 
contactors.  Disinfection with sodium hypochlorite then takes place in two on-site clean water tanks.  
The normal target range for free chlorine (pre manganese contactors) is 0.85-2.0 mg/l and the dose 
is normally set automatically and is flow paced. The normal target range for free chlorine (post 
manganese contactors) is 1.0-2.0 mg/l.  The normal target for free chlorine in the clean water tanks 
is 0.35 mg/l.  Graincliffe WTW is fed from a blend of five raw water sources (varying depending on 
water stock levels).  Raw water is dosed with ferric sulphate (as a coagulant) and pH is adjusted 
automatically with lime.  The water undergoes the following water treatment processes:  
flocculation – dosing with lime – rapid gravity filters – dosing with sodium hypochlorite, lime and 
monosodium phosphate.  The sodium hypochlorite dose is manually set but is flow proportioned.  
Finally, the water undergoes second stage filtration to remove manganese.  The normal target range 
for free chlorine in treated water is 0.6-1.1 mg/l. 
 
Airedale 2004 and Graincliffe 2004 WSZs are supplied by Graincliffe WTW, whilst Peel 
Park/Laisterdyke 2004, Bradford SE 2004, Bradford SW 2004, Shipley/Bingley 2004, and 
Idle/Pudsey 2004 WSZs are supplied by Chellow Heights WTW.  Bradford City 2004 WSZ (which 
merged with Peel Park/Laisterdyke 2004 to form Bradford Central 2008) was supplied by both 
Chellow Heights WTW and Graincliffe WTW, but the contribution from each WTW is unknown.  
Keighley 2004 WSZ is mainly supplied by Graincliffe WTW, with small contributions from three 
other WTWs (Embsay WTW, Oldfield WTW and Sladen Valley WTW). 
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 Tap water samples were collected from at least one sampling site in each of the WSZs on a 
quarterly basis, as shown in Table 4.1.  Sampling commenced in June 2007, and will continue until 
BiB recruitment ends in November 2010.  The quarterly sampling was for THMs, other volatile 
DBPs, HAAs, MX and total organic carbon (TOC), bromide and UV-absorbance.  A limited 
number of bromate samples were also collected (Table 4.1, part c).  The author was responsible for 
sampling until mid-2009, after which responsibility was handed to a colleague (Nina Iszatt) on the 
HiWATE project. 
 
Tap water samples were collected in collaboration with Yorkshire Water, and ‘piggy-backed’ onto 
the company’s routine monitoring programme.  For each round of sampling, the exact sampling site 
within each WSZ was determined by Yorkshire Water’s random sampling of their customer address 
database, and sampling sites tended to be private residential addresses.  If the Yorkshire Water 
sampling officer could not collect a sample from the specified address for any reason, then a sample 
was collected from a neighbouring property. 
 
Sampling preparation 
Sample vials for THMs, other volatile DBPs and HAAs were cleaned and prepared in accordance 
with a specified HiWATE protocol before being provided to Yorkshire Water sampling officers.  
Briefly, the vials used were 40 ml amber glass vials with polypropylene screw caps and PTFE-faced 
silica septa.  They were washed 3 times each with detergent, followed by tap water, then reverse 
osmosis (RO) water and then acetone. The vials were placed in a drying oven at 150 °C for 2 hours.  
Caps and septa were allowed to air dry overnight.  In the initial HiWATE protocol there were two 
categories of analysis: (i) THMs and volatile DBPs and (ii) HAAs. Two vials were prepared for 
each category to allow duplicate samples to be collected at each sampling site for each category.  
Once the vials were cool and dry the preservatives were added to the vials.  This was done 1 or 2 
days before the vials were sent by courier to the Yorkshire Water sampling officers.  A few crystals 
of sodium sulfite (approximately 4 mg per 40 ml sample) were added to category (i) vials to act as a 
preservative for THMs and other volatile DBPs, and approximately 4 mg ammonium chloride was 
added to category (ii) vials to act as a preservative for HAAs.  Any samples collected after 31st 
March 2008 followed an updated protocol to reflect the use of new quenching agents and pH 
buffering.  The updated protocol had four categories of analysis: (i) THMs and volatile DBPs 
except chloral hydrate, (ii) chloral hydrate, (iii) HAAs and (iv) THMs and volatile DBPs.  4 mg of 
preservative was added to each 40ml vial as follows: ammonium chloride to category (i) and 
category (iii) vials, sodium sulfite to category (ii) vials, and ascorbic acid to category (iv) vials.  pH 
adjustment was required for categories (i), (ii) and (iv). To these vials a phosphate buffer was added 
to achieve a pH in the range 4.8 to 5.5.  A buffer was prepared as a dry homogeneous mixture of 1% 
sodium phosphate dibasic (NaH2PO4)/99% potassium phosphate monobasic (K2HPO4) by weight.  
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 The buffer mixture was tested in the lab to check that when added to tap water it gave a pH in the 
required range.  The updated protocol stated that the pH of category (i), (ii) and (iv) samples should 
be measured in situ, and if the pH was out of the required range a new sample should be collected, 
however it was not possible for the sampling officers to do this in the field. 
 
The National Public Health Institute in Finland supplied 500ml poly-ethylene bottles for MX 
sampling and 50ml poly-ethylene bottles for bromate sampling.  The bottles were clean, and the 
only preparation required was to add a few crystals of ammonium sulfate to the MX bottles to act as 
a quenching agent (approximately 50mg for each 500ml bottle).  Alcontrol Laboratories supplied 
bottles for TOC (100ml clear glass), bromide (250ml PET) and UV-absorbance (250ml PET) 
sampling, which were ready for sampling and no cleaning or preservatives were required. 
 
Sample collection procedure 
Tap water samples for THMs/volatile DBPs and HAAs were all collected headspace free.  Those 
samples for MX, bromate, TOC, bromide and UV-absorbance did not need to be collected 
headspace-free.  Temperature is not a routine monitoring requirement for Yorkshire Water, but the 
sampling officer was requested to measure and record temperature when collecting HiWATE 
samples.  Other parameters such as free chlorine, total chlorine, pH, and conductivity were 
measured by Yorkshire Water as part of their routine sampling at the same sampling site and this 
data would be made available by Yorkshire Water.  Immediately after collection all tap water 
samples were stored in a refrigerator in the sampling officer’s van, until they were returned to the 
sampling depot. 
 
Once the samples were returned to the sampling depot, the pH of the MX sample was adjusted to 
1.5 – 2.0 with 7 ml of 1 M HCl.  The bromate sample was quenched of oxidants by adding 50 µl of 
5% ethylenediamine (EDA) solution to the 50 ml water sample.  TOC, bromide and UV-absorbance 
samples were submitted to Alcontrol Laboratories in Bradford for analysis.  The remaining samples 
were transported to London in cool boxes with frozen gel packs, and then refrigerated (except MX 
and bromate which were frozen).  The day after the sampling, the 40ml amber vials were sent by 
courier to the University of the Aegean (a HiWATE partner) for laboratory analysis. Courier 
shipment to University of the Aegean laboratory (located in Mytilene on the island of Lesbos) took 
3.5 days on average.  Immediately prior to collection by the courier, the samples were packed into 
cool boxes with frozen gel packs to maintain temperature between 0-4°C during transit.  Once 
collected by the courier, the cool box was transported by refrigerated van until it was placed on a 
flight to Athens.  The samples were then put onto connecting transportation to Mytilene.  
Temperature of samples was measured by laboratory staff on arrival at the lab, and as part of the 
QA/QC programme conducted on the HiWATE sampling data (see Section 4.2.3), temperature on 
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 arrival and duration of transit, was taken in to account when determining if sampling results were 
reliable.  The frozen MX and bromate samples were packed into a cool box with frozen gel packs, 
so that they remained frozen during transit, and sent for analysis at the National Public Health 
Institute in Kuopio, Finland. Courier shipment to Kuopio took 2 days, on average.   
 
Laboratory analysis and methods 
DBP samples were analysed according to the HiWATE WP1 protocol.  The method used for the 
determination of volatile DBPs (THMs, haloacetonitriles, haloketones, chloropicrin and chloral 
hydrate) was Liquid-Liquid Extraction (LLE) using methyl-tert-butyl ether (MtBE), followed by 
Gas Chromatography-Electron Capture Detector (GC-ECD).  Analysis of HAAs was performed by 
LLE with MtBE and GC-ECD, after derivatization with methanol/sulfuric acid (acidic methanol 
esterification).   The analytical method used for the determination of MX included solid phase 
extraction and propylation followed by gas chromatography/high resolution mass spectrometry 
(GC-HRMS) analysis according to the method published by Rantakokko et al.184 with slight 
modifications.  Bromate analyses in Finland were done according to Rantakokko et al.185 with slight 
modifications.  TOC was determined by chemical oxidation and infra-red spectrometry.  Bromide 
was determined by ion chromatography.  UV-absorbance was determined by UV-visible 
spectroscopy at 254nm. 
 
4.2.1.2 Swimming pool sampling 
In addition, 7 sets of samples were collected from 7 swimming pools in the study area on 29th and 
30th May 2008. 
 
4.2.2 Routine data supplied by Yorkshire Water 
Data on routinely collected samples for THMs and their determinants, and information on WSZ 
boundaries, raw water and water treatment processes, were requested from Yorkshire Water for the 
WSZs in the study area. 
 
WSZ boundary files for the study area were provided in April 2007, and an updated set of boundary 
files were supplied after the merger of two WSZs (Bradford City and Peel Park/Laisterdyke 2004 
WSZs) on 1st January 2008. 
 
In December 2008, Yorkshire Water provided data on TTHM, chloroform, DCBM, DBCM and 
bromoform concentrations for all routinely collected samples analysed for THMs from the WSZs in 
the study area from the start of 2006 to the end of September 2008.  In addition all available data on 
free and total chlorine (mg/L), TOC (mg/L), turbidity (FTU), pH, conductivity (μS/cm), and 
bromate (mg/L) collected for these same routine samples, along with eastings/northings of sample 
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 location, and date and time of sample collection were provided.  For each routine sampling, the 
exact sampling site within each WSZ was determined by Yorkshire Water’s random sampling of 
their customer address database, and sampling sites tended to be private residential addresses.  If the 
Yorkshire Water sampling officer could not collect a routine sample from the specified address for 
any reason, then a sample was collected from a neighbouring property.  Although BiB recruitment 
only commenced in March 2007, routine THM data prior to this date were requested in order run-in 
any future statistical models.  For simplicity, all 2006 and 2007 data for Peel Park/Laisterdyke 2004 
WSZ and Bradford City 2004 WSZ, were treated as coming from the one merged WSZ, i.e. 
Bradford Central 2008 WSZ.  From hereon in the exposure assessment and analyses treat this area 
as one WSZ for the entire study period, and assumes that there are 8 WSZs in the study area. 
 
In addition, for the HiWATE samples ‘piggy-backed’ onto routine sampling, Yorkshire Water 
provided data on free and total chlorine (mg/L), pH, colour (Hazen), turbidity (FTU) and 
conductivity (μS/cm), which they had measured routinely on their own samples collected from the 
same site. 
 
Information on raw water sources, water treatment process description and chlorine doses, for each 
of the 5 water treatment works (WTWs) that feed into the WSZs in the study area, was supplied by 
Yorkshire Water in January 2010. 
 
4.2.3 DBP concentration data available to use for exposure assessment 
The HiWATE sampling was conducted with the intention that predictive modelling of both THMs 
(using routine THM data and HiWATE sampling data) and non-THMs (using HiWATE sampling 
data) would be undertaken, to allow exposure assessment of both THMs and non-THMs for the BiB 
cohort. 
 
However, on examination of the HiWATE THM/volatile DBPs and HAA results for Bradford (and 
other areas) various anomalous patterns were observed which did not fit with known DBP 
behaviour.  Comparisons with Yorkshire Water routine THM monitoring data revealed a lack of 
consistency between the two datasets for THMs.  This led to a QA/QC programme being 
undertaken on the HiWATE THM/volatile DBPs and HAA data, which was only completed in May 
2010.  Due to the uncertainty surrounding the HiWATE sampling data, and the timeframe for 
completion of this PhD it was decided to use only the routine data provided by Yorkshire Water to 
perform this particular exposure assessment for THMs, with the expectation that the HiWATE data 
on non-THMs would become available for incorporation into further exposure assessment and 
future epidemiological analyses on the BiB cohort, outside the scope of this PhD. 
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 4.2.4 Predictive modelling of THM concentrations 
Routine monitoring data on THMs and other parameters from January 2006 to the end of September 
2008 for the WSZs in the study area were used for predictive modelling of THMs.  Routine 
monitoring data from October 2008 were not available at the time of data provision.  During 2006 
and 2007, WSZs in the study area were sampled 9 times per year, on average (ranging from 7-12 
samples per year). 
 
Predictive modelling of this data, as described below, was undertaken by Dr James Bennett.  The 
raw data were modelled to obtain more robust estimates of THM concentrations for times and 
places for which data were sparse, and to model to the end of 2008.  A stepwise procedure (using 
stepAIC in the statistical package R) was used to determine the best predictive model for each 
THM.  In the linear regression the log of each THM was modeled due to the skewness of the data.  
A spline in month, a factor for year and a factor for WSZ were included in all models in order to 
enable time and WSZ specific predictions.  The full data set contained 213 sample points but due to 
missing data (e.g. for determinants) the entire data set could not always be used in the models.  In 
the dataset, chloroform and DCBM were never below the limit of detection, but limits of detection 
were 0.2 μg/L for DBCM and 0.3 μg/L for the majority of bromoform samples (but occasionally 
varying between 0.17 and 0.5 μg/L).  4 out of 213 data points for DBCM were below the detection 
limit, whilst 176 out of 213 data points for bromoform were below the detection limit.  Where 
samples were below the limit of detection (LOD), a value equal to half the LOD was used for that 
sample point, as per Malliarou et al.112  Bromoform was not modeled individually because so many 
data points were below the LOD.  Instead total brominated THMs (TBROM) were modelled.  It was 
possible to model monthly estimates for THMs up until the end of 2008.  The predictive models are 
summarized in Table 4.2. 
 
Variables included in the models should not necessarily be viewed as predictors outside of the 
context of this dataset.  10-fold cross validation186 of these models was performed (i.e. splitting the 
data into 10 parts and using 9 parts to predict the 10th, repeated 10 times) for the R2.  The models 
were used to predict monthly concentrations of TTHM, chloroform, DCBM, DBCM, and TBROM, 
for January 2006 to December 2008 inclusive, for the 8 WSZs in the study area. 
 
4.2.5 Datasets used to assign area-level THM concentrations 
Three datasets were used to assign modelled area-level THM concentrations to each woman in the 
BiB cohort.  The first was area-level data on THM concentrations modelled to give monthly 
concentrations of TTHM, chloroform, DCBM, DBCM, and TBROM, as described above.  The 
second dataset was individual-level data for 4045 in the BiB cohort, from the BiB baseline dataset, 
which included residential address at BiB registration and workplace address.  The third dataset 
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 contained corresponding individual-level data from the eClipse maternity records system on date of 
delivery, estimated gestational age of baby at birth and residential address at time of delivery for 
these 4045 women. These latter two datasets were linked by BiB Study ID number. 
 
4.2.6 Linkage of modelled THM concentrations to women in the BiB cohort 
ArcMap (version 9.2, ESRI Inc.) was used to assign WSZs to each woman’s residential, and where 
applicable, workplace addresses, via GIS linkage with postcodes.  Postcode centroids (the point 
centre of a postcode unit) for 2006 (the most recent available) were overlaid onto WSZ boundaries.  
Each postcode centroid was linked to the WSZ into which it fell.  Each woman was linked via her 
postcode to a postcode centroid and was assigned the relevant WSZ for that postcode centroid. 
 
Up to 3 WSZs were assigned to each woman, as shown in Figure 4.3.  Women were each assigned a 
Home WSZ based on their residential postcode at time of recruitment to BiB (~28 weeks gestation).  
A WSZ was also assigned to their residential postcode at time of delivery, as defined by the eClipse 
system, in order to evaluate the extent of residential mobility between WSZs during the 3rd 
trimester.  Women currently employed at time of recruitment to BiB were assigned Work WSZs, on 
the basis of their workplace postcode, where possible. 
 
WSZ-specific modelled THM concentrations were available to the end of 2008, so for all women 
who gave birth on or before 1st January 2009 (i.e. the last complete day of pregnancy fell in 2008) 
and to whom a Home WSZ had been assigned (n= 2710), a set of modelled monthly THM 
concentrations for the relevant Home WSZ (and also a set for the relevant Work WSZ, where 
applicable), were linked to her Study ID, in R statistical software version 2.4.1. 
 
4.2.7 Creation of area-level metrics of THM exposure during pregnancy 
Two types of area-level THM exposure metric were created using modelled THM concentrations:  
time-weighted average THM concentrations and annual average THM concentrations, according to 
an analytical plan (shown in Appendix G) set out in advance. 
 
4.2.7.1 Time-weighted average THM concentrations 
To define the exposure window, the start of the first trimester was calculated by subtracting 
estimated gestational age at birth from delivery date, and was treated as the first complete day of 
exposure (Day 1).  The day preceding delivery was treated as the last complete day of exposure.  
Trimester 1 was defined as Days 1-93, Trimester 2 as Days 94-186, and Trimester 3 as Day 187 to 
the day preceding delivery. 
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 Time-weighted average THM concentrations were calculated for each woman for her entire 
pregnancy and each trimester based on modelled monthly THM concentrations.  This methodology 
has previously been used by Toledano et al.90 and Nieuwenhuijsen et al.187 and similar time-
weighted averages have also been used in other studies.188;189  The time-weighting was based on the 
proportion of the trimester (or entire pregnancy, as appropriate) falling into each month.  Where 
total gestational duration was less than or equal to 186 days (i.e. ≤  2 trimesters), women were not 
assigned THM concentrations for the 3rd trimester.  The basic calculation was carried out according 
to the following example for time-weighted average chloroform concentration at home for the 1st 
trimester (ChloroformHome_WSZ.T1), in which start of 1st trimester is 12th September 2007, and 1st 
trimester length is 93 days: 
 
ChloroformHome_WSZ.T1 (μg/L) =  
 
   Days_exposedSept07 / 93  ×  ChloroformSept07.Home_WSZ 
+ Days_exposedOct07 / 93  ×  ChloroformOct07.Home_WSZ 
+ Days_exposedNov07 / 93  ×  ChloroformNov07.Home_WSZ 
+ Days_exposedDec07 / 93  ×  ChloroformDec07.Home_WSZ 
 
= 19/93   ×  ChloroformSept07.Home_WSZ 
+ 31/93   ×  ChloroformOct07.Home_WSZ 
+ 30/93   ×  ChloroformNov07.Home_WSZ 
+ 13/93   ×  ChloroformDec07.Home_WSZ 
 
Where Days_exposedMonthYear represents the number of days in a given month and year that fall into 
the relevant trimester (or whole pregnancy as appropriate for the calculation), and 
ChloroformMonthYear.Home_WSZ represents the modelled chloroform concentration in a given month and 
year for the assigned home WSZ. 
 
Due to the varying number of days in different calendar months, and variations in trimester length 
(usually only for the 3rd trimester, unless a baby was born very prematurely), it was possible for 
trimesters to fall across anything from 1 to 5 calendar months.  The calculations allowed for 
differing trimester lengths and differing month lengths.   
 
The calculations were repeated 20 times to give time-weighted average concentrations for TTHM, 
chloroform, DCBM, DBCM and TBROM at home for each trimester, and for whole pregnancy. 
 
Workplace time-weighted average THM concentrations 
For women who had been assigned workplace THM values and were currently employed during 
pregnancy, the process was repeated to give 20 corresponding time-weighted average THM 
concentrations based on each woman’s workplace. 
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Combining Home and Workplace time-weighted average THM concentrations 
For those women with time-weighted average THM concentrations based on both home and 
workplace values, it was then necessary to take a weighted average according to time spent at home 
and work, to achieve an overall estimate of time-weighted average THM concentration to which 
these women were exposed.  It was assumed that during the 5-day working week, waking hours 
were split equally between home and work (8 hours at home and 8 hours at work each day), but at 
the weekend all waking hours were spent at home.  This gave a 5/14 weighting for work 
(representing 40 hours at work/112 waking hours during week) and a 9/14 weighting for home 
(representing 72 hours at home/ 112 waking hours during week).  For all other women the time-
weighted average THM concentrations were based solely on the Home WSZ THM values. 
 
4.2.7.2 Annual average THM concentrations 
In addition, area-level THM exposure metrics based on annual average THM concentrations were 
also calculated for each woman.  Annual average THM concentrations have been used as exposure 
metrics in some previous epidemiological studies,76;88;90;94 and they were calculated in this study to 
allow assessment of exposure misclassification resulting from their use - this is informative in terms 
of interpreting previous studies.   
 
From the modelled THM data, annual average concentrations for TTHM, chloroform, DCBM, 
DBCM and TBROM were calculated for each WSZ and year, by calculating the arithmetic mean of 
monthly values for each year.  Annual averages were calculated from the modelled THM data rather 
than the raw THM data, because raw data were not available for the whole of 2008, and the 
distribution of data points throughout the year was sometimes uneven, so an average would be 
skewed by over- or under-sampling in a particular season. 
 
For each woman, each trimester of pregnancy was assigned annual average THM concentrations as 
per methodology used by Toledano et al. – if the last complete day of the trimester fell before the 
15th February in a given year, the previous year’s annual average value was assigned, but if the last 
complete day of the trimester fell on or after the 15th February, the current year’s annual average 
value was assigned.90  A whole pregnancy THM concentration was calculated as the arithmetic 
mean of the three trimester-specific values.  Each mother was assigned a set of annual average 
concentrations for each trimester and whole pregnancy for TTHM, chloroform, DCBM, DBCM and 
TBROM, based on Home WSZ, and where appropriate, for Work WSZ also.  Once again, for 
women who were employed and had been assigned annual average THM concentrations based on 
both home and workplace values, a weighted average was calculated according to time spent at 
home and work, as described above, in order to give an overall estimate. 
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In total 2710 women were assigned area-level THM exposure metrics, with just one of those 
women not being assigned 3rd trimester metrics because she gave birth during the 2nd trimester. 
 
4.2.8 Statistical analysis 
4.2.8.1 Analysis of raw THM data 
Within and between WSZ variability for the raw THM data provided by Yorkshire Water was 
analysed using ANOVA.   Percentage variability due to Month, Year and Between-WSZ 
components and the residual were calculated from the ANOVA sum of squares.  To calculate the 
overall temporal component, percentage variability due to Month and Year components were 
summed.  Having taking into account variability due to differences between WSZs and temporal 
components, the residual was assumed to represent within-WSZ variability.  This ANOVA analysis 
was carried out by Dr James Bennett, as specified by the author. 
 
4.2.8.2 Descriptive analysis of modelled THM concentrations 
Basic descriptive statistics were generated for modelled monthly THM concentrations overall and 
according to WSZ.  Mean concentrations across 2006-2008 were calculated and mapped onto WSZs 
in ArcMap to visually examine spatial variation between WSZs.  Modelled THMs were plotted 
against month and year to examine temporal variation in THM concentrations. 
 
4.2.8.3 Descriptive analysis of area-level THM exposure metrics 
For the 2710 women for whom area-level THM exposure metrics had been created, basic 
descriptive statistics were generated for these exposure metrics. 
 
All statistical analysis was performed using R statistical software version 2.4.1.181  
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 4.3 RESULTS 
4.3.1 THM concentrations in tap water in the study area 
4.3.1.1 Variability in raw THM data 
Variability in raw THM concentrations is shown in Table 4.3.  Temporal variability explained the 
largest proportion of variability in TTHM and chloroform concentrations, but was less influential 
for brominated species.  There was clear evidence of between-zone variability for brominated 
species which meant it was justifiable to model THMs on a zonal basis.  With the exception of 
DBCM, temporal variability due to Month effect was always much greater than that for Year effect, 
with the Year effect representing less that 4% of total variability in all cases (not shown). 
 
4.3.1.2 Seasonal and spatial variability in modelled THM concentrations 
Basic statistics for modelled THMs are shown in Table 4.4, and mean concentrations are given for 
each WSZ in Table 4.5.  For ease, WSZs are referred to by number from hereon in (defined in Table 
4.5). 
 
Figure 4.4 shows a map of the modelled TTHM concentrations averaged over 2006-2008 for the 8 
WSZs in the study area.  There was only a small difference between the WSZs, and this is dwarfed 
when compared to variation in the rest of England and Wales (Figure 4.5).  The 8 WSZs in Figure 
4.4 (2006-2008 values) would all sit within the “Medium” exposure category (30-60 μg/l), on the 
national scale.  There was a clear pattern of spatial variation in brominated species, which were 
consistently higher for WSZs 1, 5 and 7 (Figure 4.6), which are grouped to the north of the study 
area (Figure 4.7).  However, in absolute terms variation in brominated THMs was limited (range 9.9 
μg/L). 
 
Figure 4.8 to Figure 4.11 show a clear pattern of seasonal variation in the modelled THMs, with 
concentrations of TTHM, chloroform, DCBM and TBROM peaking in late summer (September) 
and at their lowest around February.  DBCM did not show the same pattern of seasonal variation, 
but instead suggested that concentrations peaked between December and February for some WSZs 
(Figure 4.12).  There appeared to be a slight general increase in DBCM concentrations over the 
three years 2006 to 2008. 
 
4.3.2 Residence within the BiB study area and WSZs 
Table 4.6 shows that over half the women (63.2%) in the BiB cohort resided in just two of the 
WSZs (2 and 8).  With the exception of WSZ 7 in which only one woman resided, all WSZs were 
supplied by either Chellow Heights water treatment works (WTW), Graincliffe WTW or a 
combination of the two.  Ethnic composition of WSZs differed (Table 4.7).  Women residing in 
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 WSZs 2 and 8 were predominantly Pakistani, whilst those residing in WSZs 1, 3, 4 and 6 were 
predominantly White British. 
 
4.3.3 Description of area-level THM exposure metrics 
Basic statistics for the area-level THM exposure metrics for whole pregnancy and the 3rd trimester 
are shown in Table 4.8.  For time-weighted average THM concentrations variability was greater for 
3rd trimester metrics compared to whole pregnancy metrics, reflecting the greater influence of 
seasonal variation in THM concentrations upon trimester-specific metrics. Statistics for 1st and 2nd 
trimester exposure metrics (not shown) were very similar to those for 3rd trimester. 
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 Figure 4.1  BiB study area 
 
 
Key:  black dashed line = Bradford and Airedale PCT boundary, green shading = area in which the majority of women 
recruited to BiB will reside. 
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 Figure 4.2  WSZs in the BiB study area 
 
 
Key:  black dashed line = Bradford and Airedale PCT boundary, green shading = area in which the majority of women 
recruited to BiB will reside, and purple edging denotes WSZs which fall within the PCT, and thus the BiB boundary. 
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 Figure 4.3  Assignment of WSZs to residential and workplace postcodes 
 
WSZ assigned to 
residential address 
at BiB recruitment? 
2. 
3. 
1.
Reason WSZ not assigned: 
- 7 gave postcodes outside the study area and were classified as ‘Outside WSZ’. 
- 28 gave postcodes which were not recognised by the GIS 
Yes 
No 
Yes 
No 
Yes 
Yes No 
No 
N=8 
 
 
 
 
4045 
women in 
dataset 
WSZ assigned to 
residential address at 
time of delivery? 
N=4010 with WSZ assigned to residential address at 
time of delivery (as defined by eClipse system) 
WSZ 
assigned to 
workplace? 
Currently 
employed? 
N=35 
N=4037 with Home WSZ at time of recruitment to BiB. 
N=2246 
N=1077 
N=722 with Work WSZ N=1799 
Reason WSZ not assigned: 
- 7 gave postcodes outside the study area and were classified as ‘Outside WSZ’. 
- 1 gave postcode which was not recognised by the GIS 
Reason WSZ not assigned: 
- 154 gave work postcodes which mapped outside the 8 WSZs in the study area, and 
were defined as ‘Outside WSZ’ 
- 31 women reported that they worked mainly from home, and 46 women reported that 
they had no regular place of work, so separate Work WSZs were not assigned. 
- 846 gave postcodes for which GIS matching was not possible due to incomplete 
postcode (n=789), or the given postcode not being recognised by GIS (n=57) 
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 Figure 4.4  Average of modelled TTHM over 2006-2008 in the WSZs in the study area 
 
 
Key:  Black line depicts BiB recruitment boundary, i.e. Bradford and 
Airedale PCT / Bradford Metropolitan District boundary 
 
 
Figure 4.5  Modelled TTHM concentrations for England & Wales (based on 2001*) 
 
 
This figure was produced by Dr Kees de Hoogh. *Most recent data available on national scale. 
107
 Figure 4.6  Modelled TBROM according to WSZ 
 
 
 
Key to x-axis: 1=Airedale 2004 WSZ, 2=Bradford Central 2008 WSZ , 3=Bradford SE 2004 WSZ, 4=Bradford SW 
2004 WSZ, 5=Graincliffe 2004 WSZ, 6=Idle/Pudsey 2004 WSZ, 7=Keighley 2004 WSZ, 8=Shipley/Bingley 2004 
WSZ. 
 
 
 
Figure 4.7  Average of modelled TBROM over 2006-2008 in the WSZs in the study area 
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 Figure 4.8  Modelled TTHM over 2006-2008 according to WSZ 
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Key to WSZs: 1=Airedale 2004 WSZ, 2=Bradford Central 2008 WSZ , 3=Bradford SE 2004 WSZ, 4=Bradford SW 2004 WSZ, 
5=Graincliffe 2004 WSZ, 6=Idle/Pudsey 2004 WSZ, 7=Keighley 2004 WSZ, 8=Shipley/Bingley 2004 WSZ. 
 
 
Figure 4.9  Modelled Chloroform over 2006-2008 according to WSZ 
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Key to WSZs: 1=Airedale 2004 WSZ, 2=Bradford Central 2008 WSZ , 3=Bradford SE 2004 WSZ, 4=Bradford SW 2004 WSZ, 
5=Graincliffe 2004 WSZ, 6=Idle/Pudsey 2004 WSZ, 7=Keighley 2004 WSZ, 8=Shipley/Bingley 2004 WSZ. 
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 Figure 4.10  Modelled DCBM over 2006-2008 according to WSZ 
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5=Graincliffe 2004 WSZ, 6=Idle/Pudsey 2004 WSZ, 7=Keighley 2004 WSZ, 8=Shipley/Bingley 2004 WSZ. 
 
 
Figure 4.11  Modelled TBROM over 2006-2008 according to WSZ 
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Figure 4.12  Modelled DBCM over 2006-2008 according to WSZ 
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 Table 4.1  Tap water sampling schedule showing number of samples collected per WSZ and quarter 
a) Samples for THMs, HAAs, HANs, HKs, chloral hydrate, CP, 
and determinants TOC, UV-absorbance and bromide. 
Year, Month and Date of sampling   
2007 2008 2009 2010 
June Sept Nov Mar May Aug Nov Mar May Sept Nov Mar May Aug Nov 
21-22 10-11 19-20 4-12 28-30 28-29 26-27 25-27 28-29 16 25 3 10 25   Total 
WSZ 
Airedale 2004   2 1 2 1 1 1 1 1 1 1 1 1 1 1 1 17 
Bradford SE 2004   2 1 1 1 1 2 1 2 1 1 1 1 1 1 1 18 
Bradford SW 2004   1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 17 
Graincliffe 2004   1 2 1 1 1 1 1 2 1 1 1 1 1 1 1 17 
Idle/Pudsey 2004   2 1 2 1 1 1 2 1 1 1 1 1 1 1 1 18 
Keighley 2004   1 1 1 1 1 2 0† 1 1 1 1 1 1 1 1 15 
Shipley/Bingley 2004   1 2 1 1 1 2 1 2 1 1 1 1 1 1 1 18 
Bradford Central 
2008* 
Bradford City ** 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 20 Peel Park/Laisterdyke 2004 ** 1 1 1 
Total 12 11 11 8 8 13 10 11 8 8 8 8 8 8 8 140 
b) Samples for MX 
Year, Month and Date of sampling   
2007 2008 2009 2010   
June Sept Nov Mar May Aug Nov Mar May Sept Nov Mar May Aug Nov   
10-11 19-20 4-12 28-30 28 26-27 25-27 28-29 16 25 3 Total 
WSZ 
Airedale 2004     1 1 1 1 1 1 1 1 1 1 1       11 
Bradford SE 2004         1 1 1 1 1 1 1 1 1       9 
Bradford SW 2004     1 1 1 1 1 1 1 1 1 1 1       11 
Graincliffe 2004     1 1 1 1 1 1 1 1 1 1 1       11 
Idle/Pudsey 2004         1 1 1 1 1 1 1 1 1       9 
Keighley 2004     1 1 1 1 1 0† 1 1 1 1 1       10 
Shipley/Bingley         1 1 1 1 1 1 1 1 1       9 
Bradford Central 
2008* 
Bradford City **       1 1 1 1 1 1 1 1 1       11 Peel Park/Laisterdyke 2004 **   1 1 
Total   5 5 8 8 8 7 8 8 8 8 8 81 
c) Samples for Bromate 
Year, Month and Date of sampling   
2007 2008 2009 2010   
June Sept Nov Mar May Aug Nov Mar May Sept Nov Mar May Aug Nov   
  10   6-12         Total 
WSZ Airedale 2004     1   1                       2 Bradford SW 2004     1   1                       2 
Total   2 2     4 
 
* WSZ formed 01/01/2008 by merging 2 WSZs:  Bradford City and Peel Park/Laisterdyke 2004. ** WSZ which existed prior to 01/01/2008. † Sample scheduled for collection, but not collected by sampler 
and no opportunity to resample.  N.B. For all samples collected from May 2009 onwards, all DBP analysis (with the exception of MX) was carried out at Cranfield University in the UK. 
  Samples for these dates/WSZs were collected for HAA analysis and determinants TOC, UV-absorbance and bromide only. 
  Indicates date/WSZ where sampling not scheduled for this parameter. 
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 Table 4.2  Predictive THM models 
 
 
THM Predictive variables included in model, in addition to 
Month, Year and WSZ 
 
Number of data 
points 
R2 
TTHM Free Chlorine + Colour + pH 201 0.70 
Chloroform Free Chlorine + Colour + Bromate 154 0.68 
DCBM Free Chlorine + Conductivity + pH 201 0.58 
DBCM log(Free Chlorine) + log(Colour) + log(Turbidity) 202 0.35 
TBROM log(Free Chlorine) + Conductivity 153 0.57 
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 Table 4.3  Variability in raw THM data 
 
  % Total variability due to 
  
Between-WSZ 
variability Within-WSZ variability 
Temporal 
variability 
TTHM 1.3 38.8 59.9 
Chloroform 1.6 39.2 59.2 
DCBM 30.7 47.8 21.5 
DBCM 33.0 64.3 2.7 
TBROM 39.3 47.2 13.5 
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 Table 4.4  Summary statistics of modelled THMs in the study area 
 
 Mean (95% CI) SD Min 
25th 
%ile Median 
75th 
%ile Max Range 
TTHM (μg/l) 47.1 (45.7, 48.4) 11.6 26.6 37.1 45.4 56.4 79.1 52.6 
Chloroform (μg/l) 38.0 (36.7, 39.2) 10.8 21.3 28.6 35.5 47.4 69.5 48.1 
DCBM (μg/l) 7.2 (7.0, 7.3) 1.3 4.4 6.3 7.1 7.8 11.5 7.2 
DBCM (μg/l) 1.2 (1.1, 1.2) 0.5 0.5 0.8 1.0 1.6 3.2 2.7 
TBROM (μg/l) 8.5 (8.3, 8.7) 1.7 5.3 7.3 8.3 9.7 15.2 9.9 
 
 
 
Table 4.5  Mean values for modelled THMs according to WSZ 
 
   TTHM (μg/l)  Chloroform (μg/l) DCBM (μg/l) DBCM (μg/l) TBROM (μg/l) 
   Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
WSZ 
1 - Airedale 2004 WSZ 46.3 (42.5, 50.2) 36.1 (32.8, 39.5) 8.5 (8.1, 8.9) 1.7 (1.6, 1.8) 10.7 (10.3, 11.1) 
2 - Bradford Central 2008 WSZ 45.5 (41.5, 49.5) 37.4 (33.7, 41.0) 6.5 (6.2, 6.8) 0.8 (0.7, 0.8) 7.5 (7.2, 7.7) 
3 - Bradford SE 2004 WSZ 46.2 (42.4, 50.1) 40.1 (36.2, 44.0) 6.5 (6.2, 6.8) 1.0 (0.9, 1.0) 7.5 (7.2, 7.8) 
4 - Bradford SW 2004 WSZ 50.6 (46.8, 54.5) 40.5 (37.0, 44.0) 6.8 (6.5, 7.1) 0.8 (0.8, 0.9) 7.8 (7.5, 8.1) 
5 - Graincliffe 2004 WSZ 45.8 (42.1, 49.5) 34.2 (31.0, 37.5) 8.4 (8.0, 8.8) 1.9 (1.8, 2.0) 10.4 (9.9, 10.9) 
6 - Idle/Pudsey 2004 WSZ 44.5 (40.7, 48.2) 36.4 (32.9, 40.0) 6.3 (6.0, 6.6) 0.8 (0.8, 0.9) 7.0 (6.7, 7.3) 
7 - Keighley 2004 WSZ 49.5 (45.4, 53.5) 38.5 (34.9, 42.2) 7.9 (7.5, 8.3) 1.6 (1.5, 1.7) 9.9 (9.6, 10.3) 
8 - Shipley/Bingley 2004 WSZ 48.1 (43.8, 52.4) 40.5 (36.2, 44.7) 6.5 (6.3, 6.8) 1.0 (0.9, 1.0) 7.6 (7.3, 7.8) 
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 Table 4.6  Residence in WSZs 
 
  All women (n=4045)   Women assigned THM 
exposure metrics (n=2710) 
Home WSZ n %   n % 
1 - Airedale 2004 WSZ 193 4.8  138 5.1 
2 - Bradford Central 2008 WSZ 1037 25.6  695 25.6 
3 - Bradford SE 2004 WSZ 397 9.8  270 10.0 
4 - Bradford SW 2004 WSZ 520 12.9  359 13.2 
5 - Graincliffe 2004 WSZ 5 0.1  3 0.1 
6 - Idle/Pudsey 2004 WSZ 365 9.0  244 9.0 
7 - Keighley 2004 WSZ 1 0.02  1 0.04 
8 - Shipley/Bingley 2004 WSZ 1519 37.6  1000 36.9 
Outside 1-8 7 0.2  - - 
Unknown 1 0.02   - - 
 
 
Table 4.7  Percentage composition of WSZs according to ethnic group 
 
  % Women residing in each WSZ by ethnic group Total in 
WSZ 
Home WSZ 
White 
British 
White 
Other 
Black/ 
Black 
British 
Asian/ 
Asian 
British, 
Pakistani 
Asian/ 
Asian 
British, 
Other 
All 
Others 
n % 
1 - Airedale 2004 WSZ 64.2 3.6 0.5 21.2 7.8 2.6 193 100 
2 - Bradford Central 2008 WSZ 31.1 2.7 3.6 50.2 9.4 3.0 1037 100 
3 - Bradford SE 2004 WSZ 56.2 2.8 3.8 29.0 4.3 4.0 397 100 
4 - Bradford SW 2004 WSZ 68.7 1.3 1.9 19.4 6.2 2.5 520 100 
5 - Graincliffe 2004 WSZ 100 0 0 0 0 0 5 100 
6 - Idle/Pudsey 2004 WSZ 80.8 2.2 1.1 5.8 7.1 3.0 365 100 
7 - Keighley 2004 WSZ 100 0 0 0 0 0 1 100 
8 - Shipley/Bingley 2004 WSZ 15.2 2.3 2.4 69.8 6.9 3.3 1517* 100 
*does not sum to 1519 as ethnicity unknown for 2 women residing in WSZ 8. 
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 Table 4.8  Summary of area-level exposure metrics for 2710 women 
 
  
Species Mean SD CV* Min 
25th 
%ile Median 
75th 
%ile Max Range 
Area-level metrics           
Annual average 
concentration (μg/l) 
- whole pregnancy 
TTHM 46.4 2.3 0.05 42.1 44.9 46.2 48.0 52.3 10.2 
Chloroform 38.2 2.0 0.05 32.5 36.7 38.3 40.0 41.8 9.3 
DCBM 6.7 0.5 0.07 6.2 6.5 6.6 6.6 9.0 2.8 
DBCM 1.0 0.2 0.20 0.8 0.9 1.0 1.1 2.1 1.2 
TBROM 7.8 0.7 0.10 7.1 7.6 7.6 7.7 11.3 4.3 
           
Annual average 
concentration (μg/l) 
- 3rd trimester 
TTHM 47.5 2.3 0.05 42.1 46.2 48.0 48.2 52.3 10.2 
Chloroform 39.2 1.9 0.05 32.5 37.9 40.3 40.3 41.8 9.3 
DCBM 6.8 0.5 0.08 6.2 6.6 6.6 6.8 9.0 2.8 
DBCM 1.0 0.2 0.20 0.8 0.9 1.0 1.1 2.1 1.2 
TBROM 7.8 0.8 0.10 7.1 7.6 7.6 7.7 11.3 4.3 
           
Time-weighted 
average 
concentration (μg/l) 
- whole pregnancy 
TTHM 45.9 3.8 0.08 36.3 42.8 45.6 48.3 59.0 22.7 
Chloroform 37.8 3.5 0.09 29.1 35.0 37.6 40.2 48.7 19.6 
DCBM 6.6 0.6 0.09 5.7 6.2 6.5 6.8 9.6 3.9 
DBCM 1.0 0.2 0.21 0.8 0.9 1.0 1.1 2.0 1.3 
TBROM 7.7 0.8 0.10 6.6 7.3 7.5 7.8 12.0 5.4 
           
Time-weighted 
average 
concentration (μg/l) 
- 3rd trimester 
TTHM 47.2 11.0 0.23 28.2 37.4 45.3 57.8 73.1 44.9 
Chloroform 39.0 10.2 0.26 23.4 29.6 36.3 48.8 68.7 45.3 
DCBM 6.7 1.0 0.15 4.8 5.8 6.8 7.5 10.5 5.7 
DBCM 1.0 0.2 0.22 0.8 0.9 1.0 1.1 2.8 2.1 
TBROM 7.8 1.1 0.14 5.9 6.9 7.7 8.4 12.4 6.5 
           
*CV = coefficient of variation (ratio of SD to mean) 
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 CHAPTER 5: SEMI-INDIVIDUAL EXPOSURE METRICS FOR THE BiB COHORT 
 
 
5.1 INTRODUCTION 
As discussed in the literature review in Chapter 1, many previous epidemiological studies have been 
limited in their exposure assessment.  The aim of this chapter was to estimate exposure to THMs 
during pregnancy for women in the BiB cohort, improving upon the exposure assessment 
methodologies used in previous epidemiological studies; and in doing so address some of the 
uncertainties that remain in respect of DBP exposure assessment. 
 
This chapter describes the creation of semi-individual THM exposure metrics for women in the BiB 
cohort, i.e. metrics which combine area-level and individual level exposure data.  It presents the 
results of statistical analyses of these exposure metrics in order to: a) identify the factors driving 
exposure to THMs for women in the BiB cohort; b) assess potential exposure misclassification 
according to various exposure metrics, and c) identify the most appropriate exposure metric for use 
in future epidemiological analysis.  Ultimately it is aimed that these exposure estimates will be used 
in, and will inform, an epidemiological analysis of DBP exposure and fetal growth outcomes in the 
BiB cohort.  However, an epidemiological analysis was outside the scope of this PhD. 
 
5.2 METHODS 
5.2.1 Creation of semi-individual exposure metrics 
Individual-level variables on tap water intake, showering, bathing and swimming derived from the 
BiB baseline questionnaire have already been described in Chapter 3.   The individual-level 
variables required to create semi-individual THM exposure metrics were cold unfiltered tap water 
intake (L/day) and cold filtered tap water intake (L/day) at home and work/college; cold tap water 
intake (L/day) elsewhere; squash intake (L/day) and hot tap water-based drinks intake (L/day) at 
home, work/study, and elsewhere; and minutes per day spent showering, bathing, and swimming. 
 
Semi-individual exposure metrics could be calculated for all 2710 women who had been assigned 
time-weighted average THM concentrations.  The objective was to combine area-level time-
weighted average THM concentrations with individual-level tap water use data to give metrics 
better representing exposure during the relevant exposure window, as set out in an analytical plan in 
advance (Appendix G).  Two semi-individual exposure metrics were calculated: ingestion of THMs 
and integrated uptake of THMs (via ingestion, dermal and inhalation exposure routes).  The various 
area-level and individual-level data inputs into these semi-individual metrics are summarised in 
Figure 5.1.   
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 5.2.1.1 Ingestion of THMs 
Daily ingestion of each THM at each location (home, work/study and elsewhere) was calculated 
according to the following formula, in which chloroform ingestion at home during the 1st trimester 
is used as an example: 
 
Chloroform ingestion at Home during 1st trimester (μg/day)  = 
ChloroformHome_WSZ T1 (μg/L) × [Cold Unfiltered Tap Water intakeHome (L/day) + SquashHome (L/day)] 
+ ChloroformHome_WSZ T1 (μg/L) × Filtering Reduction Factor × Cold Filtered Tap Water intakeHome (L/day) 
+ ChloroformHome_WSZ T1 (μg/L) × Boiling Reduction  Factor × Hot Water-based drinks intakeHome (L/day) 
 
ChloroformHome_WSZ T1 is the time-weighted average chloroform concentration based on Home WSZ 
for the 1st trimester.  A number of assumptions were made.  If a woman stated that she filters the 
water she drinks, it was assumed that plain cold tap water intake was filtered in the BiB 
questionnaire, but all other drinks (including squash) were assumed to be made from unfiltered tap 
water to avoid introducing uncertainty, because detailed filtering information was not available 
from the questionnaire.  To take into account the effects of boiling and filtering on THM 
concentrations in the tap water, a boiling reduction factor of 92% (average TTHM reduction based 
on 2 and 5 min boiling tests36;40-42) was applied to beverages made with hot water, and a filtering 
reduction factor of 90% (average TTHM reduction based on new and used, pitcher and tap-mounted 
tests28;36-40) was applied to cold filtered tap water intake.  Although there are some small differences 
in reduction between the 4 species of THM in the literature, they were of a similar magnitude to 
reduction for TTHM, so TTHM reduction factors were applied to all THM species.  THM 
concentrations were assumed to be zero for bottled water. 
 
Daily THM ingestion at work was treated as zero for those women who were not currently 
employed at time of completing the BiB questionnaire (n=1452).  Where assigned, time-weighted 
average THM concentrations based on Work WSZ were used to calculate THM ingestion at work 
(n=476), otherwise time-weighted average THM concentrations based on Home WSZ were used as 
a proxy.  Sick/maternity leave was ignored, as it was assumed that the majority of these women 
would have been at work for most of the preceding 6 months, and very few gave any indication as 
to when their attendance at work had ceased.  The numbers who reported being on sick/maternity 
leave were relatively small (n= 133).  Location of study was not known, so for the 52 full-time 
students, THM ingestion at study had to be calculated using time-weighted average THM 
concentrations based on Home WSZ as a proxy.   
 
Ingestion from tap water consumed elsewhere was calculated using time-weighted average THM 
concentrations for the Home WSZ, as the true location was unknown.  The only difference in 
calculation was that all plain cold tap water intake was assumed to be unfiltered, as the BiB 
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 questionnaire did not collect information on water filtering elsewhere.  Daily THM ingestion at 
home, work and elsewhere were summed to give a total daily THM ingestion estimate.   
 
Total daily ingestion estimates for TTHM, chloroform, DCBM, DBCM and TBROM, for 1st, 2nd 
and 3rd trimesters, and for whole pregnancy were calculated in this manner, giving each woman 20 
separate THM ingestion estimates. 
 
5.2.1.2 Integrated uptake of THMs 
Integrated uptake of THMs was based on uptake of THMs via various routes which were calculated 
as follows, using chloroform uptake during 1st trimester, as an example: 
 
Chloroform uptake via ingestionT1 (μg/day) =  
(total daily chloroform ingestion during 1st trimester (μg/day)) × ingestion chloroform uptake factor (μg/(μg/l)l) 
 
Chloroform uptake via showering T1 (μg/day) =  
Duration showering (min/day) × ChloroformHome WSZ T1 (μg/l) × showering chloroform uptake factor (μg/(μg/l)min) 
 
Chloroform uptake via bathing T1 (μg/day) =  
Duration bathing (min/day) × ChloroformHome WSZ T1 (μg/l) × bathing chloroform uptake factor (μg/(μg/l)min) 
 
Chloroform uptake via swimming T1 (μg/day) =  
Duration swimming (min/day) × ChloroformSwim (μg/l) × swimming chloroform uptake factor (μg/(μg/l)min) 
 
THM concentrations in swimming pools (e.g. ChloroformSwim) were not based on WSZ, but taken 
from a study by Chu & Nieuwenhuijsen which sampled from 8 swimming pools in London, UK.58  
Parameter values were chloroform 121.1 μg/l, DCBM 8.3 μg/l, DBCM 2.7 μg/l, and TBROM 11.9 
μg/l.  Determinants of THM formation, e.g. pH, temperature and TOC, measured in the London 
swimming pools58, were similar to the values for pH, temperature and TOC for samples collected in 
7 swimming pools in the Bradford area.  The actual THM values reported for the Bradford 
swimming pool samples were not sufficiently reliable to use in this exposure assessment. 
 
Uptake factor parameter values used are shown in Table 5.1.  THM uptake factors were calculated 
from biomonitoring studies by Backer et al.,65 Lynberg et al.,190 and Aggazzotti et al.,60, which had 
measured blood or plasma THM concentrations before and after ingestion of THM-containing water 
or showering, bathing or swimming in THM-containing water, and had measured THM 
concentration in tap or swimming pool water.  The uptake factors were calculated as per the 
examples below for chloroform, based on methodology by Whitaker et al.64 where possible, or 
where necessary based on uptake factors previously used in the literature.     
 
120
 Ingestion uptake factor - Uptake (per litre of water ingested per μg/l chloroform) is given by the 
proportion of chloroform in the blood to the total amount of chloroform ingested: 
 
[Blood volume (l) * (Blood chloroform concentration after ingestion (μg/l) - Blood chloroform concentration before ingestion (μg/l))] 
Water chloroform concentration (μg/l) * Volume water ingested (l) 
 
Showering uptake factor - Uptake (per μg/l chloroform in water per minute spent showering) is 
given by: 
 
[Blood volume (l) * (Blood chloroform concentration after showering (μg/l) - Blood chloroform concentration before showering (μg/l))] 
Water THM concentration (μg/l) * Duration of showering (min) 
 
Bathing uptake factor:  as per formula for showering. 
 
Swimming uptake factor - Uptake (per μg/l chloroform in water per minute spent in the swimming 
pool) is given by: 
 
[Blood volume (l) * (Plasma chloroform concentration after swim (μg/l) - Plasma chloroform concentration before swim (μg/l)) * 2.135] 
Water THM concentration (μg/l) * Duration of swim (min) 
  
The formulae assume a whole body blood volume of 5 litres.  For the swimming uptake factor 2.135 
represents a plasma correction factor.  If the uptake factors for a particular activity were calculated 
from more than one study, then a weighted average of uptake factors from all the studies were taken 
based upon study size.  Whilst uptake factors such as these have been used previously, e.g. 
Villanueva et al,191 they have not been validated.  The uptake factors are based on a few 
biomonitoring studies which have measured blood THM levels before and after water use activities, 
on a small number of subjects.  It is difficult, therefore to be certain as to how accurate and 
representative these uptake factors are.   If metabolism of THMs is highly variable between 
individuals, these uptake factors may be unduly influenced by the particular THM metabolism of 
the study subjects.   However, at present, these uptake factors represent the best data available to 
estimate THM exposure in such a way that several routes of exposure can be integrated. 
 
Uptake via each route was calculated for chloroform, DCBM, DBCM and TBROM, for each 
trimester and the whole pregnancy.  Then uptake of TTHM was calculated for each route (and 
trimester/whole pregnancy), by summing uptake of chloroform and TBROM to give TTHM value.  
This allowed differences in uptake factors for chloroform and brominated THMs to be taken into 
account for the TTHM values. 
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 Finally, the integrated uptake metric was calculated by summing daily THM uptakes from 
ingestion, showering, bathing and swimming to give an integrated index of blood concentration 
(μg/day), as per the example below: 
 
Integrated uptake of chloroform in 1st trimester (μg/day) = 
Chloroform uptake via ingestionT1 (μg/day) + Chloroform uptake via showeringT1 μg/day) 
+ Chloroform uptake via bathingT1 (μg/day) + Chloroform uptake via swimmingT1 (μg/day) 
 
Integrated uptake metrics were calculated for each trimester and the whole pregnancy for TTHM, 
chloroform, DCBM, DBCM and TBROM. 
 
5.2.2 Summary of all THM exposure metrics created and available for analysis 
To summarise, for 2710 women in the BiB cohort the THM exposure metrics listed below were 
created for 1st, 2nd and 3rd trimesters and whole pregnancy, for TTHM, chloroform, DCBM, DBCM, 
and TBROM. 
 
Area-level THM exposure metrics: 
• Time-weighted average of monthly modelled THM concentrations (μg/l) 
• Annual average THM concentration (μg/l) 
 
Semi-individual THM exposure metrics: 
• THM ingestion (μg/day) 
• Integrated THM uptake (μg/day) 
 
For clarity, although the units given for both semi-individual THM exposure metrics are μg/day, the 
two metrics are on different scales and are not directly comparable.  Integrated THM uptake 
represents μg uptake of THMs into blood per day through the integrated routes of ingestion, 
showering, bathing and swimming.  THM ingestion represents simply μg of THM physically 
ingested per day (not uptake of THMs via ingestion). 
 
5.2.3 Statistical analysis 
5.2.3.1 Descriptive analysis of semi-individual THM exposure metrics 
For the 2710 women for whom THM exposure metrics had been created, basic descriptive statistics 
were generated for semi-individual THM exposure metrics. 
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 5.2.3.2 Analysis of variance to assess factors driving exposure 
ANOVA was used to assess the proportion of total variability in both area-level time-weighted 
average THM concentrations and semi-individual THM exposure metrics due to temporal, spatial 
and individual components of variability.  Annual average THM concentrations were not examined 
in this way because these demonstrated very little variability which could only be due to spatial and 
yearly variability.  The percentage contribution of each model term to total variability was 
calculated as the sum of squares due to that term, as a percentage of total sum of squares in the 
ANOVA.  This ANOVA analysis was carried out by Dr James Bennett, as specified by the author. 
 
When analysing the semi-individual THM metrics, the objective was to isolate the individual 
variability (i.e. that due to variability in individual water use) from other components of variability 
in order that its contribution could be quantified.  This was done by separating all spatial and 
temporal components from the residual (as far as possible), in order that what was left in the 
residual was likely to be only individual variability.  In order to separate all spatial and temporal 
components from the residual, interaction terms between Month, Year and WSZ were included in 
the ANOVA models.  It was known that there would be interactions between these factors in the 
modelled THM concentrations, because the modelling used Month-Year-WSZ specific 
measurements of predictors such as free chlorine, colour and pH.  These interactions generated a 
spatio-temporal component of variability which represents a mix of Month, Year and WSZ effect. 
 
For both area-level time-weighted average THM concentrations and semi-individual THM exposure 
metrics, the residual will contain a small element of variability arising from differences in the time-
weighting applied to each woman.  Even if women were pregnant across the same 9 months, the 
days of weighting could differ, e.g. the weighting could incorporate only 1 day of September and 30 
days of December, or 30 days of September and 1st day of December, and therefore the weightings 
for each month can vary.  For semi-individual metrics, however, this is likely to represent only a 
tiny part of the residual, and the majority can be assumed to represent individual variability between 
women. 
 
Two separate sets of ANOVA analyses were run in order to be able to correctly identify spatial 
components of variability in exposure metrics.  The primary analysis included women whose THM 
exposure metrics were based only on their Home WSZ (either because they were not currently 
employed, they worked in their Home WSZ, or because Home WSZ THM concentrations had to be 
used as a proxy to calculate exposure at work) (n = 2393).  The secondary analysis included only 
women who had been assigned a Work WSZ known to be different from her Home WSZ (n = 317) 
(i.e. exposure metrics take into account THM concentrations from 2 different WSZs).  These groups 
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 were analysed separately because spatial components of variability were expected to differ between 
the two groups. 
 
The models in the primary analysis included Month and Year of conception and Home WSZ as 
factors.  Month, Year and the interaction Month*Year components were summed to give percentage 
variability due to temporal components.  Home WSZ determined spatial variability.  Three 
interaction terms contributed to the spatio-temporal component: Month*HomeWSZ, 
Year*HomeWSZ, and Month*Year*HomeWSZ.  The residual reflects unexplained variation for 
area-level metrics (likely to be temporal variability on a lesser scale than month, due to different 
weightings for each month), but for semi-individual metrics this will reflect (almost entirely) 
individual variation. 
 
The models in the secondary analysis included Month and Year of conception, and both Home 
WSZ and Work WSZ as factors, which increased the number of interaction terms to 7, compared 
with 4 in the primary analysis.  Six interaction terms contributed to the spatio-temporal component: 
Month*HomeWSZ, Month*WorkWSZ, Month*Year*HomeWSZ, Year*HomeWSZ, 
Year*WorkWSZ, and Month*Year*WorkWSZ.    It was necessary to include all these interaction 
terms in the model in order to attempt to isolate individual variability from all spatial and temporal 
components of variability.  It appears that the ANOVA models for semi-individual metrics in this 
secondary analysis were over-parameterised due to the increased number of interaction terms.  
Essentially this means that some components of variability were not uniquely identifiable, because 
for some specific combinations of parameters there were no data-points in that group.  For example, 
for the interaction Month*Year*WorkWSZ there may not have been a specific data point for every 
one of the 192 possible Month*Year*WorkWSZ combinations (12 x 2 x 8 = 192).  Ultimately this 
meant that it was not possible for the model to identify and separate out the different components of 
variability and thus the residual did not accurately reflect the individual component of variation. 
 
5.2.3.3 Percentage uptake in integrated metrics from each exposure route 
To examine the contribution of each exposure route (ingestion, personal washing and swimming) to 
integrated THM uptake metrics, uptake via each route was calculated as a percentage of total 
integrated THM uptake for each woman.  Mean percentage contributions from each exposure route 
are reported.  The analysis was also performed separately for employed, unemployed, full-time 
students and swimmers. 
 
5.2.3.4 Analysis of agreement between exposure metrics 
Area-level time-weighted average THM concentrations and semi-individual exposure metrics for 
THM ingestion and integrated THM uptake were categorised into tertiles, representing “low”, 
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 “medium” and “high” exposure.  Area-level annual average THM concentrations and individual tap 
water use metrics could not be categorised because many women had the same values, making it 
impossible to create equally sized tertiles. 
 
Agreement between the categorical THM exposure metrics was assessed using the Kappa statistic 
(unweighted and weighted).  To examine the degree of exposure misclassification according to 
different categorical THM exposure metrics, percentage misclassification was calculated from 
contingency tables, on the assumption that the semi-individual metrics were the gold-standard 
against which exposure misclassification by an area-level metric could be assessed.  The analysis 
was performed separately for employed, unemployed, full-time students and swimmers. 
 
Although it was not possible to examine cross-classification of semi-individual metrics with 
individual water use or annual average area-level metrics, because neither could be categorised into 
equal tertiles, Spearman’s correlations between continuous semi-individual metrics, and both 
individual water use and area-level metrics were calculated.  Correlations were calculated for all 
women, and then separately for employed, unemployed, full-time students, swimmers, and 
separately for those women whose exposure metrics had been based solely on Home WSZ THM 
values, and those whose exposure metrics had incorporated both Home WSZ and Work WSZ THM 
values.  Spearman’s correlation was used due to skewness of individual water use variables and 
semi-individual metrics.  All statistical analysis was performed using R statistical software version 
2.4.1.181 
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5.3 RESULTS 
5.3.1 Descriptive analysis of semi-individual THM exposure metrics 
Basic statistics for semi-individual THM exposure metrics for whole pregnancy and the 3rd trimester 
are shown in Table 5.2.  The coefficient of variation (ratio of standard deviation to mean) ranged 
from 0.67 to 1.00 for semi-individual metrics, demonstrating greater variability for semi-individual 
metrics when compared to coefficients of variation for area-level metrics shown in Chapter 4 (see 
Table 4.8).  This suggests that semi-individual metrics would be better able to distinguish between 
different levels of exposure than area-level metrics.  Variability tended to be greater for 3rd trimester 
metrics compared to whole pregnancy metrics, reflecting the influence of seasonal variation in 
THM concentrations in the tap water supply on trimester-specific measures (Table 5.2).  Basic 
descriptive statistics for 1st and 2nd trimester exposure metrics (not shown) were very similar to 
those for 3rd trimester. 
 
5.3.2 Analysis of variance to assess factors driving THM exposure 
ANOVA was used to assess the proportion of total variability in time-weighted average THM 
concentrations and semi-individual THM exposure metrics due to temporal, spatial and individual 
components of variability. 
 
5.3.2.1 Primary analysis 
The percentage components of variability in exposure metrics for women in the primary analysis 
(i.e. women for whom exposure metrics were calculated using only a Home WSZ, n=2393) are 
shown in Table 5.3. 
 
Time-weighted average THM concentrations 
For time-weighted average THM concentrations as the speciation of THMs shifts from chlorinated 
to brominated, the contribution of temporal variability decreases whilst the contribution of spatial 
variability increases (Table 5.3).  Most of the temporal component was due to a Month effect (i.e. 
seasonal variation), although the Year effect explained ~4% of variation in whole pregnancy TTHM 
and chloroform estimates, but this was not observed in trimester-specific estimates, nor for other 
individual THM species or TBROM estimates (not shown). 
 
Temporal components are greater and spatial components smaller for trimester-specific metrics 
compared to whole pregnancy metrics.  This can be explained because seasonal variation has 
greater influence on trimester-specific metrics, and thus the contribution of spatial variation is 
smaller.  Residual variability is small (≤ 5%), and this is likely to represent temporal variation due 
to different time weightings determined by the day of the month on which the pregnancy or relevant 
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 trimester started and ended.  Within-WSZ variation could not be observed here because this could 
not be included in the predictive THM modelling.  Results for 1st and 2nd trimester exposure metrics 
were very similar to those for the 3rd trimester (not shown). 
 
Semi-individual THM exposure metrics 
The majority of total variability in THM ingestion metrics (83-95%) and integrated THM uptake 
metrics (90-96%), is explained by individual variation in behaviour (i.e. the residual) (Table 5.3).  
For semi-individual metrics the residual represents variability due to individual behaviour, because 
as far as possible, all other components of variability have been separated out of the residual.   
 
In line with observations for area-level metrics, as the speciation of THMs shifts from chlorinated to 
brominated, the contribution of spatial variability increases slightly and the contribution of temporal 
variability decreases.  The temporal component of variability was greater for trimester-specific 
metrics compared to whole pregnancy metrics.  As expected, seasonal variation in THM 
concentrations in tap water has greater influence on trimester-specific metrics compared to whole 
pregnancy metrics.  Overall, the temporal and spatial patterns observed in the raw and modelled 
data are reflected in semi-individual exposure metrics.  However, once individual data are combined 
with area-level data, the temporal and spatial contributions are dwarfed by variability in individual 
behaviour. 
 
Results for 1st and 2nd trimester exposure metrics (not shown) were very similar to those for the 3rd 
trimester. 
 
5.3.2.2 Secondary analysis 
A secondary analysis was performed for women who had been assigned a Work WSZ which was 
different from her Home WSZ (n=317).  For these women THM exposure metrics accounted for 
differences in THM concentrations between home and workplace, and it was therefore appropriate 
to analyse them separately. 
 
However, it was clear from the results that it had not been possible to isolate the individual 
component of variability, because estimates for the spatio-temporal component appeared to have 
been substantially over-estimated.  It is thought that the ANOVA models for semi-individual 
metrics in this secondary analysis were over-parameterised due to the increased number of 
interaction terms.  The results of this secondary analysis were not meaningful. 
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 5.3.3 Percentage uptake in integrated metrics from each exposure route 
To examine the contribution of the three exposure routes (ingestion, personal washing and 
swimming) to integrated THM uptake metrics, uptake via each route was calculated as a percentage 
of total integrated uptake for each woman.  Mean percentage contributions by each exposure route 
to integrated THM uptakes for whole pregnancy are shown in Table 5.4.  Uptake via personal 
washing (combined showering/bathing) contributes most (>77%) to integrated uptake of THMs, but 
the proportion is ~10% greater for brominated, compared to chlorinated, species. 
 
For swimmers only, the largest percentage contribution to uptake was from swimming (~49-67%).  
The analysis was also performed separately for employed, unemployed, and full-time students.  
Results were very similar to those for all women, with the exception that slightly more uptake was 
due to swimming for employed vs. unemployed, but this simply reflected a greater proportion of 
swimmers in the employed group.  Results for trimester-specific metrics (not shown) were almost 
identical to those for whole pregnancy. 
 
5.3.4 Agreement between exposure metrics 
5.3.4.1 Agreement between categorical exposure metrics 
Table 5.5 shows agreement between semi-individual metrics and time-weighted average THM 
concentrations (each categorised into tertiles representing ‘low’, ‘medium’ and ‘high’ exposure) in 
terms of percentage misclassification and according to the Kappa statistic.  The semi-individual 
metrics are assumed to be the gold-standard (i.e. closest to “true” exposure) for THM exposure 
assessment against which less sophisticated exposure metrics should be compared. 
 
Percentage misclassification 
If THM ingestion metrics are treated as the gold-standard, time-weighted average THM 
concentrations misclassify ~42-45% of women into an adjacent category, and ~12-21% into a far 
category (i.e. misclassified from “low” to “high” or vice versa)(Table 5.5).  Similarly, compared to 
integrated uptake of THMs, time-weighted average THM concentrations misclassify ~43-45% into 
an adjacent category, and ~11-20% into a far category.  Less than half of women are classified 
correctly by the area-level exposure metric.  Percentage misclassification values were very similar 
for 1st and 2nd trimester metrics (not shown). 
 
Additionally, if integrated uptake of THMs alone is assumed to be the gold-standard, then the THM 
ingestion metric also misclassifies ~42-44% of women into an adjacent category, and ~14-21% in a 
far category (data not shown). 
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 Kappa statistic for agreement 
According to the Kappa statistic, agreement between semi-individual metrics and time-weighted 
average THM concentration categories was very weak, although agreement was slightly better for 
3rd trimester metrics compared to whole pregnancy metrics.  Values for 1st and 2nd trimester metrics 
were very similar to those for the 3rd trimester (Table 5.5).  The Kappa statistic also demonstrated 
that agreement was weak when comparing the two semi-individual metrics, integrated uptake and 
ingestion (data not shown). 
 
5.3.4.2 Correlation between continuous exposure metrics 
Spearman’s correlations between continuous semi-individual metrics and both continuous area-level 
metrics and continuous individual water use measures were calculated.  Results for whole 
pregnancy metrics are shown in Table 5.6.  
 
Correlations between area-level THM concentrations and semi-individual exposure metrics for 
whole pregnancy were very weak (0.07-0.24)(Table 5.6).  Results (not shown) were similar for 
trimester-specific metrics. 
 
Strong correlations were observed between daily ingestion of THMs and individual intakes of plain 
cold tap water, cold tap water beverages and total tap water intake.  There was no correlation 
between hot tap water-based beverage intake and THM ingestion.  This is as expected, because 
reduction in THMs due to boiling was taken into account in the calculation of THM ingestion 
metrics.  In general, correlations for tap water intake at home were similar to, but slightly weaker 
than, those for tap water intake across all locations.  The correlations were very similar when using 
trimester-specific ingestion metrics (results not shown). 
 
However, correlations between daily integrated uptake of THMs and any of the individual tap water 
intake measures were weak (≤ 0.18).  Combined showering and bathing was very strongly 
correlated with daily integrated uptake of THMs (0.87-0.93, p<0.0001), but correlations were more 
moderate for bathing, showering and swimming.  Correlations were very similar when using 
trimester-specific integrated uptake metrics (results not shown). 
 
Correlations were also examined separately for employed, unemployed, full-time students, 
swimmers, women whose THM exposure metrics were based solely on Home WSZ, and women 
whose metrics were based on different Home and Work WSZs (results not shown).  The results 
were largely similar to those for all women, although a few differences are noted below. 
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 Overall, correlations between tap water intakes and THM ingestion metrics were always a little 
greater (by ~5-20%) for unemployed women compared to employed women, except for hot tap 
water intake for which correlations were negligible as expected regardless of employment status.  
For full-time students correlations between THM ingestion metrics and cold/total tap water intakes, 
although still relatively strong, were somewhat weaker compared to those for employed or 
unemployed women, but there was no clear explanation for this.  
 
Correlation between swimming and integrated uptake of THMs was always greater for employed 
and full-time students (0.37-0.51) compared to unemployed (0.24-0.29), reflecting the higher 
proportion of swimmers amongst the employed and student subgroups. 
 
For swimmers only, correlations between area-level time-weighted average THM concentrations 
and semi-individual integrated THM uptake metrics were consistently weaker than those for all 
women.  This is as expected because integrated THM uptake metrics for swimmers take into 
account swimming pool THM concentrations in addition to tap water THM concentrations. 
 
For swimmers, correlations between individual water use activities and integrated uptake of THMs 
were strongest for swimming (0.73-0.91, p<0.0001), with the exception of DCBM, for which 
combined showering/bathing (0.78) was slightly greater than for swimming (0.73). 
 
5.3.5 Potential error in exposure assessment due to mobility between WSZs during 
pregnancy 
Mobility between WSZs can arise because a woman lives and works in different WSZs, or because 
a woman moves address to a different WSZ.  If mobility between WSZs is not accounted for this 
could lead to error in exposure estimates. 
 
Of all 1799 currently employed women, 876 (48.7%) gave a workplace postcode which could be 
mapped in GIS.  Overall, 40.1% of currently employed women were assigned work WSZs within 
the study area and 1.7% were known to work at home.  For these women THM concentrations at 
their workplace tap could be properly accounted for, as both the WSZ in which they worked was 
known and modelled THM concentrations in tap water were available for those WSZs.  However 
8.6% of currently employed women were known to work outside the 8 WSZs of the study area (for 
which no data on THM concentrations in tap water were available), 2.6% had no regular place of 
work, and 47.0% could not be assigned a work WSZ as they had given insufficient details of their 
work address to allow matching in GIS.  For these women it was not possible to account for THM 
concentrations in tap water at the workplace in their THM exposure estimates.  Of the 876 women 
for whom workplace could be mapped in GIS, 71% lived and worked in different WSZs (be they 
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 within or outside the study area), so there appears to be a relatively high proportion of mobility 
between WSZs for work. 
 
Of the total sample (n = 4045), 14.5% reported having lived at their current address for 6 months or 
less at time of recruitment to the cohort (approximately 28 weeks gestation).  However, it was not 
possible to discern how many of these women had moved address to a different WSZ during the 
first 6 months of pregnancy because previous address is not retained in the medical records.  6.1% 
of women moved address between recruitment and delivery, but only 2.2% moved address to a 
different WSZ post-recruitment.  1.9% of women moved address both in the 6 months preceding 
recruitment and between recruitment and delivery.  Overall, approximately 19% of women moved 
address during pregnancy.  Assuming the proportions moving within and between WSZs prior to 
recruitment are similar to those observed post-recruitment, the author estimates residential mobility 
between WSZs pre-recruitment to be 5.3%, and during pregnancy as a whole to be 7.5%.  
Residential mobility between WSZs could not be accounted for in this exposure assessment because 
data on previous addresses and moving dates were not available. 
 
There may be error in THM exposure estimates due to the inability to account for residential 
mobility between WSZs, and the inability to fully account for THM concentrations at the workplace 
tap.  However, given that the results of this study show that there is a) relatively little spatial 
variation in THM concentrations between WSZs in this study area (see section 4.3.1.2), and b) that 
spatial variability in THM concentrations between WSZs plays a minor role in driving semi-
individual THM exposure estimates (see section 5.3.2.1, Semi-individual THM exposure metrics), 
failure to account for mobility between WSZs is unlikely to introduce a large degree of error into 
exposure estimates for this particular cohort.  The extent of spatial variability in THM 
concentrations outside the study area is unknown, so there is a greater potential for error in exposure 
estimates for the small proportion (8.6%) of employed women working outside the study area, or 
for any women who may have moved to/from an address outside the study area. 
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 Figure 5.1  Summary of area-level and individual-level data inputs into semi-individual exposure metrics 
 
Bathing (min/day) 
Swimming (min/day) 
Showering (min/day) 
INGESTION 
INTEGRATED EXPOSURE 
Time-weighted average THM 
concentrations at Home: 
- Whole pregnancy & each trimester 
- Chloroform, DCBM, DBCM, TBROM 
Time-weighted average THM 
concentrations at Work: 
- Whole pregnancy & each trimester 
- Chloroform, DCBM, DBCM, TBROM 
SEMI-INDIVIDUAL 
METRICS
Tap water intakes at Work: 
- cold filtered tap water (L/day) 
- cold unfiltered tap water (L/day) 
- squash (L/day) 
- hot-water-based drinks (L/day) 
- Tap water intakes at Home:
- cold filtered tap water (L/day) 
- cold unfiltered tap water (L/day) 
- squash (L/day) 
- hot-water based drinks (L/day) 
Tap water intakes Elsewhere:
- cold tap water (L/day) 
- squash (L/day) 
- hot water-based drinks (L/day) 
INDIVIDUAL-LEVEL 
DATA 
AREA-LEVEL DATA
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 Table 5.1  THM uptake factors 
 
Activity DBP Units Uptake factor Reference 
Ingestion Chloroform  μg/(μg/l)l 0.00490196 Backer et al.65 
 DCBM μg/(μg/l)l 0.00108696 Backer et al.65 
 DBCM μg/(μg/l)l 0.00115 Backer et al.65 
 Brominated THM  μg/(μg/l)l 0.00111848 Average of DCBM and DBCM uptake 
factors above (as used by Villanueva et 
al.191) 
     
Showering Chloroform  μg/(μg/l)min 0.001563091 Weighted average from Backer et al.65 and 
Lynberg et al.190 
 DCBM μg/(μg/l)min 0.001322253 Weighted average from Backer et al.65 and 
Lynberg et al.190 
 DBCM μg/(μg/l)min 0.001355042 Weighted average from Backer et al.65 and 
Lynberg et al.190 
 Brominated THM  μg/(μg/l)min 0.0013386475 Average of DCBM and DBCM uptake 
factors for showering above. 
     
Bathing Chloroform  μg/(μg/l)min 0.001320755 Backer et al.65 
 DCBM μg/(μg/l)min 0.001189711 Backer et al.65 
 DBCM μg/(μg/l)min 0.001401709 Backer et al.65 
 Brominated THM  μg/(μg/l)min 0.00129571 Average of DCBM and DBCM uptake 
factors for bathing above. 
     
Swimming Chloroform  μg/(μg/l)min 0.002541407 Aggazzotti et al.60 – based on non-
competitive swimmers. 
Swimming Brominated THM  μg/(μg/l)min 0.0022367211 As used by Villanueva et al.191 – based on 
expert judgement. 
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 Table 5.2  Summary of semi-individual exposure metrics for 2710 women 
 
  
Species Mean SD CV* Min 
25th 
%ile Median 
75th 
%ile Max Range 
Semi-individual 
metrics                     
Ingestion (μg/day) - 
whole pregnancy 
TTHM 48.8 32.9 0.67 0.0 25.7 43.9 66.4 267.6 267.6 
Chloroform 40.2 27.2 0.67 0.0 21.0 36.4 54.8 224.9 224.9 
DCBM 7.0 4.8 0.68 0.0 3.8 6.4 9.5 38.0 38.0 
DBCM 1.1 0.8 0.72 0.0 0.5 0.9 1.5 7.9 7.9 
TBROM 8.2 5.6 0.68 0.0 4.5 7.5 11.0 46.0 46.0 
           
Ingestion (μg/day) - 
3rd trimester 
TTHM 50.4 36.5 0.72 0.0 25.4 44.6 68.0 303.7 303.7 
Chloroform 41.7 30.7 0.74 0.0 20.6 36.1 56.6 252.3 252.3 
DCBM 7.1 5.0 0.69 0.0 3.7 6.4 9.6 43.0 43.0 
DBCM 1.1 0.8 0.72 0.0 0.6 1.0 1.5 6.8 6.8 
TBROM 8.3 5.7 0.69 0.0 4.3 7.4 11.1 50.6 50.6 
           
Integrated (μg/day) 
- whole pregnancy 
TTHM 1.89 1.81 0.96 0.19 0.92 1.39 2.19 32.20 32.00 
Chloroform 1.64 1.59 0.97 0.17 0.80 1.19 1.86 28.37 28.20 
DCBM 0.21 0.18 0.89 0.02 0.10 0.16 0.25 3.04 3.02 
DBCM 0.04 0.04 1.03 0.00 0.02 0.03 0.04 0.61 0.61 
TBROM 0.26 0.23 0.91 0.02 0.12 0.19 0.31 3.83 3.81 
           
Integrated (μg/day) 
- 3rd trimester 
  
TTHM 1.94 1.91 0.98 0.19 0.91 1.42 2.28 39.00 38.81 
Chloroform 1.68 1.69 1.00 0.16 0.79 1.23 1.97 34.80 34.64 
DCBM 0.21 0.19 0.90 0.02 0.10 0.16 0.26 3.51 3.50 
DBCM 0.04 0.04 1.03 0.00 0.02 0.03 0.04 0.63 0.62 
TBROM 0.26 0.24 0.92 0.02 0.12 0.20 0.32 4.20 4.18 
*CV = coefficient of variation (ratio of SD to mean) 
 
 
N.B.  For clarity, although the units given for the ingestion and integrated exposure metrics in the table 
above are both μg/day, the two metrics are on different scales and are not directly comparable.  
Integrated exposure represents μg uptake of THMs into blood per day through the integrated routes of 
ingestion, showering, bathing and swimming.  Ingestion represents simply μg of THM physically 
ingested per day (not uptake of THMs via ingestion).  This is why the values for the integrated metrics 
are lower than those for the ingestion metric.   
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 Table 5.3  Percentage components of variability in exposure metrics - primary analysis 
 
    % total variability explained by: 
    Temporal 
* 
Spatial 
** 
Spatio-
temporal*** 
Residual 
**** 
Area-level 
metrics 
     
Time-weighted 
average 
concentration 
(μg/l) - whole 
pregnancy 
TTHM 70.4 23.7 1.3 4.6 
Chloroform 74.2 18.9 2.0 5.0 
DCBM 19.6 78.0 1.1 1.3 
DBCM 1.2 97.9 0.8 0.1 
TBROM 8.9 89.6 0.9 0.6 
      
Time-weighted 
average 
concentration 
(μg/l) - 3rd 
trimester 
TTHM 92.7 3.2 0.9 3.2 
Chloroform 93.1 2.2 1.3 3.5 
DCBM 66.4 29.1 1.9 2.6 
DBCM 6.4 89.9 2.7 1.0 
TBROM 42.3 54.2 1.9 1.7 
      
Semi-individual 
metrics           
Ingestion (μg/day) 
- whole pregnancy 
TTHM 0.9 1.1 3.1 94.8 
Chloroform 1.2 1.2 3.1 94.5 
DCBM 0.5 1.3 3.5 94.7 
DBCM 0.6 8.6 3.8 87.0 
TBROM 0.5 1.9 3.7 94.0 
      
Ingestion (μg/day) 
- 3rd trimester 
TTHM 10.4 0.8 3.0 85.8 
Chloroform 12.8 0.8 3.0 83.4 
DCBM 3.7 1.2 3.6 91.5 
DBCM 0.8 8.5 3.9 86.9 
TBROM 2.3 1.9 3.6 92.1 
      
Integrated uptake 
(μg/day) - whole 
pregnancy 
TTHM 1.2 0.7 3.3 94.9 
Chloroform 1.2 0.7 3.3 94.7 
DCBM 0.8 0.8 2.9 95.6 
DBCM 0.8 1.9 3.2 94.0 
TBROM 0.7 1.0 3.0 95.3 
      
Integrated uptake 
(μg/day) - 3rd 
trimester 
TTHM 5.2 0.7 3.1 91.0 
Chloroform 5.9 0.7 3.2 90.3 
DCBM 2.1 0.9 2.9 94.0 
DBCM 0.9 2.1 3.4 93.6 
TBROM 1.4 1.1 3.0 94.5 
 
(n=2393, women for whom exposure metrics were calculated using only a Home WSZ) 
* Temporal reflects the sum of Month, Year and Month*Year interaction components. 
** Spatial reflects variation due to Home WSZ.  
*** Spatio-temporal reflects the contribution of Month*Year*HomeWSZ interaction. 
**** The residual reflects unexplained variation for area-level metrics, but for semi-individual metrics this reflects 
(almost entirely) individual variation. 
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 Table 5.4  Percentage integrated uptake from each exposure route 
 
  Mean % contribution of each route to integrated uptake* (95% CI) 
  Ingestion Personal washing† Swimming 
All women 
(n=2710) 
TTHM 15.8 (15.3, 16.3) 79.3 (78.6, 80.0) 4.9 (4.2, 5.6) 
Chloroform 17.3 (16.8, 17.8) 77.7 (77.0, 78.4) 5.0 (4.3, 5.7) 
DCBM 5.8 (5.6, 6.0) 90.5 (90.0, 91.1) 3.7 (3.2, 4.2) 
DBCM 5.5 (5.3, 5.8) 89.6 (88.9, 90.3) 4.8 (4.2, 5.5) 
TBROM 5.7 (5.5, 5.9) 90.4 (89.8, 90.9) 4.0 (3.4, 4.5) 
        
Swimmers 
only 
(n=204)  
TTHM 4.7 (4.2, 5.2) 30.3 (28.2, 32.4) 65.0 (62.9, 67.1) 
Chloroform 4.9 (4.4, 5.5) 28.6 (26.6, 30.6) 66.5 (64.4, 68.5) 
DCBM 2.3 (2.1, 2.6) 48.5 (46.2, 50.9) 49.1 (46.7, 51.5) 
DBCM 1.5 (1.3, 1.7) 34.0 (31.7, 36.4) 64.4 (62.1, 66.7) 
TBROM 2.1 (1.9, 2.4) 45.0 (42.6, 47.4) 52.8 (50.5, 55.2) 
* integrated uptake for whole pregnancy 
† combined showering/bathing 
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Table 5.5  Percentage misclassification and Kappa statistics for agreement between categorical exposure metrics 
 
     
Assumed 
"true" 
exposure 
    
% classified correctly or 
misclassified by the corresponding 
time-weighted area-level metric 
(μg/l): 
Agreement with corresponding 
 time-weighted area-level metric (μg/l): 
Kappa statistic 
  Correct Misclassified 
Unweighted 
Kappa 
 
Weighted 
Kappa 
 
    
Same 
tertile 
Adjacent 
tertile 
Far 
tertile (95% CI) (95% CI) 
Ingestion 
(μg/day) 
Whole 
pregnancy 
metrics 
TTHM 38.2 42.3 19.6 0.07 (0.04, 0.10) 0.08 (0.04, 0.13) 
Chloroform 38.4 42.7 18.9 0.08 (0.05, 0.10) 0.10 (0.05, 0.14) 
DCBM 36.1 42.7 21.3 0.04 (0.01, 0.07) 0.04 (0.00, 0.08) 
DBCM 41.0 43.7 15.3 0.12 (0.09, 0.14) 0.16 (0.12, 0.21) 
TBROM 36.7 42.5 20.8 0.05 (0.02, 0.08) 0.05 (0.01, 0.10) 
         
3rd 
trimester 
metrics 
TTHM 44.3 42.6 13.1 0.16 (0.14, 0.19) 0.23 (0.18, 0.27) 
Chloroform 45.6 42.2 12.3 0.18 (0.16, 0.21) 0.25 (0.20, 0.30) 
DCBM 38.8 44.8 16.4 0.08 (0.05, 0.11) 0.13 (0.08, 0.17) 
DBCM 40.5 44.0 15.5 0.11 (0.08, 0.14) 0.16 (0.11, 0.20) 
TBROM 37.5 45.1 17.3 0.06 (0.04, 0.09) 0.10 (0.06, 0.15) 
  
  
               
  
  
Integrated 
uptake 
(μg/day) 
Whole 
pregnancy 
metrics 
TTHM 36.1 44.5 19.4 0.04 (0.01, 0.07) 0.06 (0.02, 0.11) 
Chloroform 37.5 43.4 19.1 0.06 (0.04, 0.09) 0.08 (0.04, 0.13) 
DCBM 35.7 44.1 20.1 0.04 (0.01, 0.06) 0.05 (0.01, 0.09) 
DBCM 38.0 43.5 18.6 0.07 (0.04, 0.10) 0.09 (0.05, 0.14) 
TBROM 35.8 44.1 20.2 0.04 (0.01, 0.06) 0.05 (0.01, 0.09) 
         
3rd 
trimester 
metrics 
TTHM 44.9 43.0 12.2 0.17 (0.14, 0.20) 0.24 (0.20, 0.29) 
Chloroform 46.4 42.5 11.1 0.20 (0.17, 0.22) 0.27 (0.23, 0.32) 
DCBM 39.9 43.3 16.8 0.10 (0.07, 0.13) 0.13 (0.09, 0.18) 
DBCM 38.7 42.8 18.5 0.08 (0.05, 0.11) 0.10 (0.06, 0.15) 
TBROM 38.6 43.8 17.6 0.08 (0.05, 0.11) 0.11 (0.07, 0.16) 
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 Table 5.6  Spearman's correlation between continuous exposure metrics 
   S E M I - I N D I V I D U A L  M E T R I C S  
   Ingestion (μg/day) - whole pregnancy Integrated uptake (μg/day) - whole pregnancy 
                   
   TTHM  Chloroform DCBM  DBCM  TBROM TTHM  Chloroform DCBM  DBCM  TBROM 
      rho p rho p rho p rho p rho p rho p rho p rho p rho p rho p 
A
R
E
A
-
L
E
V
E
L
 
M
E
T
R
I
C
S
 
Annual average 
concentration 
(μg/L) - whole 
pregnancy 
TTHM 0.08 <0.001         0.07 <0.001         
Chloroform   0.10 <0.001          0.07 <0.001       
DCBM     0.07 <0.001          0.08 <0.001     
DBCM       0.23 <0.001          0.14 <0.001   
TBROM         0.08 <0.001          0.09 <0.001 
                      
Time-weighted 
average 
concentration 
(μg/L) - whole 
pregnancy 
TTHM 0.12 <0.001         0.11 <0.001         
Chloroform   0.13 <0.001          0.13 <0.001       
DCBM     0.08 <0.001          0.09 <0.001     
DBCM       0.24 <0.001          0.15 <0.001   
TBROM         0.08 <0.001          0.08 <0.001 
I
N
D
I
V
I
D
U
A
L
 
W
A
T
E
R
 
U
S
E
 
Tap water intake (L/day) at                     
Home                     
Plain cold tap water 0.62 <0.001 0.62 <0.001 0.62 <0.001 0.62 <0.001 0.62 <0.001 -0.05 0.008 -0.04 0.046 -0.12 <0.001 -0.10 <0.001 -0.12 <0.001 
Cold beverages from tap water 0.84 <0.001 0.84 <0.001 0.84 <0.001 0.82 <0.001 0.84 <0.001 0.08 <0.001 0.09 <0.001 0.00 0.802 0.00 0.840 -0.01 0.777 
Hot beverages from tap water* 0.01 0.443 0.01 0.469 0.02 0.349 0.02 0.435 0.02 0.307 0.01 0.443 0.01 0.474 0.02 0.369 0.02 0.407 0.02 0.318 
Total tap water 0.71 <0.001 0.71 <0.001 0.71 <0.001 0.68 <0.001 0.71 <0.001 0.11 <0.001 0.12 <0.001 0.04 0.054 0.03 0.080 0.04 0.052 
                      
All locations                      
Plain cold tap water 0.66 <0.001 0.66 <0.001 0.67 <0.001 0.66 <0.001 0.67 <0.001 -0.01 0.655 0.00 0.843 -0.08 <0.001 -0.07 <0.001 -0.08 <0.001 
Cold beverages from tap water 0.89 <0.001 0.89 <0.001 0.89 <0.001 0.87 <0.001 0.89 <0.001 0.13 <0.001 0.14 <0.001 0.04 0.031 0.04 0.026 0.04 0.033 
Hot beverages from tap water* -0.04 0.053 -0.04 0.034 -0.03 0.125 -0.03 0.097 -0.03 0.150 0.05 0.011 0.05 0.017 0.06 0.004 0.06 0.002 0.06 0.002 
Total tap water 0.72 <0.001 0.71 <0.001 0.72 <0.001 0.70 <0.001 0.72 <0.001 0.17 <0.001 0.18 <0.001 0.10 <0.001 0.10 <0.001 0.10 <0.001 
                      
Showering & Bathing (min/wk)                      
Showering           0.35 <0.001 0.36 <0.001 0.36 <0.001 0.29 <0.001 0.33 <0.001 
Bathing           0.50 <0.001 0.49 <0.001 0.55 <0.001 0.56 <0.001 0.57 <0.001 
Combined showering and bathing           0.87 <0.001 0.86 <0.001 0.93 <0.001 0.87 <0.001 0.92 <0.001 
                      
Swimming (min/wk)           0.40 <0.001 0.41 <0.001 0.31 <0.001 0.38 <0.001 0.33 <0.001 
*hot beverages from tap water = tea + coffee 
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CHAPTER 6: VALIDATION OF INDIVIDUAL WATER USE AND DBP EXPOSURE 
ASSESSMENT IN THE BiB COHORT 
 
 
6.1 INTRODUCTION 
As discussed in the literature review in Chapter 1, a major limitation of previous epidemiological 
studies has been potential measurement error in both area-level and individual-level DBP exposure 
assessment.  Many studies have used area-level estimates of trihalomethane concentrations, but 
have lacked information on water use at the individual level.  Although some epidemiological 
studies on fetal growth outcomes have incorporated individual water use data (usually self-reported 
by questionnaire) into exposure assessment, these have not necessarily included all major exposure 
routes.  A few studies have examined validity of self-reported water use questionnaires,29;30;32;111 but 
only one epidemiological study of DBPs and fetal growth79 used a questionnaire which had been 
validated in a  previous study.32  Errors in exposure assessment commonly act to reduce the power 
to detect associations with health outcomes, or bias the associations found,192 and it is therefore 
important to validate exposure estimates and understand error in exposure data, in order to correct 
epidemiological analysis/exposure assessment for measurement error and to be able to better 
interpret results of epidemiological analysis. 
 
This chapter describes the methods and results of a validation study nested within the BiB cohort 
study.  The nested study was designed to collect detailed exposure information which could be used 
to validate exposure assessment for DBPs and air pollution for the main BiB cohort.  This chapter 
deals only with the water and DBP aspects of this study.  The air pollution components do not relate 
to this PhD, and will only be referred to where necessary to explain the study design.  The aim of 
the nested study was to validate individual water use data collected by the BiB baseline 
questionnaire, and identify error in water use data and DBP exposure estimates. 
 
6.2 METHODS 
6.2.1 Recruitment 
Recruitment took place at the GTT clinic at Bradford Royal Infirmary where recruitment to the 
main BiB cohort already occurs, as described in Chapter 3 (see section 3.2.2).  Women were 
approached, where possible, to take part in this nested study immediately after their completion of 
BiB main cohort recruitment and baseline questionnaire.  The process for recruitment to the nested 
study is outlined in Figure 6.1.  The Participant Information Leaflet and Recruitment Form used 
during recruitment are shown in Appendix H and I respectively.  The recruitment process generally 
took about 15 minutes. 
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The eligibility criteria for this nested study comprised consent to participate in the main BiB cohort, 
completion of the BiB baseline questionnaire, an ability to speak and read English, and living in the 
air pollution environmental monitoring catchment area.  The language criteria were necessary 
because the study was largely self-administered based on written instructions and budgetary 
constraints did not allow for translation of study materials, nor the translation services that would 
have been required in order to recruit non-English speaking women. 
 
For logistical reasons the recruitment and fieldwork for this nested validation study was carried out 
in 2 phases, the first during February/March 2008 and the second during May 2008, which hereafter 
will be referred to as Phase 1 and Phase 2 respectively.   This allowed Phase 1 to act as a pilot 
phase, leaving scope for improvement of the study design and methods for Phase 2 if necessary. 
 
The number of women recruited to the study, and reasons for non-participation are shown in Figure 
6.2.  Overall, 56 women were recruited to the nested study.  This represented 24% of all women 
recruited to the BiB cohort during the 2 phases.  30 women were recruited in Phase 1 and 26 women 
were recruited in Phase 2.  
 
12 women withdrew from the study after recruitment.  9 women actively said that they had changed 
their mind, either at the Day 5 visit or by telephone.  The remaining 3 women did not answer the 
door or were not at home for the pre-arranged home visit and could not be contacted.  Several 
attempts at contact were made, but when these failed the women were assumed to have changed 
their minds about participating, and were treated as having withdrawn from the study.  This left 44 
women participating in the study. 
 
6.2.2 Study Design & Materials 
At recruitment each participant was issued with a study pack containing a study diary, participant 
information sheet, frequently asked questions (FAQ) sheet, urine sampling tubes and NO2 
monitoring tubes, and full instructions on how to complete the study.    Prior to commencement of 
the study, feedback had been obtained from BiB participants and staff on the design of the diary, 
and other study materials, and used to improve these.  Each diary was given a unique Study ID 
number which matched that on the corresponding recruitment form.  No identifying information 
was recorded in the diary.  All urine specimen tubes, NO2 monitoring tubes and tap water sampling 
bottles/vials were labelled with a unique Study ID number for each participant.  The study protocol 
(shown in Appendix J) and supporting study documentation were approved by the Bradford 
Research Ethics Committee. 
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 6.2.2.1 Diary 
Participants were supplied with a prospective 7-day water exposure diary (also comprising time-
activity component for air pollution aspects of study).  The diary is shown at Appendix K.  The 
water components of the diary were largely, but not wholly, based on Kaur et al.29  A 7-day 
exposure diary is assumed to be the gold-standard for measuring exposures such as water and food, 
as they do not rely on memory, and diary data can be used to validate a questionnaire.  Women 
completed the diary (hereafter referred to as Diary 1) over 7 consecutive days, commencing, on 
average, one day after completing the BiB baseline questionnaire.  Diary 1 recorded the same 
information as the questionnaire (i.e. daily intake of tap water, bottled water, tea, coffee and squash, 
at home, work/study or elsewhere; frequency and duration of showering, bathing and swimming; 
and water filtering habits), but also some additional sources of tap water (hot chocolate, homemade 
and powdered soup, instant noodle snacks), and fluid intake (milk, fruit juice, soft drinks, alcoholic 
beverages, soup in a can/carton), additional activities involving water (washing dishes by hand, 
running a dishwasher, cooking involving boiling water, washing laundry by hand, bathing children), 
and variables which might modify DBP exposure (bathroom ventilation during 
showering/bathing/bathing children).  At the end of the diary there were some closing questions to 
assess potential for exposure to chlorinated solvents during the diary week.  Some chlorinated 
solvents can be metabolised to TCAA, and therefore potentially influence urinary TCAA biomarker 
concentrations, which were also being measured in this study.  Chlorinated solvents are used in dry 
cleaning and metal degreasing processes (e.g. trichloroethylene and tetrachloroethylene), and are 
present in some consumer products such as paint and varnish removers.193  Some medications 
(anxiolytics and hypnotics) contain chloral hydrate, which also metabolises to TCAA in the body.  
However, it is recommended to avoid the prescribing of chloral hydrate during pregnancy,194 so it is 
unlikely that any of the subjects in our study would be exposed to chloral hydrate via medication, 
therefore it was decided not to be necessary to ask about current medications in the diary. 
 
In line with Kaur et al, the diary required participants to record their cold drink consumption in 
glasses and their hot drink consumption in mugs, both of which were assumed to be 200ml.29  A 
bowl was assumed to be 400ml.  Pictures of a glass, mug and bowl of those approximate volumes 
were printed onto the front of the diary for reference.  However, because there is variation, if the 
participant habitually used a glass, mug or bowl that appeared to be very differently sized to those 
shown on the diary, participants were instructed to measure and record the volume of the 
glass/mug/bowl, as appropriate, so this could be taken into account.  5 participants recorded using 
glasses of different volume and 4 participants recorded using mugs of different volume.  
 
At the Day 8 home visit to collect the completed diary and NO2 monitoring tubes, in almost all cases 
it was possible to go through the diary in the participant’s presence in order to check for any 
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 obvious errors or problems.  If any problems were noted, if possible it was ascertained why the 
problem had occurred and the diary was corrected where necessary.  If any part of the diary was 
incomplete the participant was prompted for answers where required.  Any issues which may have 
affected study completion, either noticed by the author, or brought up by the participant, were noted 
for future reference. 
 
6.2.2.2 Tap water sampling 
Tap water samples were collected by the author at each woman’s home on Day 5.  For consistency, 
the sample was always collected from the cold tap at the kitchen sink.  Vials for tap water sampling 
had been cleaned and prepared with the appropriate preservatives according to the HiWATE 
sampling protocol.  Those vials for HAA sampling contained approximately 4 mg ammonium 
chloride to act as a dechlorinating agent, and thus prevent further formation of HAAs once the 
sample had been collected.  Tap water samples for DBP analysis were collected headspace free in 
40ml amber glass vials.  Free and total chlorine was measured by colorimeter (Lovibond 
Comparator 2000+ with a 3/40A test disc of range 0.1-1.0 mg/l), using tablet reagents as per the 
manufacturer’s instructions.  pH and temperature were recorded using a pH meter (Hanna HI-98128 
waterproof pHep pH/c meter).  Immediately after collection all tap water samples were stored in a 
cool box with ice packs, until they could be refrigerated once the day’s visits had been collected. 
 
The tap water samples were sent by courier to the University of the Aegean, Greece, as described in 
Section 4.2.1.1 (Tap water sampling in Bradford, Sample collection procedure), for analysis as part 
of the HiWATE project183  DBP samples were analysed for a range of DBPs, including 
trihalomethanes, and haloacetic acids (HAAs) within 14 days of collection, as described in Chapter 
4 (see section 4.2.1.1, Laboratory analysis and methods).  Briefly, the method used for the 
determination of THMs and other volatile DBPs was Liquid-Liquid Extraction (LLE) using methyl-
tert-butyl ether (MtBE), followed by Gas Chromatography-Electron Capture Detector (GC-ECD), 
and the analysis of HAAs was performed by LLE with MtBE and GC-ECD, after derivatization 
with methanol/sulfuric acid (acidic methanol esterification).  
 
6.2.2.3 Urine sampling for trichloroacetic acid (TCAA) 
For urine sampling, each participant was provided with a standard 25ml universal Sterilin container 
supplied by the Health & Safety Laboratory.  Participants were instructed to collect a first morning 
urine sample 3 days after collection of tap sample, on Day 8 of the study (i.e. the day after they 
completed the diary).  The urine sample was taken 3 days after the tap water sample to allow 
comparison of tap water and urine TCAA concentrations to take into account the approximate half-
life of TCAA in the body.  Telephone reminders for urine sampling were made on Day 7, the day 
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 before required collection.  With 3 exceptions all urine samples were collected on the third day after 
tap water collection.   
 
Participants were instructed to take the sample from first morning urine (FMU), for uniformity, and 
because urinary TCAA concentration collected in FMU samples has been validated as a biomarker 
for exposure to chlorination by-products.195  TCAA is one of the most common HAAs found in 
chlorinated drinking water, it has a much longer elimination half-life in the body than the THMs, 
and has been found to demonstrate an exposure-response relationship between ingestion of TCAA 
containing water and urinary TCAA excretion, indicating that TCAA is expected to be a useful 
biomarker for measuring DBP exposure by ingestion of drinking water.195   
 
Participants were asked to record the time at which the sample was taken.  The sample was frozen 
by participants in order to minimise sample degradation.  These frozen urine samples were collected 
at the Day 8 home visit, and immediately stored in a cool box with ice packs, until they could be 
transferred to a freezer once the day’s visits had been completed. 
 
Participants who did not wish to, or could not, keep the sample in the freezer, were provided with 
appropriate packaging and freepost envelopes for the samples to be posted direct to the Health & 
Safety Laboratory in Buxton, Derbyshire.  This is a standard method of sample return used by the 
HSL for urine samples in their occupational health studies.  Only 4 participants chose to post their 
unfrozen urine sample directly to the laboratory.  These 4 samples were frozen on receipt by the 
Health & Safety Laboratory. 
 
At the end of both Phase 1 and Phase 2, all other frozen urine samples were transported to the 
Health & Safety Laboratory by car, in a cool box with ice packs and remained frozen through 
transit.  The samples were stored in a freezer upon receipt by the Health & Safety Laboratory.  Once 
at the Health & Safety Laboratory all samples remained frozen until analysis.   
 
The Health & Safety Laboratory analysed the urine samples for trichloroacetic acid (TCAA) using 
solid phase extraction (SPE) followed by liquid-chromatography-tandem mass spectrometry.   
 
One millilitre of urine was diluted with 2 ml pH7 buffer.  100 µl of deuterated TCAA solution (1 
ppm) was added to all tubes.  Calibration standards were prepared in urine over the range 0 to 100 
µg/l.  Quality control samples had been prepared from an external quality assurance standard (G-
EQUAS, www.g-equas.de) and the laboratory used the official acceptance limits of this for their 
acceptance limits.  Extraction took place using Strata X-AW cartridges (30 mg/1 ml), which are 
weak anion exchangers.  Cartridges were conditioned with 1 ml methanol and 1 ml pH7 buffer.  The 
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 sample was then loaded and washed with 1ml water then 1ml methanol.  The cartridges were dried 
and the TCAA eluted using 1ml 1% HCl in methanol.  Analysis was by LC-MS-MS (API3200, 
ABSciex) using electrospray ionisation with negative polarity.  Instrument conditions were as 
follows: curtain gas 40 psi, collision gas 6 psi, ion spray voltage –4500V, temperature 300oC, ion 
source gases 30 and 40 psi, declustering potential –15V, entrance potential –3V, collision energy –
10V, and collision cell exit potential –4V.  The HPLC column was 150 x 4.6 mm Hydro-RP 
(Phenomenex), flowrate 0.5 ml/min.  Mobile phase was isocratic with 30% methanol and 70% 
20mM ammonium acetate (pH5).  Injection volume was 25 µl.  Using multiple reaction monitoring 
(MRM), TCAA was monitored using the transition 160.8/116.8 and the internal standard transition 
was 161.8/117.7.  The limit of detection for TCAA was 3 nmol/L.  Analytical precision was 15%. 
 
Samples were also analysed for creatinine, an indicator of rate of urine production, so that urinary 
TCAA results could be adjusted for concentration of urine.196  Creatinine was determined using a 
Cobas Mira (ABX, France) and an automated alkaline picrate method.197  The coefficient of 
variation for within-day analysis was 1.5% and for between-day analysis was 3% at 6 mM. 
 
For statistical analysis, any samples below the TCAA detection limit were assigned a value of 1.5 
nmol/L (half the LOD).  Two urine samples could not be analysed, one because the sample tube had 
been over-filled and had shattered on freezing, and the other because the sample volume provided 
was too small. 
 
6.2.2.4 Feedback from Phase 1 
Participants were asked for feedback on the study at the final visit.  Some small ambiguities were 
highlighted in the study diary, and these were resolved for Phase 2.  Most said they did not have any 
problems with the water diary.  Some women commented that filling in the water diary had made 
them aware that they ought to drink more water, and as such could have resulted in behaviour 
modification with regard to water consumption.  A few participants found the time-activity 
component of the diary difficult to complete, and some had problems following the instructions 
relating to the NO2 monitoring tubes and/or found the personal monitoring tube inconvenient to 
wear.  
 
6.2.2.5 Alterations to study design for Phase 2 
Difficulties experienced by participants in setting up the NO2 monitoring tubes during Phase 1 
meant it was necessary to modify the study design for Phase 2.  A home visit was introduced on 
Day 1 in order that the author and colleagues could set up the NO2 monitoring tubes, rather than 
relying on the participants to do this.  In order to avoid having to make 3 home visits, the tap water 
sampling was moved to the Day 1 visit.  The urine sampling day was altered from Day 8 to Day 4, 
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 i.e. 3 days post tap water sampling, to maintain consistency with Phase 1.  Clear instructions were 
inserted into the diary for the participant to collect the urine on Day 4 and put the sample in the 
freezer until collection on Day 8.  The Day 8 home visit to collect the completed diary, NO2 
monitoring tubes and frozen urine sample remained the same.  Participants were given a text/phone 
call on Day 3 to remind them to collect the urine sample the following morning, unless they had 
expressed the wish not to have a reminder. 
 
Minor alterations were made to the diary for Phase 2, as it was clear that a few participants had 
misunderstood how to complete duration for showering if they had multiple showers per day, i.e. 
whether they should record time per shower, or total time showering per day.  The same applied for 
bathing.  For Phase 1 participants these issues were almost all clarified at diary collection/follow-
up.  For Phase 2 it was made explicit that women should complete total time spent on an activity 
that particular day i.e. Phase 1 “Duration (minutes)” was altered to Phase 2 “Total time today 
(minutes)”, and Phase 1 “Time spent in bathroom afterwards (minutes)” altered to Phase 2 “Total 
time spent in bathroom afterwards (minutes)”.  The water diary page for Phase 2 is shown at 
Appendix L.  The only other alterations to study documentation for Phase 2 were in relation to the 
instructions for NO2 monitoring tubes, urine sampling and the change of days for home visits. 
 
6.2.2.6 Repeat study –  7-day water exposure diary and urine sampling 
Participants were asked if they were willing to repeat the study a few weeks later.  18 (46%) women 
agreed, of whom 14 (36%) completed a second diary (hereafter referred to as Diary 2).  Diary 2 
only contained the water exposure pages of the diary (there was no time-microenvironment-activity 
component).  6 women from Phase 1 completed their repeat study in May 2008 and 8 women from 
Phase 2 completed their repeat study in July 2008.  On average, Diary 2 was commenced 9 weeks 3 
days after Diary 1.  Urine samples were collected as before, i.e. for Phase 1 on Day 8, and for Phase 
2 participants on Day 4 for exact repetition of their previous study.    No tap water samples were 
collected for the repeat studies (due to budgetary constraints on the DBP analysis), nor any NO2 
monitoring. 
 
6.2.3 Power calculation 
The study size was limited because there was funding for analysis of only 150 NO2 monitoring 
tubes.  Each participant required 3 tubes, and thus it was only possible to recruit a maximum of 50 
participants.  However, it was calculated that this sample size would allow detection of a correlation 
of at least 0.45 between questionnaire and diary responses, with 90% power and a significance level 
of 0.05, against a null hypothesis of zero correlation,198 and detection of a correlation of at least 0.65 
to within 0.2 either way (i.e. if a correlation of 0.65 was observed, then the true population 
correlation coefficient would lie within 0.45 to 0.85, with 95% confidence).  As correlation 
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 increases from 0.65 the confidence interval would narrow.  If correlation was below 0.65, then the 
confidence interval would widen.  Previous studies demonstrated reasonably good correlation 
between questionnaire and diary responses in relation to water exposure, with correlation 
coefficients largely ranging between 0.5 to 0.8.29;30;32;111  Given that we would expect to achieve 
correlation coefficients in line with previous studies, a sample size of 50 would provide sufficient 
power to detect agreement between questionnaire and diary responses. 
 
6.2.4 Data sources for analysis 
6.2.4.1 7-day exposure diary data 
Out of 44 participants, 39 women completed Diary 1 correctly, of whom 14 women also completed 
Diary 2.  4 women failed to complete or return Diary 1, and 1 woman completed Diary 1 
incorrectly, having failed to understand the study instructions properly, and no useful data was 
recorded. 
 
6.2.4.2 Urinary TCAA biomarker data 
All 39 participants who had completed Diary 1 also provided a urine sample, but 2 of these samples 
could not be analysed (1 because the sample volume was too small, and 1 because the sample tube 
shattered on freezing), leaving 37 participants with urinary TCAA concentration data.  All 14 
women who completed Diary 2 also provided a urine sample which could be analysed, and had 
corresponding urinary TCAA concentration data. 
 
6.2.4.3 Tap water TCAA concentration data 
Following completion of the HiWATE QC/QA programme on sampling data in May 2010 (see 
section 4.2.3) tap water TCAA concentration data were available for all but one of the 39 
participants who had completed Diary 1.  Although all 39 sets of tap water samples had been 
analysed, quality assurance deemed the TCAA result for one sample to be unreliable and it had to 
be excluded from the dataset. 
 
6.2.4.4 BiB baseline questionnaire data 
An extract of BiB baseline questionnaire data was provided for the 44 women who participated in 
the study, although for analysis this was limited to the 39 who had completed Diary 1.  There were 
2 queries raised regarding extreme values in this questionnaire dataset.  These queries were checked 
against the original paper questionnaire, and where the original questionnaire differed from the 
dataset, the dataset was manually corrected. 
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 6.2.5 Preparation of 7-day exposure diary data 
6.2.5.1 Diary data entry, checking and coding 
Data from Diary 1 and Diary 2 were manually entered into an Excel spreadsheet.  Once all data 
entry was complete, the entries were visually checked against the diaries, in order to identify and 
correct any data entry errors. 
 
During data entry, it was noted that durations of showering, bathing, and household tasks involving 
water were, for the most part, reported in 5 minute increments in the diary, and it is likely that 
rounding was occurring.  In addition a few inconsistencies/queries in relation to diary entries arose, 
which had not been immediately obvious at time of diary collection, or which had not been 
answered if the participant had not herself been present at diary collection.  Permission was sought 
from BiB to contact the participants by telephone, first ensuring that none of the participants had 
withdrawn from BiB or suffered an adverse pregnancy outcome in the intervening period.  22 
participants were contacted by telephone to resolve minor queries with regard to their diary data or 
urine collection data.  All queries and responses were logged along with the date of response.  For 
the most part the participants could be contacted and the queries were resolved.  Follow-up calls 
were generally made 5 to 8 months after the completion of the study, depending on whether the 
participant had been part of Phase 1 or Phase 2.  3 participants could not be contacted despite 
repeated attempts and assumptions had to be made as follows: 3 women had not indicated volume 
of soft drink as glass or can, so it was assumed to be a glass; for 1 woman who had not indicated 
volume of soup consumption as mug or bowl it was assumed to be a bowl; and for 1 woman where 
it was not clear if duration of showering represented duration per shower or total duration of 
multiple showers per day, it was assumed to be total duration of showering. 
 
For questions on usage of household products where multiple usages had been recorded but only 
one duration was specified, unless the participants specified this to be total duration for a number of 
usages, it was assumed that duration was for each usage.  When coding product usage/industry 
visits in the 3 days prior to urine collection, if urine was collected late, e.g. Day 9, then only 
usage/visits on Day 6 and Day 7 were counted as relevant.  If the urine sample was collected on 
time (i.e. Day 8 for Phase 1 or Day 4 for Phase 2), then Days 5, 6 and 7 or Days 1, 2 and 3 were 
counted for Phases 1 and 2 respectively.  If the urine sample was collected early, e.g. Day 3, then 
only Days 1 and 2 were counted. 
 
6.2.5.2 Identifying ingredients in household products recorded in the diary 
For some household products recorded in the diaries, participants could not give the exact name of 
the product, and thus its ingredients could not be identified.  All nail polish remover entries were 
excluded, as the diary specifically instructed participants not to record these.  Particular substances 
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 of interest were trichloroethylene (TCE) and tetrachloroethylene (PERC), as they are known to 
metabolise to TCAA.193 Other chlorinated solvents to be flagged up were trichloroethane, 
dichloroethane, trichloropropane, ethylene dichloride, dichloropropane, dichloroethylene, carbon 
tetrachloride, chloroform, methylene chloride, tetrachloroethane.  In addition sodium 
hypochlorite/hypchlorous acid in bleach products were to be noted, because use of sodium 
hypochlorite bleach leads to increased chloroform and carbon tetrachloride, and DBCM, DCBM 
and bromoform in indoor air,199 and thus potentially could affect THM exposure. 
 
Out of the 39 distinct household products recorded as used, for 27 the exact product could be 
identified and for 26 the ingredients listings were available.  None of those 26 products contained 
chloral hydrate, trichloroethylene or tetrachloroethylene, or any of the other chlorinated solvents 
listed above.  Nine of the products contained sodium hypochlorite or hypochlorous acid.  All but 2 
out of 21 disinfectant products recorded were identified and ingredients lists available, but it was 
mainly glues/adhesives and paints/varnishes for which ingredient listings were missing, often 
because the participant had recorded insufficient information to accurately identify the product. 
 
6.2.5.3 Preparation of Diary variables 
Water consumption 
All water/fluid consumption units were converted into litres. A mug or glass was assumed to be 
200ml, and a bowl 400ml, unless the subject recorded habitual use of a mug, glass or bowl that 
differed greatly from these volumes, in which case the volume recorded by the participant was used.  
Aggregate tap water consumption variables were calculated for home, work, elsewhere and all 
locations.  Total tap water consumption included tap water, tea, coffee and squash (i.e. the variables 
recorded in the questionnaire) to allow direct comparison with the questionnaire.  A second 
aggregate tap water measure also included the additional tap water sources recorded in the diary: 
hot chocolate made with water, homemade and powdered soups, and instant noodle snacks.  A total 
fluid consumption variable included all beverage/foods (tap water based or not) recorded in the 
diary.  Cold tap water consumption (the sum of plain cold tap water and squash) and hot tap water 
consumption (the sum of tea and coffee) variables were also created.  Mean daily consumption was 
calculated by averaging across the 7 days of the diary, to allow comparison with the typical daily 
consumption recorded in the questionnaire. 
 
Water filtering 
If the participant stated that she was not working, all questions about filtering at work were coded as 
not applicable.  Any consumption entries on diary pages under “Tap water” were treated as 
unfiltered, except for women who had reported having a filter on their tap at home or work, in 
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 which case consumption entries under “Tap Water” were coded as “Filtered Water” at home or 
work, as appropriate. 
 
Showering, bathing and swimming 
Location of showering and bathing was not specified in the questionnaire, so diary data on 
showering at Home and Elsewhere was aggregated into one variable representing all showering in 
order to compare with the questionnaire.  Likewise an aggregate variable was created for bathing.  
Showering, bathing and swimming were each summed across the 7 days of the diary to give number 
of events per week and minutes of activity per week.  Mean duration per event was calculated from 
the diary data for showering, bathing and swimming. 
 
6.2.6 Preparation of questionnaire variables 
Water use variables from the BiB baseline questionnaire data were prepared by converting 
individual water consumption from glasses/cups to litres, to give volume per day.  Total tap water 
consumption was calculated by summing tap water, tea, coffee and squash intakes to give total tap 
water consumption per day at home, work, elsewhere, and then aggregated to give total tap water 
consumption per day across all locations.   Cold tap water consumption (sum of plain cold tap water 
and squash) and hot tap water consumption (sum of tea and coffee) variables were also calculated.  
For showering, bathing and swimming, frequency and duration were multiplied to give minutes 
spent showering, bathing and swimming per week.  Minutes of showering and bathing per week 
were summed to give a combined showering/bathing (min/week) variable. 
 
Ethnic categories were collapsed to give 3 subgroups: White (incorporating White British and 
White Other), South Asian (incorporating Pakistani and Indian), and Other (incorporating Black or 
Black British and All Other).  For employment subgroups, subjects on maternity/sick leave were 
kept with the employed group because numbers were small. 
 
6.2.7 Creation of TCAA ingestion variable 
TCAA ingestion via tap water at home was calculated by multiplying TCAA concentration 
measured in the tap sample at each participant’s home with her volume of tap water intake at home, 
taking into account a 32% reduction in TCAA concentration for boiling (average based on 2 and 5 
min boiling tests 40-42) and 64% reduction for filtering (average based on all new and used, pitcher 
and tap-mounted tests 28;36;37;40), as shown below: 
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 TCAA ingestion (μg/day)  =  
Tap TCAA (μg/l) x [Cold Unfiltered Tap Water (l/day) + Squash (l/day)] + 
Tap TCAA (μg/l) x 0.36 x Cold Filtered Tap Water (l/day) + 
Tap TCAA (μg/l) x 0.68 x [Tea (l/day) + Coffee (l/day)] 
 
Three TCAA ingestion measures were calculated based on a) daily tap water consumption at home 
from the questionnaire, b) mean daily tap water consumption at home over 7 days of Diary 1 and c) 
mean daily tap water consumption at home across 3 days of Diary 1 preceding urine sample 
collection. 
 
It had been an original intention of the author to compute also a TCAA ingestion metric using an 
area-level TCAA concentration modelled from the HiWATE sampling data.  However, this was not 
possible because the HiWATE sampling data were not available to use for modelling in the time-
scale of this PhD (as mentioned in Section 4.2.3).   
 
6.2.8 Statistical analysis 
6.2.8.1 Analysis of questionnaire validity 
To assess questionnaire validity, agreement between responses given in the questionnaire and Diary 
1 was examined by calculating mean difference between methods, 95% limits of agreement for 
mean difference,200 and the intra-class correlation coefficient (ICC).  As 3 out of the 4 previous 
water exposure validation studies report either Pearson’s or Spearman’s correlations as their main 
measure of agreement, Spearman’s correlations (as the data were not normally distributed) were 
also calculated for comparative purposes.  Difference-mean plots were used to examine agreement 
visually.200  95% confidence intervals are reported.   
 
6.2.8.2 Analysis of variability in water use during pregnancy 
Similar statistical methods were used to compare Diaries 1 and 2 to assess variability in water use 
during pregnancy, with the exception that ICCs were based on consistency rather than absolute 
agreement. 
 
6.2.8.3 Correlation analysis using urinary TCAA biomarker  
Correlation between urinary TCAA concentration (both unadjusted and adjusted for creatinine), and 
mean daily total tap water consumption (based on questionnaire, 7 days of Diary 1 and 3 days 
preceding urine collection for Diary 1); tap water TCAA concentration, and daily TCAA ingestion 
at home (based on questionnaire, 7 days of Diary 1 and 3 days preceding urine collection for Diary 
1) were examined using Spearman’s correlation coefficient.  Urinary TCAA concentration was not 
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 compared with showering/bathing variables because the main route of exposure for HAAs has been 
shown to be ingestion (inhalation and dermal absorption are negligible).50;51 
 
Correlations between urinary TCAA concentration (unadjusted and adjusted for creatinine) and 
various 2nd and 3rd trimester THM exposure metrics were also examined using Spearman’s 
correlation coefficient.  The THM exposure metrics examined were time-weighted average THM 
concentrations at the tap (μg/L), and semi-individual metrics of THM ingestion (μg/day) and 
integrated uptake of THMs (μg/day).  Creation of these THM exposure metrics has been described 
in Chapters 4 and 5.   
 
All statistical analysis was performed using R statistical software version 2.4.1.181 
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6.3 RESULTS 
6.3.1 Characteristics of the nested study subset 
Table 6.1 shows characteristics of the women who took part in the nested study.  Mean age of 
participants was 29.7 years.  The nested subset contained a greater proportion of White British 
women and a lower proportion of Pakistani women compared to the main cohort.  The nested subset 
appeared better educated and had a greater proportion of women in higher income brackets 
compared with the main cohort, but was similar with regards to age, marital status, parity and 
smoking.  Within the nested subset there were large differences in ethnic and income profile 
according to employment status, as shown in Table 6.2. 
 
6.3.2 Validity of water use data collected by questionnaire 
Table 6.3 shows results of analysis of questionnaire validity. 
 
6.3.2.1 Tap water intake 
Intraclass correlation coefficients (ICCs) of 0.70 and 0.60 demonstrate strong agreement between 
the questionnaire and Diary 1 for tap water intakes at home, and thus good validity of the 
questionnaire for these variables (Table 6.3).  However for tap water intakes outside the home 
agreement ranged from poor to moderate, indicating validity of the questionnaire was less 
satisfactory for these variables.  On average, the questionnaire overestimated total tap water intake 
across all locations by 0.41 L/day (0.13, 0.69), indicating a degree of systematic error in 
participants’ questionnaire responses (Table 6.3). 
 
6.3.2.2 Showering and bathing 
Showering and bathing both demonstrated moderate agreement between questionnaire and Diary 1 
responses according to ICCs (Table 6.3).  Whilst the questionnaire demonstrated little systematic 
error for showering, it overestimated bathing by almost 30 minutes per week on average (28.32 
min/week (7.40, 49.24)).  This is important as it suggests that measurement error could be 
dependent upon facilities available to an individual i.e. shower vs. bath, or if they have access to 
both, their preferred mode of washing. 
 
6.3.2.3 Swimming 
Only 6 (15.4%) women reported swimming in the questionnaire and 4 (10.3%) in Diary 1, of whom 
only 2 reported swimming in both.  Mean difference between methods was small, but agreement as 
measured by ICC was weak (Table 6.3).  However, with so little activity reported, there was 
insufficient power to assess questionnaire validity for this variable.   
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 6.3.3 The effect of employment status on questionnaire validity 
Stratification by employment status revealed that agreement between questionnaire and Diary 1 was 
consistently much stronger for responses given by unemployed women (ICCs ranged from 0.64 to 
0.80) compared to employed women (ICCs ranged from 0.19 to 0.59) (Table 6.4).  For employed 
women ICCs were very similar for tap water intakes at both home and work, of both plain tap water 
(0.59 and 0.54 respectively) and total tap water (0.38 and 0.40 respectively) (Table 6.4).  This 
suggests little difference in employed women’s accuracy in estimating tap water intakes according 
to location.  Difference-mean plots show greater systematic error (i.e. poorer validity) and greater 
random error (i.e. poorer precision) in total tap water intake (Figure 6.3), greater random error in 
showering (Figure 6.4), and greater systematic error in bathing (Figure 6.5) reported by employed 
women compared to unemployed women.  
 
6.3.4 The effect of ethnicity, income and age on questionnaire validity 
When stratifying by ethnicity, income and age, there were no patterns of difference as clear-cut or 
as consistent as those observed for employment status (Table 6.5).  Results suggested possible 
differences in agreement for showering and bathing according to ethnicity (South Asian vs. White), 
which could not be explained according to the proportions of employed and unemployed in each 
subgroup. 
 
6.3.5 Water filtering 
Information on water filtering was collected using different questions in the questionnaire and Diary 
1.  Table 6.6 shows responses given to water filtering questions according to both methods.  
Potentially, 4 women (10%) were misclassified by the questionnaire with regards to water filtering 
at home.  6 employed women (29%) were potentially misclassified by the questionnaire with 
regards to water filtering at work.  Data on consumption of filtered water elsewhere was not 
captured by the questionnaire.  3 women (8%) recorded consuming tap water from a filter jug 
elsewhere in Diary 1 (≤  0.1 L/day).   
 
6.3.6 Water consumption and activities not captured by the Questionnaire 
Diary 1 recorded extra sources of tap water consumption not captured by the questionnaire, but on 
average these extra sources constituted only 2.1% of overall daily tap water consumption as 
recorded by Diary 1.  Table 6.7 shows additional water-related activities recorded in Diary 1, over 
and above those captured by the questionnaire.  Whilst the questionnaire captures almost all tap 
water consumption, there is considerable water-related activity with potential for DBP exposure via 
inhalation and dermal absorption which it does not capture, suggesting scope for exposure 
measurement error within this cohort. 
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 6.3.7 Factors potentially modifying DBP exposure not captured by the Questionnaire 
59% (n=23) of women reported the extractor fan being on and/or the bathroom window being open 
during some or all of their showering or bathing at home.  Gloves were used during some or all 
hand dishwashing by 18% (n=7) of women, and worn by one woman whilst she did laundry by 
hand.  Diary 1 also asked participants to record showering and bathing according to location 
(“home” or “away from home”), and 15% (n=6) reported showering away from home and 8% (n=3) 
reported bathing away from home, during the diary week. 
 
6.3.8 Variability of water use during pregnancy 
14 women completed Diary 2, with an average gap of 9 weeks and 3 days between completion of 
Diaries 1 and 2.  Table 6.8 shows results of comparison between Diaries 1 and 2.  Overall, mean 
differences between the two diaries were small, with the exception of bathing which had increased, 
on average, by 19.3 min/week (Table 6.8).  Total tap water intake across all locations, and at home, 
demonstrated strong agreement between Diary 1 and Diary 2 with ICCs of 0.82 (0.55, 0.94) and 
0.75 (0.40, 0.91) respectively, indicating that a high proportion of total variance in tap water intake 
was attributable to between–person variability.  ICCs for tap water intakes at work and elsewhere 
were lower suggesting a greater proportion of total variance was due to within-person variability.  
Overall agreement between diaries was poor for showering (ICC = -0.15 (-0.61, 0.39)) and bathing 
(ICC = 0.48 (-0.02, 0.80)) suggestive of substantial within-person variability in these activities 
during pregnancy.  Stratification by employment status revealed that employed women had 
increased bathing by an average of 32.6 min/week, compared to an increase of 1.4 min/week for 
unemployed women. 
 
6.3.9 Concentration of TCAA in urine and tap water samples 
6.3.9.1 Concentration of TCAA in urine 
Table 6.9 shows summary statistics for urinary TCAA concentration and creatinine-adjusted urinary 
TCAA.  Mean concentration of TCAA in urine was 37.1 nmol/L (28.9, 45.2), and when adjusted for 
creatinine was 4.9 μmol/mol creatinine (3.4, 6.3) (Table 6.9).  The distributions were right-skewed.  
There was a 6-fold difference between the 10th and 90th percentiles (11.8 and 70.6 nmol/L 
respectively) for the urinary TCAA distribution.  According to the t-test there was no difference in 
mean urinary TCAA concentration between Phase 1 and 2 participants (p=0.28), nor between 
employed and unemployed women (Student’s t-test, p = 0.74). 
 
The mean concentration of TCAA in urine of 37.1 nmol/L (range 1.5–112 nmol/L) observed in this 
study converts to 6.1 μg/L (range 0.25-18.3 μg/L), and this compares well with a median 
concentration of 3.3 μg/L (25th and 90th percentiles 0.6 μg/L and 23μg/L) observed in a background 
level study on a US general population sample.201 
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6.3.9.2 Concentration of TCAA in tap water samples 
Summary statistics for concentration of TCAA in tap water at home are shown in Table 6.10.  Mean 
concentration of TCAA in tap water was 11.3 μg/L (10.1, 12.5).  Variability of TCAA concentration 
in tap water was low with only a 2.3 fold difference between the 10th and 90th percentiles (7.3 and 
16.6 μg/L respectively).  According to the t-test, there was no significant difference in mean TCAA 
concentration at the tap according to phase of study (p=0.17) or employment status (p=0.88). 
 
6.3.10 Validation using urinary TCAA biomarker 
6.3.10.1 Correlation between urinary TCAA concentration and tap water intake 
Table 6.11 shows Spearman’s correlation coefficients between urinary TCAA concentration and 
total tap water intake according to both the questionnaire and Diary 1.  Correlation between total tap 
water intake at home measured by the questionnaire and urinary TCAA concentration was weak 
(0.31, p=0.06), but slightly stronger when total tap water intake at home was calculated from Diary 
1 for the 3 days preceding collection of urine sample (0.40 p=0.017). 
 
Correlation between total tap water intake at home and urinary TCAA concentration was very 
strong for unemployed women regardless of whether consumption was calculated from the 
questionnaire (0.72, p=0.001) or Diary 1 (0.75, p<0.001), but for employed women correlations 
were very poor and not significantly different from zero, again regardless of whether the 
questionnaire or Diary 1 was used.  For employed women, correlation between total tap water 
intake at work and urinary TCAA concentration was also weak.  Overall, urinary TCAA 
concentration was well correlated with total tap water intake for unemployed women, but poorly 
correlated for employed women.  This finding is in line with results earlier in this chapter (see 
section 6.3.3) suggesting that questionnaire data is a less accurate reflection of tap water intake for 
employed women compared to unemployed women.  However, for employed women correlations 
are also poor with tap water intake measured by Diary 1, suggesting that accuracy of Diary 1 data 
may also be poorer for employed women, compared to unemployed women. 
 
For total tap water intake at home and across all locations the analysis was stratified by phase of 
recruitment in order to take into account any potential differences arising from seasonal variation of 
TCAA concentrations in the tap water supply.  Overall, correlations were slightly stronger for Phase 
2, although these tended not to reach significance for either phase.   
 
When using creatinine-adjusted urinary TCAA concentration, correlation with tap water 
consumption measures tended to be weaker, compared to correlations with unadjusted urinary 
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 TCAA concentration, but similar patterns according to employment status were observed (Table 
6.11). 
 
6.3.10.2 Correlation between urinary TCAA biomarker and tap water TCAA concentration 
There was no statistically significant correlation between urinary TCAA concentration and TCAA 
concentration at the tap at home (0.18, p=0.29) (Table 6.12), and results were similar for creatinine-
adjusted urinary TCAA. Spearman’s correlation appeared slightly higher for unemployed compared 
with employed women, but was not statistically significant from zero for either group (Table 6.12).   
 
6.3.10.3 Correlation between urinary TCAA biomarker and ingestion of TCAA 
Correlations between urinary TCAA concentration and daily ingestion of TCAA at home are shown 
in Table 6.12.  Overall, correlation between urinary TCAA concentration and daily TCAA ingestion 
at home based on the questionnaire was moderate (0.50, p=0.002), and very similar when TCAA 
ingestion based on Diary 1.  The correlation was stronger for unemployed (0.78, p<0.001) 
compared to employed women (0.31, p=0.19).    This may reflect poorer accuracy of water 
consumption data collected in the questionnaire for employed women, and/or the influence of 
TCAA ingestion at work upon urinary TCAA for employed women.  Correlations were weaker 
when using creatinine-adjusted urinary TCAA concentration. 
 
Figure 6.7 shows urinary TCAA concentration plotted against TCAA ingestion at home calculated 
first from the questionnaire (Figure 6.7, part i) and then Diary 1 (Figure 6.7, part ii).  When the 
relationships are examined visually, it is clear that TCAA ingestion at home is poorly correlated 
with urinary TCAA for employed women, especially when TCAA ingestion is calculated from 
Diary 1.   Given that one might expect a similar relationship for both unemployed and employed 
women if TCAA ingestion could be measured without error, Figure 6.7 part ii) b) and c) suggest 
that employed women could be under-reporting their tap water consumption in Diary 1, thus 
depressing their TCAA ingestion measures. 
 
6.3.10.4 Correlation between urinary TCAA biomarker and  area-level and semi-individual 
metrics of THM exposure  
Table 6.13 shows correlations between urinary TCAA concentration and 3rd trimester area-level and 
semi-individual metrics of THM exposure (as created in Chapters 4 and 5 respectively).  
Correlations between urinary TCAA concentration and time-weighted area-level THM 
concentrations were weak and not significantly different from zero.  For semi-individual THM 
ingestion metrics, correlations with urinary TCAA concentration were moderate (0.36-0.41), but 
consistently stronger for unemployed (0.53-0.61) compared to employed women (0.24-0.27).  
Correlations between urinary TCAA concentration and integrated THM uptake metrics were 
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 relatively modest (0.24-0.39) (Table 6.13).  Correlations with 2nd trimester THM exposure metrics 
were also examined, and results were similar to those for 3rd trimester metrics (data not shown).  
With the exception of THM ingestion metrics for unemployed women, both area-level and semi-
individual metrics were poor proxy measures for individual exposure to TCAA in this cohort. 
 
Comparison of the correlations presented in Tables 6.12 and 6.13 with the correlations between 
urinary TCAA and volume of tap water intake presented in Table 6.11 shows very clearly that the 
correlations are driven by tap water intake and that they are not improved when environmental 
levels of TCAA or THMs in tap water are taken into account. 
 
6.3.10.5 Adjustment of urinary TCAA concentration for creatinine 
On the whole, correlations between creatinine-adjusted urinary TCAA concentration and volume of 
tap water consumption (Table 6.11), tap water TCAA concentrations (Table 6.12), TCAA ingestion 
at home (Table 6.12), and semi-individual THM exposure  metrics (data not shown) tended to be 
weaker compared to those with unadjusted urinary TCAA concentration. 
 
6.3.10.6 Potential for confounding of relationships with urinary TCAA biomarker due to 
metabolism of other compounds to TCAA 
Of the 37 women for whom urinary TCAA concentrations were available, 1 woman reported 
visiting a dry cleaners in the 3 days prior to collecting her urine sample, however her urinary TCAA 
concentration was in the lowest quartile.  No-one reported visiting or working in metal 
manufacturers, the auto-parts industry, textile production, paint production or printers, during the 
diary week and nor did anyone report that a household member currently worked in the dry cleaning 
industry, so exposure to chlorinated solvents from these sources can be ruled out. 
 
Of the 26 household products used for which ingredients listings could be found, none contained 
any chlorinated solvents.  No-one reported using paint/varnish thinners or removers, or pesticides 
during the diary week.  However, products types for which ingredients listings could not be found 
were correction fluid, some paints/wood varnish, glues/adhesives, and laminate cleaner, so it is not 
fully possible to rule out exposure to chlorinated solvents via these sources during the diary week.  
The only ingredients identified which could influence DBP exposure, were sodium hypochlorite and 
hypochlorous acid found in bleach disinfectant products.  However, whilst these could potentially 
influence THM exposure via inhalation, they are unlikely to affect HAA exposure, and thus urinary 
TCAA, because HAAs are non-volatile.   
 
In addition, DBP analysis on the tap water samples from the women’s homes suggest little 
possibility that urinary TCAA concentrations were influenced by chloral hydrate (which can be 
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 metabolised to TCAA) from tap water sources.  For 30 women, chloral hydrate was not detected in 
the tap water at home.  For the remaining 7 women, chloral hydrate values for tap water were not 
available because 1 sample broke in transit to the lab and for the other 6 chloral hydrate results were 
deemed unreliable after quality assurance.  Nonetheless, given the relatively small geographical 
area over which the nested study was carried out, and the known low spatial variability of other 
DBPs between WSZs within the study area, it seems unlikely that those 7 women for whom tap 
water chloral hydrate concentrations were not available, would have experienced any chloral 
hydrate exposure via their tap water supply. 
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 Figure 6.1  Process for recruitment to nested study 
 
 
Yes 
No 
Not eligible 
Eligible 
No 
Yes 
Woman recruited to BiB by BiB study team 
Each woman given a Participant Information Leaflet, which the author/colleagues 
used to explain briefly what the study involved and why it was being carried out. 
End of recruitment process
The study was explained in further detail, showing the study diary and how it had to be 
completed, the NO2 monitoring tubes and the urine sampling kit.  A study pack was 
issued to the participant. 
 
Following this, a recruitment form was completed, which recorded name, address, date 
of birth, contact telephone number and date of recruitment. 
 
A diary start date was agreed with each participant, and a date and time was agreed for 
the first home visit on Day 5 of the diary. 
Second 
eligibility 
check 
Recruitment process ended 
Is the woman 
interested in 
participating? 
Recruitment process ended 
Woman eligible 
and can be 
approached for 
nested study?
Woman not 
approached 
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 Figure 6.2  Response to recruitment and participation in the nested study 
 
  
78 women could not be approached 
 
Reasons: 
- Did not want to discuss further research, n=50 
- No further time to spare, n=2 
- Complicated pregnancy/ill health/personal 
problems, n=3 
- Poor English ability, n=1 
- Lived outside catchment area, n=1 
- Left GTT clinic before they could be 
approached, n=6 
- Recruitment target for particular phase of 
nested study reached, n=8 
- No reason recorded, n=7 
310 women attend GTT 
clinic during 2 phases 
of recruitment for 
nested study 
96 women approached
to take part in nested 
study 
233 women recruited to 
BiB 
174 women eligible for 
nested study 
56 women agreed to 
participate in the nested 
study 
40 women did not participate 
 
Reasons: 
- Lived outside catchment area, n=1 
- Required husband’s permission, n=1 
- Complexity of study/difficult to remember to do 
everything required, n=2 
- Did not want to be visited at home, n=2 
- On holiday during study period, n=3 
- Did not want to wear NO2 monitoring tube, n=2 
- Too busy / tired, n=3 
- Living away from home, n=1 
- No reason given, n=25 
12 women withdrew from the nested study 
after recruitment 
77 women not recruited to BiB 
59 women not eligible for nested study 
 
(lacked consent/questionnaire for BiB or completed 
BiB questionnaire in language other than English) 
44 women participate in 
study 
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 Figure 6.3  Difference-mean plot for total tap water consumption across all locations 
 
 
 
Key:  solid line = mean difference between methods, dashed line = 95% limits of agreement for mean difference (+/- 2SD), Q = questionnaire, D = Diary 1 
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 Figure 6.4  Difference-mean plot for duration of showering per week 
 
 
 
 
 
Key:  solid line = mean difference between methods, dashed line = 95% limits of agreement for mean difference (+/- 2SD), Q = questionnaire,D = Diary 1 
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 Figure 6.5  Difference-mean plot for duration of bathing per week 
 
 
 
Key:  solid line = mean difference between methods, dashed line = 95% limits of agreement for mean difference (+/- 2SD), Q = questionnaire, D = Diary 1 
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 Figure 6.6  Plot of urinary TCAA (nmol/L) against the concentration of TCAA at tap at home for each woman 
 
 
Key:  solid line = line of best fit 
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 Figure 6.7  Plot of urinary TCAA against TCAA ingestion at home, split by employment status and method of calculating TCAA ingestion  
 
i) TCAA ingestion 
at home calculated 
from Questionnaire 
 
 
ii) TCAA ingestion 
at home calculated 
from Diary 1  
(7 days) 
 
Key:  solid line = line of best fit 
165
 Table 6.1  Characteristics of the nested study subset 
 
    Nested subset Main cohort 
Characteristics n % n % 
All   39 100.0 4070 100.0 
Age <20 2 5.1 302 7.4 
20-24 4 10.3 1088 26.7 
25-29 13 33.3 1317 32.4 
30-34 15 38.5 839 20.6 
35-39 4 10.3 450 11.1 
≥  40 1 2.6 73 1.8 
Missing data   1 0.02 
Ethnicity White British 19 48.7 1573 38.6 
White Other 1 2.6 96 2.4 
Pakistani 15 38.5 1873 46.0 
Indian 1 2.6 159 3.9 
Bangladeshi 0 0 94 2.3 
Any other Asian origin 0 0 40 1.0 
Black or Black British 1 2.6 105 2.6 
 Mixed 0 0 67 1.6 
 All Other 2 5.1 59 1.4 
 Not stated/missing   4 0.1 
Employment 
status 
Employed 20 51.3 1624 39.9 
Unemployed 18 46.2 2258 55.5 
Maternity/Sick leave 1 2.6 184 4.5 
Missing data   4 0.1 
Highest 
Educational 
Qualification 
None 4 10.3 698 17.1 
O level/GCSE or A level 13 33.3 1389 34.1 
Degree 14 35.9 827 20.3 
Other (e.g. NVQ) 8 20.5 1094 26.9 
Don't know   53 1.3 
Missing data   9 0.2 
Household 
Income 
<£20,000 15 38.5 1876 46.1 
£20,000-40,000 14 35.9 953 23.4 
>£40,000 7 17.9 332 8.2 
Don't know 3 7.7 846 20.8 
Not stated/missing   63 1.4 
Smoking Current smoker 4 10.3 562 13.8 
Past smoker 8 20.5 612 15.0 
Never smoker 27 69.2 2896 71.2 
Parity 0 14 35.9 1587 39.0 
1 15 38.5 1198 29.4 
2 7 17.9 657 16.1 
3+ 3 7.7 528 13.0 
Missing data   100 2.5 
Marital Status Married 31 79.5 2864 70.4 
Single 8 20.5 1198 29.4 
Missing data   8 0.2 
 
166
 Table 6.2  Characteristics of the nested study subset split by employment status 
 
    Employed Unemployed 
Characteristics n % n % 
  All 21 100.0 18 100.0 
          
Age <20 0 0 2 11.1 
20-24 1 4.8 3 16.7 
25-29 8 38.1 5 27.8 
30-34 8 38.1 7 38.9 
35-39 3 14.3 1 5.6 
>40 1 4.8 0 0 
          
Ethnicity White British 12 57.1 7 38.9 
White Other 1 4.8 0 0 
Black or Black British 1 4.8 0 0 
Pakistani 4 19.0 11 61.1 
Indian 1 4.8 0 0 
Bangladeshi 0 0 0 0 
Any other Asian origin 0 0 0 0 
Mixed 0 0 0 0 
All Other 2 9.5 0 0 
          
Highest 
Educational 
Qualification 
None 1 4.8 3 16.7 
O level/GCSE or A level 6 28.6 7 38.9 
Degree 9 42.9 5 27.8 
Other (e.g. NVQ) 5 23.8 3 16.7 
          
Household 
Income 
<£20,000 3 14.3 12 66.7 
£20,000-40,000 12 57.1 2 11.1 
>£40,000 5 23.8 2 11.1 
Don't know 1 4.8 2 11.1 
          
Smoking Current 3 14.3 1 5.6 
Past 4 19.0 4 22.2 
Never 14 66.7 13 72.2 
          
Parity 0 10 47.6 4 22.2 
1 9 42.9 6 33.3 
2 2 9.5 5 27.8 
3+ 0 0 3 16.7 
          
Marital status Married 17 81.0 14 77.8 
Single 4 19.0 4 22.2 
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 Table 6.3  Comparison of questionnaire and Diary 1 responses 
 
  n ICC 95% CI for 
ICC 
Mean 
difference 
(Q-D)* 
95% CI for 
mean 
difference 
SD of 
differences 
(Q-D) 
95% Limits of 
Agreement 
Spearman's 
correlation 
coefficient 
           Lower Upper rho p 
Tap water intake                    
Home                      
Plain tap water   (L/day) 39 0.70 (0.48, 0.83) 0.18 (0.03, 0.34) 0.48 -0.78 1.15 0.77 <0.001 
Total tap water intake (L/day) 39 0.60 (0.28, 0.79) 0.40 (0.18, 0.62) 0.69 -0.98 1.78 0.66 <0.001 
Work                      
Plain tap water   (L/day) a 21 0.54 (0.16, 0.78) 0.08 (-0.09, 0.25) 0.38 -0.67 0.83 0.65 0.002 
Total tap water intake (L/day) a 21 0.40 (0.01, 0.70) 0.29 (0.06, 0.53) 0.52 -0.74 1.33 0.26 0.25 
Elsewhere                      
Plain tap water   (L/day) 39 0.00 (-0.21, 0.25) -0.05 (-0.08, -0.03) 0.08 -0.22 0.12 NA NA 
Total tap water intake (L/day) 39 0.00 (-0.15, 0.20) -0.15 (-0.21, -0.10) 0.17 -0.48 0.18 NA NA 
All locations                      
Total tap water intake (L/day) 39 0.55 (0.27, 0.74) 0.41 (0.13, 0.69) 0.87 -1.33 2.14 0.70 <0.001 
                       
Showering and bathing                      
Showering (min/week) 39 0.53 (0.26, 0.72) 3.02 (-15.26, 21.30) 56.39 -109.76 115.81 0.71 <0.001 
Bathing (min/week) 39 0.53 (0.25, 0.73) 28.32 (7.40, 49.24) 64.54 -100.76 157.40 0.65 <0.001 
                       
Swimming                      
Swimming (min/week) 39 0.19 (-0.11, 0.47) 6.54 (-2.00, 15.07) 26.34 -46.14 59.21 0.32 0.049 
a amongst those who were employed, *Q-D mean difference between questionnaire and Diary 1, when the Diary 1 value is subtracted from the questionnaire value 
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 Table 6.4  Comparison of questionnaire and Diary 1 responses stratified by employment status 
 
  n Employment 
Status 
ICC 95% CI for 
ICC 
Mean 
difference 
(Q-D)* 
95% CI for 
mean 
difference 
SD of 
differences 
(Q-D) 
95% Limits of 
Agreement 
Spearman's 
correlation 
coefficient 
             Lower Upper rho p 
Tap water intake            
Home                        
Plain tap water   (L/day) 21 Employed 0.59 (0.23, 0.81) 0.22 (-0.01, 0.46) 0.52 -0.81 1.26 0.71 <0.001 
18 Unemployed 0.80 (0.55, 0.92) 0.14 (-0.09, 0.36) 0.45 -0.77 1.04 0.82 <0.001 
            
Total tap water intake (L/day) 21 Employed 0.38 (-0.01, 0.68) 0.42 (0.06, 0.78) 0.78 -1.15 1.99 0.51 0.019 
18 Unemployed 0.77 (0.39, 0.91) 0.37 (0.08, 0.66) 0.58 -0.79 1.54 0.81 <0.001 
            
Work                         
Plain tap water   (L/day) 21 Employed 0.54 (0.16, 0.78) 0.08 (-0.09, 0.25) 0.38 -0.67 0.83 0.65 0.002 
Total tap water intake (L/day) 21 Employed 0.40 (0.01, 0.70) 0.29 (0.06, 0.53) 0.52 -0.74 1.33 0.26 0.25 
            
All locations                         
Total tap water intake (L/day) 21 Employed 0.38 (-0.01, 0.68) 0.59 (0.12, 1.06) 1.02 -1.45 2.63 0.60 0.004 
18 Unemployed 0.79 (0.54, 0.92) 0.19 (-0.11, 0.49) 0.61 -1.02 1.40 0.78 <0.001 
            
Showering and bathing                        
Showering (min/week) 21 Employed 0.34 (-0.12, 0.67) 2.30 (-27.50, 32.10) 65.34 -128.38 132.98 0.55 0.010 
18 Unemployed 0.73 (0.41, 0.89) 3.86 (-18.84, 26.57) 45.65 -87.45 95.17 0.83 <0.001 
Bathing (min/week) 21 Employed 0.28 (-0.09, 0.61) 38.86 (-36.19, 113.90) 62.21 -85.56 163.27 0.59 0.005 
18 Unemployed 0.64 (0.27, 0.85) 16.03 (-17.19, 49.25) 66.79 -117.56 149.61 0.80 <0.001 
*Q-D mean difference between questionnaire and Diary 1, when the Diary 1 value is subtracted from the questionnaire value
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 Table 6.5  Comparison of questionnaire and Diary 1 responses stratified by ethnicity, income and age  
(continues on following page) 
 
 
  n Stratum ICC 95% CI for 
ICC 
Mean 
difference 
(Q-D)* 
95% CI for mean 
difference 
SD of 
differences 
(Q-D) 
95% Limits of 
Agreement 
Spearman's 
correlation 
coefficient 
 
 
               Lower Upper rho p 
E
T
H
N
I
C
I
T
Y
 
Plain tap water at home 
(L/day) 
20 White 0.71 (0.41, 0.87) 0.14 (-0.04, 0.31) 0.37 -0.61 0.89 0.81 <0.001 
16 South Asian 0.61 (0.20, 0.84) 0.26 (-0.07, 0.59) 0.61 -0.96 1.48 0.53 0.035 
3 Other 0.81 (-1.35, 1.00) 0.07 (-1.05, 1.19) 0.45 -0.83 0.97 0.87 0.33 
Total tap water intake at 
home (L/day) 
20 White 0.58 (0.09, 0.82) 0.48 (0.19, 0.76) 0.61 -0.75 1.70 0.79 <0.001 
16 South Asian 0.63 (0.21, 0.85) 0.42 (0.01, 0.83) 0.77 -1.12 1.95 0.56 0.024 
3 Other 0.19 (-1.74, 0.97) -0.20 (-1.91, 1.50) 0.69 -1.58 1.17 0.50 1.00 
Total tap water intake at 
all locations (L/day) 
20 White 0.61 (0.22, 0.83) 0.37 (0.37, 0.37) 0.65 -0.92 1.66 0.77 <0.001 
16 South Asian 0.52 (0.09, 0.80) 0.44 (0.44, 0.44) 1.15 -1.87 2.75 0.61 0.012 
3 Other 0.37 (-0.35, 0.97) 0.50 (0.50, 0.50) 0.53 -0.55 1.56 0.87 0.33 
Showering (min/week) 
20 White 0.69 (0.36, 0.86) 2.19 (-17.34, 21.73) 41.80 -81.41 85.79 0.81 <0.001 
16 South Asian 0.39 (-0.13, 0.74) 9.94 (-29.75, 49.62) 74.52 -139.11 158.98 0.51 0.044 
3 Other 0.68 (-0.13, 0.99) -28.33 (-71.93, 15.26) 17.56 -63.45 6.79 0.87 0.33 
Bathing (min/week) 
20 White 0.70 (0.40, 0.87) 16.48 (-6.56, 39.51) 49.29 -82.11 115.06 0.69 <0.001 
16 South Asian 0.39 (-0.05, 0.73) 41.25 (-3.43, 85.93) 83.91 -126.58 209.08 0.59 0.016 
3 Other 0.73 (-0.09, 0.99) 38.33 (-8.66, 85.33) 18.93 0.47 76.19 0.87 0.33 
             
H
O
U
S
E
H
O
L
D
 
I
N
C
O
M
E
 
Plain tap water at home 
(L/day) 
15 <£20k 0.68 (0.29, 0.88) 0.10 (-0.08, 0.27) 0.31 -0.52 0.71 0.81 <0.001 
14 £20-40k 0.63 (0.19, 0.86) 0.19 (-0.12, 0.50) 0.54 -0.89 1.26 0.68 0.007 
7 >£40k 0.78 (0.24, 0.96) 0.20 (-0.24, 0.64) 0.47 -0.75 1.15 0.95 <0.001 
3 Don't know 0.67 (-0.53, 0.99) 0.56 (-1.83, 2.96) 0.96 -1.36 2.49 0.50 1.00 
Total tap water intake at 
home (L/day) 
15 <£20k 0.69 (0.29, 0.88) 0.30 (-0.02, 0.61) 0.57 -0.85 1.44 0.78 <0.001 
14 £20-40k 0.41 (-0.07, 0.75) 0.41 (-0.08, 0.91) 0.86 -1.30 2.13 0.46 0.095 
7 >£40k 0.70 (0.08, 0.94) 0.28 (-0.19, 0.75) 0.50 -0.73 1.29 0.85 0.016 
3 Don't know 0.69 (-0.08, 0.99) 1.14 (-0.13, 2.41) 0.51 0.12 2.16 0.50 1.00 
Total tap water intake at 
all locations (L/day) 
15 <£20k 0.72 (0.37, 0.90) 0.17 (-0.15, 0.50) 0.59 -1.01 1.35 0.76 <0.001 
14 £20-40k 0.31 (-0.14, 0.69) 0.68 (-0.02, 1.38) 1.21 -1.73 3.09 0.40 0.16 
7 >£40k 0.91 (0.58, 0.98) 0.09 (-0.24, 0.42) 0.36 -0.63 0.80 0.87 0.010 
3 Don't know 0.65 (-0.03, 0.99) 1.06 (0.39, 1.73) 0.27 0.52 1.60 1.00 0.33 
Showering (min/week) 
15 <£20k 0.70 (0.31, 0.89) -7.41 (-29.92, 15.10) 40.74 -88.89 74.06 0.74 0.002 
14 £20-40k 0.38 (-0.15, 0.74) 18.57 (-17.25, 54.39) 62.04 -105.52 142.66 0.51 0.064 
7 >£40k 0.61 (-0.25, 0.92) -5.86 (-61.07, 49.35) 59.62 -125.10 113.39 0.86 0.024 
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  n Stratum ICC 95% CI for 
ICC 
Mean 
difference 
(Q-D)* 
95% CI for mean 
difference 
SD of 
differences 
(Q-D) 
95% Limits of 
Agreement 
Spearman's 
correlation 
coefficient 
 
 
               Lower Upper rho p 
3 Don't know -0.92 (-2.88, 0.91) 3.33 (-249.04, 255.71) 101.66 -199.98 206.65 -1.00 0.33 
Bathing (min/week) 
15 <£20k 0.66 (0.26, 0.87) 12.23 (-15.31, 39.78) 49.86 -87.48 111.94 0.51 0.053 
14 £20-40k 0.29 (-0.17, 0.68) 33.57 (-3.76, 70.91) 64.67 -95.77 162.91 0.59 0.027 
7 >£40k 0.61 (-0.12, 0.92) 21.57 (-31.52, 74.66) 57.33 -93.10 136.24 0.96 <0.001 
3 Don't know 0.49 (-0.41, 0.98) 100.00 (-201.00, 401.00) 121.24 -142.49 342.49 0.50 1.00 
             
A
G
E
 
Plain tap water at home 
(L/day) 
6 under 25 0.41 (-0.26, 0.88) 0.47 (-0.25, 1.19) 0.68 -0.90 1.84 0.47 0.35 
13 25-29 0.51 (-0.06, 0.82) 0.05 (-0.27, 0.37) 0.53 -1.01 1.10 0.68 0.011 
15 30-34 0.93 (0.81, 0.98) 0.08 (-0.08, 0.24) 0.29 -0.50 0.66 0.92 <0.001 
5 35 or over 0.56 (-0.15, 0.94) 0.50 (0.02, 0.98) 0.39 -0.28 1.28 1.00 0.017 
Total tap water intake at 
home (L/day) 
6 under 25 0.33 (-0.15, 0.83) 0.92 (0.20, 1.63) 0.68 -0.45 2.28 0.61 0.20 
13 25-29 0.39 (-0.20, 0.77) 0.09 (-0.35, 0.53) 0.73 -1.37 1.54 0.47 0.10 
15 30-34 0.72 (0.31, 0.90) 0.39 (0.03, 0.76) 0.66 -0.92 1.71 0.85 <0.001 
5 35 or over 0.31 (-0.07, 0.85) 0.62 (0.32, 0.92) 0.24 0.13 1.11 0.67 0.22 
Total tap water intake at 
all locations (L/day) 
6 under 25 0.37 (-0.15, 0.85) 0.76 (0.17, 1.35) 0.57 -0.37 1.89 0.74 0.096 
13 25-29 0.49 (-0.07, 0.82) 0.15 (-0.54, 0.84) 1.14 -2.13 2.43 0.51 0.074 
15 30-34 0.62 (0.17, 0.85) 0.46 (0.02, 0.90) 0.79 -1.12 2.05 0.87 <0.001 
5 35 or over 0.38 (-0.20, 0.89) 0.50 (-0.64, 1.06) 0.45 -0.41 1.40 0.67 0.22 
Showering (min/week) 
6 under 25 0.80 (0.16, 0.97) 34.33 (-13.46, 82.12) 45.55 -56.76 125.43 1.00 <0.001 
13 25-29 0.25 (-0.35, 0.70) 12.81 (-33.57, 59.19) 76.71 -140.61 166.23 0.44 0.13 
15 30-34 0.69 (0.30, 0.89) -4.24 (-24.42, 15.93) 36.51 -77.26 68.77 0.68 0.005 
3 35 or over 0.18 (-0.23, 0.80) -38.20 (-81.20, 4.80) 34.59 -107.37 30.97 0.05 0.93 
Bathing (min/week) 
6 under 25 0.80 (0.06, 0.97) -2.50 (-46.49, 41.49) 41.92 -86.65 81.35 0.90 0.015 
13 25-29 0.36 (-0.15, 0.74) 32.58 (-10.99, 76.14) 72.05 -111.52 176.68 0.48 0.097 
15 30-34 0.47 (0.01, 0.78) 38.73 (-2.25, 79.72) 74.17 -109.62 187.08 0.75 0.001 
3 35 or over 0.34 (-0.25, 0.88) 23.00 (-7.96, 53.96) 24.90 -26.80 72.80 0.56 0.33 
*Q-D mean difference between questionnaire and diary, when the diary value is subtracted from the questionnaire value
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Table 6.6  Comparison of water filtering information according questionnaire and Diary 1 
(tables show frequency) 
 
      Questionnaire  
   Do you filter the water you drink at home?  
      Yes No or Don't know  
Diary 
Q1.  Do you have a water filter on your 
kitchen tap at home? 
Yes 0 1  
No or Don't know 8 30  
         
Q2.  Do you use a freestanding filter (e.g. 
Brita filter jug) at home? 
Yes 5 0  
No or Don't know 3 31  
     
Yes to one or both of questions above 5 1  
No or Don't know to both questions above 3 30  
      
      Questionnaire 
   Do you filter the water you drink at work? 
      Yes No or Don't know Not applicable 
Diary 
Q5.  Do you have a water filter on your tap 
at work or college? 
Yes 3 2 1 
No or Don't know 2 11 2 
       
Q6.  Do you use a freestanding filter (e.g. 
Brita filter jug) at work or college? 
Yes 0 0 1 
No or Don't know 5 13 2 
         
Yes to one or both of questions above 3 2 2 
No or Don't know to both questions above 2 11 1 
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 Table 6.7  Water-related activities recorded in Diary 1, but not captured in Questionnaire 
 
  
      Percentile Distribution 
Performed 
 activity  
  Mean (95% CI) SD Min 25th %ile Median 75th %ile Max n % 
Time spent in bathroom:           
In bathroom after showering all locations (min/week) 28 (19, 37) 28 0 9 22 40 125 33 84.6 
in bathroom after bathing all locations (min/week) 11 (6, 16) 15 0 0 4 15 65 20 51.3 
Total time in bathroom after showering/bathing all locations (min/week) 39 (30, 47) 26 0 21 35 45 125 38 97.4 
           
Other Water Activities           
Cooking with boiling water (min/week) 90 (54, 126) 111 0 20 60 129 600 34 87.2 
Washing up by hand (min/week) 72 (49, 94) 69 0 23 45 98 320 35 89.7 
Running a dishwasher (min/week) 52 (10, 94) 130 0 0 0 1 616 10 25.6 
Laundry by hand (min/week) 11 (1, 20) 29 0 0 0 0 120 7 17.9 
No. times bathing children per week 2 (1, 3) 3 0 0 2 3 14 22 56.4 
Bathing children (min/week) 32 (20, 44) 38 0 0 20 58 130 22 56.4 
In bathroom after bathing children (min/week) 9 (5, 14) 15 0 0 2 15 55 20 51.3 
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 Table 6.8  Comparison of Diary 1 and Diary 2 
 
  
n Employment 
status 
ICC 95% CI for 
ICC 
Mean 
difference 
(Diary 2 – 
Diary 1) 
95% CI for 
mean 
difference 
SD of 
differences 
(Diary 2 – 
Diary 1) 
95% Limits of 
Agreement 
Spearman's 
correlation coefficient 
Lower Upper rho p 
Tap water intake                 
Home                      
Plain tap water   (L/day) 14 All 0.84 (0.58, 0.95) 0.09 (-0.17, 0.36) 0.46 -0.83 1.02 0.82 <0.001 
8 Employed 0.86 (0.49, 0.97) 0.31 (-0.07, 0.69) 0.45 -0.60 1.21 0.75 0.031 
6 Unemployed 0.77 (0.12, 0.96) -0.20 (-0.52, 0.13) 0.31 -0.81 0.42 0.99 <0.001 
Total tap water intake (L/day) 14 All 0.75 (0.40, 0.91) 0.11 (-0.21, 0.43) 0.56 -1.00 1.22 0.59 0.028 
8 Employed 0.80 (0.33, 0.96) 0.29 (-0.08, 0.67) 0.45 -0.61 1.19 0.83 0.015 
6 Unemployed 0.64 (-0.14, 0.94) -0.13 (-0.79, 0.53) 0.63 -1.39 1.13 0.09 0.92 
Work                        
Plain tap water   (L/day) 8 Employed 0.01 (-0.63, 0.67) -0.08 (-0.30, 0.14) 0.26 -0.60 0.44 0.28 0.50 
Total tap water intake (L/day) 8 Employed 0.11 (-0.57, 0.72) -0.09 (-0.31, 0.13) 0.27 -0.62 0.44 0.26 0.54 
Elsewhere                        
Plain tap water   (L/day) 14 All 0.57 (0.10, 0.84) -0.01 (-0.05, 0.02) 0.06 -0.13 0.10 0.65 0.012 
8 Employed -0.11 (-0.70, 0.60) -0.02 (-0.06, 0.02) 0.05 -0.12 0.08 0.07 0.88 
6 Unemployed 0.70 (-0.03, 0.95) -0.01 (-0.08, 0.07) 0.07 -0.15 0.13 0.81 0.053 
Total tap water intake (L/day) 14 All 0.12 (-0.40, 0.60) -0.06 (-0.15, 0.03) 0.16 -0.37 0.26 0.06 0.83 
8 Employed 0.06 (-0.60, 0.70) -0.06 (-0.20, 0.07) 0.16 -0.38 0.26 -0.01 0.97 
6 Unemployed 0.21 (-0.59, 0.83) -0.05 (-0.23, 0.13) 0.17 -0.40 0.29 0.20 0.70 
All locations                       
Total tap water intake (L/day) 14 All 0.82 (0.55, 0.94) 0.005 (-0.26, 0.27) 0.46 -0.91 0.91 0.80 <0.001 
8 Employed 0.87 (0.56, 0.97) 0.14 (-0.16, 0.44) 0.36 -0.58 0.87 0.87 0.005 
6 Unemployed 0.67 (-0.09, 0.94) -0.18 (-0.74, 0.38) 0.53 -1.25 0.89 0.26 0.66 
Showering and bathing                       
Showering (min/week) 14 All -0.15 (-0.61, 0.39) 0.8 (-37.5, 39.1) 66.4 -132.0 133.5 -0.02 0.95 
8 Employed 0.82 (0.37, 0.96) 1.7 (-15.4, 18.7) 20.5 -39.3 42.6 0.79 0.028 
6 Unemployed -0.53 (-0.90, 0.36) -0.4 (-109.8, 108.9) 104.2 -208.9 208.1 -0.64 0.17 
Bathing (min/week) 14 All 0.48 (-0.02, 0.80) 19.3 (-27.6, 66.1) 81.1 -142.9 181.4 0.68 0.007 
8 Employed 0.00 (-0.64, 0.66) 32.6 (-36.4, 101.7) 82.8 -132.9 198.2 0.51 0.19 
6 Unemployed 0.67 (-0.08, 0.95) 1.4 (-85.3, 88.1) 82.7 -163.9 166.7 0.93 0.008 
Swimming                         
Swimming (min/week) 14  All 0.20 (-0.33, 0.65) -3.6 (-13.1, 5.9) 16.5 -36.5 29.3 0.41 0.14 
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 Table 6.9  Summary statistics for concentration of TCAA in urine in nested subset 
 
    n   Mean (95% CI) SD Min 25th %ile Median 75th %ile Max 
Urinary TCAA 
(nmol/L) 
All 37   37.1 (28.9, 45.2) 24.4 1.5 21.0 33.0 45.0 112.0 
Phase 1 20  32.9 (22.7, 43.2) 21.9 1.5 18.3 31.0 41.3 86.0 
Phase 2 17  42.0 (28.1, 55.9) 27.0 13.0 24.0 34.0 50.0 112.0 
Unemployed 17  38.5 (27.3, 49.7) 21.8 5.0 21.0 36.0 45.0 86.0 
Employed 20  35.9 (23.2, 48.5) 27.0 1.5 23.3 29.0 41.3 112.0 
             
Creatinine-
adjusted 
urinary TCAA 
(μmol/mol 
creatinine) 
All 37  4.9 (3.4, 6.3) 4.4 0.1 2.2 3.5 6.7 20.6 
Phase 1 20  4.2 (2.0, 6.3) 4.6 0.1 2.1 2.6 4.2 20.6 
Phase 2 17  5.7 (3.6, 7.8) 4.1 1.5 3.1 4.5 6.9 15.1 
Unemployed 17  3.7 (2.5, 4.9) 2.3 1.0 2.1 3.4 4.1 8.5 
Employed 20   5.9 (3.3, 8.4) 5.4 0.1 2.4 4.2 7.7 20.6 
 
 
 
 
Table 6.10  Summary statistics for concentration of TCAA in tap water for nested subset 
 
    n  Mean (95% CI) SD Min 25th %ile Median 75th %ile Max 
Concentration of 
TCAA at the tap 
(μg/L) 
All 36  11.3 (10.1, 12.5) 3.4 5.3 8.9 10.5 13.6 17.7 
Phase 1 20  10.6 (9.1, 12.1) 3.2 5.3 8.5 10.2 12.8 17.5 
Phase 2 16  12.2 (10.3, 14.1) 3.6 5.9 9.6 11.6 15.1 17.7 
Unemployed 17  11.4 (9.5, 13.3) 3.7 5.3 8.7 12.4 14.2 17.5 
Employed 19  11.2 (9.6,  12.8) 3.3 5.9 9.3 10.2 12.4 17.7 
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 Table 6.11  Correlation between urinary TCAA concentration and total tap water intake 
 
    Spearman's correlation with urinary TCAA concentration (nmol/L) 
 
 
All  Employed Unemployed  Phase 1 Phase 2 
 (n=37)  (n=20) (n=17)  (n=20) (n=17) 
  rho p-value   rho p-value rho p-value   rho p-value rho p-value 
Mean daily 
total tap 
water intake 
(L/day) by 
location of 
consumption 
and method 
of data 
collection: 
Home - Questionnaire 0.31 0.062   0.01 0.96 0.72 0.001   0.34 0.14 0.41 0.11 
Home - Diary 1 (7 days) 0.30 0.071  -0.07 0.77 0.75 <0.001  0.39 0.087 0.36 0.16 
Home - Diary 1 (3 days preceding urine sample) 0.40 0.017  0.16 0.52 0.76 <0.001  0.49 0.032 0.49 0.052 
             
Work - Questionnaire    0.35 0.13        
Work - Diary 1 (7 days)    -0.19 0.42        
Work - Diary 1 (3 days preceding urine sample)    -0.32 0.20        
             
Elsewhere - Questionnaire * *  * * * *      
Elsewhere - Diary 1 (7 days) -0.21 0.20  -0.14 0.56 -0.31 0.23      
Elsewhere - Diary 1 (3 days preceding urine sample) -0.10 0.59  -0.15 0.54 -0.18 0.50      
             
All Locations - Questionnaire 0.35 0.035  0.07 0.77 0.72 0.001  0.32 0.16 0.52 0.033 
All Locations - Diary 1 (7 days) 0.27 0.10  -0.12 0.61 0.71 0.001  0.24 0.31 0.45 0.072 
All Locations - Diary 1 (3 days preceding urine sample) 0.29 0.09  -0.08 0.74 0.71 0.001  0.26 0.29 0.45 0.080 
   
  Spearman's correlation with creatinine-adjusted urinary TCAA concentration  (μmol/mol creatinine) 
Mean daily 
total tap 
water intake 
(L/day) by 
location of 
consumption 
and method 
of data 
collection: 
Home - Questionnaire 0.21 0.22   -0.10 0.69 0.52 0.034   0.37 0.11 0.33 0.20 
Home - Diary 1 (7 days) 0.15 0.39  -0.03 0.89 0.43 0.083  0.28 0.24 0.08 0.75 
Home - Diary 1 (3 days preceding urine sample) 0.34 0.045  0.32 0.20 0.45 0.067  0.42 0.074 0.22 0.40 
             
Work - Questionnaire    0.26 0.26        
Work - Diary 1 (7 days)    0.05 0.83        
Work - Diary 1 (3 days preceding urine sample)    -0.25 0.32        
             
Elsewhere - Questionnaire * *  * * * *      
Elsewhere - Diary 1 (7 days) -0.34 0.041  -0.15 0.52 -0.51 0.037      
Elsewhere - Diary 1 (3 days preceding urine sample) -0.26 0.13  -0.14 0.59 -0.45 0.072      
             
All Locations - Questionnaire 0.30 0.068  0.01 0.96 0.52 0.034  0.38 0.10 0.49 0.047 
All Locations - Diary 1 (7 days) 0.18 0.29  -0.06 0.79 0.39 0.12  0.17 0.48 0.24 0.36 
All Locations - Diary 1 (3 days preceding urine sample) 0.21 0.23   0.02 0.95 0.38 0.13   0.20 0.40 0.16 0.56 
              
* Correlation could not be calculated as no women in the nested study recorded any tap water intake elsewhere according to the questionnaire. 
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 Table 6.12  Correlation between urinary TCAA concentration and a) concentration of TCAA in tap water at home, and b) TCAA ingestion at home 
 
      Spearman's correlation with urinary TCAA concentration (nmol/L) 
   All  Employed  Unemployed 
 
TCAA exposure metric 
(n=36)  (n=19)  (n=17) 
  rho p-value   rho p-value   rho p-value 
           
a) Concentration of TCAA (μg/L) in tap water at home 0.18 0.29  0.04 0.89  0.22 0.39 
                     
                      
b) TCAA 
ingestion at 
home (μg/day) 
according to: 
Questionnaire 0.50 0.002  0.31 0.20  0.78 <0.001 
 Diary 1 (7 days) 0.48 0.003  0.26 0.28  0.80 <0.001 
  Diary 1 (3 days preceding urine sample) 0.53 0.001   0.40 0.11   0.72 0.001 
           
      Spearman's correlation with creatinine-adjusted urinary TCAA concentration (μmol/mol creatinine) 
   All  Employed  Unemployed 
 
TCAA exposure metric 
(n=36)  (n=19)  (n=17) 
  rho p-value   rho p-value   rho p-value 
           
a) Concentration of TCAA (μg/L) in tap water at home 0.15 0.38  0.08 0.75  0.15 0.56 
                     
                      
b) TCAA 
ingestion at 
home (μg/day) 
according to: 
Questionnaire 0.26 0.13  -0.12 0.63  0.59 0.012 
 Diary 1 (7 days) 0.25 0.14  0.23 0.35  0.53 0.029 
  Diary 1 (3 days preceding urine sample) 0.31 0.08   0.28 0.27   0.45 0.07 
* n=17 because for two employed women tap water consumption in the 3 days immediately prior to urine calculation could not be calculated 
because one had collected the urine sample late, and one had started the diary a day late. 
 
177
 Table 6.13  Correlation between urinary TCAA concentration and metrics of THM exposure 
 
     Spearman's correlation with urinary TCAA concentration (nmol/L) 
   All  Employed  Unemployed 
 
Exposure metric 
(n=37)  (n=20)  (n=17) 
 rho p-value   rho p-value   rho p-value 
A
R
E
A
-
L
E
V
E
L
 
M
E
T
R
I
C
 
                   
Time-
weighted 
average 
concentration 
(μg/L) - 3rd 
trimester 
TTHM 0.11 0.51  0.22 0.36  -0.05 0.85 
Chloroform 0.10 0.57  0.20 0.40  -0.05 0.85 
DCBM 0.02 0.91  0.24 0.30  -0.37 0.15 
DBCM -0.12 0.49  -0.09 0.70  -0.15 0.57 
TBROM 0.03 0.87  0.22 0.36  -0.36 0.16 
   
S
E
M
I
-
I
N
D
I
V
I
D
U
A
L
 
M
E
T
R
I
C
S
 
Ingestion 
(μg/day) - 3rd 
trimester 
TTHM 0.40 0.015  0.24 0.30  0.59 0.012 
Chloroform 0.41 0.012  0.27 0.26  0.61 0.009 
DCBM 0.41 0.011  0.24 0.31  0.61 0.010 
DBCM 0.36 0.028  0.24 0.32  0.53 0.027 
TBROM 0.40 0.015  0.26 0.27  0.58 0.014 
          
Integrated 
uptake 
(μg/day) - 3rd 
trimester 
TTHM 0.32 0.056  0.36 0.11  0.25 0.34 
Chloroform 0.31 0.061  0.34 0.15  0.25 0.33 
DCBM 0.39 0.018  0.46 0.043  0.25 0.34 
DBCM 0.24 0.15  0.29 0.21  0.09 0.72 
TBROM 0.37 0.025  0.42 0.063  0.21 0.41 
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 CHAPTER 7: DISCUSSION 
 
 
In this chapter the main findings presented in Chapters 3, 4, 5 and 6 are evaluated in the context of 
previous work in this field, and their implications for both the future epidemiological analysis of the 
BiB cohort, and research in this field in general, are discussed. 
 
The first section of this chapter evaluates the main study findings coming out of the exposure 
assessment, analysis of exposure metrics, and the validation study; in the light of previous research 
findings.  In the second section of this chapter, implications of the study findings are discussed in 
relation to individual exposure assessment, residual confounding, and future epidemiological 
analysis of the BiB cohort.  Strengths and limitations of this study are considered in the third 
section.  The fourth section sets out the key conclusions of this study and its contribution to 
knowledge in this research field.  Finally, recommendations are made for extending this particular 
study and for future avenues of research. 
  
7.1. EVALUATION OF STUDY FINDINGS 
7.1.1 Findings of exposure assessment 
Individual water use 
The present study finds that the majority of tap water intake occurs at home for both unemployed 
and employed women in the BiB cohort.  An acknowledged limitation of many previous studies on 
DBPs and adverse fetal growth outcomes is that exposure assessment has been based on maternal 
residence only (see section 1.5.3.1, Lack of information on mobility during pregnancy).  If, as this 
study suggests, the majority of tap water intake occurs at home, potential exposure misclassification 
arising from failure to account for THM concentrations at other locations, such as workplace, 
should be relatively small.  However, it is not easy to generalise from this as the percentage of 
employed women is relatively low in this cohort and spatial variability in DBPs is assumed to be 
small within and between WSZs. 
 
Tap water exposures in the present study were somewhat higher than previously reported estimates 
for pregnant women in the UK by Kaur et al. of total tap water intake at 1.31 L/day (calculated by 
the author from reported weekly consumption), 54.3 min/week spent showering and 54.7 min/week 
spent bathing.29  Higher average tap water intake in the present study (1.6 L/day) may reflect 
differences in use of bottled water as a tap water substitute.  The proportion of women drinking 
bottled water was very low in the BiB cohort, compared to consumption of bottled water by 80% of 
pregnant women reported by Kaur et al.29  A recent DWI report found a fairly even spread of people 
who drink bottled water across the UK, with the exception of Yorkshire (where the BiB cohort is 
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 based) where only 26% consumed bottled water, compared to the average of 46%.35  Outside the 
UK, estimates of tap water intake amongst pregnant women from studies in Italy, Russia and the US 
range from 0.6 L/day to 3.4 L/day, and were lower than observed in the present study in 3 
studies28;30;32 but higher in 2 other studies.33;34  Forssén et al.33 report 120 min/week showering 
amongst pregnant women in the US, which is greater than observed in this study, but bathing was 
less at 50 min/week.  The proportion of women reporting swimming in the BiB cohort (7.3%) was 
much lower than the 51.4% reported for pregnant women in London.29  The different proportions 
reporting swimming in the two studies may reflect the lower income, lower educational 
achievement and higher proportion of non-White ethnicity that characterises the BiB cohort 
compared to the sample of women in Kaur et al.29 
 
The present study has shown that there are differences in tap water intake, showering, bathing and 
swimming according to ethnicity, education, employment status, smoking, passive smoking, age, 
and household income, although overall these variables explained little of the total variability in 
water use activities.  The findings are consistent with previous studies that found tap water intake 
varied by ethnicity33 and increased with age,35 and that time spent showering/bathing varied by 
ethnicity,33;55 was greater for smokers,33 was inversely associated with SES,33 and decreased with 
age.33;35 
 
THM exposure in the BiB cohort 
In the BiB study area there is little spatial variability between WSZs for TTHM and chloroform, but 
some spatial variability between WSZs for brominated THM species.   TTHM and chloroform 
concentrations are mainly influenced by temporal variability, and there is a clear pattern of seasonal 
variation with THM concentrations highest in September and lowest in February.  Area-level time-
weighted average THM concentrations during pregnancy are mainly influenced by temporal 
variability for TTHM and chloroform, and between-WSZ variability for brominated species.  
Between-WSZ variability in brominated THMs probably reflects differences between the two main 
water treatment works supplying the BiB study area, perhaps in terms of differing raw water 
characteristics, e.g. bromide.  Unfortunately, bromide in raw water is not measured by the water 
company, and in any event, raw water data were not available from the water company so it was not 
possible to analyse differences in the raw water characteristics between water treatment works.  The 
contribution of temporal variability increases when exposure is considered for specific trimesters.  
Although it was justified in the present study to model THMs zonally due to the differences 
between WSZs observed for brominated THMs, given that between-WSZ variability in raw THM 
data was less than within-WSZ variability, area-level metrics alone are unlikely to distinguish 
sufficiently well between low and high exposure if individual behaviour is not also taken into 
account. 
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Average integrated TTHM uptake during pregnancy of 1.89 μg/day in the BiB cohort, is higher than 
the integrated TTHM uptakes of 1.12 and 1.29 μg/day amongst pregnant women in a study by 
Villanueva et al.191  Average residential TTHM concentration during pregnancy of 50.9 μg/L191 was 
of a similar magnitude so higher TTHM uptake in the present study is likely to reflect the much 
greater time spent showering and bathing, and higher tap water consumption, on average, by women 
in the BiB cohort, and perhaps higher parameter values for swimming pool THM concentrations 
used in the present study.  However, integrated TTHM uptake in present study is slightly lower than 
the 2.0 μg/day reported in a time to pregnancy study by MacLehose et al., perhaps due to the 
somewhat higher average residential TTHM concentration (66.5 μg/L) observed in that study.202 
 
This study estimates that residential mobility during pregnancy in the BiB cohort is approximately 
19%.  This is similar to a previous UK estimate of 23%203 but higher than an estimate of 9% 
recently reported for the north of England alone.99  Residential mobility is actually a very small 
problem in this study, as over half of mobility during pregnancy appeared to be within a WSZ.  This 
suggests that less than half of the residential mobility occurring during pregnancy introduces 
exposure error for DBP research in the UK.  Whilst residential mobility between WSZs during 
pregnancy could not be accounted for in THM exposure assessment in this study, exposure 
estimates were based on residential address at 28 weeks, i.e. at a time point during the relevant 
exposure period.  It is common practice in reproductive environmental epidemiology to use address 
at birth to assign exposure for pregnancy, e.g. a recent case control study of childhood cancer and 
radiofrequency exposure from mobile phone masts during pregnancy.204  Results from the present 
study suggest that this practice may introduce error in exposure assessment given that almost one 
fifth of women move address during pregnancy.  The extent of error will depend upon the 
proportion of pregnancy for which exposure is misclassified.  For example, if exposure estimates 
for the BiB cohort were based on birth address, for the 6.1% of women who moved address between 
28 weeks and delivery, exposure for at least two thirds of the pregnancy would be based on the 
incorrect address.  Whilst inability to account for mobility between WSZs is unlikely to result in 
large error in the present study, for environmental exposures likely to exhibit greater spatial 
variability within small geographical units (e.g. less than 100m), e.g. air pollution, or those 
influenced by distance from a point source, basing exposure assessment on birth address (or failure 
to account for residential mobility during pregnancy) could potentially result in sizeable error in 
exposure estimates and thus limit the ability of the study to detect true excess risks. 
 
Factors driving THM exposure 
The present study finds that individual variability in water use explains the majority of total 
variability in both THM ingestion and integrated THM uptake semi-individual metrics for women 
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 in the BiB cohort.  Underlying patterns of temporal and spatial variability in the area-level tap water 
concentrations are reflected in these semi-individual metrics, but only very weakly (see section 
5.3.2.1, Semi-individual THM exposure metrics).  The present study findings are consistent with a 
study by Villanueva et al.191 which indicated that individual behaviour explained the majority of 
total variation in THM uptake.  Villanueva et al. found showering, bathing and swimming explained 
78% of total THM uptake variability, whilst water consumption and distribution system did not 
make a significant contribution,191 however, the contribution of temporal and spatial variability to 
total THM uptake was not explicitly quantified.  The present study is the first to quantify the 
contribution of temporal, spatial and individual components of variability to a fully integrated 
measure of THM exposure.  The results of the present study may not be generalisable to every 
situation, but indicate that for studies in a limited geographical area (and thus likely to exhibit 
limited between-WSZ variability), but with considerable seasonal variability in THM levels, that 
individual variability in water use is the most influential factor driving THM exposure.  
Nonetheless, for studies at the national level (e.g. Toledano et al.90 and Nieuwenhuijsen et al.187) 
this may not hold true.  Determinants of THM formation, e.g. source water type, DBP precursor 
concentrations, rainfall, and treatment practices, may exhibit much greater variability on the 
national scale, thus resulting in greater spatial variability of THM concentrations between-WSZs, 
compared to this study.  The larger scale of national studies may mean that spatial variability is the 
most influential factor driving THM exposure.  The range of spatial variability in WSZ THM means 
on the national scale (based on 3 water companies in England and Wales for 1992-199812) is 
roughly calculated to be 10 to 20-fold greater than for WSZ means in the BiB study area, depending 
on THM species.  A THM exposure simulation study by Whitaker et al.64 found integrated 
chloroform uptake to be strongly correlated with chloroform in tap water, suggesting that on the 
national scale, THM concentrations may be more influential in determining THM exposure than 
observed in the BiB study area. 
 
Contribution of different water-related activities to integrated THM uptake 
The present study finds that of the three exposure routes considered, personal washing (combined 
showering and bathing) is the major contributor to integrated TTHM uptake (79.3%), followed by 
ingestion (15.8%), with only a small contribution by swimming (4.9%).  This is consistent with 
previous studies which have found showering and bathing to account for the majority of total 
TTHM exposure or uptake,64;107;175;191 although it is worth noting that two of these previous studies 
did not account for swimming in exposure assessment.107;175  Where swimming was accounted for,  
showering contributed 64%, swimming 23%, bathing 12% and drinking water 1% to total THM 
uptake.191  Differing contributions of swimming and water consumption compared to the present 
study can be explained by much higher swimming pool attendance (47%), and much lower 
consumption of tap water (8% at home and 20% in the workplace) in the study by Villanueva et 
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 al.191 compared to the BiB cohort (swimming 7.3%, tap water consumption 81% at home, 27% at 
work).  TTHM uptake via showering and bathing is likely to reflect dermal absorption and 
inhalation routes fairly equally, as previous experimental studies have indicated that internal 
chloroform dose due to dermal exposure during showering is approximately equal to that due to 
inhalation exposure during showering.52;205   
 
When limiting the analysis to swimmers only, the contribution to integrated THM uptake due to 
swimming is large (65% for TTHM) for swimmers in the present study, corroborating a previous 
exposure simulation study which found that swimming had a large impact on an individual’s total 
chloroform uptake.64 
 
Exposure misclassification 
Misclassification if individual water use is not incorporated in exposure metrics 
In the present study, area-level THM metrics misclassify over 50% of women in the BiB cohort 
when cross-classifying with either THM ingestion or integrated THM uptake semi-individual 
metrics, with 11-20% being misclassified across more than one tertile.  Kappa statistics also 
indicate very poor agreement between tertiles for these metrics.  These results indicate that area-
level metrics are a poor surrogate for ‘true’ exposure (assuming semi-individual metrics to be as 
close to ‘true’ exposure as can be measured in the present study), and that failure to incorporate 
individual water use into exposure metrics leads to extensive exposure misclassification.  The 
present study findings are consistent with previous studies which have found 43-55% of subjects are 
classified differently by metrics representing THM concentrations at the tap (area-level or 
household level) and metrics incorporating THM concentrations and individual water use.64;107;108   
 
However, correlations between these metrics as continuous variables are relatively weak in the 
present study (0.07-0.24), in contrast to much stronger correlations of 0.6 64 and 0.73 107 observed in 
previous studies between THM concentration at the tap and total exposure metrics incorporating 
individual water use.  Differences may reflect a different method for calculating total exposure 
metrics and use of subject-specific household THM levels by King et al.107 and differences in water 
use distributions and THM concentration distributions64 compared to the present study. 
 
Misclassification if all exposure routes are not accounted for in exposure metrics 
Agreement between the two semi-individual metrics, THM ingestion and integrated THM uptake is 
weak in the present study, with over 50% classified differently according to the two metrics.  This 
implies that studies which only include individual tap water consumption in THM exposure 
assessment may be subject to extensive exposure misclassification.  This can be loosely compared 
with a previous study which found only 32.2% agreement between quartiles of THM ingestion and 
183
 THM exposure via showering/bathing for lifetime exposure to THMs.206  Clearly, failure to 
incorporate all exposure routes results in exposure misclassification.  In epidemiological studies 
where one or other route has not been included in exposure assessment (e.g. a study by Savitz et 
al.77 in which exposure assessment reflects only the ingestion route), exposure metrics may be a 
poor surrogate for total exposure and result in exposure misclassification. 
 
Correlation between water use and semi-individual THM exposure metrics 
Correlation between integrated THM uptake metrics and individual water use is high for combined 
showering and bathing (0.86-0.93), but weak for tap water intake, in the present study.  A previous 
study reported correlations between total THM uptake and water intake, frequency of showering, 
bathing, and swimming of 0.08, 0.40, 0.18 and 0.70 respectively for pregnant women.191  The 
present study finds correlations between integrated THM uptake metrics and tap water intake are 
also low (≤  0.18), and of a similar magnitude for showering (0.29-0.36), but much higher for 
bathing (0.49-0.57), and much lower for swimming (0.31-0.41).  These differences can be explained 
by the higher proportion of women bathing, greater time spent on bathing, and the smaller 
proportion of swimmers in the BiB cohort.   
 
In the present study, correlations between THM ingestion metrics and individual tap water intakes 
are high for cold water intake (0.87-0.89), but negligible for hot water intake as expected, because 
reduction in THMs due to boiling was taken into account in the calculation of THM ingestion 
metrics. 
 
These findings imply that combined showering and bathing would be a good proxy for integrated 
THM uptake, and volume of cold tap water intake (including beverages made from cold tap water) 
would be a good proxy for THM ingestion, in the BiB cohort at least. 
 
7.1.2 Findings of the nested validation study 
Validation with the 7-day diary 
The present study found that overall, the questionnaire tends to overestimate water exposure, but 
validity of the questionnaire was good for measuring tap water intakes at home, but poorer for tap 
water intakes outside the home.  These results are consistent with previous studies, which report 
overestimation of tap water intakes by questionnaire, and high correlation between questionnaires 
and diaries for intakes at home but weaker correlation for tap water intakes outside the 
home.29;30;32;111  Validity of the BiB questionnaire for assessing showering and bathing activity is 
moderate.      For showering the BiB questionnaire overestimates by less than 5 minutes per week, 
in line with two previous studies,30;111 although Kaur et al.29 found their questionnaire to 
underestimate showering by 12.43 min/week.  Maskiell et al.111 reports stronger agreement (ICC of 
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 0.72) between questionnaire and diary for showering than observed in the present study, however in 
that study 40% of participants completed the diary prior to the questionnaire, perhaps allowing 
those participants to estimate their showering more accurately in the subsequent questionnaire, thus 
improving agreement between the two methods.111  In the present study the questionnaire 
substantially overestimated time spent bathing,  the magnitude of systematic error for bathing being 
3-4 fold greater than observed in previous studies.29;30  This difference cannot be explained by the 
proportion of employed women in the present study as this was similar or higher in the previous 
studies. 
 
Few women in the present study report swimming, making it difficult to assess the questionnaire 
validity for this variable.  In contrast, about half the women surveyed by Kaur et al.29 reported 
swimming and their questionnaire underestimated swimming by 60 min/month. 
 
The main finding from Chapter 6 was a difference in validity of questionnaire response data by 
employment status, with agreement between questionnaire and Diary 1 being much stronger for 
unemployed women compared to employed women (see section 6.3.3).  Only one other study has 
examined employment status in relation to self-reported water exposure, but in contrast, it found no 
difference according to employment status during the last trimester of pregnancy.32  However it 
differed from the present study in that questionnaires and diaries were completed much later in 
pregnancy (36th week or later), by which time few of the employed women were still at work.32  In 
the present study, in contrast, only 1 out of 21 employed women was on sick/maternity leave at the 
time of the study completion (≈ 28th week of pregnancy).  A possible explanation for this finding 
could be that employed women lead busier lives (combining dual family and work roles) and feel 
they have less time to give up therefore tend to answer the questionnaire more quickly and less 
carefully.  In contrast, unemployed women may have more time for the interview process (and may 
actively enjoy the interaction with the interviewer, if they spend a lot of time at home on their 
own/without adult company), and therefore take more care over their responses to the questionnaire.  
Alternatively, or in addition, employed and unemployed women could differ in the accuracy of their 
diary responses, e.g. employed women might not take the diary to work with them, but instead 
complete at the end of the day, and thus be subject to recall error (although this should not be severe 
as the recall period is short).  This could explain some of the observed difference in questionnaire-
Diary 1 agreement according to employment status.  The questionnaire has perhaps greater scope 
for error, because it requires subjects to calculate an average of their behaviour on a “typical” day or 
week.  This may be more difficult for employed women due to activity at both home and work 
locations, and it may be more difficult to interpret what constitutes a “typical” day, as patterns of 
behaviour are likely to be different across working and non-working days. 
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 This is a novel finding, because there are no published studies in the water exposure literature 
reporting differences in the accuracy of self-reported exposure estimates according to employment 
status.  On examining the wider environmental exposure and nutritional assessment literature, there 
are two studies207;208 in which employment status has been examined as a potential predictor of 
exposure reporting error.  Feldman et al.208 found no association between employment status and 
recall bias.  Rull et al.207 report periconceptional employment to be associated with greater error in 
reporting of proximity to agricultural crops during the periconceptional period, however, it is not 
possible to say if this reflects employment status at time of exposure assessment which occurred 
approximately 4 years after conception.  However, studies have also found reporting error to differ 
according to other factors such as age, educational level and SES.207-212 
 
The present study revealed there is considerable water-related activity with potential for DBP 
exposure via inhalation and dermal absorption, and common-place behaviour with potential to 
modify DBP exposure, which is not captured by the BiB questionnaire, thus reflecting potential for 
exposure measurement error.  Future studies must account for these activities in order to avoid 
potential measurement error.  In this validation study 59% of the nested subset reported having an 
extractor fan turned on and /or a bathroom window open during some or all showering or bathing.  
An exposure modelling study has predicted that turning on the extractor fan in a bathroom during a 
shower decreases inhalation exposure to DCBM by about 45%.27    
 
Validation with urinary TCAA biomarker  
This study found no correlation between TCAA concentration in tap water and in urine, and this is 
consistent with a previous study by Weisel et al.213 but in contrast to the good correlation (0.66, 
p<0.001) between tap and urinary TCAA concentrations observed by Zhang et al.195  However, in 
the Zhang et al. study subjects were experimentally supplied with drinking water with a wide range 
of TCAA concentrations (0-121 μg/L), rather than exposure reflecting residential drinking water 
skewed to low TCAA concentrations, as in the present study and Weisel et al.213  Lack of 
correlation in the present study may reflect low variability in TCAA concentrations at the tap.  This 
finding suggests that concentrations of DBPs at the tap have little effect on overall exposure 
variability in this cohort, supporting the finding that individual variability is the main driver of 
THM exposure.  This implies that not having workplace THM/DBP concentrations for some of this 
cohort will matter little, but that the main emphasis must be on individual water consumption and 
use, and how to improve this where there is error, or by taking error into account in the 
epidemiological analysis. 
 
Overall, correlations between urinary TCAA concentration and tap water intake measures, TCAA 
ingestion and semi-individual THM exposure metrics were weak to moderate.  The present study 
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 findings are similar to the weak correlations between volume of tap water intake and urinary TCAA 
concentration either unadjusted (r =0.13, p<0.001) or adjusted for creatinine (r =0.27, p=<0.001), 
observed by Zhang et al.195   
 
When stratified by employment status, the present study found cold tap water intake, total tap water 
intake, TCAA ingestion and semi-individual THM ingestion metrics to be highly correlated with 
urinary TCAA concentration for unemployed women, but for employed women urinary TCAA was 
poorly correlated with these exposure metrics.  Previous studies have observed reasonably good 
correlations between TCAA ingestion (calculated using concentration of TCAA at home tap and 
volume of tap water intake reported by 48 hour recall questionnaire) and urinary TCAA excretion 
rate, with r2 values of 0.58 (p<0.0001)214 and 0.53 (p<0.0001).213  Consistent with the present study 
stronger correlation has been observed for those not working (r2 = 0.66).213  Good correlation 
between TCAA ingestion and urinary TCAA concentration (r=0.65, p<0.001) observed by Zhang et 
al.195 may be explained by the study’s experimental design which represents an artificial ‘one-
source’ exposure. The previous studies have shown that FMU urinary TCAA is a valid biomarker 
for chronic TCAA ingestion exposure, but suggest it is better for women who have little exposure to 
sources of tap water outside the home.  This may explain, in part, the differences in correlation 
according to employment status observed in the present study. 
 
In the present study, correlations between urinary TCAA and TCAA ingestion are only slightly 
stronger than correlations between urinary TCAA and volume of water consumption suggesting that 
for the BiB cohort the concentration of TCAA at the tap has little influence upon actual TCAA 
exposure variability, and that volume of tap water intake, or more specifically cold tap water intake, 
is most important for determining TCAA exposure.  This is consistent with the findings from 
Chapter 5 that individual variability in water use is the major determinant of THM exposure in the 
main cohort.  Volume of tap water intake certainly appears a better surrogate for TCAA exposure 
than semi-individual THM ingestion metrics, for unemployed women. 
 
High correlation between urinary TCAA concentration and tap water intake from the questionnaire 
for unemployed women indicates that volume of tap water intake recorded in the BiB questionnaire 
is a good surrogate for TCAA exposure. 
 
In the present study, the urinary biomarker indicates that volume of tap water intake, TCAA 
ingestion (calculated from questionnaire/Diary 1 and home tap TCAA concentration), and semi-
individual THM ingestion metrics are much poorer surrogates for ‘true’ TCAA exposure for 
employed women compared to unemployed women (regardless of the source of additional error in 
exposure estimates for employed women).  This could reflect greater error in tap water intakes 
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 recorded in the questionnaire (and Diary 1) for employed women.  It could also reflect the fact that 
tap TCAA concentration measured at the woman’s home does not reflect tap TCAA concentration 
at the workplace, which employed women may also be exposed to.  However, given that the present 
study finds the majority of tap water intake to occur at home regardless of employment status, 
failure to reflect workplace TCAA concentrations is unlikely to be the sole explanation, and 
suggests that much of the ‘additional’ error for employed women must lie in the tap water intake 
data.  Whilst there may be some analytical error in urinary TCAA concentrations (analytical 
precision was 15%), this should not differ by employment status, and thus cannot explain the 
differences observed between employed and unemployed women.  It is also possible that urinary 
TCAA was influenced by unknown exposure to other sources of TCAA or substances which 
metabolise to TCAA thus affecting the correlation between urinary TCAA and TCAA exposure 
based on ingestion.  It is plausible that exposure to other TCAA sources could differ by employment 
status, although the present study did rule out any obvious occupational/industrial sources (see 
section 6.3.10.6).  However, the finding that correlation between urinary TCAA and volume of tap 
water intake recorded in Diary 1 (and TCAA ingestion calculated from this) was also much weaker 
for employed women, casts some doubt upon the accuracy of diary data for employed women, and 
suggests that for employed women the diary may not be a gold-standard against which the 
questionnaire can be validated.  The author speculates, but cannot prove, that employed women may 
have underreported their tap water intake in Diary 1. 
 
This study shows the value of using a urinary TCAA biomarker as an objective measure of 
exposure – whilst initially correlation between urinary TCAA and tap water intake/TCAA ingestion 
measures appeared weak, when the analysis was stratified by employment status, clear differences 
in correlation between urinary TCAA and tap water intake/TCAA ingestion measures could be 
observed, reinforcing an earlier finding of differences in error in self-reported water use according 
to employment status. 
 
In the present study correlations with tap water intake and TCAA ingestion were consistently higher 
when using unadjusted urinary TCAA concentration compared to creatinine-adjusted urinary TCAA 
concentration.  Zhang et al.195 observed that adjusting urinary TCAA concentration for creatinine 
did not improve correlation with TCAA ingestion, but values tended to be similar.  Whilst subjects 
in previous urinary TCAA biomarker studies were female, in contrast to the present study, they 
were not pregnant.195;213;214  There are physiological changes in creatinine clearance during 
pregnancy215 and urinary creatinine may be unusually diluted or concentrated during pregnancy.216  
Studies on phthalate biomarkers suggest that creatinine adjustment may not be the most appropriate 
method of normalising urinary biomarker concentrations to control for variations in urine flow rate, 
for pregnant women.216;217  This may explain why in the present study unadjusted urinary TCAA 
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 concentration correlates better with exposure measures (tap water intake, TCAA ingestion) than 
creatinine-adjusted urinary TCAA concentration. 
 
There are some physiological parameters and sampling conditions which may influence TCAA 
biomarker levels which have not been accounted for in this analysis. Inter-individual variability in 
absorption, metabolism and excretion of TCAA in the human body may result in different levels of 
TCAA in urine for the same exposure.218  Factors such as age, physical conditions, physical activity, 
BMI, and fat intake may influence the absorption, metabolism and excretion of chemicals.218;219  
These sources of inter-individual variability in urinary TCAA levels were not accounted for in this 
study, and they might weaken correlations observed between urinary TCAA concentration and 
TCAA or water exposure metrics.  Metabolism of TCAA may vary with gestation.  However, all 
but one woman who participated in the validation study were at a very similar stage of gestation, as 
they were all recruited at 26-28 weeks, therefore this should not introduce a large degree of 
variability into urinary TCAA levels in this study. Variability in the collection, storage and handling 
of biological samples, during which contamination, loss or degradation of analytes may occur, 
could have influenced TCAA biomarker levels.  Such variability was minimised as far as possible, 
by giving clear instructions to the study participants about collection and storage of samples.  As 
described in Section 6.2.2.3 Urine sampling for trichloroacetic acid for uniformity all participants 
were instructed to collect the sample from FMU.  The FMU is a traditional practice for 
standardising sample collection time to reduce the effect of diurnal variation and the effects of 
preceding meals.218  It is possible that urinary TCAA levels were influenced by unmeasured 
differences in sampling conditions.   
 
Variability in water use 
Comparison of repeated diaries in this nested subset suggested little change in overall tap water 
intake during pregnancy, but considerable within-person variability for tap water intakes outside the 
home, and showering and bathing.  Previous studies have assessed variability of water use during 
pregnancy using repeated questionnaires/interviews,32;111;220 but not diaries.  Present study findings 
for tap water intake, but not showering and bathing, are consistent with two previous studies which 
reported low within-person variability for tap water ingestion, showering and bathing measured by 
questionnaires carried out 7 days (ICCs ≥  0.87)111 and 20 days (ICCs ≥ 0.77)32 apart, although tap 
water ingestion at work was noted as an exception to this.32  With regard to showering and bathing 
the present study is more consistent with Forssen et al.220 which found considerable variation in 
behaviour, e.g. 44% reported changes in showering time by ≥  35 min/week, between two 
questionnaires completed in early and mid-pregnancy, with a much longer average interval (83 
days) between questionnaires.220  In the present study the average interval between Diary 1 and 
Diary 2 was relatively long at 66 days, and this may explain the considerable within-person 
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 variability observed in showering and bathing behaviour which might be expected to change 
towards the end of pregnancy, and with season.  Variability in intakes at work may reflect change in 
working patterns/maternity leave. 
 
7.2. IMPLICATIONS OF STUDY FINDINGS 
7.2.1 Critical importance of individual water use 
In the BiB cohort, individual variability in water use is the most influential factor driving THM 
exposure, much more so than any temporal or spatial variation in THM concentrations at the tap.  
Failure to incorporate individual water use into exposure assessment results in exposure 
misclassification, which may lead to loss of study power and bias of risk estimates.110  In addition, 
this study found that exposure estimates which only addressed the ingestion route (semi-individual 
THM ingestion metrics) also misclassified over 50% of women when compared to an integrated 
measure of THM uptake which incorporated ingestion, showering, bathing and swimming.  These 
findings have implications for interpretation of previous epidemiological studies, and design and 
analysis for future epidemiological studies. 
 
The findings of the present study imply that the previous studies which have incorporated individual 
water use data on water consumption and personal washing (showering/bathing) into exposure 
assessment may, as a group, provide a more accurate indication of any relationship between 
exposure to THMs and adverse fetal growth outcomes, than those which simply relied on measures 
of THM concentration at the tap, or those which incorporated only data on the ingestion route 
(which are likely to be subject to extensive exposure misclassification).  As discussed in the 
literature review in Chapter 1 (see section 1.5.3.1, Individual behaviour) only three studies79;80;95 
incorporated some individual information on water consumption and showering/bathing and thus 
meet these criteria of minimum required components.  Aggazzotti et al79 observed no excess risk of 
SGA associated with THM exposures, however THM levels were extremely low in this study.  
Whilst THM exposure in the study jointly accounted for THM concentrations, tap water 
consumption and inhalation from showering/bathing, the data were not integrated into one metric, 
and individual water use was crudely characterised (tap water consumption as tap water 
consumer/not consumer and inhalation exposure as ‘high’ if showering/bathing frequency was at 
least daily, or ‘low’ if less frequent).  As such the exposure assessment is unlikely to reflect fully 
the variability in individual water use, which the present study has been found to be so influential.  
Infante-Rivard80 found no excess risk of IUGR when analysing separately either estimates of THM 
ingestion based on number of glasses of water per day or an index of exposure to THMs based on 
frequency and duration of showering.  The two activities were not integrated into one metric.  Only 
Hoffman et al.95 observed an elevated risk of SGA (RR=1.6, 95% CI: 1.0-2.1), in association with 
the highest category of TTHM uptake via showering and bathing.  Hoffman et al. report that results 
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 for estimates of total combined TTHM exposure through tap water ingestion and showering and 
bathing were similar to results for estimated TTHM exposure through showering and bathing alone.  
The present study observed that combined showering/bathing contributed the most to integrated 
THM uptake.  It is the author’s opinion, in the light of the present study findings that the results of 
these 3 studies79;80;95 are likely to represent the best evidence available, in particular analyses 
relating to showering and bathing.  Differences in exposure assessment and THM levels between 
the three studies may partly explain differences in results.  Examining exposure to THMs and fetal 
growth outcomes in the BiB cohort will provide a valuable addition to this limited evidence base. 
 
Whilst the exact contribution of individual water use to THM exposure found in the present study 
may not be applicable to all other studies, especially if the pattern of temporal/spatial variability in 
THM levels is very different to the BiB study area, clearly the present study findings imply that it 
would be incorrect to ignore individual water use in any future studies examining the health effects 
of DBPs, and to do so will likely result in exposure misclassification.  Nonetheless, it is the author’s 
opinion that exposure metrics should still incorporate information on THM concentrations at the 
tap, because the effects of spatial and temporal variation in underlying tap water concentrations 
could still be observed, albeit very weakly, in semi-individual exposure metrics.   
 
Whilst the present study establishes the importance of incorporating individual water use data into 
exposure estimates, it also finds individual water use to be associated with various other factors, and 
to display complex error patterns, which have implications for the conduct and interpretation of 
future epidemiological analyses and suggest that incorporation of individual water use into exposure 
assessment requires careful consideration. 
 
7.2.2 Potential confounding 
The present study has shown that there are differences in tap water intake, showering, bathing and 
swimming according to ethnicity, education, employment status, smoking, passive smoking, age, 
and household income.  Of particular interest in the BiB cohort are differences between White 
British women and Pakistani women, the two main ethnic groups in Bradford.  White British 
women have, on average, greater tap water and swimming exposures than Pakistani women.  It is 
important to understand these differences in water behaviour, because adverse fetal growth 
outcomes are known to be associated with SES,221 ethnicity,222;223 maternal age and smoking224 and 
these variables may act as confounders if they are also independently associated with water use, and 
thus DBP exposure.  Future epidemiological analyses on the BiB cohort investigating DBPs and 
fetal growth outcomes should adjust for these demographic characteristics and lifestyle factors to 
avoid residual confounding.   
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 7.2.3 Error in individual water use data 
The general tendency for questionnaires to overestimate water use, and thus DBP exposure, would 
have the effect of weakening any observed relationship between DBP exposure and adverse health 
outcomes, resulting in underestimation of the risk associated with a given level of exposure. 
 
The results of the present study show that the questionnaire is a valid instrument for measuring 
individual water use in unemployed women in the BiB cohort, however similar confidence in the 
questionnaire is not justified for employed women.  Results of the biomarker analysis have shown 
than exposure metrics in general, not just water use metrics, display greater error for employed 
women compared to unemployed women.  These findings have implications for future 
epidemiological analyses of the BiB cohort with regard to DBPs and fetal growth outcomes.  As a 
lesson for future research, the author sets out below how health risk estimates could have been mis-
interpreted, without the benefit to the knowledge gained from this validation study. 
 
In general, one would expect measurement error in self-reported water use data to follow the 
classical error model, which, if error is non-differential by outcome, would bias health risk 
estimates towards the null and lead to loss of study power.110  Assuming all other things are equal, 
and that measurement error is non-differential by outcome, if the epidemiological analysis was 
stratified by employment status greater exposure measurement error for employed women would 
cause greater attenuation of health-risk estimates for employed compared to unemployed women.  
Suppose hypothetical ORs for SGA associated with “high” THM exposure were 1.3 for 
unemployed women but 1.2 for employed women, in this situation.  It would appear that the effect 
of “high” THM exposure upon risk of SGA was heterogeneous across strata, and that employment 
conferred some protective effect.  However, with the knowledge of the underlying error distribution 
gained from the validation study the interpretation would differ:  the difference in ORs is likely to 
be the result of greater error in exposure estimates for employed women compared to unemployed 
women.  The spurious effect modification is observed “because the magnitude of error, and hence 
bias due to it, depends on the putative effect-modifier”.192  The discussion of this point so far 
assumes error in exposure estimates is non-differential by outcome.  However, if employment status 
is associated with both measurement error and the outcome of interest the situation becomes more 
complex.  In effect, exposure measurement error becomes differential by outcome, albeit indirectly.  
The consequences of differential error may follow, i.e. risk estimates can be biased either upwards 
or downwards,110 further complicating interpretation.  It is quite plausible that employment status 
could be associated with adverse fetal growth outcomes, for example, increased risk is associated 
with certain occupations,225  long working hours or job strain.226 
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 However, non-differentiality of error is itself not sufficient to guarantee bias of effect estimates 
towards the null;  other assumptions are required, such as independence of errors in both exposure 
and other variables in the analysis.227  The present study has only examined water use, but data on 
many other factors were collected in the BiB baseline questionnaire.  It is plausible that similar 
differences in response error according to employment status might exist for other factors measured 
by the questionnaire, e.g. alcohol consumption, caffeine consumption or smoking.  Indeed, 
dependent errors among exposure variables are common, especially in questionnaire-based 
studies.228  Therefore, errors between covariates likely to be included in multivariate regression 
models could be correlated, and a correlated error structure makes the direction of bias more 
difficult to predict.229  The present study found within-subject variability in individual water use 
within the nested subset, which may cause measurement error, because in the main BiB cohort 
water use is only measured once during pregnancy. 
 
This finding has wider implications for research on health - whilst the direction of bias in the BiB 
questionnaire may overestimate water exposures, if there is a more general systematic difference in 
reporting error by employment status, then this has major implications for analysis and 
interpretation of all epidemiological studies which use self-reported data. 
 
7.2.4 Future epidemiological analysis of BiB cohort 
Semi-individual THM exposure metrics (as calculated in the present study) should be used in the 
main BiB epidemiological analysis (whole pregnancy and trimester-specific metrics).  The author 
suggests that the epidemiological analysis be carried out using both integrated THM uptake metrics 
and THM ingestion metrics as exposure variables, because individuals can be classified quite 
differently by the two metrics and the relative importance of different routes from a mechanistic 
perspective is unknown. 
 
It may also be informative to carry out a sensitivity analysis simply using individual water use 
metrics as exposure variables, because the present study finds particular individual water use 
variables to be good proxies for semi-individual metrics, and this would be useful because exposure 
estimates which incorporate area-level DBP concentrations and individual-level information will 
combine elements of both Berkson and classical error which may make interpretation of health risk 
estimates more difficult.109  However, for the BiB cohort it would not be appropriate to use area-
level exposure metrics on their own as they clearly do not reflect the individual exposure 
experience. 
 
Perhaps the epidemiological analysis should consider a sensitivity analysis which excludes 
swimmers because the nature of their exposure is so different to non-swimmers.   
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Most importantly, however, future epidemiological analysis of DBP exposure and fetal growth 
outcomes in the BiB cohort could incorporate a sensitivity analysis focusing on unemployed women 
only, as the present study indicates that their exposure estimates are more accurate.  Alternatively, 
the data collected in the present validation study could be incorporated into future epidemiological 
analyses to correct for measurement error, in order to reduce bias in effect estimates.    Corrections 
will not in general, affect the p-value of a test of the null hypothesis of no association, nor will 
power be improved, but confidence intervals will normally get wider.192  There are a range of 
correction methods available, most falling into one of the following groups:  regression calibration, 
maximum likelihood, semi-parametric and Bayesian methods.230;231  In regression calibration, for 
example, data from a validity study can be used to “estimate a calibration factor, λ, as the regression 
coefficient of accurate exposure (Y variable) on approximate exposure (X variable) – this estimates 
the average change in the accurate exposure corresponding to unit change in the approximate 
variable.  Observed regression coefficients from the main study are divided by λ to obtain an 
unbiased estimate of the true coefficient”.192  Correction may be appropriate in future 
epidemiological analyses on the BiB cohort given the measurement error observed in this validation 
study.  However, given the differences in error according to employment status, it may be necessary 
for any correction to be carried out separately for employed and unemployed women, as clearly any 
validity coefficient or calibration factors would differ by employment status.  Taking into account 
the uncertainty in validation study parameters due to small sample size, the uncertainty as to the 
diary’s value as a gold-standard for employed women, and the additional complexity and error that 
will be added by incorporating area-level THM estimates to the exposure assessment - perhaps any 
measurement error correction should be in the spirit of a sensitivity analysis to show how error 
might influence effect estimates, rather than expecting it to give a definitive effect estimate. 
 
There is likely to be clustering of demographic and lifestyle factors within certain groups in 
Bradford, due to its particular ethnic composition.  These factors may influence risk of adverse fetal 
growth outcomes.  It is known that the South Asian population are over-represented within inner 
city areas of Bradford associated with social deprivation232 and in this study it has been observed 
that Asian-Pakistani women are over-represented in unemployed and low education categories.   
Clustering of these factors may pose a challenge to a future epidemiological analysis, making it 
difficult to identify the effects of collinear variables which may influence fetal growth, and thus 
identify any effect of DBPs which is likely to be small. 
 
7.2.5 Implications for future exposure assessment and validation 
It is difficult and burdensome for both participants and investigators to collect individual water use 
data to a fine level of detail.  However, given the overwhelming influence of individual variability 
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 in water use in the present study, and also the complex patterns of error in individual water use 
observed in the nested validation study, clearly greater effort and resources should be invested in 
assessing and validating individual water use during pregnancy.  In particular, in areas with limited 
spatial variability, finite exposure assessment resources might be better utilised on collecting more 
extensive and more accurate individual water use data, than on any further refinement of THM/DBP 
sampling and analysis.   
 
Clearly it is unsafe to assume that exposure measurement error is uniformly distributed across a 
study population, and future validation studies need to take this into account by stratifying the 
analyses.  As validation studies are often small due to the high cost of detailed exposure assessment, 
it may be difficult to detect differences between subgroups, but sample size calculations for 
validation studies should in future factor in the need for subgroup analyses. 
 
Validation with a biomarker was clearly valuable in the present study, as it suggested that the ‘gold-
standard’ diary was not in fact a gold-standard for employed women.  This demonstrates the merits 
of using more than one means of validation in the same study, and future validation studies should 
consider using objective measures such as a biomarker. 
 
7.3. STRENGTHS & LIMITATIONS 
This is the largest study reporting estimates of water use amongst pregnant women to date. The 
large sample size has allowed a high degree of precision in estimates of water use.  However, water 
use estimates in the present study are based on a self-selecting sample of women from one city in 
the UK and may not therefore be generalisable to the wider population of pregnant women.  
Nonetheless, given that there is very little information available on water use by pregnant women in 
the UK, these results are useful as estimates of water use in pregnancy and to indicate that 
differences in water use in relation to population characteristics and lifestyle factors should be 
considered in epidemiological studies of DBPs.  A particular strength of the BiB cohort is the large 
quantity of data collected prospectively on population characteristics and lifestyle factors, which 
allowed the present study to assess variability in water use activities according to such 
characteristics, and to identify potential confounders.  However, analysis of water use according to 
household income may have been limited by a large proportion of the cohort responding that they 
did not know their household income, and these women being disproportionately of Asian origin. 
 
Regular routine THM monitoring data was available with sufficient data points per WSZ per year to 
allow THM concentrations to be modelled for each month of the year, instead of on a quarterly 
basis.  Modelling of THMs improved the robustness of THM concentration estimates, and allowed 
prediction of THM concentrations for particular times when data were sparse. However, it was not 
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 possible to model spatial variability of THM concentrations within WSZs because there were 
insufficient sampling data points for each WSZ to be able to do so.  Therefore, a limitation of this 
study is that area-level and semi-individual exposure metrics do not reflect within-WSZ variability. 
 
This is the first study to quantify the contributions of temporal, spatial and individual variability to 
integrated THM exposure estimates.  Whilst it was possible to quantify the individual component of 
variability in semi-individual exposure metrics in the primary ANOVA analysis, it was not possible 
to do so for the secondary ANOVA analysis (see section 5.3.2.2).  In this respect the results may 
only be generalisable to individuals who work and reside in the same WSZ, or those who do not 
work at all and for whom most exposure occurs in the home. 
 
Geographically, the BiB study area is limited, so the results of this study may not be wholly 
transferable to studies covering a more widespread geographical area with potential for greater 
between-WSZ variability in THM concentrations.  Nonetheless, given that the contribution of 
considerable seasonal variability in THMs was clearly overshadowed by individual variability in 
water use in the present study, it is plausible that between-WSZ variability would have to be very 
great before it became the dominant contributor to variability in THM exposure in a study 
population. 
 
Whilst mobility between WSZs during pregnancy could not be fully accounted for in exposure 
assessment, it is a strength of the present study and a future epidemiological analysis, that 
residential mobility between WSZs was low.  Thus, less than half of residential mobility during 
pregnancy (which could not be accounted for due to lack of information on previous addresses and 
moving dates) introduces exposure error.  Whilst tap water intake in the workplace was taken into 
account, it was not possible to fully account for workplace THM concentrations for a proportion of 
employed women in the cohort for whom workplace WSZ was either unknown or outside the study 
area.  However, given the small contribution of spatial variability between WSZs to semi-individual 
exposure metrics in this study, inability to fully account for mobility between WSZs may not pose a 
major problem for the results of the present study, or a future epidemiological analysis.  
Nonetheless, the author would recommend that further work is undertaken to increase matching of 
workplace addresses to WSZs, and that routine THM data for WSZs adjacent to the study area be 
requested from the water company so that for women who work outside the study area THM levels 
can be fully accounted for.  Unfortunately, at the time of planning exposure assessment for this 
cohort and requesting routine THM data from the water company, there were no data available on 
the number of women working outside the study area, or the geographical spread of workplace 
locations.  Future epidemiological analysis on the BiB cohort should include a sensitivity analysis 
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 excluding any women who worked during pregnancy, but to whom a workplace WSZ and thus 
workplace-specific THM/DBP concentrations cannot be assigned. 
 
There are some factors which may affect the THM concentrations in tap water which could not be 
accounted for in exposure assessment, either because individual level data was not collected, e.g. on 
water temperature during showering/bathing, or because there has been too little research to date to 
provide parameter estimates for adjustment factors, e.g. on the effect of addition of organic matter 
to tap water when making drinks such as tea or coffee.   
 
This study could not account for variability in THM concentrations in swimming pool water.  
Although water samples were collected from a number of swimming pools in the Bradford study 
area as part of the water sampling campaign, the analytical results were deemed unreliable, 
therefore parameter values were taken from the literature instead.  However, only 7.3% of women 
in the BiB cohort report swimming, so resulting error in exposure estimates will be limited to the 
small proportion of the study population, and can be managed by a sensitivity analysis which 
excludes swimmers. 
 
This is the first epidemiological study in this particular research field to incorporate a nested 
validation study, and to use biomarkers for validation of DBP exposure in an epidemiological study.  
Water use behaviour data was collected at approximately 28 weeks of pregnancy, at which time all 
but one of the employed women in this nested study were still at work.  Use of a 7-day diary 
allowed a full week of exposure data to be recorded, incorporating both working/non-working and 
week/weekend days.  As such, the average of exposure data collected by diary is not influenced by 
the day of the week on which the subject decided to commence the diary.  Use of a biomarker in 
addition to an exposure diary allowed secondary validation against a completely objective gold-
standard.  This study was used as an opportunity to examine variation in water use during 
pregnancy; however, this was limited by the small number of women who repeated the diary.  There 
were some other limitations, for example, collection of individual exposure data was burdensome, 
which led to some refusals and drop-out, and self-selection into the study may have imposed 
selection bias.  Due to the prohibitive cost of translation, it was not possible to recruit non-English 
speakers to our study.  It is plausible that a language element could introduce further complexities 
into the manner in which a questionnaire or diary is completed, which it has not been possible to 
assess in the present study.  These limitations may affect the portability of measurement error 
parameters to the wider cohort.  The nested study sample size was limited by the high cost of 
personal exposure assessment, and stratification left small numbers in categories, resulting in wide 
confidence intervals, and therefore, uncertainty in parameter estimates. 
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 7.4. CONCLUSIONS 
Key study findings and their relevance to future research 
The two key findings of the exposure assessment and analysis of exposure metrics (Chapters 4 and 
5) were a) that individual water use is the main driver of THM exposure in this cohort, and b) 
failure to incorporate individual water use into exposure assessment, and reliance simply on area-
level THM concentrations, results in exposure misclassification.  These findings show that it is 
critically important to incorporate individual water use data into DBP exposure metrics, particularly 
when spatial variability in DBPs is limited across the study area.  These findings make a useful 
contribution to our understanding of the factors driving DBP exposure.  They also indicate that in 
the future, exposure assessment resources would be best focussed on improving individual water 
use assessment, if spatial variability is likely to be limited in a study area. 
 
The key finding from the analysis of individual water use (Chapter 3) was that tap water intake, 
showering, bathing and swimming vary according to a number of demographic characteristics and 
lifestyle factors (ethnicity, education, employment status, smoking, passive smoking, age, and 
household income).  This finding indicates factors which may potentially confound the relationship 
between DBPs and fetal growth, and should therefore be adjusted for in future epidemiological 
analyses.  However, it may not be easy to study associations with environmental factors in a cohort 
with such a large heterogeneity in risk factors for low birth weight, many of which are associated 
with water use habits. 
 
There were four key findings from the validation study (Chapter 6).  The first key finding of the 
validation study was that error in self-reported water use and TCAA ingestion estimates differs by 
employment status, with error being greater for employed women.  For unemployed women the 
questionnaire is a valid tool for assessment of tap water intake, showering and bathing.  This finding 
indicates that future validation studies must stratify analysis by employment status to check for 
differential error patterns, so that i) measurement error is properly understood, ii) measurement 
error correction is performed appropriately and iii) health risk estimates can be correctly interpreted.  
In fields of environmental epidemiology where exposure assessment is often difficult, e.g. DBPs or 
air pollution, studies often report small excess risks which may currently be partially or wholly 
explained by poorly understood measurement error.  Gaining a proper understanding of potential 
errors in exposure measurement is extremely important if risk estimates are to be correctly 
interpreted and measurement error correction is to be carried out appropriately.  Given that 
individual variability in water use is highly influential in exposure to THMs in the BiB cohort, it 
will be important to find an appropriate way to manage, or correct for, the observed error patterns in 
individual water use data collected in the BiB questionnaire. 
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 The next two key findings of the validation study were a) that pregnant women undertake 
considerable water-related activity (with potential for DBP exposure) which is not captured by the 
questionnaire; and b) that there is within-person variability in some water use activities during the 
third trimester.  These key findings indicate that individual water use assessment in future DBP 
research should expand to cover i) activities other than consumption, showering, bathing and 
swimming, and ii) different time-points during pregnancy, in order to reduce potential exposure 
measurement error.  This is particularly important as the critical trimester of pregnancy for exposure 
is currently not established. 
 
The last key finding of the validation study was that urinary TCAA was not correlated with TCAA 
concentration in tap water, but was strongly correlated with tap water intake for unemployed 
women.  This indicates that TCAA concentration in tap water has little influence upon TCAA 
exposure variability in this cohort, and that individual water use is far more influential in 
determining exposure.  This finding provides further evidence that individual water use is the main 
driver of DBP exposure in this cohort. 
 
Contribution of this study and its findings to addressing knowledge gaps in this research field 
(see section 1.10) 
Key findings of both the THM exposure assessment and the biomarker analysis address the 
knowledge gap regarding factors driving DBP exposure.  This is the first study to quantify the 
spatial, temporal and individual components of variability in THM exposure estimates.  The 
findings improve our understanding of how to target exposure assessment resources appropriately, 
in order to generate meaningful exposure metrics which can differentiate individuals according to 
their true exposure. 
 
This study addresses the need for more sophisticated exposure assessment in this research field.  
THM data were modelled to improve robustness of estimates, and then combined with individual 
water use data to create semi-individual exposure metrics for each woman, incorporating three main 
routes (consumption, showering/bathing and swimming) by which DBP exposure may occur.  In 
addition, this study has created semi-individual exposure metrics for 1st, 2nd and 3rd trimesters to be 
used in a future epidemiological analysis of the BiB cohort.  This will allow in-depth analyses 
comparing exposure metrics for different trimesters of pregnancy, in order to address the current 
knowledge gap regarding the critical window in which DBP exposure may affect fetal growth. 
 
The majority of epidemiological studies in this field to date have examined only THMs, which may 
not be a good proxy for other DBPs such as HAAs and MX.  There is currently a need to investigate 
relationships between fetal growth outcomes and non-THM DBPs in order to understand which, if 
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 any, specific DBPs are driving the associations observed.  This study has conducted sampling for a 
range of non-THM DBPs (HAAs, HANs, HKs, CP, chloral hydrate and MX) in the BiB study area.  
This will allow for statistical modelling of non-THM DBPs, and creation of non-THM exposure 
metrics (based on the exposure framework set out in this study) for use in a future epidemiological 
analysis of the BiB cohort.  As discussed in Section 1.6, there is toxicological evidence that some of 
these DBPs (HAAs, HANs and MX) may have impacts upon the fetus.  The sampling has also 
contributed to a European DBP database which will provide a valuable resource to improve our 
understanding of DBP occurrence across Europe.   
 
This study addresses the lack of exposure validation in previous epidemiological studies in this 
field, and its results can be used to correct for exposure measurement error in the future 
epidemiological analysis of the BiB cohort. 
 
The validation study findings highlight issues to be considered when collecting, using and 
validating self-reported exposure data in future.  This study makes a useful contribution to the 
exposure validation literature by indicating that error in self-reported data may differ by 
employment status.  The biomarker analysis suggests that water use diaries may not be a gold-
standard measure of water use for employed women.  In this respect the validation study 
demonstrates the merits of using more than one means of validation in the same study, and using an 
objective gold-standard such as a biomarker. 
 
Finally, whilst biomarkers for DBPs exist, they have not been used as part of DBP exposure 
assessment or validation in any of the previous epidemiological studies in this research field.  This 
study makes a positive contribution to the future of this research field by showing proof of concept 
for the use of urinary TCAA biomarkers in validation studies, and on a larger scale, as a main 
measure of exposure in epidemiological studies. 
 
7.5. RECOMMENDATIONS FOR FURTHER WORK 
Extending this study 
Prior to the epidemiological analysis of DBPs and fetal growth outcomes in the whole BiB cohort 
(for which recruitment is still ongoing), further work is needed to increase matching of workplace 
addresses/postcodes to WSZs.  Further routine THM data should also be requested from the water 
company for the WSZs surrounding the study area, and the THM model extended, so that for 
women who work outside the study boundary THM levels at their workplace can be fully accounted 
for in exposure assessment.  A re-sampling of water from swimming pools in the Bradford area, and 
analysis of these samples for a range of DBPs, would provide Bradford-specific parameter 
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 estimates, and useful information on non-THMs in swimming pools, for use in exposure 
assessment. 
 
Notwithstanding the useful findings of the present study in relation to THM exposure, there is a 
need to consider other emerging DBPs.  THMs are not necessarily useful surrogates for the 
emerging DBPs, and from a toxicological standpoint THMs are not the most important DBPs - the 
rank order of combined cytotoxicity and genotoxicity of DBP classes is halonitromethanes > 
haloacetamides > haloacetonitriles > haloacetic acids > halomethanes.11  In addition, there is the 
possibility of new disinfection treatments and as yet unknown DBPs.  Whilst it is not possible for a 
future epidemiological analysis of the BiB cohort to address all these DBP classes, data on HANs, 
HAAs, HKs, CP, chloral hydrate and MX have been collected for the BiB study area by the present 
study.  Exposure assessment can be extended for the BiB cohort by using these water sampling data 
for non-THM DBPs (which are part of the HiWATE database) to model DBPs such as HAAs and 
MX at the area-level, and then create semi-individual exposure estimates for these non-THMs.  This 
is appropriate because there is toxicological evidence to suggest that these DBPs may have adverse 
effects upon the fetus (see Section 1.6).  Individual-level tap water DBP concentrations for HAAs 
and MX collected during the present validation study, could be used to validate area-level models.  
The contribution of temporal, spatial and individual variability components to non-THM exposure 
estimates could usefully be assessed, and also the contribution of different exposure routes. 
 
It would be useful to extend this study by performing more extensive multivariate modelling of 
water use for the BiB cohort.  The range of explanatory variables could be expanded beyond those 
which were deemed potential confounders in the present study, and could include variables such as 
physical exercise and diet (collected in the BiB baseline questionnaire), and maternal health data 
such as gestational diabetes (if available).  This multivariate modelling would improve our general 
understanding of water use behaviours during pregnancy. 
 
Prior to the end of BiB recruitment, a second nested validation study could be performed – data 
could be pooled with the validation study in the present study to increase study size and improve 
precision of measurement error parameter estimates.  The author would recommend using a water 
diary (without time-activity components) close to baseline questionnaire, a repeated questionnaire 
later in 3rd trimester, and urinary TCAA biomarker.  The study sample for a second validation study 
should be specifically selected to provide sufficient employed and unemployed women to detect a 
significant difference.  In the BiB study more generally, researchers should consider validating 
other self-reported exposures in the baseline questionnaire, e.g. caffeine or alcohol, stratified by 
employment status and other population characteristics.  Further evaluation of diary data already 
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 collected in the present validation study could be carried out – analysis of day-to-day variation and 
week-to-weekend variation. 
 
Future avenues of research 
The findings of the present study suggest questionnaire validation studies, in general, should stratify 
by population characteristics and lifestyle factors to identify patterns of error in subgroups.  It 
would also be of interest to assess the influence of language of completion on error in questionnaire 
and diary completion, which could not be assessed in the present study.  In addition, validation 
studies for DBP exposure assessment should include biomarkers as an objective gold-standard 
against which measurement error can be assessed. 
 
This study has shown proof of concept for use of urinary TCAA biomarkers on a larger scale in 
epidemiological studies.  Urinary TCAA biomarkers should be used for exposure assessment in 
birth cohorts that have collected urine samples.  As a result of the present validation study, funding 
has been obtained (Toledano et al.) to conduct urinary TCAA analysis in the Spanish INMA birth 
cohort, using a nested case-control design (n=1000).  Biomarker data will be used as the main 
exposure assessment. 
 
In the present study cohort ~50% of tap water intake, on average, is derived from tea, coffee, and 
squash.  More research is needed to evaluate the effects of making drinks such as tea and coffee on 
further formation of DBPs and the important determinants of such processes (e.g., brand of tea, 
instant coffee vs. fresh coffee), brewing time, so that data on relevant parameters can be collected 
by questionnaire. 
 
The present validation study revealed that pregnant women spend considerable time performing 
other water-related household activities which have potential for DBP exposure, i.e. cooking with 
boiling water, laundry, dishwashing, and bathing children.  These are activities for which 
individual-level data should be collected in future exposure assessment.  Given the influence of 
showering and bathing on integrated THM exposure, future efforts to measure exposure should 
include more detailed questions on showering and bathing habits. Given that this study shows that 
individual variability is highly influential in determining THM exposure, it becomes imperative for 
future studies to gather as much information on individual water use as possible, which means 
taking into account these other routes and exposure determinants, and perhaps focussing more 
exposure assessment resources on such efforts.  Perhaps innovative methods are required to capture 
or validate this information, e.g. collecting real-time diary data by SMS at several time points 
during pregnancy. 
202
 BIBLIOGRAPHY 
 
Reference List 
 
 (1)  IPCS (International Programme on Chemical Safety). Disinfectants and Disinfectant 
By-Products. Environmental Health Criteria 2000; 216. 
 (2)  Cutler D, Miller G. The role of public health improvements in health advances: the 
twentieth-century United States. Demography 2005; 42(1):1-22. 
 (3)  Rook JJ. Formation of haloforms during chlorination of natural waters. Water 
Treatment Examination 1974; 23:234-243. 
 (4)  Bellar TA, Lichtenberg JJ, Kroner RC. The Occurrence of Organohalides in 
Chlorinated Drinking Waters. Journal of the American Water Works Association 
1974; 66:703-706. 
 (5)  Nieuwenhuijsen MJ, Grellier J, Smith R, Iszatt N, Bennett J, Best N et al. The 
epidemiology and possible mechanisms of disinfection by-products in drinking 
water. Philos Transact A Math Phys Eng Sci 2009; 367(1904):4043-4076. 
 (6)  Barker D.J.P, Osmond C, Simmonds SJ, Wield GA. The relation of head size and 
thinness at birth to death from cardiovascular disease in adult life. BMJ 1993; 
306:422-426. 
 (7)  Gulmezoglu M, de Onis M, Villar J. Effectiveness of interventions to prevent or 
treat impaired fetal growth. Obstetric & Gynaecological Survey 1997; 52(2):139-
149. 
 (8)  Grellier J, Bennett J, Patelarou E, Smith RB, Toledano MB, Rushton L et al. 
Exposure to disinfection by-products, fetal growth, and prematurity: a systematic 
review and meta-analysis. Epidemiology 2010; 21(3):300-313. 
 (9)  Krasner SW. Chemistry and Occurrence of Disinfection By-products. In: Craun GF, 
Hauchman FS, Robinson DS, editors. Microbial Pathogens and Disinfection By-
products in Drinking Water: Health Effects and Management of Risks. ILSI; 2001. 
197-210. 
 (10)  Krasner SW, McGuire MJ, Jacangelo JG, Patania NL, Reagan KM, Aieta EM. The 
Occurrence of Disinfection by-products in US Drinking Water. Journal of the 
American Water Works Association 1989; 81:41-53. 
 (11)  Richardson SD, Plewa MJ, Wagner ED, Schoeny R, DeMarini DM. Occurrence, 
genotoxicity, and carcinogenicity of regulated and emerging disinfection by-
products in drinking water: a review and roadmap for research. Mutat Res 2007; 
636(1-3):178-242. 
 (12)  Whitaker H, Nieuwenhuijsen MJ, Best N, Fawell J, Gowers A, Elliott P. 
Description of trihalomethanes levels in three UK water suppliers. Journal of 
Exposure Analysis and Environmental Epidemiology 2003; 13:17-23. 
203
  (13)  Rouse M. New Drinking Water Regulations in the UK. [http://www dwi gov 
uk/papers/newreg htm ] 2001  [cited 2008 Jan. 13]; Available from: 
URL:http://www.dwi.gov.uk/papers/newreg.htm 
 (14)  US EPA. Stage 2 Disinfectants and Disinfection Byproducts Rule.  2006.  
 
 (15)  World Health Organisation (WHO). Guidelines for drinking water quality. 
[http://www who int/water_sanitation_health/dwq/GDW12rev1and2 pdf ] 2008 
(3rd):[451-455] Available from: 
URL:http://www.who.int/water_sanitation_health/dwq/gdwq3rev/en/ 
 (16)  Sadiq R, Rodriguez MJ. Disinfection by-products (DBPs) in drinking water and 
predictive models for their occurrence: a review. Science of The Total Environment 
2004; 321(1-3):21-46. 
 (17)  Krasner SW, Sclimenti MJ, Means EG. Quality degradation: implications for DBP 
formation. Journal of the American Water Works Association 1994; 86(6):34-47. 
 (18)  Hua G, Reckhow DA. Comparison of disinfection byproduct formation from 
chlorine and alternative disinfectants. Water Res 2007; 41:1667-1678. 
 (19)  Stevens AA, Moore LA, Miltner RJ. Formation and Control of Non-Trihalomethane 
Disinfection By-products. Journal of the American Water Works Association 1989; 
81:54-60. 
 (20)  US EPA. Controlling disinfection by-products and microbial contaminants in 
drinking water. 600-R-01-110. 2001.  United States Environmental Protection 
Agency.  
 
 (21)  Goslan EH, Krasner SW, Bower M, Rocks SA, Holmes P, Levy LS et al. A 
comparison of disinfection by-products found in chlorinated and chloraminated 
drinking waters in Scotland. Water Res 2009; 43(18):4698-4706. 
 (22)  Krasner SW. The formation and control of emerging disinfection by-products of 
health concern. Philos Transact A Math Phys Eng Sci 2009; 367(1904):4077-4095. 
 (23)  Chen WJ, Weisel CP. Halogenated DBP concentrations in a distribution system. 
Journal of the American Water Works Association 1998; 90:151-163. 
 (24)  Rodriguez MJ, Serodes J. Spatial and temporal evolution of THMs in three water 
distribution systems. Water Res 2001; 36(6):1572-1586. 
 (25)  Rodriguez MJ, Serodes J, Levesque S. Behavior of trihalomethanes and haloacetic 
acids in a drinking water distribution system. Water research 2004; 38(20):4367-
4382. 
 (26)  Alkhatib E, Peters R. Wet weather impact on trihalomethane formation potential in 
tributaries to drinking water reservoirs. Environ Monit Assess 2008; 139(1-3):173-
181. 
 (27)  Kim E, Little JC, Chiu N. Estimating exposure to chemical contaminants in 
drinking water. Environ Sci Technol 2004; 38(6):1799-1806. 
204
  (28)  Egorov AI, Tereschenko AA, Altshul LM, Vartiainen T, Samsonov D, LaBrecque B 
et al. Exposures to drinking water chlorination by-products in a Russian city. Int J 
Hyg Environ Health 2003; 206(6):539-551. 
 (29)  Kaur S, Nieuwenhuijsen MJ, Ferrier H, Steer P. Exposure of pregnant women to tap 
water related activities. Occup Environ Med 2004; 61(5):454-460. 
 (30)  Shimokura GH, Savitz DA, Symanski E. Assessment of water use for estimating 
exposure to tap water contaminants. Environ Health Perspect 1998; 106(2):55-59. 
 (31)  Ershow AG, Brown LM, Cantor KP. Intake of tapwater and total water by pregnant 
and lactating women. Am J Public Health 1991; 81(3):328-334. 
 (32)  Barbone F, Valent F, Brussi V, Tomasella L, Triassi M, Di LA et al. Assessing the 
exposure of pregnant women to drinking water disinfection byproducts. 
Epidemiology 2002; 13(5):540-544. 
 (33)  Forssen UM, Herring AH, Savitz DA, Nieuwenhuijsen MJ, Murphy PA, Singer PC 
et al. Predictors of use and consumption of public drinking water among pregnant 
women. J Expo Sci Environ Epidemiol 2007; 17(2):159-169. 
 (34)  Zender R, Bachand AM, Reif JS. Exposure to tap water during pregnancy. J Expo 
Anal Environ Epidemiol 2001; 11:224-230. 
 (35)  DWI. National Tap Water Consumption Study DWI 70/2/217 Phase Two Final 
Report. [http://www dwi gov uk/research/reports/DWI70_2_217 pdf ] 2008  
Available from: URL:http://www.dwi.gov.uk/research/reports/DWI70_2_217.pdf 
 (36)  Weinberg HS, Pereira VR, Singer PC, Savitz DA. Considerations for improving the 
accuracy of exposure to disinfection by-products by ingestion in epidemiologic 
studies. Sci Total Environ 2006; 354(1):35-42. 
 (37)  Levesque S, Rodriguez MJ, Serodes J, Beaulieu C, Proulx F. Effects of indoor 
drinking water handling on trihalomethanes and haloacetic acids. Water Res 2006; 
40(15):2921-2930. 
 (38)  Eslinger SA, Weinberg HS. Estimating average daily exposure to disinfection by-
products in drinking water by examining alternate ingestion pathways. Presented at 
the AWWA Water Quality Technology Conference of the American Water Works 
Association 2-6 November 2003 2003. 
 (39)  Gibbons J, Laha S. Water purification systems: a comparative analysis based on the 
occurrence of disinfection by-products. Environ Pollut 1999; 106(3):425-428. 
 (40)  Ma A. Investigation into different tap water household handling treatments to 
determine the effects on disinfectant by-products [ MSc thesis - Imperial College 
London]; 2008. 
 (41)  Krasner SW, Wright JM. The effect of boiling water on disinfection by-product 
exposure. Water research 2005; 39(5):855-864. 
205
  (42)  Wu WW, Benjamin MM, Korshin GV. Effects of thermal treatment on halogenated 
disinfection by-products in drinking water. Water Res 2001; 35(15):3545-3550. 
 (43)  Batterman S, Huang A-T, Wang S, Zhang L. Reduction of ingestion exposure to 
trihalomethanes due to volatilization. Environ Sci Technol 2000; 34:4418-4424. 
 (44)  Huang AT, Batterman S. Formation of trihalomethanes in foods and beverages. 
Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2009; 26(7):947-
957. 
 (45)  Saleh MA, Abdel-Rahman FH, Woodard BB, Clark S, Wallace C, Aboaba A et al. 
Chemical, microbial and physical evaluation of commercial bottled waters in greater 
Houston area of Texas. J Environ Sci Health A Tox Hazard Subst Environ Eng 
2008; 43(4):335-347. 
 (46)  Huang AT, Batterman S. Sorption of trihalomethanes in foods. Environ Int 2010; 
36(7):754-762. 
 (47)  Robinson D, Mead GC, Barnes KA. Detection of Chloroform in the Tissues of 
Freshly Eviscerated Poultry Carcasses Exposed to Water Containing Added 
Chlorine Or Chlorine Dioxide. Bulletin of Environmental Contamination and 
Toxicology 1981; 27(2):145-150. 
 (48)  Weisel CP, Chen WJ. Exposure to chlorination by-products from hot water uses. 
Risk Anal 1994; 14(1):101-106. 
 (49)  Xu X, Weisel CP. Human respiratory uptake of chloroform and haloketones during 
showering. J Expo Anal Environ Epidemiol 2005; 15(1):6-16. 
 (50)  Xu X, Weisel CP. Inhalation exposure to haloacetic acids and haloketones during 
showering. Environ Sci Technol 2003; 37(3):569-576. 
 (51)  Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of 
trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol 2002; 
184(1):19-26. 
 (52)  Weisel CP, Jo WK. Ingestion, inhalation, and dermal exposures to chloroform and 
trichloroethene from tap water. Environ Health Perspect 1996; 104(1):48. 
 (53)  Jo WK, Weisel CP, Lioy PJ. Routes of chloroform exposure and body burden from 
showering with chlorinated tap water. Risk Anal 1990; 10(4):575-580. 
 (54)  Kerger BD, Schmidt CE, Paustenbach DJ. Assessment of Airborne Exposure to 
Trihalomethanes from Tap Water in Residential Showers and Baths. Risk Analysis 
2000; 20(5):637-652. 
 (55)  Williams BL, Florez Y, Pettygrove S. Inter- and intra-ethnic variation in water 
intake, contact, and source estimates among Tucson residents: Implications for 
exposure analysis. J Expo Anal Environ Epidemiol 2001; 11(6):510-521. 
206
  (56)  Backer LC, Lan Q, Blount BC, Nuckols JR, Branch R, Lyu CW et al. Exogenous 
and endogenous determinants of blood trihalomethane levels after showering. 
Environ Health Perspect 2008; 116(1):57-63. 
 (57)  Nuckols JR, Ashley DL, Lyu C, Gordon SM, Hinckley AF, Singer P. Influence of 
tap water quality and household water use activities on indoor air and internal dose 
levels of trihalomethanes. Environ Health Perspect 2005; 113(7):863-870. 
 (58)  Chu H, Nieuwenhuijsen MJ. Distribution and determinants of trihalomethane 
concentrations in indoor swimming pools. Occup Environ Med 2002; 59(4):243-
247. 
 (59)  Aggazzotti G, Fantuzzi G, Righi E, Predieri G. Blood and breath analyses as 
biological indicators of exposure to trihalomethanes in indoor swimming pools. Sci 
Total Environ 1998; 217(1-2):155-163. 
 (60)  Aggazzotti G. Environmental and biological monitoring of chloroform in indoor 
swimming pools. Journal of chromatography 1995; 710(1):181. 
 (61)  Dufour AP, Evans O, Behymer TD, Cantu R. Water ingestion during swimming 
activities in a pool: a pilot study. J Water Health 2006; 4(4):425-430. 
 (62)  Gordon SM, Brinkman MC, Ashley DL, Blount BC, Lyu C, Masters J et al. 
Changes in breath trihalomethane levels resulting from household water-use 
activities. Environ Health Perspect 2006; 114(4):514-521. 
 (63)  Ashley DL, Blount BC, Singer PC, Depaz E, Wilkes C, Gordon S et al. Changes in 
blood trihalomethane concentrations resulting from differences in water quality and 
water use activities. Arch Environ Occup Health 2005; 60(1):7-15. 
 (64)  Whitaker HJ, Nieuwenhuijsen MJ, Best NG. The relationship between water 
concentrations and individual uptake of chloroform: a simulation study. Environ 
Health Perspect 2003; 111(5):688-694. 
 (65)  Backer LC, Ashley DL, Bonin MA, Cardinali FL, Kieszak SM. Household 
exposures to drinking water disinfection by-products: whole blood trihalomethane 
levels. Journal of Exposure Analysis and Environmental Epidemiology 2000; 
10(4):321. 
 (66)  Wilcox AJ. On the importance - and the unimportance - of birthweight. 
International Journal of Epidemiology 2001; 30:1233-1241. 
 (67)  Bukowski R, Smith GCS, Malone FD, Ball RH, Nyberg DA, Comstock CH et al. 
Fetal growth in early pregnancy and risk of delivering low birth weight infant: 
prospective cohort study. BMJ 2007. 
 (68)  Bamberg C, Kalache KD. Prenatal diagnosis of fetal growth restriction. Semin Fetal 
Neonatal Med 2004; 9(5):387-394. 
 (69)  Maulik D. Fetal growth compromise: definitions, standards, and classification. 
Clinical obstetrics and gynecology 2006; 49(2):214-218. 
207
  (70)  Ott WJ. Sonographic diagnosis of fetal growth restriction. Clin Obstet Gynecol 
2006; 49(2):295-307. 
 (71)  Zhang J, Merialdi M, Platt LD, Kramer MS. Defining normal and abnormal fetal 
growth: promises and challenges. Am J Obstet Gynecol 2010; 202(6):522-528. 
 (72)  Mamelle N, Cochet V, Claris O. Definition of Fetal Growth Restriction According 
to Constitutional Growth Potential. Biology of the neonate 2001; 80(4):277-285. 
 (73)  Ego A, Subtil D, Grange G, Thiebaugeorges O, Senat M-V, Vayssiere C et al. 
Customized versus population-based birth weight standards for identifying growth 
restricted infants:  A French multicenter study. American Journal of Obstetrics and 
Gynaecology 2006; 194:1042-1049. 
 (74)  Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. 
Ultrasound in obstetrics & gynecology 1995; 6:168-174. 
 (75)  Gelbaya TA, Nardo LG. Customised fetal growth chart: a systematic review. 
Journal of obstetrics and gynaecology 2005; 25(5):445-450. 
 (76)  Kramer MD, Lynch CF, Isacson P, Hanson JW. The association of waterborne 
chloroform with intrauterine growth retardation. Epidemiology 1992; 3(5):407-413. 
 (77)  Savitz DA, Andrews KW, Pastore LM. Drinking water and pregnancy outcome in 
central North Carolina: source, amount, and trihalomethane levels. Environ Health 
Perspect 1995; 103(6):592-596. 
 (78)  Kanitz S, Franco Y, Patrone V, Caltabellotta M, Raffo E, Riggi C et al. Association 
between drinking water disinfection and somatic parameters at birth. Environ 
Health Perspect 1996; 104(5):516-520. 
 (79)  Aggazzotti G, Righi E, Fantuzzi G, Biasotti B, Ravera G, Kanitz S et al. 
Chlorination by-products (CBPs) in drinking water and adverse pregnancy 
outcomes in Italy. J Water Health 2004; 2(4):233-247. 
 (80)  Infante-Rivard C. Drinking water contaminants, gene polymorphisms, and fetal 
growth. Environ Health Perspect 2004; 112(11):1213-1216. 
 (81)  Bove FJ, Fulcomer MC, Klotz JB, Esmart J, Dufficy EM, Savrin JE. Public 
drinking water contamination and birth outcomes. Am J Epidemiol 1995; 
141(9):850-862. 
 (82)  Dodds L, King W, Woolcott C, Pole J. Trihalomethanes in public water supplies 
and adverse birth outcomes. Epidemiology 1999; 10(3):233-237. 
 (83)  Jaakkola JJK, Magnus P, Skrondal A, Hwang BF, Becher G, Dybing E. Foetal 
growth and duration of gestation relative to water chlorination. Occup Environ Med 
2001; 58(7):437-442. 
 (84)  Kallen BA, Robert E. Drinking water chlorination and delivery outcome-a registry-
based study in Sweden. Reprod Toxicol 2000; 14(4):303-309. 
208
  (85)  Lewis C, Suffet IH, Ritz B. Estimated Effects of Disinfection By-products on Birth 
Weight in a Population Served by a Single Water Utility. Am J Epidemiol 2006; 
163(1):38-47. 
 (86)  Yang CY. Drinking water chlorination and adverse birth outcomes in Taiwan. 
Toxicology 2004; 198(1-3):249-254. 
 (87)  Yang CY, Cheng BH, Tsai SS, Wu TN, Lin MC, Lin KC. Association between 
chlorination of drinking water and adverse pregnancy outcome in Taiwan. Environ 
Health Perspect 2000; 108(8):765-768. 
 (88)  Wright JM, Schwartz J, Dockery DW. Effect of trihalomethane exposure on fetal 
development. Occup Environ Med 2003; 60(3):173-180. 
 (89)  Wright JM, Schwartz J, Dockery DW. The Effect of Disinfection By-products and 
Mutagenic Activity on Birth Weight and Gestational Duration. Environ Health 
Perspect 2004; 112(8):920-925. 
 (90)  Toledano MB, Nieuwenhuijsen MJ, Best N, Whitaker H, Hambly P, de Hoogh C et 
al. Relation of trihalomethane concentrations in public water supplies to stillbirth 
and birth weight in three water regions in England. Environ Health Perspect 2005; 
113(2):225-232. 
 (91)  Gallagher MD, Nuckols JR, Stallones L, Savitz DA. Exposure to trihalomethanes 
and adverse pregnancy outcomes. Epidemiology 1998; 9(5):484-489. 
 (92)  Porter CK, Putnam SD, Hunting KL, Riddle MR. The effect of trihalomethane and 
haloacetic acid exposure on fetal growth in a Maryland county. Am J Epidemiol 
2005; 162(4):334-344. 
 (93)  Hinckley AF, Bachand AM, Reif JS. Late pregnancy exposures to disinfection by-
products and growth-related birth outcomes. Environ Health Perspect 2005; 
113(12):1808-1813. 
 (94)  Yang CY, Xiao ZP, Ho SC, Wu TN, Tsai SS. Association between trihalomethane 
concentrations in drinking water and adverse pregnancy outcome in Taiwan. 
Environ Res 2007. 
 (95)  Hoffman CS, Mendola P, Savitz DA, Herring AH, Loomis D, Hartmann KE et al. 
Drinking water disinfection by-product exposure and fetal growth. Epidemiology 
2008; 19(5):729-737. 
 (96)  Nieuwenhuijsen MJ, Northstone K, Golding J, ALSPAC Study Team. Swimming 
and Birth Weight. Epidemiology 2002; 13(6):1-4. 
 (97)  Juhl M, Kogevinas M, Andersen PK, Andersen AM, Olsen J. Is swimming during 
pregnancy a safe exercise? Epidemiology 2010; 21(2):253-258. 
 (98)  Keegan T, Whitaker H, Nieuwenhuijsen MJ, Toledano MB, Elliott P, Fawell J et al. 
Use of routinely collected data on trihalomethane in drinking water for 
epidemiological purposes. Occup Environ Med 2001; 58(7):447-452. 
209
  (99)  Hodgson S, Shirley M, Bythell M, Rankin J. Residential mobility during pregnancy 
in the north of England. BMC Pregnancy Childbirth 2009; 9:52. 
 (100)  Khoury MJ, Stewart W, Weinstein A, Panny S, Lindsay P, Eisenberg M. Residential 
mobility during pregnancy: implications for environmental teratogenesis. J Clin 
Epidemiol 1988; 41(1):15-20. 
 (101)  Shaw GM, Malcoe LH. Residential mobility during pregnancy for mothers of 
infants with or without congenital cardiac anomalies: a reprint. Arch Environ Health 
1992; 47(3):236-238. 
 (102)  Lupo PJ, Symanski E, Chan W, Mitchell LE, Waller DK, Canfield MA et al. 
Differences in exposure assignment between conception and delivery: the impact of 
maternal mobility. Paediatr Perinat Epidemiol 2010; 24(2):200-208. 
 (103)  Chen L, Bell EM, Caton AR, Druschel CM, Lin S. Residential mobility during 
pregnancy and the potential for ambient air pollution exposure misclassification. 
Environ Res 2010; 110(2):162-168. 
 (104)  Canfield MA, Ramadhani TA, Langlois PH, Waller DK. Residential mobility 
patterns and exposure misclassification in epidemiologic studies of birth defects. J 
Expo Sci Environ Epidemiol 2006; 16(6):538-543. 
 (105)  Miller A, Siffel C, Correa A. Residential Mobility During Pregnancy: Patterns and 
Correlates. Matern Child Health J 2009. 
 (106)  Madsen C, Gehring U, Walker SE, Brunekreef B, Stigum H, Naess O et al. Ambient 
air pollution exposure, residential mobility and term birth weight in Oslo, Norway. 
Environ Res 2010; 110(4):363-371. 
 (107)  King WD, Dodds L, Armson BA, Allen AC, Fell DB, Nimrod C. Exposure 
assessment in epidemiologic studies of adverse pregnancy outcomes and 
disinfection byproducts. J Expo Anal Environ Epidemiol 2004; 14(6):466-472. 
 (108)  Wright JM, Murphy PA, Nieuwenhuijsen MJ, Savitz DA. The impact of water 
consumption, point-of-use filtration and exposure categorization on exposure 
misclassification of ingested drinking water contaminants. Science of The Total 
Environment 2006; 366(1):65. 
 (109)  Nieuwenhuijsen M, Toledano MB, Elliott P. Uptake of chlorination disinfection by-
products; a review and a discussion of its implications for exposure assessment in 
epidemiological studies. J Expo Anal Environ Epidemiol 2000; 10(6 Pt 1):586-599. 
 (110)  Armstrong BG. Effect of measurement error on epidemiological studies of 
environmental and occupational exposures. Occupational and environmental 
medicine 1998; 55(10):651-656. 
 (111)  Maskiell KE, Heyworth JS, McCaul KA. Validation of a water consumption 
questionnaire for a study of the adverse health outcomes associated with 
disinfection by-products. Int J Environ Health Res 2006; 16(2):145-153. 
210
  (112)  Malliarou E, Collins C, Graham N, Nieuwenhuijsen MJ. Haloacetic acids in 
drinking water in the United Kingdom. Water Res 2005; 39(12):2722-2730. 
 (113)  Tardiff RG, Carson ML, Ginevan ME. Updated weight of evidence for an 
association between adverse reproductive and developmental effects and exposure 
to disinfection by-products. Regul Toxicol Pharmacol 2006; 45(2):185-205. 
 (114)  Kirkwood BR, Sterne JAC. Essential Medical Statistics. Second ed. Oxford: 
Blackwell Science; 2003. 
 (115)  Graves CG, Matanoski GM, Tardiff RG. Weight of Evidence for an Association 
between Adverse Reproductive and Developmental Effects and Exposure to 
Disinfection By-products: A Critical Review. Regulatory Toxicology and 
Pharmacology 2001; 34(2):103-124. 
 (116)  Nieuwenhuijsen MJ, Toledano MB, Eaton NE, Fawell J, Elliott P. Chlorination 
disinfection byproducts in water and their association with adverse reproductive 
outcomes: a review. Occup Environ Med 2000; 57(2):73-85. 
 (117)  Ruddick JA, Villeneuve DC, Chu I, Valli VE. A teratological assessment of four 
trihalomethanes in the rat. Journal of Environmental Science and Health, Part B 
1983; 18(3):333-349. 
 (118)  Thompson DJ, Warner SD, Robinson VB. Teratology studies on orally administered 
chloroform in the rat and rabbit. Toxicology and Applied Pharmacology 1974; 
29(3):348-357. 
 (119)  Murray FJ, Schwetz BA, McBride JG, Staples RE. Toxicity of inhaled chloroform 
in pregnant mice and their offspring. Toxicology and Applied Pharmacology 1979; 
50(3):515-522. 
 (120)  Dilley JV, Chernoff N, Kay D, Winslow N, Newell GW. Inhalation teratology 
studies of five chemicals in rats. Toxicology and Applied Pharmacology 41[1], 196. 
1977. - Abstract 
 
 (121)  Schwetz BA, Leong BKJ, Gehring PJ. Embryo- and fetotoxicity of inhaled 
chloroform in rats. Toxicology and Applied Pharmacology 1974; 28(3):442-451. 
 (122)  Christian MS, York RG, Hoberman AM, Fisher LC, Brown WR. Oral (Drinking 
Water) Two-Generation Reproductive Toxicity Study of Bromodichloromethane 
(BDCM) in Rats. International Journal of Toxicology 2002; 21(2):115-146. 
 (123)  Christian MS, York RG, Hoberman AM, Diener RM, Fisher LC. Oral (Drinking 
Water) Developmental Toxicity Studies of Bromodichloromethane (BDCM) in Rats 
and Rabbits. International Journal of Toxicology 2001; 20(4):225-237. 
 (124)  Narotsky MG, Pegram RA, Kavlock RJ. Effect of Dosing Vehicle on the 
Developmental Toxicity of Bromodichloromethane and Carbon Tetrachloride in 
Rats. Fundamental and Applied Toxicology 1997; 40(1):30-36. 
 (125)  Delaney JC, Wolfe GW, Kaiser L, Lanning L, Klinefelter G, Hunter ES et al. Short 
term reproductive and developmental effects of chlorodibromomethane in S-D rats 
211
 when administered in the drinking water. Toxicologist 36[1, Part 2], 257. 1997. - 
Abstract 
 
 (126)  National Toxicology Program. Short Term Reproductive and Developmental 
Toxicity of Bromodichloromethane (CAS No. 75-27-4) Administered in the 
Drinking Water to Sprague-Dawley Rats. http://ntp.niehs.nih.gov/index 
cfm?objectid=070EC97E-B871-16C6-1C7596B55DF73B20 [1998  Available from: 
URL:http://ntp.niehs.nih.gov/index.cfm?objectid=070EC97E-B871-16C6-
1C7596B55DF73B20 
 (127)  Chen J, Thirkill TL, Lohstroh PN, Bielmeier SR, Narotsky MG, Best DS et al. 
Bromodichloromethane Inhibits Human Placental Trophoblast Differentiation. 
Toxicol Sci 2004; 78(1):166-174. 
 (128)  Chen J, Douglas GC, Thirkill TL, Lohstroh PN, Bielmeier SR, Narotsky MG et al. 
Effect of Bromodichloromethane on Chorionic Gonadotrophin Secretion by Human 
Placental Trophoblast Cultures. Toxicol Sci 2003; 76(1):75-82. 
 (129)  Borzelleca JF, Carchman RA. Effects of selected organic drinking water 
contaminants on male reproduction. EPA-600/1-82-009, NTIS PB82-259847. 1982.  
U.S. Environmental Protection Agency, Health Effects Research Laboratory, 
Research Triangle Park, NC.  
  Ref Type: Report 
 (130)  Gulati DK, Hope E, Barnes LH, Russell S, Poonacha KB. Bromoform: 
Reproduction and Fertility Assessment in Swiss CD-1 Mice When Administered by 
Gavage. NTP-89-068,NTIS PB89-169254. 1989.  National Toxicology Program, 
Research Triangle Park, NC.  
  Ref Type: Report 
 (131)  Smith MK, Randall JL, Read EJ, Stober JA. Developmental toxicity of 
dichloroacetate in the rat. Teratology 1992; 46(2):217-223. 
 (132)  Smith MK, Randall JL, Read EJ, Stober JA. Teratogenic activity of trichloroacetic 
acid in the rat. Teratology 1989; 40(5):445-451. 
 (133)  Christian MS, York RG, Hoberman AM, Frazee J, Fisher LC, Brown WR et al. Oral 
(Drinking Water) Two-Generation Reproductive Toxicity Study of Dibromoacetic 
Acid (DBA) in Rats. International Journal of Toxicology 2002; 21(4):237-276. 
 (134)  Klinefelter GR, Strader LF, Suarez JD, Roberts NL, Goldman JM, Murr AS. 
Continuous Exposure to Dibromoacetic Acid Delays Pubertal Development and 
Compromises Sperm Quality in the Rat. Toxicol Sci 2004; 81(2):419-429. 
 (135)  Smith MK, George EL, Zenick H, Manson JM, Stober JA. Developmental toxicity 
of halogenated acetonitriles: Drinking water by-products of chlorine disinfection. 
Toxicology 1987; 46(1):83-93. 
 (136)  Ahmed AE, El-Mazar HM, Nagy AA, bdel-Naim AB. Chloroacetonitrile induces 
intrauterine growth restriction and musculoskeletal toxicity in fetal mouse. Toxicol 
Ind Health 2008; 24(8):511-518. 
212
  (137)  Smith MK, Randall JL, Stober JA, Read EJ. Developmental toxicity of 
dichloroacetonitrile: A by-product of drinking water disinfection. Fundamental and 
Applied Toxicology 1989; 12(4):765-772. 
 (138)  Christ SA, Read EJ, Stober JA, Smith K. Developmental Effects of 
Trichloroacetonitrile administered in corn oil to pregnant Long-Evans rats. Journal 
of Toxicology and Environmental Health, Part A 1996; 47(3):233-247. 
 (139)  Smith MK, Randall JL, Tocco DR, York RG, Stober JA, Read EJ. Teratogenic 
effects of trichloroacetonitrile in the Long-Evans rat. Teratology 1988; 38(2):113-
120. 
 (140)  Christ SA, Read EJ, Stober JA, Smith MK. The developmental toxicity of 
bromochloroacetonitrile in pregnant Long-Evans rats. International Journal of 
Environmental Health Research 1995; 5(2):175-188. 
 (141)  Exon JH, Koller LD. Toxicity of 2-Chlorophenol, 2,4-Dichlorophenol, and 2,4,6-
Trichlorophenol. In: Jolley RL, Bull RJ, Davis WP, Katz S, Roberts M.H.Jr, Jacobs 
VA, editors. Water Chlorination: Chemistry, Environmental Impact and Health 
Effects. Lewis Publishers, Inc.; 1985. 307-330. 
 (142)  Borzelleca JF, Condie LW, Hayes JR. Toxicological Evaluation of Selected 
Chlorinated Phenols. In: Jolley RL, Bull RJ, Davis WP, Katz S, Roberts M.H.Jr, 
Jacobs VA, editors. Water Chlorination: Chemistry, Environmental Impact and 
Health Effects. Lewis Publishers, Inc.; 1985. 331-343. 
 (143)  Kallman MJ, Kaempf GL, Balster RL. Behavioral toxicity of chloral in mice: an 
approach to evaluation. Neurobehav Toxicol Teratol 1984; 6(2):137-146. 
 (144)  Teramoto S, Takahashi K, Kikuta M, Kobayashi H. Potential teratogenicity of 3-
chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in micromass in vitro 
test. Journal of Toxicology and Environmental Health Part A 1998; 53:607-614. 
 (145)  Marsteinstredet U, Wiger R, Brunborg G, Hongslo JK, Holme JA. Apoptosis in HL-
60 cells induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone (MX). 
Chemico-Biological Interactions 1997; 106:89-107. 
 (146)  Lilly PD, Simmons JE, Pegram RA. Dose-Dependent Vehicle Differences in the 
Acute Toxicity of Bromodichloromethane. Fundamental and Applied Toxicology 
1994; 23(1):132-140. 
 (147)  Dowty BJ, Laseter JL. The Transplacental Migration and Accumulation in Blood of 
Volatile Organic Constituents. Pediatric Research 1976; 10:696-701. 
 (148)  Danielsson BR, Ghantous H, Dencker L. Distribution of chloroform and methyl 
chloroform and their metabolites in pregnant mice. Biol Res Pregnancy Perinatol 
1986; 7:77-83. 
 (149)  Scholl TO, Stein TP. Oxidant damage to DNA and pregnancy outcome. The Journal 
of Maternal-Fetal Medicine 2001; 10:182-185. 
213
  (150)  Myatt L, Cui X. Oxidative stress in the placenta. Histochemistry and Cell Biology 
2004; 122:369-382. 
 (151)  Karowicz-Bilinska A, Suzin J, Sieroszewski P. Evaluation of oxidative stress 
indices during treatment in pregnant women with Intrauterine Growth Retardation. 
Med Sci Monit 2002; 8(3):CR211-216. 
 (152)  Matsubasa T, Uchino T, Karashima S, Tanimura M, Endo F. Oxidative stress in 
very low birth weight infants as measured by urinary 8-OHdG. Free Radical 
Research 2002; 36(2):189-193. 
 (153)  Kim Y-J, Hong Y-C, Lee K-H, Park HJ, Park EA, Moon H-S et al. Oxidative stress 
in pregnant women and birth weight reduction. Reproductive toxicology 2005; 
19:487-492. 
 (154)  Beddowes EJ, Faux SP, Chipman JK. Chloroform, carbon tetrachloride and 
glutathione depletion indcue secondary genotoxicity in liver cells via oxidative 
stress. Toxicology 2003; 187:101-115. 
 (155)  Yuan J, Wu X-J, Lu W-Q, Cheng X-L, Chen D, Li X-Y et al. Chlorinated river and 
lake water extract caused oxidative damage, DNA migration and cytotoxicity in 
human cells. Int J Hyg Environ Health 2005; 208:481-488. 
 (156)  Marabini L, Frigerio S, Chiesara E, Radice S. Toxicity evaluation of surface water 
treated with different disinfectants in HepG2 cells. Water Res 2006; 40(2):267-272. 
 (157)  Gao P, Thornton-Manning JR, Pegram RA. Protective effects of glutathione on 
bromodichloromethane in vivo toxicity and in vitro macromolecular binding in 
Fischer 344 rats. Journal of Toxicology and Environmental Health 1996; 49(2):145-
159. 
 (158)  Hassoun EA, Ray S. The induction of oxidative stress and cellular death by the 
drinking water disinfection by-products, dichloroacetate and trichloroacetate in 
J774.A1 cells. Comparative Biochemistry and Physiology Part C 2003; 135(2):119-
128. 
 (159)  Larson JL, Bull RJ. Metabolism and lipoperoxidative activity of trichloroacetate and 
dichloroacetate in rats and mice. Toxicol Appl Pharmacol 1992; 115(2):268-277. 
 (160)  Abdel-Naim A, Nagy AA, Mohamadin AM, El-Mazar HM, Ahmed AE. 
Chloroacetonitrile induces oxidative stress and apoptosis in mouse fetal liver. 
Toxicol Lett 2009; 190(2):123-127. 
 (161)  Meek ME, Beauchamp R, Long G, Moir D, Turner L, Walker M. Chloroform: 
Exposure Estimation, Hazard Characterization, and Exposure-Response Analysis. 
Journal of Toxicology and Environmental Health 2002; Part B, 5:283-334. 
 (162)  Gemma S, Vittozzi L, Testai E. Metabolism of chloroform in the human liver and 
identification of the competent P450s. Drug Metab Dispos 2003; 31(3):266. 
 (163)  Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J 
Clin Nutr 2000; 71(5 Suppl):1295S-1303S. 
214
  (164)  Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of 
placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic 
review. Placenta 1999; 20(7):519-529. 
 (165)  Muthayya S, Kurpad AV, Duggan CP, Bosch RJ, Dwarkanath P, Mhaskar A et al. 
Low maternal vitamin B12 status is associated with intrauterine growth retardation 
in urban South Indians. Eur J Clin Nutr 2006; 60(6):791-801. 
 (166)  Li D, Pickell L, Liu Y, Wu Q, Cohn JS, Rozen R. Maternal 
methylenetetrahydrofolate reductase deficiency and low dietary folate lead to 
adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr 
2005; 82(1):188-195. 
 (167)  Burgoon JM, Selhub J, Nadeau M, Sadler TW. Investigation of the effects of folate 
deficiency on embryonic development through the establishment of a folate 
deficient mouse model. Teratology 2002; 65(5):219-227. 
 (168)  Alston TA. Inhibition of vitamin B12-dependent methionine biosynthesis by 
chloroform and carbon tetrachloride. Biochem Pharmacol 1991; 42(12):R25-R28. 
 (169)  Dow JL, Green T. Trichloroethylene induced vitamin B(12) and folate deficiency 
leads to increased formic acid excretion in the rat. Toxicology 2000; 146(2-3):123-
136. 
 (170)  Chen AT, Reidy JA, Sever LE. Re: "Public drinking water contamination and birth 
outcomes". Am J Epidemiol 1996; 143(11):1179-1180. 
 (171)  Owen P, Donnet ML, Ogston SA, Christie AD, Howie PW, Patel NB. Standards for 
ultrasound fetal growth velocity. British Journal of Obstetrics and Gynaecology 
1996; 103:60-69. 
 (172)  Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. 
Fetal Growth and Perinatal Viability in California. Obstetrics and Gynaecology 
1982; 59(5):624-632. 
 (173)  Smith GC. First trimester origins of fetal growth impairment. Semin Perinatol 2004; 
28(1):41-50. 
 (174)  Brzezinski MR, Boutelet-Bochan H, Person RE, Fantel AG, Juchau MR. Catalytic 
activity and quantitation of cytochrome P-450 2E1 in prenatal human brain. J 
Pharmacol Exp Ther 1999; 289(3):1648-1653. 
 (175)  Hoffman CS, Mendola P, Savitz DA, Herring AH, Loomis D, Hartmann KE et al. 
Drinking water disinfection by-product exposure and duration of gestation. 
Epidemiology 2008; 19(5):738-746. 
 (176)  Bradford and District Infant Mortality Commission. Bradford and District Infant 
Mortality Commission - Interim Report on Progress.  2005.  
 
 (177)  Bradford and District Infant Mortality Commission. Bradford and District Infant 
Mortality Commission: Final Report.  2006.  
 
215
  (178)  Raynor P, Born in Bradford Collaborative Group. Born in Bradford, a cohort study 
of babies born in Bradford, and their parents: protocol for the recruitment phase. 
BMC Public Health 2008; 8:327. 
 (179)  National Academic Recognition Information Centre (NARIC). International Guide 
to Qualifications in Education. 4th ed. London: Mansell Publishing Ltd; 1996. 
 (180)  Moser K, Stanfield KM, Leon DA. Birthweight and gestational age by ethnic group, 
England and Wales 2005: introducing new data on births. Health Stat Q 
2008;(39):22-55. 
 (181)  R Development Core Team. R: A Language and Environment for Statistical 
Computing.  2008. Vienna, Austria, R Foundation for Statistical Computing.  
 
 (182)  Smith RB, Toledano MB, Wright J, Raynor P, Nieuwenhuijsen MJ. Tap water use 
amongst pregnant women in a multi-ethnic cohort. Environ Health 2009; 8(Suppl 
1): S7. 
 (183)  Nieuwenhuijsen MJ, Smith R, Golfinopoulos S, Best N, Bennett J, Aggazzotti G et 
al. Health impacts of long-term exposure to disinfection by-products in drinking 
water in Europe: HIWATE. J Water Health 2009; 7(2):185-207. 
 (184)  Rantakokko P, Yritys M, Vartiainen T. Matrix effects in the gas chromatographic-
mass spectrometric determination of brominated analogues of 3-chloro-4-
(dichloromethyl)-5-hydroxy-2(5H)-furanone. J Chromatogr A 2004; 1028(2):179-
188. 
 (185)  Rantakokko P, Mustonen S, Vartiainen T. Suppressor current switching: a simple 
and effective means to reduce background noise in ion chromatography. J 
Chromatogr A 2003; 1020(2):265-272. 
 (186)  Lewis PD. R for Medicine and Biology. Sudbury, MA: Jones and Bartlett 
Publishers; 2010. 
 (187)  Nieuwenhuijsen MJ, Toledano MB, Bennett J, Best N, Hambly P, de HC et al. 
Chlorination disinfection by-products and risk of congenital anomalies in England 
and Wales. Environ Health Perspect 2008; 116(2):216-222. 
 (188)  Hwang BF, Jaakkola JJ, Guo HR. Water disinfection by-products and the risk of 
specific birth defects: a population-based cross-sectional study in Taiwan. 
Environmental Health 2008; 7:23. 
 (189)  Patelarou E, Kargaki S, Stephanou EG, Nieuwenhuijsen M, Sourtzi P, Gracia E et 
al. Exposure to brominated trihalomethanes in drinking water and reproductive 
outcomes. Occup Environ Med 2010. 
 (190)  Lynberg M, Nuckols JR, Langlois P, Ashley D, Singer P, Mendola P et al. 
Assessing exposure to disinfection by-products in women of reproductive age living 
in Corpus Christi, Texas, and Cobb county, Georgia: descriptive results and 
methods. Environ Health Perspect 2001; 109(6):597-604. 
216
  (191)  Villanueva CM, Gagniere B, Monfort C, Nieuwenhuijsen MJ, Cordier S. Sources of 
variability in levels and exposure to trihalomethanes. Environ Res 2007; 
103(2):211-220. 
 (192)  Armstrong B. Measurement error: consequences and design issues. In: Baker D, 
Nieuwenhuijsen MJ, editors. Environmental epidemiology: study methods and 
application. 1 ed. Oxford: Oxford University Press; 2008. 93-112. 
 (193)  IARC (International Agency for Research on Cancer). Dry Cleaning, Some 
Chlorinated Solvents and Other Industrial Chemicals. IARC Monographs on the 
Evaluation of Carcinogenic Risks to Humans 1997; 63. 
 (194)  British National Formulary. British National Formulary 53 [ 2007  [cited 2007 June 
6]; Available from: URL:http://www.bnf.org/bnf/bnf/current/126588.htm 
 (195)  Zhang W, Gabos S, Schopflocher D, Li XF, Gati WP, Hrudey SE. Validation of 
urinary trichloroacetic acid as a biomarker of exposure to drinking water 
disinfection by-products. J Water Health 2009; 7(3):359-371. 
 (196)  Droz P, Nieuwenhuijsen MJ. Biological Monitoring. In: Nieuwenhuijsen MJ, editor. 
Exposure Assessment in Occupational and Environmental Epidemiology. Oxford: 
Oxford University Press; 2003. 
 (197)  Bonsnes RW, Taussky HH. On the colorimetric determination of creatinine by the 
Jaffe reaction. Journal of Biological Chemistry 1945; 158(3):581-591. 
 (198)  Bland M. An introduction to medical statistics. Third ed. Oxford: Oxford University 
Press; 2000. 
 (199)  Odabasi M. Halogenated volatile organic compounds from the use of chlorine-
bleach-containing household products. Environ Sci Technol 2008; 42(5):1445-1451. 
 (200)  Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat 
Methods Med Res 1999; 8(2):135. 
 (201)  Calafat AM, Kuklenyik Z, Caudill SP, Ashley DL. Urinary levels of trichloroacetic 
acid, a disinfection by-product in chlorinated drinking water, in a human reference 
population. Environ Health Perspect 2003; 111:151-154. 
 (202)  MacLehose RF, Savitz DA, Herring AH, Hartmann KE, Singer PC, Weinberg HS. 
Drinking water disinfection by-products and time to pregnancy. Epidemiology 2008; 
19(3):451-458. 
 (203)  Dolk H. The influence of migration in small area studies of environment and health 
- migration during pregnancy. ONS Longitudinal Study Update 1997; 17:6-8. 
 (204)  Elliott P, Toledano MB, Bennett J, Beale L, de HK, Best N et al. Mobile phone base 
stations and early childhood cancers: case-control study. BMJ 2010; 340:c3077. 
 (205)  Jo WK, Weisel CP, Lioy PJ. Routes of chloroform exposure and body burden from 
showering with chlorinated tap water. Risk Anal 1990; 10(4):575-580. 
217
  (206)  Villanueva CM, Cantor KP, Grimalt JO, Castano-Vinyals G, Malats N, Silverman D 
et al. Assessment of lifetime exposure to trihalomethanes through different routes. 
Occup Environ Med 2006; 63(4):273-277. 
 (207)  Rull RP, Ritz B, Shaw GM. Validation of self-reported proximity to agricultural 
crops in a case-control study of neural tube defects. J Expo Sci Environ Epidemiol 
2006; 16(2):147-155. 
 (208)  Feldman Y, Koren G, Mattice K, Shear H, Pellegrini E, MacLeod SM. 
Determinants of recall and recall bias in studying drug and chemical exposure in 
pregnancy. Teratology 1989; 40(1):37-45. 
 (209)  Boylan SM, Cade JE, Kirk SF, Greenwood DC, White KL, Shires S et al. Assessing 
caffeine exposure in pregnant women. Br J Nutr 2008; 100(4):875-882. 
 (210)  Stallone DD, Brunner EJ, Bingham SA, Marmot MG. Dietary assessment in 
Whitehall II: the influence of reporting bias on apparent socioeconomic variation in 
nutrient intakes. Eur J Clin Nutr 1997; 51(12):815-825. 
 (211)  Crozier SR, Inskip HM, Godfrey KM, Robinson SM. Dietary patterns in pregnant 
women: a comparison of food-frequency questionnaires and 4 d prospective diaries. 
Br J Nutr 2008; 99(4):869-875. 
 (212)  Merlo J, Berglund G, Wirfalt E, Gullberg B, Hedblad B, Manjer J et al. Self-
administered questionnaire compared with a personal diary for assessment of 
current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol 
2000; 152(8):788-792. 
 (213)  Weisel CP, Kim H, Haltmeier P, Klotz JB. Exposure Estimates to Disinfection By-
Products of Chlorinated Drinking Water. Environ Health Perspect 1999; 
107(2):103-110. 
 (214)  Kim H, Haltmeier P, Klotz JB, Weisel CP. Evaluation of Biomarkers of 
Environmental Exposures: Urinary Haloacetic Acids Associated with Ingestion of 
Chlorinated Drinking Water. Environ Res 1999; 80(2):187-195. 
 (215)  Nelson-Piercy C. Handbook of Obstetric Medicine. 3rd ed. New York: Informa 
Healthcare; 2009. 
 (216)  Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. Associations between urinary 
phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod 2007; 
22(10):2715-2722. 
 (217)  Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R et al. 
Characterization of phthalate exposure among pregnant women assessed by repeat 
air and urine samples. Environ Health Perspect 2008; 116(4):467-473. 
 (218)  Zhang W, Gabos S, Schopflocher D, Li XF, Gati WP, Hrudey SE. Reliability of 
using urinary and blood trichloroacetic acid as a biomarker of exposure to 
chlorinated drinking water disinfection byproducts. Biomarkers 2009; 14(6):355-
365. 
218
  (219)  Manini P, De PG, Mutti A. Exposure assessment at the workplace: implications of 
biological variability. Toxicol Lett 2007; 168(3):210-218. 
 (220)  Forssen UM, Wright JM, Herring AH, Savitz DA, Nieuwenhuijsen MJ, Murphy 
PA. Variability and predictors of changes in water use during pregnancy. J Expo Sci 
Environ Epidemiol 2009; 19(6):593-602. 
 (221)  Kramer MS, Seguin L, Lydon J, Goulet L. Socio-economic disparities in pregnancy 
outcome: why do the poor fare so poorly? Paediatr Perinat Epidemiol 2000; 
14(3):194-210. 
 (222)  Frisbie WP, Biegler M, de TP, Forbes D, Pullum SG. Racial and ethnic differences 
in determinants of intrauterine growth retardation and other compromised birth 
outcomes. Am J Public Health 1997; 87(12):1977-1983. 
 (223)  Kramer MS. Determinants of low birth weight: methodological assessment and 
meta-analysis. Bull World Health Organ 1987; 65(5):663-737. 
 (224)  Breeze ACG, Lees CC. Prediction and perinatal outcomes of fetal growth 
restriction. Semin Fetal Neonatal Med 2007; 12(5):383-397. 
 (225)  Meyer JD, Nichols GH, Warren N, Reisine S. Maternal occupation and risk for low 
birth weight delivery: assessment using state birth registry data. J Occup Environ 
Med 2008; 50(3):306-315. 
 (226)  Vrijkotte TG, van der Wal MF, van Eijsden M, Bonsel GJ. First-trimester working 
conditions and birthweight: a prospective cohort study. Am J Public Health 2009; 
99(8):1409-1416. 
 (227)  Jurek AM, Greenland S, Maldonado G, Church TR. Proper interpretation of non-
differential misclassification effects: expectations vs observations. Int J Epidemiol 
2005; 34(3):680-687. 
 (228)  Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-
Raven; 1998. 
 (229)  Michels KB, Bingham SA, Luben R, Welch AA, Day NE. The effect of correlated 
measurement error in multivariate models of diet. Am J Epidemiol 2004; 160(1):59-
67. 
 (230)  Bashir SA, Duffy SW. The correction of risk estimates for measurement error. Ann 
Epidemiol 1997; 7(2):154-164. 
 (231)  Thurigen D, Spiegelman D, Blettner M, Heuer C, Brenner H. Measurement error 
correction using validation data: a review of methods and their applicability in case-
control studies. Stat Methods Med Res 2000; 9(5):447-474. 
 (232)  Philips D. The Changing Geography of South Asians in Bradford.  2001.  
http://www.bradford2020.com/pride/suplimentary.html.  
 
219
  
Appendix A.  
Nieuwenhuijsen MJ, Grellier J, Smith R, Iszatt N, Bennett J, Best N 
et al. The epidemiology and possible mechanisms of disinfection by-
products in drinking water. Philos Transact A Math Phys Eng Sci 
2009; 367(1904):4043-4076. 
 
Author’s contribution to this paper:  the literature review written by the author for this thesis 
made a substantial contribution to the writing of aspects of this paper (Nieuwenhuijsen et al. 
2010) relating to epidemiological studies investigating fetal growth outcomes and DBPs, 
epidemiological study limitations and mechanisms of DBP action.  The author read and 
provided comments on draft manuscripts of this paper. 
220
Phil. Trans. R. Soc. A (2009) 367, 4043–4076
doi:10.1098/rsta.2009.0116
The epidemiology and possible mechanisms
of disinfection by-products in drinking water
BY MARK J. NIEUWENHUIJSEN1,2,3,4,*, JAMES GRELLIER4,
RACHEL SMITH4, NINA ISZATT4, JAMES BENNETT4, NICKY BEST4
AND MIREILLE TOLEDANO4
1Centre for Research in Environmental Epidemiology (CREAL), Parc de
Recerca Biomèdica de Barcelona—PRBB (Ofﬁce 183.05), C. Doctor Aiguader,
88, 08003 Barcelona, Spain
2Municipal Institute of Medical Research (IMIM-Hospital del Mar),
Barcelona, Spain
3CIBER Epidemiologia y Salud Pública (CIBERESP), Spain
4Imperial College London, UK
This paper summarizes the epidemiological evidence for adverse health effects associated
with disinfection by-products (DBPs) in drinking water and describes the potential
mechanism of action.
There appears to be good epidemiological evidence for a relationship between exposure
to DBPs, as measured by trihalomethanes (THMs), in drinking water and bladder
cancer, but the evidence for other cancers including colorectal cancer is inconclusive and
inconsistent. There appears to be some evidence for an association between exposure to
DBPs, speciﬁcally THMs, and little for gestational age/intrauterine growth retardation
and, to a lesser extent, pre-term delivery, but evidence for relationships with other
outcomes such as low birth weight, stillbirth, congenital anomalies and semen quality
is inconclusive and inconsistent. Major limitations in exposure assessment, small sample
sizes and potential biases may account for the inconclusive and inconsistent results in
epidemiological studies. Moreover, most studies have focused on total THMs as the
exposure metric, whereas other DBPs appear to be more toxic than the THMs, albeit
generally occurring at lower levels in the water.
The mechanisms through which DBPs may cause adverse health effects including
cancer and adverse reproductive effects have not been well investigated. Several
mechanisms have been suggested, including genotoxicity, oxidative stress, disruption
of folate metabolism, disruption of the synthesis and/or secretion of placental
syncytiotrophoblast-derived chorionic gonadotropin and lowering of testosterone levels,
but further work is required in this area.
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1. Introduction
Disinfection of drinking water has led to major improvements in public health
in developed countries since its introduction in the ﬁrst half of the twentieth
century. It has now been more than 30 years since the discovery that by-products
can be formed in small quantities as part of the chlorination process (Rook
1974). Disinfection by-products (DBPs) are formed when water is disinfected,
and natural organic matter, bromide and iodide in the water react with
chlorine, chlorine dioxide, chloramines and/or ozone (Bichsel & von Gunten 2000;
Zhang et al. 2000). Their formation and occurrence depend on many factors
including disinfectant type(s) and dose(s), type(s) of treatment, pH, temperature,
contact time(s) with disinfectant(s), water source, amount and character of
natural organic matter and bromide and iodide levels (Reckhow & Singer 1985;
Stevens et al. 1989; Amy et al. 1991; Singer 1994). Up to 600 DBPs have
been identiﬁed (Richardson 1998; Richardson et al. 2007), and these chemicals
differ considerably in their physico-chemical properties (e.g. volatility). Different
mixtures of by-products may exist in different locations depending on the various
factors mentioned earlier, making it more difﬁcult to ascertain the risk, if any, of
health effects in relation to speciﬁc DBPs and mixtures of DBPs, as well as to
compare the ﬁndings from different epidemiological studies.
Trihalomethanes (THMs) are the most commonly formed group of DBPs.
These are volatile DBPs, and individuals may be exposed not only through
ingestion but also through inhalation and dermal absorption during activities such
as showering, bathing and swimming (Weisel & Jo 1996; Nieuwenhuijsen et al.
2000a). For non-volatile DBPs such as the haloacetic acids (HAAs), ingestion
is thought to be the main route of exposure. However, dermal adsorption has
also been examined for such DBPs (Kim & Weisel 1998). Recent modelling of
THM uptake suggested that swimming may lead to the highest levels in the
blood (Whitaker et al. 2003). Uptake of DBPs through showering, bathing and
swimming was associated with an increased risk of bladder cancer in a recent
Spanish epidemiology study (Villanueva et al. 2007).
In this paper, we ﬁrst summarize the epidemiological evidence regarding
health effects associated with exposure to DBPs, particularly for reproductive
outcomes, and brieﬂy describe the main mechanisms proposed for the action of
these compounds.
2. Epidemiological studies examining health effects related to exposure
to chlorination disinfection by-products
(a) Cancer
The health effects of DBPs in drinking water have been a concern since DBPs
were ﬁrst reported in the 1970s. According to a review by the IPCS (2000): ‘more
studies have considered bladder cancer than any other cancer. The authors of
the report caution against a simple interpretation of the observed associations.
The epidemiological evidence for an increased relative risk for bladder cancer is
not consistent—different risks are reported for smokers and non-smokers, for men
and women, and for low and high water consumption. Risk may differ among
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Table 1. Pooled analysis of bladder cancer and total THM exposure.
total THM OR (95% CI)
exposure
level (mg)a male female
0–15 1.00 1.00
>15–50 1.22 (1.01–1.48) 0.92 (0.65–1.32)
>50–400 1.28 (1.08–1.51) 0.94 (0.70–1.27)
>400–1000 1.31 (1.09–1.58) 1.02 (0.74–1.41)
>1000 1.50 (1.22–1.85) 0.92 (0.65–1.30)
aTHM exposure level= concentration× consumption per day× years exposed. Adapted from
Villanueva et al. (2004).
various geographic areas because the DBP mix may be different or because
other water contaminants are also present’. For example, as part of an improved
exposure assessment (Amy et al. 2005) for two well-conducted bladder cancer
epidemiology studies (King & Marrett 1996; Cantor et al. 1998), substantial
differences in the mixture of DBPs were found within and between one US state
and one Canadian province (e.g. amount of brominated DBPs, relative proportion
of THMs to HAAs, relative proportion of di- and trihalogenated HAAs). A
recent pooled analysis by Villanueva et al. (2004), which provided quantitative
information on THM exposure, conﬁrmed some of the gender differences. For men,
there was an exposure–response relationship between THM intake and bladder
cancer, but there was no relationship for women (table 1). For other cancers, the
evidence is much weaker. Some studies have suggested an association between
DBPs and colorectal cancers, whereas others have not (Wilkins & Comstock
1981; Young et al. 1981, 1987; Doyle et al. 1997, Koivusalo & Vartiainen 1997;
Hildesheim et al. 1998; King et al. 2000a; Bove et al. 2007). Furthermore, there
is little evidence for an association between exposure to DBPs and other cancers
such as liver, kidney, brain, lung and breast cancer, lymphomas, cancer of the
pancreas, but the number of studies is small (IPCS 2000). A recent report
suggested an association between THMs and skin cancer, but further work needs
to be conducted (Karagas et al. 2008).
(b) Reproductive outcomes
Reproductive health outcomes should be easier to study than cancer because
of the shorter relevant exposure period. Among others, congenital anomalies,
stillbirth, spontaneous abortion, birth weight, prematurity and semen quality
have been the focus of investigation. Various thorough reviews have been
conducted and have concluded that the relationship between DBP exposure and
reproductive health outcomes remains unclear, mainly owing to limitations in the
exposure assessment in most studies (Reif et al. 1996; IPCS 2000; Nieuwenhuijsen
et al. 2000b; Gevecker Graves et al. 2001; Bove et al. 2002; Tardiff et al. 2006).
A number of studies have found statistically signiﬁcant positive associations
between THMs and neural tube defects (NTDs), one of the most studied groups of
congenital anomalies (Bove et al. 1995; Klotz & Pyrch 1999; Dodds & King 2001),
whereas other studies have not found statistically signiﬁcant associations
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(Dodds et al. 1999; Magnus et al. 1999; Källen & Robert 2000; Hwang et al.
2002; Shaw et al. 2003; Nieuwenhuijsen et al. 2008) (table 2). Klotz & Pyrch
(1999) found a statistically signiﬁcant association between total THM (TTHM)
levels in the water and NTDs, but not with levels of haloacetonitriles and
HAA. Also, the effects were most pronounced in offspring from women who
did not take supplementary vitamins, but these ﬁndings were not conﬁrmed
by the Shaw et al. (2003) study. Cedergren et al. (2002), Hwang et al. (2002)
and Chisholm et al. (2008) found signiﬁcant associations between chlorinated
water, levels of TTHM above 10μg l−1 and high levels (i.e. 130μg l−1 or more)
of THMs and cardiovascular congenital anomalies, respectively, but other studies
did not ﬁnd such an association (Bove et al. 1995; Dodds et al. 1999; Magnus
et al. 1999; Källen & Robert 2000; Dodds & King 2001; Shaw et al. 2003;
Nieuwenhuijsen et al. 2008).
Few studies have been published on chlorinated water and respiratory
congenital anomalies, but two studies found a signiﬁcant positive association
(Aschengrau et al. 1993; Hwang et al. 2002), whereas two did not (Chisholm
et al. 2008; Nieuwenhuijsen et al. 2008).
Similarly, for urinary tract defects, three studies reported statistically
signiﬁcant positive associations (Aschengrau et al. 1993; Magnus et al. 1999;
Hwang et al. 2002), while one did not (Nieuwenhuijsen et al. 2008) and another
one showed almost statistically signiﬁcant effects (Chisholm et al. 2008; odds ratio
(OR) = 1.40, 95% conﬁdence interval (CI): 0.98–1.99).
Studies on oral cleft or cleft palate, including a meta-analysis (Hwang et al.
2008), have found no positive relationship with DBP exposure, except for the
study by Bove et al. (1995).
Evidence for risk of hypospadias is also inconclusive. There was no association
with THM or HAA concentrations or proxies (Källen & Robert 2000; Luben
et al. 2007; Hwang et al. 2008); however, estimates of actual THM ingestion were
associated with increased risk of hypospadias (Luben et al. 2007).
In a meta-analysis, Hwang & Jaakkola (2003) reported evidence for an effect
of exposure to chlorination by-products on the risk of neural tube and urinary
system defects, but results for respiratory system, major cardiac and oral cleft
defects were heterogeneous and inconclusive. The exposure index used was,
however, fairly crude, without levels of DBPs being taken into account. Since
the meta-analysis was published in 2003, the largest study published to date
by Nieuwenhuijsen et al. (2008) was conducted, which was larger than all
previous studies combined and which reported no association between THMs
and cleft palate/lip, abdominal wall, major cardiac, neural tube, urinary and
respiratory defects, except for a restricted set of anomalies with isolated defects,
which appears to be due to a more reliable means of case identiﬁcation. There
were excess risks in the highest exposure categories of TTHMs (i.e. 60μg l−1
or more) for ventricular septal defects and the highest exposure category of
bromoform (i.e. 4μg l−1 or more) and a subset of major cardiovascular defects
and gastroschisis (Nieuwenhuijsen et al. 2008). In the meta-analysis by Hwang
et al. (2008), the summary OR for ventricular septal defects (OR 1.59, 95% CI:
1.21, 2.07) for high versus low exposure to DBPs was statistically signiﬁcant,
but the exposure categories in the individual studies were inconsistent (different
levels of THMs, or chlorination as a proxy), rendering the results difﬁcult
to interpret.
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Only a few studies have assessed the relationship between DBPs and
spontaneous abortion. The Californian study has attracted the most attention
since its authors found a statistically signiﬁcant association between TTHMs (i.e.
75μg l−1 or more), especially for bromodichloromethane (BDCM) (i.e. 18μg l−1
or more)—together with a high consumption of water (ﬁve glasses or more
per day)—and spontaneous abortion (Waller et al. 1998). The ORs were even
larger after re-analysis when restricting it to subjects for whom exposure had
been characterized with greater conﬁdence (Waller et al. 2001). However, in
a study trying to replicate these results with substantially improved exposure
assessments—including a study site with high-bromide water—Savitz et al. (2006)
found no evidence for an association between a number of DBPs and spontaneous
abortion, nor did they ﬁnd any such association in an earlier study (Savitz et al.
1995).
A number of Canadian studies and one English study found statistically
positive associations between DBPs and stillbirth (Dodds et al. 1999, 2004; King
et al. 2000b; Toledano et al. 2005). However, the case–control study by Dodds et al.
(2004) did not show a monotonic relationship between THM levels and stillbirth,
and they did not ﬁnd an association between HAAs and stillbirth (King et al.
2005).
Studies on pre-term delivery have generally shown no statistically signiﬁcant
associations with DBPs (Kramer et al. 1992; Bove et al. 1995; Savitz et al. 1995;
Gallagher et al. 1998; Wright et al. 2003; Aggazzotti et al. 2004; Hinckley et al.
2005; Lewis et al. 2007; Yang et al. 2007), with the exception of the study by Yang
et al. (2000a) and Yang (2004), who found a statistically signiﬁcant increased risk.
Wright et al. (2004) and Jaakkola et al. (2001) found a statistically signiﬁcant
decreased risk of pre-term delivery.
Study results on (term) low birth weight (LBW) have been mixed, with some
studies reporting statistically signiﬁcant associations (Bove et al. 1995; Gallagher
et al. 1998; Källen & Robert 2000; Lewis et al. 2006) and others not (Kramer
et al. 1992; Savitz et al. 1995; Kanitz et al. 1996; Dodds et al. 1999; Yang et al.
2000a, 2007; Jaakkola et al. 2001; Wright et al. 2003; Yang 2004; Toledano
et al. 2005). Hinckley et al. (2005) found no association with THMs, but did
for some speciﬁc HAAs. Studies on small for gestational age (SGA) and/or
intrauterine growth retardation (IUGR) showed some more consistent results,
and a good proportion of them have found statistically signiﬁcant associations
(Kramer et al. 1992; Bove et al. 1995; Wright et al. 2003, 2004), while some
did not (Dodds et al. 1999; Porter et al. 2005; Yang et al. 2007; Hoffman et al.
2008b) (table 3). Aggazzotti et al. (2004) found some effects with by-products of
chlorine dioxide. Wright et al. (2004) found statistically signiﬁcant associations
with THMs and a measure of mutagenicity, but not with HAAs or the chlorinated
furanone 3-chloro-4-(dichloromethyl)-5-hydroxy-2-(5H )-furanone (MX) (table 4).
Infante-Rivard (2004) found that the association between THMs and IUGR
was modiﬁed by a metabolic polymorphism, with newborns with the CYP2E1
(G1259C) variant at high risk.
Two small case–control studies have investigated the relationship between
DBPs and semen quality (Fenster et al. 2003; Luben et al. 2007). Halogenated
acetic acids have been found to cause testicular damage in rats through disruption
of spermatogenesis and motility, with the brominated analogues being the
strongest toxicants (Smith et al. 1989; Toth et al. 1992; Linder et al. 1994a,b,
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Table 3. Association between SGA/IUGR and DBP exposure.
study exposure risk estimate
Källen & Robert (2000) chlorinated (average TTHM= 9.4μg l−1)
versus non-chlorinated
1.07 (0.96–1.19)∗
Jaakkola et al. (2001) chlorinated (average TTHM= 9.4μg l−1)
versus non-chlorinated
1.00 (0.91–1.10)∗∗
Kramer et al. (1992) 0 versus ≥10μg l−1 CHCl3 1.8 (1.1–2.9)∗
Bove et al. (1995) ≤20 versus >100μg l−1 TTHM 1.5 (1.2–1.9)∗
Dodds et al. (1999) 0–49 versus >100μg l−1 TTHM 1.08 (0.99–1.18)∗∗∗
Wright et al. (2003) 0–60 versus >80μg l−1 TTHM 1.14 (1.02–1.26)
Wright et al. (2004) >74–163 versus 0–33μg l−1 TTHM 1.13 (1.07–1.20)
Aggazzotti et al. (2004) THMs ≥30μg l−1, chlorite or chlorate
≥200μg l−1
1.38 (0.92–2.07)
Infante-Rivard (2004) >90th percentile versus ≤90th percentile:
29.4μg l−1 TTHM
0.97 (0.57–1.62)
Porter et al. (2005) highest versus lowest quintile 1.17 (0.96–1.42)
Hinckley et al. (2005) ≥53 versus <40μg l−1 TTHM 1.09 (1.00–1.18)
Yang et al. (2007) THM4 >13.1 versus ≤4.9μg l−1 0.96 (0.91–1.02)
Hoffman et al. (2008) 74.9–108.8 versus 2.2–4.6 1.3 (0.7–2.3)
∗≤5th percentile; ∗∗≤10th percentile; ∗∗∗≤2 s.d.
Table 4. Association between SGA/IUGR and various DBPs (μg l−1) (except for MX, which has
ng l−1 units) and mutagenicity (rev l−1) (Wright et al. 2004).
exposure level risk estimate
TTHM >74–163 versus 0–33 1.13 (1.07–1.20)
CHCl3 >63–135 versus 0–26 1.11 (1.04–1.17)
BDCM >13–46 versus 0–5 1.15 (1.08–1.22)
total HAAs >49–58 versus 4–30 0.97 (0.77–1.23)
TCAA >27–37 versus 0–18 0.95 (0.76–1.19)
DCAA >22–24 versus 2–15 0.90 (0.75–1.09)
MX >46–80 versus 4–20 1.14 (0.95–1.37)
mutagenicity >2250 versus <1250 1.25 (1.04–1.51)
1995, 1997a,b). The results of the two epidemiology studies were inconclusive,
with inconsistent evidence across various measures of semen quality and DBP
exposure. Fenster et al. (2003) found that TTHM levels were not associated with
decrements in semen quality. Per cent normal morphology decreased and per cent
head defects increased at higher levels of a THM ingestion metric compared with
the lowest level, although there were no monotonic dose–responses, and at this
level, they observed a small decrease in per cent morphologically normal sperm.
BDCM exposure was inversely related to linearity (a motility parameter). Luben
et al. (2007) studied the relation between exposure to classes of DBPs and sperm
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concentration and morphology, as well as DNA integrity and chromatin maturity,
but found no association—or consistent pattern—of increased abnormal semen
quality with elevated exposure to THMs or HAAs.
MacLehose et al. (2008) investigated time to pregnancy in relation to DBP
exposure, but found little evidence for a relationship. Joyce et al. (2008)
investigated the effect of DBPs on pre-laboural rupture of membranes but found
no relationship.
Very few studies have examined the gene–environment interaction and/or the
presence of susceptible groups. Infante-Rivard (2004) found that newborns with
a high-metabolism CYP2E1 gene variant who experienced pregnancy average
exposures of more than 29.4μg l−1 for TTHMs were at much higher risk (OR=
13.2, 95% CI: 1.19–146.7) of IUGR compared with those without this CYP2E1
variant, but found no indication that MTHFR C677T modiﬁed the effect of
exposure to chloroform and risk of foetal growth in humans. A study investigating
NTDs, isolated cleft lip palate with or without cleft palate, also found no evidence
that MTHFR C677T modiﬁed the effect of TTHM exposure (Shaw et al. 2003).
Lewis et al. (2006) reported an increased risk of term LBW in non-Caucasians
associated with second trimester exposure to THMs greater than the increased
risk found for Caucasians and non-Caucasians combined.
(c) Limitations
The major limiting factor in these studies has often been crude exposure
assessment, with the exception of some of the more recent studies. The use
of ecological water supply zone estimates as an exposure index may result in
exposure misclassiﬁcation (Whitaker et al. 2003), which likely biases the measures
of effect towards the null. Furthermore, while ingestion has generally been the
primary exposure route of interest, uptake through showering, bathing and
swimming could be considerable, speciﬁcally for THMs owing to their volatility
and dermal adsorption, but these routes have only been considered in a few studies
(e.g. Savitz et al. 2006; Luben et al. 2007, 2008; Villanueva et al. 2007; Hoffman
et al. 2008a,b; MacLehose et al. 2008). Combining information on individual
water use with water supply zone estimates would provide more detailed exposure
assessment, but the individual information should be evaluated for measurement
error because within-subject variability in questionnaire data may be substantial
(Forssén et al. in press) and attenuate risk estimates. Furthermore, exposure
estimates have been based primarily on maternal residence at birth. This ignores
any exposure that occurs outside the home, e.g. in the workplace, and also ignores
the possibility that a mother may have moved her residence during her pregnancy.
Exposure assessment based on maternal residence at birth may, therefore, result
in exposure misclassiﬁcation.
In addition, studies from countries including Scandinavia (Magnus et al. 1999;
Källen & Robert 2000; Jaakkola et al. 2001; Cedergren et al. 2002; Hwang
et al. 2002) and Taiwan (Yang et al. 2000a,b, 2007; Yang 2004; Hwang et al.
2008) have generally shown low levels of DBPs with a small range, making the
assessment of risks more difﬁcult owing to both a higher probability of exposure
misclassiﬁcation and a smaller difference in exposure between dose groups.
Furthermore, Cedergren et al. (2002) (in Sweden) and Chisholm et al. (2008) (in
Australia) found signiﬁcant associations between levels of TTHM above 10μg l−1
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and high levels greater than or equal to 130μg l−1 of THMs and cardiovascular
congenital anomalies, respectively, but the low exposure group in the latter study
(i.e. less than 60μg l−1) represented higher levels of THM exposure than that of
the cases in the former study (i.e. more than 10μg l−1), making the comparison
more difﬁcult. Moreover, other studies did not ﬁnd such an association, such as
in Magnus et al. (1999) (in Norway), in which the average level of TTHMs for
chlorinated water was 9.4μg l−1. In the latter study, exposure assessment was
based on whether the mothers received unchlorinated or chlorinated water, albeit
with relatively low levels of THMs (on average) in the latter group. Thus, neither
group had high exposure to THMs (on average). Where seasonal variability in
DBPs has not been taken into account, further errors in the exposure assessment
are likely.
Particularly for reproductive epidemiological studies, the sample sizes have
often been insufﬁcient to produce robust results, especially for congenital
anomalies and, to a lesser extent, for stillbirth, semen quality and other outcomes,
but there are exceptions. For example, studies on SGA/IUGR by Dodds et al.
(1999), Wright et al. (2003, 2004) and Hinckley et al. (2005), on congenital
anomalies by Hwang et al. (2002, 2008) and Nieuwenhuijsen et al. (2008) and
on stillbirth by Toledano et al. (2005) provide sufﬁciently large numbers of cases
to create various exposure categories with more robust risk estimates, which could
improve the overall assessment of risk.
The retrospective and registry-based nature of many of the reproductive studies
has meant that information on potential confounders, and other risk factors for
birth outcomes, such as maternal smoking and alcohol consumption, have often
been lacking.
On the whole, epidemiological studies have used TTHMs as a proxy for total
DBP load, but TTHMs are not necessarily a good proxy measure. Some studies
have examined individual (brominated) THM species (e.g. Waller et al. 1998;
King et al. 2000b; Dodds & King 2001; Shaw et al. 2003; Dodds et al. 2004;
Wright et al. 2004; Nieuwenhuijsen et al. 2008). In addition, some studies have
investigated other DBPs such as HAAs and/or MX (e.g. Klotz & Pyrch 1999;
Wright et al. 2004; Hinckley et al. 2005; Porter et al. 2005; Savitz et al. 2006;
Luben et al. 2007, 2008; Hoffman et al. 2008; MacLehose et al. 2008) and/or
total organic halides (TOX) (e.g. Savitz et al. 2006; Hoffman et al. 2008). The
metabolism of different DBP species varies (IPCS 2000), the toxicity of different
DBP classes varies, speciﬁc DBPs in a particular class have substantially different
toxicities (e.g. Hunter et al. 2006) and the relationship of THMs to that of other
DBPs (e.g. HAAs and TOX) varies, so it is insufﬁcient to use TTHMs as a proxy
for DBPs as a whole. Investigation of the relation between non-THM by-products
and reproductive outcomes is required in order to help elucidate the speciﬁc DBPs
driving the associations observed. A detailed assessment of the DBP mixture
(including speciation within different DBP classes) is necessary to explain any
observed epidemiological results. Wright et al. (2004) is a good example of a
study in which different DBP classes were examined, as well as speciﬁc DBPs
within these classes (table 4).
Furthermore, outcomes such as spontaneous abortion, foetal growth restriction
or congenital anomalies have not been deﬁned well and/or are difﬁcult to
study. Previous epidemiological studies have used a variety of outcomes as
proxies for foetal growth restriction: terms LBW, IUGR and SGA. There are
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some limitations to these measures. LBW is rather crudely deﬁned—the ﬁxed
criterion of birth weight below 2500 g takes no account of population-speciﬁc
birth weight distributions (Wilcox 2001). Somewhat confusingly, the terms IUGR
and SGA have been used interchangeably in the literature, and criteria for
IUGR/SGA diagnosis have varied, some studies using the 5th and some the
10th percentile of gestational speciﬁc weight according to a standard population
growth chart as a cut-off point. These measures fail to distinguish between those
babies who are constitutionally small and those who are pathologically small
(i.e. growth restricted). Some small but normally grown babies will fall below
the cut-off point, and some growth-restricted babies will reach a weight above
the cut-off point. Therefore, a proportion of infants are misclassiﬁed, and in
epidemiological studies, this may bias any association towards the null. There
is evidence to show that the use of customized foetal growth charts, which
take into account factors such as maternal height and ethnicity, signiﬁcantly
reduce the proportion of false-positive and false-negative diagnoses of foetal
growth restriction, compared with using standard population growth charts
(Gelbaya & Nardo 2005; Gardosi 2006), but these are poorly developed at
present.
Congenital anomalies have often been analysed either as one group or in
main categories, e.g. neural tube, major heart and abdominal defects, owing
to the small number of cases in each study. These anomalies, however, are
generally heterogeneous with respect to both phenotype and presumed aetiology.
Nieuwenhuijsen et al. (2008) showed that focusing on isolated subcategories
may result in different ﬁndings. Furthermore, in some countries, registration of
congenital anomalies may occur up to 1 year after the birth (e.g. in Taiwan),
which will improve the completeness of the registry by including cases, such as
hypospadias, that are more difﬁcult to identify at birth.
Investigation of gene–environment interaction and/or the effects on susceptible
groups has been limited (e.g. Shaw et al. 2003; Infante-Rivard 2004). Preliminary
studies suggest that certain groups may be more susceptible to the inﬂuence of
DBPs (Lewis et al. 2006), and thus these effects may be masked in studies that
only look at the population in general.
3. Mechanisms
The mechanisms through which DBPs may cause adverse health effects, including
cancer and adverse reproductive effects, are not well investigated. Several
mechanisms have been suggested that involve genotoxicity, oxidative stress,
disruption of folate metabolism, disruption of the synthesis and/or secretion
of placental syncytiotrophoblast-derived chorionic gonadotropin and lowering of
testosterone levels.
(a)Genotoxicity/mutagenicity
Richardson et al. (2007) reviewed 30 years of research on the occurrence,
genotoxicity and carcinogenicity of 85 DBPs. Of these, 11, including THMs,
are currently regulated by the United States Environmental Protection Agency
and 74 are considered emerging DBPs owing to their moderate occurrence
levels and/or toxicological properties. Sixty-eight of the 85 DBPs reviewed were
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considered genotoxic, including the regulated brominated THMs, where the
THMs are generally at higher levels in drinking water. In general, the brominated
DBPs are more genotoxic and carcinogenic than chlorinated compounds, and
iodinated DBPs are the most genotoxic (Plewa et al. 2008). Moreover, certain
nitrogenous DBPs were found to be more genotoxic than the regulated
carbonaceous DBPs (i.e. THMs and HAAs) (Plewa et al. 2008). Recently, Ross &
Pegram (2004) reported GSTT1-1-dependent covalent binding of brominated
THMs to DNA and formation of deoxyguanosine adducts in vitro. Because
there is structural similarity among the brominated THMs and evidence for
common pathways of bioactivation (DeMarini et al. 1997; Pegram et al. 1997),
the ﬁndings of Ross & Pegram (2004) support the idea that glutathione (GSH)
conjugation of tribromomethane may lead to the formation of DNA-reactive
metabolites in the liver, and perhaps even more likely in the colons, of rodents and
humans.
(b)Oxidative stress
There is evidence that maternal oxidative stress during pregnancy may play
an important role in adverse foetal development (Scholl & Stein 2001; Meek
et al. 2002; Myatt & Cui 2004; Kim et al. 2005; Min et al. 2006). For example,
increased concentrations of oxidative stress biomarkers (8-OH-dG and MDA)
observed in the urine of pregnant women have been associated with decreased
birth weight (Scholl & Stein 2001; Kim et al. 2005). In late gestation, an
increase in oxidative stress is observed in pregnancies complicated by IUGR,
pre-eclampsia and diabetes, and this is associated with increased trophoblast
apoptosis and alterations to placental vascular reactivity (Myatt & Cui 2004).
There is also evidence to suggest that exposure to DBPs can cause oxidative stress
in human cells. An in vitro study on human hepatoma (HepG2) cells reported that
increasing chloroform dose resulted in decreasing GSH, which induces oxidative
stress (Beddowes et al. 2003). Another in vitro study on human HepG2 cells
found that when exposed to chlorinated drinking water, MDA increased and GSH
decreased in a dose-dependent manner, indicating oxidative stress (Yuan et al.
2005).
Cytochrome P-450E1 (CYP2E1) is the primary enzyme involved in the
metabolism of low doses of chloroform (Meek et al. 2002), and Tomasi et al.
(1985) showed that chloroform metabolism generates free radicals. Chloroform
is oxidatively metabolized and decomposed to electrophilic phosgene, which is
highly reactive and will bond to cell components including proteins, phospholipid
polar heads and reduced GSH (Gemma et al. 2003).
Other compounds such as trichloroethanol, trichloroacetic acid and
dichloroacetic acid have all been shown to induce lipid peroxidation, a biomarker
of oxidative stress, presumably via a free radical mechanism (Larson & Bull 1992;
Ni et al. 1996).
Polymorphisms in pro-inﬂammatory cytokines (i.e. tumour necrosis factor
(TNF)) have been associated with pre-term births (Crider et al. 2005; Engel et al.
2005a), whereas polymorphisms in anti-inﬂammatory cytokines (i.e. interleukin
(IL)-4) have been associated with SGA outcomes (Engel et al. 2005b). Animal
studies have shown that both pro-inﬂammatory (TNF, IL-6 and IL-8) and
anti-inﬂammatory (IL-10 and transforming growth factor) cytokines have been
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affected by exposure to carbon tetrachloride, a haloalkane similar to chloroform,
and to phosgene, a metabolite of chloroform (Sciuto et al. 2003; Weber et al.
2003).
The observed associations between various adverse birth outcomes and markers
of oxidative stress, and the associations between exposure to DBPs and their
metabolites and markers of oxidative stress, suggest the possibility that DBPs
may act on foetal growth via the oxidative stress mechanism.
(c) Folate metabolism
One suggested mechanism by which DBPs could cause cancer and adverse
birth outcomes is the interference of folate metabolism by DBPs. Folate and folic
acid are the forms of the B vitamin that are involved in the synthesis, repair
and functioning of DNA and required for the production and maintenance of
cells (Kamen 1997). Folate plays an important role for cells that are undergoing
rapid turnover such as tissues in the colon and the developing foetus. Folate
is involved in the synthesis of methionine, an essential amino acid. Low levels
of folate have been associated with several forms of cancer and congenital
anomalies such as NTDs. Furthermore, defects in the methionine–homocysteine
metabolic pathway, which can be the result of low folate levels and result
in elevated homocysteine levels, may be a contributing factor for abruptio
placentae (Ray & Laskin 1999). Both chloroform and TCAA have been found to
inhibit the vitamin B12-dependent methionine biosynthesis pathway. Inhibition
of this pathway can lead to vitamin B12 deﬁciency and consequently folate
deﬁciency. Alston (1991) found that chloroform inhibited methionine biosynthesis
in cell culture. Dow & Green (2000) showed that trichloroacetic acid interacts
with vitamin B12, probably by a free radical mechanism, inhibiting both the
methylmalonyl CoA and methionine salvage pathways in rats. As a result of
the latter, a secondary folate deﬁciency develops owing to the ‘methyl folate
trap’, leading to a major impairment in formate metabolism. Geter et al. (2005)
showed that rats exposed to bromoform and fed a no-folate diet had signiﬁcant
increases in aberrant crypt foci (putative precursor lesions in the development
of colon cancer) when compared with rats exposed to bromoform and fed a
normal diet.
(d) Chorionic gonadotropin disruption
Chen et al. (2003) showed that the THM BDCM reduced the secretion of
immunoreactive and bioactive chorionic gonadotropin in primary cultures of
human trophoblasts and thus appears to target human placental trophoblasts.
Trophoblasts are the sole source of chorionic gonadotropin during normal
human pregnancy; a decrease in the amount of this bioactive hormone could
have adverse effects on pregnancy outcome, including those leading to growth
retardation. Chen et al. (2004) reported that BDCM directly inhibits the
morphological differentiation of mononucleated placental cytotrophoblast cells
to multi-nucleated syncytiotrophoblast-like colonies in vitro. Syncytiotrophoblast
formation was inhibited in a dose-dependent manner and was accompanied by no
loss of cell viability.
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(e) Testosterone
Potter et al. (1996) showed that all of the THMs reduced serum testosterone
in rats treated with 1.5mmol kg−1 by oral gavage for 7 days. The ﬁnding that
male F-344 rats treated with THMs had decreased circulating concentrations of
testosterone also raises the question as to whether THMs may produce androgenic
deﬁciency in male rats.
The various mechanisms described earlier begin to provide plausible biological
pathways through which DBPs may cause adverse health effects, including cancer
and adverse reproductive effects. However, they are clearly still in their infancy
and further research is required to provide more deﬁnitive evidence for causal
biological mechanisms.
4. Conclusion
There appears to be good epidemiological evidence for an association between
chlorination by-products, as measured by THMs, in drinking water and bladder
cancer, but the evidence for other cancers including colorectal cancer appears
to be inconclusive and inconsistent. There appears to be some evidence for a
relationship between chlorination by-products and SGA and IUGR and, to a
lesser extent, pre-term delivery, but evidence for other outcomes such as LBW,
stillbirth, congenital anomalies and semen quality appears to be inconclusive
and inconsistent. Major limitations in exposure assessment, small sample sizes
and potential biases may account for the inconclusive and inconsistent results in
epidemiological studies. Moreover, most studies have focused on TTHMs as the
exposure metric, whereas some emerging DBPs appear to be more toxic than the
THMs. The mechanisms through which DBPs may cause adverse health effects,
including cancer and adverse reproductive effects, have not been well investigated
to date.
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Exposure to Disinfection By-products,
Fetal Growth, and Prematurity
A Systematic Review and Meta-analysis
James Grellier,a James Bennett,a Evridiki Patelarou,b Rachel B. Smith,a Mireille B. Toledano,a
Lesley Rushton,a David J. Briggs,a and Mark J. Nieuwenhuijsena,c
Background: Exposure to total trihalomethanes in drinking water
has been associated with several adverse birth outcomes relating to
fetal growth and prematurity.
Methods: We carried out a systematic review and meta-analysis of
epidemiologic studies featuring original peer-reviewed data on the
association of total trihalomethane exposure and health outcomes
related to fetal growth and prematurity.
Results: A comprehensive literature search yielded 37 studies, 15 of
which were selected for the extraction of relative risks relating
adverse birth outcomes to trihalomethane exposure. Sufficient data
were available for meta-analyses to be carried out for 4 adverse birth
outcomes: low birth weight (LBW), term low birth weight (term
LBW), preterm delivery, and small for gestational age (SGA)
(including intra uterine growth retardation). We found little or no
evidence for associations between third trimester trihalomethane
exposure and LBW (odds ratio per 10 g total trihalomethane/L 
1.00 95% confidence interval  0.97–1.03), term LBW (1.03
0.93–1.15), or preterm delivery (0.99 0.98–1.00), but some
evidence for SGA (1.01 1.00–1.02).
Conclusions: There was little or no evidence for associations
between total trihalomethane concentration and adverse birth out-
comes relating to fetal growth and prematurity, with the possible
exception of SGA. We discuss these findings and the uncertainties—
relating particularly to exposure—that may have affected them.
(Epidemiology 2010;21: 300–313)
Supplies of drinking water were first disinfected usingchlorine at the start of the 20th century,1 primarily as a
means of reducing mortality and morbidity associated with
waterborne infectious disease.2,3 Chlorination was wide-
spread in cities across the developed world by the 1920s, and
the method remains a relatively inexpensive and effective
means of disinfecting drinking water.
Chlorine reacts with organic compounds such as fulvic
and humic acids in the source water to produce disinfection
by-products. First identified in disinfected drinking water in
the 1970s,4,5 trihalomethanes are generally the most abundant
of the disinfection by-products, but many other chemicals
may also be present.6,7 Over 600 disinfection by-products
have been reported8,9; their presence and relative concentra-
tion vary seasonally and geographically, due to differences in
the chemical character and physical properties of the source
water and in the treatment and distribution systems.10,11
PREGNANCY OUTCOMES ASSOCIATED WITH
DISINFECTION BY-PRODUCTS
Over the last 2 decades, human studies have assessed
the association of disinfection by-products with various
outcomes related to fetal growth and prematurity. These
outcomes have included low birth weight (LBW),12–20 term
LBW,13,21–26 very LBW,12,18,21,27 small for gestational age
(SGA),13,15,18–20,24,28,29 intra uterine growth retardation
(IUGR),16,22,27,30,31 preterm delivery (PTD)12–17,20,22,24–26,32–35
and very PTD,22 and fetal death (miscarriage,17 spontaneous
abortion,36–38 and stillbirth12,18,39,40).
Six systematic reviews of the epidemiologic evidence for
reproductive and developmental effects of exposure to disinfec-
tion by-products have been published: 2 narrative reviews,6,41 2
comprehensive weight-of-evidence reviews,42,43 and 2 meta-
analyses of chlorination and birth defects.44,45
The results from studies of fetal growth and prematurity
are mixed, varying in both direction and magnitude of effect.
Existing reviews present a useful synthesis and critique of the
available literature, but they have not attempted to produce
summary measures of effect. The weight of evidence is sugges-
tive of small, positive associations between trihalomethane con-
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centrations in drinking water and some adverse birth outcomes
related to fetal growth restriction (term LBW, SGA, IUGR),
although evidence is not conclusive.
OBJECTIVES
Our objectives were to systematically review existing
epidemiologic evidence and to carry out a meta-analysis of
these data, to produce best-estimate exposure-response slopes
of total trihalomethane exposure and adverse birth outcomes
relating to fetal growth and prematurity. Ultimately, the
objective is that these quantitative results would be suitable
for the estimation of burden of disease using routine moni-
toring data on drinking water quality.
METHODS
Search Methods
We carried out a systematic review of the existing
literature on trihalomethanes and adverse birth outcomes
related to fetal growth and prematurity, using the following
review question: “Given existing epidemiologic evidence,
what is the exposure-response relationship between exposure
of pregnant women to trihalomethanes in drinking water and
the risk of various adverse birth outcomes related to fetal
growth and prematurity?” We drew up a review protocol for
the meta-analysis in advance, broadly following guidelines
laid out in Egger et al.46 We conducted and reported on our
search methods and results following standards outlined in
the QUOROM statement47 and the MOOSE Guidelines.48
We carried out a systematic, comprehensive biblio-
graphic search using the US National Library of Medicine
Medline database for the years 1980–2007, using the
PubMed interface. Full details of the search are provided in
eAppendix (http://links.lww.com/EDE/A379). We checked
the list of studies identified thus far for completeness against
studies referenced in existing reviews.6,10,41–43
We defined a priori eligibility criteria for studies. We
retained only studies that were reported in peer-reviewed
journals or published by a reputable independent body such
as the World Health Organization (WHO) or the US Envi-
ronmental Protection Administration (EPA). Studies were
included if they were published in English, were epidemio-
logic studies, used maternal residence for exposure estima-
tion, and presented odds ratio (OR), relative risk (RR), or
other comparable measure of effect for at least one adverse
birth outcome associated with exposure to disinfection by-
products. Studies not meeting these criteria were excluded
and the specific reasons for their exclusion were noted.
The list of included studies was narrowed down further
on the basis of the exposure assessment methods used: only
those that characterized disinfection by-product exposure using
at least 3 exposure categories were included. We excluded
studies that dichotomized exposure, primarily because such a
measure offers only a crude index of exposure; early epidemi-
ologic studies that classified exposure according to water treat-
ment methods have been criticized for their failure to capture a
more detailed picture of exposure to disinfection by-products.11
Second, we considered it impractical to combine relative risks
from studies with binary exposure characterization and contin-
uous/categorical exposure. Third, because trihalomethane con-
centrations from routine monitoring data on drinking water are
generally available an estimate of a continuous odds ratio slope was
considered to provide health impact assessments with the most
useful information. Fourth, in developed countries, the reporting of
drinking water treatment type is generally not mandatory, whereas
reporting of trihalomethane concentrations is a legal obligation.
Lastly, mixing of drinking water that has undergone different
treatments is common practice in many countries.
The following data were extracted systematically from
each included study by 2 researchers using a standard data
collection form: study design, exposure characterization, def-
initions of exposure categories, and measures of effect and
confidence intervals for each exposure category (Table 1).
We checked the 2 datasets against one another and addressed
any inconsistencies. The final set of studies was reviewed
qualitatively to assess between-study heterogeneities.
Statistical Methods
In each of the studies reviewed, exposure had been pre-
sented in terms of concentration of total trihalomethanes or, in
one case, trichloromethane (chloroform), using one of 2 mea-
sures: either parts per million (ppm) or micrograms per liter
(g/L). We considered concentrations in ppm as equivalent to
g/L, because at the low concentrations present in drinking
water these are virtually equivalent. To include the one study
reporting only chloroform concentrations,16 we multiplied re-
ported exposure categories by a factor of 1.33, on the assump-
tion that chloroform might make up 75% of the total triha-
lomethane mixture and that concentrations of chloroform and
total trihalomethanes in drinking water are highly correlated.49
The majority of studies presented their results as ORs
with 95% confidence intervals (CIs), although some used
hazard ratio (HR) or relative risk, or risk ratio (both RR). For
the purposes of this analysis, these measures were assumed to
be equivalent to odds ratios. One study presented results at
nested levels of confidence other than 95%.21 In this instance,
we calculated the standard error on the OR from the 99% CIs
provided using the formula:
standard error  (lnupper 99% CI
 lnlower 99% CI)/(2  2.575)
Upper and lower 95% confidence intervals were then calcu-
lated as follows:
upper 95% CI  exp(lnOR  (1.96  standard error)
lower 95% CI  exp(lnOR  (1.96  standard error)
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The majority of the studies reported measures of effect
adjusted for confounders. Adjustment had been carried out
for a range of covariates that varied across the studies, but the
majority adjusted for the same important factors (maternal
age, parity, smoking, and social deprivation). Several studies
did not provide unadjusted results and so adjusted results
were used in the meta-analysis. We used unadjusted results in
the one case where only unadjusted results were reported.
Details regarding individual studies are presented in Table 2.
We sought to minimize between-study heterogeneity re-
lating to exposure assessment methods. Thus, only those studies
characterizing exposure based on maternal residence were in-
cluded in this analysis. We subsequently grouped studies ac-
cording to the exposure agent measured, the type of measure
used, and the timing of exposure that was assumed. The timing
of exposure in each study was either categorized by trimester or
summarized for the whole pregnancy. The number of exposure
categories used in studies varied from 3 to 6. Given the variation
in the exposure assessment among studies, we carried out a
2-stage subset analysis to investigate differences in exposure
agent and exposure timing for each health outcome. The analysis
was divided on the basis of including the study that used
chloroform as the exposure agent.16
For each of these 2 subsets, analysis was further di-
vided according to exposure timing. The first subset included
studies that reported measures of effect associated solely with
exposure in the third trimester, because most fetal growth
occurs in this period; the second included only those report-
ing on entire pregnancy exposure; for completeness—and
because exposure in different periods are likely correlated—
the third subset included all studies regardless of exposure
timing (where both third trimester and entire pregnancy
exposure were reported in the same study, measures of effect
for third trimester were used). We carried out meta-analyses
only for those subsets including at least 4 studies.
It was not practical to quantitatively explore other
heterogeneities among the studies for a number of reasons:
studies were relatively similar in overall design; differences
among studies were not consistently presented; and, where
meta-analysis might have been stratified on the basis of
between-study variability (overall study design, variables
adjusted for, geographical location of study, etc.), the number
of studies in such subgroups was too few for the application
of meta-analytical methods.
Techniques for pooling correlated estimates to compute
regression slopes across exposure categories in individual
studies have been described previously.50 All studies pro-
vided measures of effect for several exposure categories,
although cut-off points of these categories differed among
studies (Table 2). Meta-analysis was carried out with the R
software package51 using scripts adapted from those devel-
oped by Key et al.52 For each study, we fitted a weighted
least-squares regression of ln(OR) against exposure, the
weight being inversely proportional to the variance on ln(OR)
at each exposure category midpoint. If there was no upper
limit to the topmost exposure category, a midpoint was
derived using half the width of the preceding category.
The use of various dose-response models to obtain
study-specific slope estimates has been explored previ-
ously,53 and slope estimates (and standard errors) were ob-
served to be higher when using dose, as compared with
ln(dose). Using Bayes information criterion to assess the fit of
each dose-response model, it has been demonstrated that
neither dose nor ln(dose) in a linear model was more advan-
tageous. Therefore, we carried out a regression of ln(OR)
against exposure. In the regression, we assumed that exposure
to zero disinfection by-products from water was unlikely,
because exposure to volatile disinfection by-products such as
trihalomethanes can occur in the domestic environment
through several routes (ingestion, inhalation, dermal absorp-
tion) and through a variety of pathways (drinking, eating,
cooking, washing); therefore the intercepts of the regression
slopes were not constrained to go through the origin. The
reference categories used in each study differed (Table 2),
which further supported this decision.
In addition to the qualitative investigation of heteroge-
neity between the studies, as described above, Cochran Q-
statistic was used to test for between-study heterogeneity.
Regression was carried out using both fixed effects and
random effects models, and the results compared. The overall
choice of a random effects model was informed by the
findings of these analyses. Regression slopes of exposure-
response derived from individual studies were plotted, to-
gether with the summary slopes produced from the meta-
analysis (Fig. 1) and forest plots (Fig. 2).
To investigate the role of publication bias and other
biases in the meta-analysis, we produced funnel plots (eFig-
ure 2, http://links.lww.com/EDE/A379) for visual inspection
of the symmetry of the data, as well as carrying out the Egger
regression test.54
We investigated the relative influence of individual
studies on summary measures of effect using a leave-one-out
sensitivity analysis for every subset analysis. Differences
between the magnitude and direction of summary measures
of effect for each study left out were investigated.
We calculated the risk of each pregnancy outcome for
third trimester exposure to total trihalomethane at levels
currently prescribed as guidelines in the United States55 and
the European Union56 (80 g/L and 100 g/L, respectively).
RESULTS
Results of Search, Data Extraction, and Study
Evaluation
Figure 3 shows the numbers of studies identified and
selected/excluded in each phase of the search. No additional
studies were identified by means of searching in databases other
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FIGURE 1. Plots of individual study slopes (solid colored lines)
and the random-effects regression slope (dashed blue line)
(both per 10 g/L TTHM) estimated from these for third
trimester exposure to TTHM only, for (A) LBW, (B) term LBW,
(C) PTD, and (D) SGA. Crosses indicate midpoints of exposure
categories versus OR in that category.
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than Medline. Manual searching of bibliographies provided
additional studies that met broad eligibility criteria: all but one
were later excluded on the basis of more detailed criteria. A
QUOROM diagram demonstrates the search method and the
reasoning behind the exclusion of studies (Fig. 3). Further data
were provided for the study by Porter et al,31 to give exposure
category quintiles for the analyses of interest that had not been
presented in the published paper. Ultimately, fifteen studies were
deemed suitable for inclusion in the meta-analysis. Characteris-
tics of the studies included in the analysis are given in Table 1.
The meta-analysis included 2 population-based case-control
studies,16,17 2 cross-sectional studies,21,24 1 cohort study,13 2
retrospective cohort studies,12,22 2 prospective pregnancy stud-
ies,29,33 and 5 studies for which the design type was not explic-
itly named.18,26,31,34,35 For the purposes of this review, the
studies were defined as population case-control studies, retro-
spective pregnancy cohort studies, or prospective pregnancy
cohort studies (Table 1). The qualitative review of between-
study heterogeneities found that the studies differed in their
geographical location, their quoted measure of effect, adjustment
for confounders, exposure characterization and categorization,
and the definitions of health outcomes.
Eleven studies were conducted in the United States, 1
in the United Kingdom, 1 in Canada, and 1 in Taiwan. Three
studies used data from Massachusetts, but these could be
combined because the time periods did not overlap. Two
studies looked at the same populations in the United States,
but reported on different outcomes.29,33
The majority of studies reported their results as odds
ratios; 1 study reported relative risk,12 2 reported risk ra-
tios,29,33 and 1 reported a hazard ratio (HR)34 (Table 2). Eight
studies provided only adjusted measures of effect; 5 provided
crude and adjusted results, and 1 study provided crude figures
where the difference between crude and adjusted was less
than 15%.21 Apart from this last exception, adjusted measures
of effect were used in the meta-analysis. Adjustment for
confounding in all studies had been done using logistic
regression analysis, except one study that had used a Poisson
regression model.12 The covariates adjusted for in each study
are shown in eFigure 2 (http://links.lww.com/EDE/A379).
The search retrieved studies in which exposure charac-
terization differed, particularly in terms of exposure assess-
ment. Studies not characterizing exposure with quantitative
DBP concentration measurements were excluded. Exposure
assessment methods used in the studies are given in Table 1.
The types of measure included concentrations, either from
sampling or monitoring data. Only one of the studies did not
use total trihalomethane as an exposure agent, but instead
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FIGURE 2. Forest plots of OR slopes per 10 g/L TTHM for third
trimester exposure to TTHM for (A) LBW, (B) term LBW, (C) PTD,
and (D) SGA. Study OR slopes are plotted with squares sized
proportionally to their weight in the meta-analysis regression;
horizontal lines indicate 95% CIs on these slopes. The red
vertical line indicates no effect (ie, OR slope  1.0). The blue
dashed line is the summary OR slope, with the tips of the
diamond indicating 95% CIs around this estimate.
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used trichloromethane (chloroform).16 Total trihalomethane
concentration was by far the most common exposure agent
across the studies. Many studies characterized exposure sim-
ply by taking the concentrations for the area (eg, water
company, municipality, etc.) encompassing the maternal
place of residence at birth. One study used hydraulic model-
ing to assign specific exposures to mothers,13 while most
studies made use of routine monitoring data. Two provided
measures of effect both for residential trihalomethane con-
centration derived from sampling, and for personal exposure
calculated using published algorithms.29,33
There were some disparities in the definitions of ad-
verse birth outcomes among studies (Table 2). LBW was
universally defined as birthweight 2500 g (or imperial
equivalent). Term LBW was also universally defined as
2500 g for term births (themselves defined as37 weeks of
gestation). PTD was generally defined as a birth of 37
weeks of gestation, although one study used a definition that
incorporated limits on gestational age and birth weight.34 The
definitions of SGA (including IUGR) varied the most, with
differences in the age-weight distributions and cut-off
points, and whether only term births were included. Def-
initions of SGA also varied in terms of the population
weight percentile cut-off points. Such differences among
studies contributed to our decision to employ a random
effects model in the meta-analysis.
Results of Meta-analysis
Figure 2 shows the study-specific exposure-response
slopes and the pooled slope for each of the outcomes inves-
tigated. Results of the Q-test suggested that there was no
heterogeneity among studies. The Q-test, however, has lim-
ited ability to detect heterogeneity when numbers of studies
are small.57 Differences in results with fixed effects and
random effects were scarcely distinguishable. In the light of
these findings, and given the results of the qualitative review
of between-study heterogeneities, we applied the more con-
servative approach of using the random effects model. The
results of the random-effects meta-analysis are summarized
in Table 3. These are given as odds ratio slopes (OR per 10
g trihalomethane/L) with 95% confidence intervals; Coch-
ran Q-statistics are also provided for each subgroup analysis.
Overall, we found little or no evidence for associations
between trihalomethane concentration and the pregnancy out-
comes examined.
Forest plots for the various pregnancy outcomes are
given in Figure 2, assuming only total trihalomethane as a
measure of exposure for the third trimester. We considered
the distribution of studies in funnel plots (total triha-
lomethane only and third trimester exposure) (eFigure 1,
http://links.lww.com/EDE/A379) to indicate that further
investigation of bias would be justified, particularly in the case
Potentially relevant articles identified using PubMed, ISI Web of Knowledge Google Scholar search engine (n = 42)
Bibliographies of articles retrieved were searched for additional articles (i.e. “explosion” of references), that were 
also retrieved (n = 18)
Total retrieved: n = 60
Articles excluded due to:
•Not journal article
•Not English language
•Solely birth defects, stillbirth or spontaneous abortion outcome investigated
•Associated with DBPs in drinking water not examined
•Not epidemiologic (e.g. toxicologic or veterinary)
•Narrative review
Studies excluded: n = 37
Articles retained for detailed evaluation: n = 23
Articles excluded due to narrow eligibility criteria:
I ffi i h i i ( 6 T hill l 1992 K i l 1996 Källé
Articles retained for meta-analysis: n = 15
• nsu c ent exposure c aracter sat on n = ; ut et a . , an tz et a  , n
& Robert 2000, Yang et al. 2000, Jaakkola et al. 2001, Yang 2004)
•Too few exposure categories defined (n = 2; Aggazzotti et al. 2004, Infante-Rivard 2004)
Studies excluded: n = 8
Articles divided by health outcomes into four separate meta-analyses: meta-analyses were carried out for those 
adverse birth outcomes on which ≥4 separate studies provided quantitative estimates of risk): SGA (n = 8), PTD (n = 
8), LBW (n = 6), TLBW (n = 6).
FIGURE 3. Summary QUOROM dia-
gram showing how studies were
identified and selected for inclusion.
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of PT (although the low number of studies made their interpre-
tation difficult). The results of weighted and unweighted Egger’s
regression tests (eTable 1, http://links.lww.com/EDE/A379)
provided no evidence for publication bias (or similar biases) in
any of the subset analyses.
The leave-one-out sensitivity analysis results were tab-
ulated, and differences between the results of each iteration
and the original full subset analysis were calculated. Full
results of the sensitivity analysis are presented in eTable 2
(http://links.lww.com/EDE/A379). Some very small changes
of magnitude and changes of direction of effect were noted.
Nevertheless, in none of the subset analyses did omitting an
individual study change the summary measure of effect by
more than 2%, with most differences being several orders of
magnitude less. The direction of effect was altered only for
analyses looking at LBW. This finding can be attributed to
the summary OR slope being extremely close to 1.00. Re-
moving the only study using chloroform as an exposure index
instead of total trihalomethane16 had an effect on the direc-
tion of only one analysis (LBW, third trimester)—again the
summary OR slope was very close to 1.00.
DISCUSSION
We used quantitative meta-analysis techniques to investi-
gate associations between exposure to total trihalomethane in
drinking water and indicators of fetal growth and prematurity.
Meta-analytic techniques can increase the statistical power to
detect small excess risks. Nonetheless, we found little or no
evidence for associations with most indicators of fetal growth
and prematurity, with the exception of SGA.
These results are broadly in line with narrative reviews
carried out previously, which have found evidence for an
association of disinfection by-product exposure with SGA but
not with LBW or PTD.42,43 In contrast to previous qualitative
results of these reviews, this meta-analysis did not find a
positive association with term LBW.
We carried out subset analyses to investigate the effects
of exposure timing and the inclusion of a study using chlo-
roform as the exposure agent; small positive effects for SGA
were reported only for analyses that included total triha-
lomethane as the exposure agent and third-trimester exposure
or any exposure timing. We consider SGA to be the best
characterized of these fetal growth outcomes because it takes
gestational age of the fetus into account. As such, with SGA
we expect to have more power to detect small risks relating to
retarded fetal growth.
The Cochran test for homogeneity indicated a lack of
heterogeneity among the studies. This was in contrast to the
findings of our qualitative review of the studies, which
showed study differences in the characteristics of the study
populations, in the degree to which confounding was con-
trolled, and in definitions of health outcomes. In addition,
because total trihalomethane acts as a surrogate for exposure
to an unknown putative agent, the actual concentrations of
this agent (or agents) might differ among the studies. The
outcome for which the meta-regression graphs display the
least between-study heterogeneity (in terms of gradient) is
that of SGA (Fig. 1D), where all but one of the studies
indicate a positive slope. Because of these qualitative find-
ings, and the fact that the Q-test is known to have a low power
when the number of studies is small,58 we considered a
random effects model to be most appropriate for the regres-
sion of the study-specific slopes.59 Other tests of heterogene-
ity, such as the I2-test, were not employed as these are
similarly limited when studies are few.60
The OR slopes should be viewed in the context of
levels of total trihalomethane typically present in drinking
water, and where potentially large populations are exposed.
TABLE 3. Summary Table of Results of Meta-analyses for all Health Outcomes, Including Results of Subset Analyses for
Exposure Agent and Exposure Timing
Exposure Agent Exposure Timing Health Outcome
No. Studies
Included
OR Slope per
10 g/L 95% CI Q-Statistic
Only TTHM Third trimester LBW 4 0.9999 (0.9735–1.0270) 2.244
Term LBW 4 1.0337 (0.9272–1.1525) 3.987
PTD 6 0.9896 (0.9781–1.0013) 1.840
SGA 6 1.0100 (1.0006–1.0194) 3.569
Any exposure timing LBW 5 1.0013 (0.974681–1.0286) 2.495
Term LBW 5 1.0228 (0.9456–1.1063) 4.008
PTD 8 0.9894 (0.9777–1.0007) 4.124
SGA 8 1.0096 (1.0009–1.0184) 4.641
Entire pregnancy SGA 4 1.0105 (0.9712–1.0514) 4.659
TTHM and chloroform Any exposure timing LBW 5 1.0001 (0.9737–1.0272) 2.495
PTD 9 0.9894 (0.9777–1.0007) 4.125
Entire pregnancy PTD 4 0.9696 (0.9139–1.0286) 1.441
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We applied our summary estimates of effect to United States
and European guidelines (80 g/L and 100 g/L, respec-
tively). As an example, we found that the risks of SGA for
third trimester exposure to total trihalomethane at these levels
were OR 1.08 (95% CI 1.01–1.17) and 1.10 (1.01–1.21),
respectively. Results for the other 3 outcomes are provided in
eTable 3 (http://links.lww.com/EDE/A379).
We carried out this meta-analysis under the assumption
that the log-odds of the response variables varied linearly against
concentration of total trihalomethane; this was in the absence of
data to support other exposure-response relationships. This is a
limitation of our analysis, and should be taken into account when
using the slope estimates, particularly when extrapolating to
high concentrations of total trihalomethane. Were it possible to
pool all original data from these studies, specific exposure
cut-offs might be examined, thereby facilitating investigation of
exposure-response slopes.
The few number of studies included in some meta-anal-
ysis subsets limited the degree to which we could investigate
differences in exposure assessment. Although some studies re-
ported various exposure timings, these have not been extensively
explored in the available literature; the majority of studies
looked only at the third trimester, which is regarded as the most
critical exposure period for these outcomes. For SGA, slightly
stronger evidence was found for an association with exposure in
the third trimester, which might be expected given that weight
gain occurs mainly in the third trimester.43 Few studies reported
exposure specifically to chloroform, limiting the analysis of
different exposure agents. However, total trihalomethane and
chloroform both presumably serve merely as indicators for the
unknown putative agent.
In the leave-one-out sensitivity analysis, individual
studies had little effect on the magnitude of the OR slopes,
although direction of the effect was altered in some instances.
The large study by Dodds et al35 exerted considerable influ-
ence on the summary measure. Inspection of the meta-
analysis regression slopes (Fig. 1C) showed that a study with
very narrow exposure categories22 tended to produce slopes
with tight confidence intervals, which thus increased their
weighting in the meta-analysis. Results changed very little in
the leave-one-out sensitivity analysis for any of the SGA
subgroup analyses, further supporting evidence of an associ-
ation for this outcome.
Interpretation of the funnel plots was hampered by the
small number of studies. Although the results of Egger’s
regression test (both weighted and unweighted) demonstrated
that there was no notable publication bias in results of any
subset analysis, the robustness of this test was limited.
Although definitions of LBW, term LBW, and PTD
were consistent across all studies, definitions for SGA (some-
times called IUGR, in spite of differences between the 2
outcomes) differed in the weight percentile cut-off points and
the degree to which reference curves had been adjusted for
various factors (Table 2).
It was not possible to explore the effects of varying
the exposure categories because the studies did not pre-
sent the distribution of their exposure data in sufficient
detail. The selection of exposure category midpoints may
have introduced bias into the model for the uppermost
exposure categories which, if open-ended, were set using the
midpoint from the preceding category. Use of the exposure-
response slope in the assessment of population health risks
should take this into account.
No toxicologic data were incorporated into the analysis.
An investigation has been published previously53 on the use
of Bayesian methods for the combination of epidemiologic
and toxicologic studies. Trihalomethane exposure and LBW
were used for illustration; combining study-specific dose-
response slope estimates. Results were found to be contingent
on robust data and consistent definitions for health outcomes
in humans and in animals. Furthermore, epidemiologic stud-
ies commonly use total trihalomethane concentration in water
as a proxy for exposure, rather than a measure of ingested
dose. In addition, in normalizing the epidemiologic studies to
toxicologic ones, the assumption is made that epidemiologic
studies have reported on trihalomethanes as the putative agent
and that all exposure is through ingestion. The validity of
these assumptions may be questioned.
We expected Berkson error associated with aggregate
total trihalomethane data to dominate over random error for
residential exposure estimates in the individual studies, and
hence in the summary estimate. Berkson error may have
reduced the power of the studies, but the risk estimates were
probably not attenuated as they might have been if random
error were dominant. Mobility of women during their preg-
nancies, and other factors such as changing residence, be-
tween areas with different exposure, may have led to expo-
sure misclassification and attenuation of the summary
measures of effect.
Elevated risks of restricted fetal growth have been
associated with exposure to total trihalomethane of those
mothers and infants carrying a genetic polymorphism for
CYP2E1, the enzyme primarily involved in the metabolism
of low doses of chloroform.30 If these data are corroborated,
people carrying the CYP2E1 variant could have considerably
greater risk of SGA than what we report here for pooled
populations.
Studies generally used indirect estimates of exposure
based on monitoring data linked to maternal residence at
birth. As such, exposure data were aggregated in both space
and time, due to marked variations in trihalomethane concen-
tration occurring from home to home and throughout each
pregnancy. Hundreds of disinfection by-products might be
present in any one drinking water sample. Only studies using
area-level concentration of total trihalomethane (and, in one
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instance, chloroform) in drinking water were combined in
this meta-analysis. Some studies estimated exposure through
different routes or pathways, but we included only those
based on maternal residence. Area-level total trihalomethane
data represent the most practicable means of categorizing
exposure in large studies; the costs of accurately estimating
intake in large populations are prohibitively high. As long as
the putative agent in the DBP mixture remains unknown, the
results of this meta-analysis may be useful in health impact
assessment or other estimations of burden of disease attrib-
utable to disinfection by-products, where routine total triha-
lomethane monitoring data are available. It would be worth-
while to examine the potential effects of individual
disinfection by-products, if such data became available.
Large, well-designed epidemiologic studies are needed
that take into account relevant confounders and characteriza-
tion of disinfection by-product exposure, and with carefully
defined health outcomes.11,42,43 In the absence of such stud-
ies, meta-analysis provides the best possible estimate mea-
sure for use in risk assessment and public health policy.
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Mother's questionnaire Version 41 dt 14-09-2007Page 34 of 42
Section I Water Consumption
*I1. On a typical day how much of the following do you drink?
a) Tap water
b) Bottled
water (Includes
water cooler)
c) Tea (any sort)
d) Coffee
e) Squash
At home At work/study Elsewhere
Glasses per day: Glasses per day: Glasses per day:
Glasses per day: Glasses per day: Glasses per day:
Cups per day: Cups per day: Cups per day:
Cups per day: Cups per day: Cups per day:
Glasses per day: Glasses per day: Glasses per day:
I2. Do you filter the water you drink at home? (Cross ONE box ONLY)
Yes No Don't Know
I3. Do you filter the water you drink at work? (Cross ONE box ONLY)
Yes No Don't Know N/A
I4. In a typical week while you have been pregnant how often and for how
long do you undertake the following?
(if you do not do any then fill in 0)
Shower ............
Times per week Minutes each time
Bath .................
Swim ................
(Including any other drinks
made with tap water)
1 2 3 4 5
Draft
Draft
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Abstract
Background: Studies of disinfection by-products in drinking water and measures of adverse fetal
growth have often been limited by exposure assessment lacking data on individual water use, and
therefore failing to reflect individual variation in DBP exposure.
Methods: Pregnant women recruited to the Born in Bradford cohort study completed a
questionnaire which covers water exposure. Information was collected on water consumption,
showering, bathing and swimming. Water exposure data from a subset of 39 women of the cohort
are described here.
Results: Mean total tap water intake was 1.8 l/day, and women on average spent 146 minutes per
week showering and bathing. Most tap water intake occurred at home (100% for unemployed,
71.8% for employed). Differences between age groups were observed for total tap water intake
overall (p = 0.02) and at home (p = 0.01), and for bottled water intake (p = 0.05). There were
differences between ethnic groups for tap water intake at home (p = 0.02) and total tap water
intake at work (p = 0.02). Total tap water intake at work differed by income category (p = 0.001).
Duration per shower was inversely correlated with age (Spearman's correlation -0.39, p = 0.02),
and differed according to employment status (p = 0.04), ethnicity (p = 0.02) and income (p = 0.02).
Conclusion: This study provides estimates of water exposure in pregnant women in a multi-ethnic
population in the north of England and suggests differences related to age, employment, income
and ethnicity. The findings are valuable to inform exposure assessment in studies assessing the
relationship between DBPs and adverse birth outcomes.
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Disinfection by-products (DBPs) are formed, when the
added chlorine reacts with natural organic matter and/or
bromide ions in the water [1]. Humans can be exposed to
DBPs in drinking water by ingestion, or by inhalation and
dermal absorption during activities such as showering [2].
There is some evidence to suggest that exposure to DBPs
during pregnancy may be related to measures of compro-
mised fetal growth, e.g. term low birth weight, or intra-
uterine growth retardation [3,4], however findings are
inconsistent and the evidence remains inconclusive. A
major limitation in previous studies has been crude or
incomplete exposure assessment; in particular, studies
have often ignored individual variation in water use,
therefore ignoring a potential source of variation in DBP
exposure.
We are investigating the relationship between DBPs and
measures of fetal growth in the Born in Bradford birth
cohort [5]. We aim to improve on previous exposure
assessment, by generating personalised DBP exposure
estimates for each woman in the cohort during her preg-
nancy. At the area level, we have routinely collected infor-
mation on trihalomethane concentrations in tap water
supplied by the local water company, and as part of the
HiWATE project [6] we have also conducted extra tap
water sampling in the study area for non-trihalomethane
DBPs. At the individual level, our exposure assessment
involves evaluating exposure to water amongst pregnant
women in the cohort. In this paper we describe patterns of
water exposure within a subset of the cohort.
Methods
Born in Bradford is a prospective multi-ethnic birth
cohort in the north of England which is recruiting 10,000
mother and baby couplets between 2007-2010. Pregnant
women are recruited to the cohort at approximately 28
weeks gestation. At recruitment detailed questionnaires
are administered by bilingual researchers collecting data
on the mothers' lifestyle, environment, ethnicity and
health. Questions include water exposures: consumption
of tap water, bottled water, tea, coffee, and squash at
home, work/college, or elsewhere, water filtering habits at
home and work, and showering, bathing and swimming
habits. As part of a nested validation study 56 women
were recruited from the main cohort during March and
May 2008. The aim of the nested study was to collect
detailed information which could be used to validation
exposure estimates to DBPs and air pollution for the main
cohort. To be eligible for the nested study women had to
be able to speak and read English. Out of 166 eligible
women, 56 (33.7%) agreed to take part. 12 women with-
drew and 5 failed to complete the study, leaving 39
women. As part of this nested study we were provided
with an extract of baseline questionnaire data for these 39
women by the Born in Bradford study, in advance of com-
pletion of the dataset for the main cohort for which
recruitment is still ongoing. We analysed the baseline
questionnaire data on this subset to provide descriptive
statistics of water use, which are reported in this paper.
Analysis was performed using R 2.4.1 [7]. Consumption
was reported in cups or glasses per day (cup/glass
assumed to be 200 ml), and converted into litres for anal-
ysis. Total tap water intake was calculated by summing tap
water, tea, coffee and squash intakes. Total fluid intake
was calculated by also including bottled water. When ana-
lysing by ethnicity, categories were collapsed to give 3 sub-
groups: White (incorporating White British and White
Other), South Asian (incorporating Pakistani and
Indian), and Other (incorporating Black or Black British
and All Other), because numbers were small, and for
employment subgroups, subjects on maternity/sick leave
were kept with the employed group. The Born in Bradford
study and the nested study were approved by the Bradford
Research Ethics Committee.
Results
Demographics
Mean age of subjects was 29.7 years with just over half of
the women employed (Table 1). A sizeable proportion of
the women were educated to degree level (35.9%). 48.7%
were of White British origin and 38.5% were of Pakistani
origin. Income levels varied and only 10.3% reported cur-
rently smoking.
Water consumption
Overall
Mean total tap water intake across all locations was 1.8 l/
day, whilst total fluid intake was 2.1 l/day (Table 2(a)).
Tap water consumption (cold tap water and tap water
based beverages) represented 84.3% of all fluid intake.
For unemployed women, 100% of tap water intake
occurred at home. For employed women 71.8% of tap
water intake occurred at home, and 28.2% at work.
Home
Total tap water intake at home averaged 1.5 l/day. The
largest component of total tap water intake at home came
from cold tap water (50.7%), followed by tea (23.1%)
and then squash (18.9%). The majority of cold tap water
intake was unfiltered (73.1%). 7.7% of women reported
no tap water intake from any source at home.
Work
Amongst employed women, total tap water intake at work
averaged 0.6 l/day. All tap water consumed at work was
unfiltered. The largest component of total tap water intake
at work came from cold tap water (43.1%), followed by
tea (29.3%) and then coffee (17.2%). Women consumed
similar quantities of cold tap water and bottled water atPage 2 of 7
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Table 1: Demographic characteristics
Nested subset Main cohort
Characteristics n % n %
All 39 100.0 4070 100.0
Age <20 2 5.1 302 7.4
20-24 4 10.3 1088 26.7
25-29 13 33.3 1317 32.4
30-34 15 38.5 839 20.6
35-39 4 10.3 450 11.1
≥40 1 2.6 73 1.8
Missing data 1 0.02
Marital Status Married 31 79.5 2864 70.4
Single 8 20.5 1198 29.4
Missing data 8 0.2
Highest Educational Qualification None 4 10.3 698 17.1
O level/GCSE or A level 13 33.3 1389 34.1
Degree 14 35.9 827 20.3
Other (e.g. NVQ) 8 20.5 1094 26.9
Don't know 53 1.3
Missing data 9 0.2
Employment status Employed 20 51.3 1624 39.9
Unemployed 18 46.2 2258 55.5
Maternity/Sick leave 1 2.6 184 4.5
Missing data 4 0.1
Parity 0 14 35.9 1587 39.0
1 15 38.5 1198 29.4
2 7 17.9 657 16.1
3+ 3 7.7 528 13.0
Missing data 100 2.5
Household Income <£20,000 15 38.5 1876 46.1
£20,000-40,000 14 35.9 953 23.4
>£40,000 7 17.9 332 8.2
Don't know 3 7.7 846 20.8
Not stated/missing 63 1.4
Ethnicity White British 19 48.7 1573 38.6
White Other 1 2.6 96 2.4
Pakistani 15 38.5 1873 46.0
Indian 1 2.6 159 3.9
Bangladeshi 0 0.0 94 2.3
Any other Asian origin 0 0.0 40 1.0
Black or Black British 1 2.6 105 2.6
Mixed 0 0.0 67 1.6
All Other 2 5.1 59 1.4
Not stated/missing 4 0.1
Smoking Current smoker 4 10.3 562 13.8
Past smoker 8 20.5 612 15.0
Never smoker 27 69.2 2896 71.2
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2a: Water Consumption Mean Min Percentile Distribution Max Consumed
Variable 0.25 0.50 0.75 n %
HOME Tap water (filtered and unfiltered) 
(l/day)
0.7 0.0 0.2 0.6 0.8 2.6 32 82.1
Filtered tap water (l/day) 0.2 0.0 0.0 0.0 0.0 2.0 8 20.5
Unfiltered tap water (l/day) 0.5 0.0 0.0 0.4 0.8 2.6 24 61.5
Tea (l/day) 0.3 0.0 0.0 0.2 0.4 2.4 22 56.4
Coffee (l/day) 0.1 0.0 0.0 0.0 0.0 2.0 7 17.9
Squash/cordial (l/day) 0.3 0.0 0.0 0.0 0.0 1.2 21 53.8
Total tap water intake (l/day) 1.5 0.0 0.7 1.4 2.2 4.2 36 92.3
Bottled water (l/day) 0.2 0.0 0.0 0.0 0.0 4.0 7 17.9
Total fluid intake (l/day) 1.6 0.2 0.8 1.4 2.4 4.2 39 100.0
WORK Tap water (filtered and unfiltered) 
(l/day) *
0.2 0.0 0.0 0.0 0.4 2.0 6 28.6
Filtered tap water (l/day) * 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Unfiltered tap water (l/day) * 0.2 0.0 0.0 0.0 0.4 2.0 6 28.6
Tea (l/day) * 0.2 0.0 0.0 0.0 0.2 1.0 6 28.6
Coffee (l/day) * 0.1 0.0 0.0 0.0 0.0 0.8 5 23.8
Squash/cordial (l/day) * 0.1 0.0 0.0 0.0 0.0 0.8 2 9.5
Total tap water intake (l/day) * 0.6 0.0 0.0 0.4 0.8 2.8 15 71.4
Bottled water (l/day) * 0.3 0.0 0.0 0.0 0.6 2.0 8 38.1
Total fluid intake (l/day) * 0.9 0.0 0.4 0.8 1.0 2.8 18 85.7
ELSEWHERE Tap water (l/day) 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Tea (l/day) 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Coffee (l/day) 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Squash/cordial (l/day) 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Total tap water intake (l/day) 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Bottled water (l/day) 0.0 0.0 0.0 0.0 0.0 0.2 1 2.6
Total fluid intake (l/day) 0.0 0.0 0.0 0.0 0.0 0.2 1 2.6Page 4 of 7
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intake from any source at work.
Showering & bathing
Showering was reported by 87.2%, and bathing by 66.7%,
of women (Table 2(b) ). Amongst those women who
reported showering mean duration per shower was 16
minutes. Mean duration of bath was 40 minutes, amongst
those reporting bathing. Bath duration tended to be
longer than shower duration, but overall time spent show-
ering or bathing per week was similar for both activities.
Swimming
Only 6 women (15.4%) actually reported going swim-
ming at least once a week. Amongst these women, average
duration of swimming session was 53 minutes.
Water use stratified by demographic characteristics
Age
No clear monotonic trends were observed for water con-
sumption across age groups, although there were differ-
ences between groups for intakes of total tap water at
home (p = 0.01), total tap water overall (p = 0.02) and
bottled water (p = 0.05) (see Additional file 1). Duration
per shower and total time spent showering and bathing
per week were inversely correlated with age (Spearman's
correlation: -0.39 (p = 0.02) and -0.36 (p = 0.03) respec-
tively).
Employment status
There were no differences in tap water consumption over-
all, or at home, according to employment status. Duration
per shower was significantly longer for unemployed than
for employed women (p = 0.04).
Income
No clear monotonic trends were observed across income
categories, although differences were observed for total
tap water intake at work (p = 0.001) and duration per
shower (p = 0.02).
Ethnicity
When stratifying by ethnicity, the results suggest women
of South Asian origin may consume more tap water than
ALL Total tap water intake (l/day) 1.8 0.0 1.0 1.4 2.4 5.8 37 94.9
Total fluid intake (l/day) 2.1 0.4 1.2 1.8 2.7 5.8 39 100.0
2b: Showering, Bathing, 
Swimming
Mean Min Percentile Distribution Max Activity carried out
Variable 0.25 0.50 0.75 n %
SHOWERING & BATHING No. showers per week 5 0 3 5 7 14 34 87.2
Duration per shower (min) † 16 5 10 15 20 60
Showering (min/week) 74 0 35 60 100 300 34 87.2
No. baths per week 2 0 0 2 3 7 26 66.7
Duration per bath (min) ‡ 40 10 26 30 38 120
Bathing (min/week) 72 0 0 60 120 360 26 66.7
Total time showering/bathing 
(min/week)
146 35 73 110 185 540 39 100.0
SWIM No. swimming sessions per week 1 0 0 0 0 2 6 15.4
Duration per swim (min) § 53 10 26 53 60 120
Swimming (min/week) 10 0 0 0 0 120 6 15.4
* amongst those who were employed (n = 21), † amongst those who reported at least one shower per week (n = 34), ‡ amongst those who 
reported at least one bath per week (n = 26), §amongst those who reported going swimming at least once per week (n = 6)
Table 2: Summary of water exposures (Continued)Page 5 of 7
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showering and bathing, however differences between
groups only reached statistical significance for tap water
intake at home (p = 0.02), total tap water intake at work
(p = 0.02), and duration per shower (p = 0.02).
Differences between the subgroups may exist for other
water use variables, but they did not reach statistical sig-
nificance.
Discussion
These results show that cold tap water and tap water based
beverages constitute a major part of daily fluid intake for
pregnant women, and that the majority of tap water
intake occurs at home for both unemployed and
employed women. However, for employed women some
tap water ingestion occurs at work and this should be con-
sidered in DBP exposure assessment. Many previous stud-
ies on DBPs and adverse birth outcomes have assessed
exposure only at the mother's home, e.g. by using tri-
halomethane concentrations in the water supply of the
mother's residence at time of birth. If, as our study sug-
gests, the majority of tap water intake occurs at home,
potential exposure misclassification from excluding expo-
sures at other locations should be relatively small.
Water exposures in our study were higher than reported by
the only other UK study on water use by pregnant women.
Kaur et al. [8] found overall total tap water intake to be
1.31 l/day (calculated from their reported consumption
per week), and that women spent 54.3 min/week shower-
ing and 54.7 min/week bathing. Barbone et al. [9] report
total tap water intake of 0.6 l/day in Italy, whilst in the US,
Shimokura et al. [10] report 0.78 l/day and Zender et al.
[11] 3.4 l/day. Forssén et al. [12] report 120 min/week
showering amongst pregnant women in the US, which is
greater than we found, but bathing was less at 50 min/
week.
Our results suggest that there may be some differences for
tap water intake and showering/bathing behaviour
according to age, employment status, income and ethnic-
ity. Tap water intake has previously been shown to differ
by ethnicity [12] and showering and bathing by ethnicity
[13] and socioeconomic status [12]. However, as we
found no clear-cut patterns, these factors need further
investigation in a larger group of women from the birth
cohort. It is important to understand these differences in
water behaviour, because maternal age, socioeconomic
status, and ethnicity are associated with fetal growth and
low birth weight [14-16], and may act as confounders if
they are also independently associated with exposure to
water. In studies using individual-level data these factors
tend to be adjusted for. However, many studies on DBPs
and adverse birth outcomes have relied upon exposure
assessment and confounding data at an ecological level
[17,18] or, due to their retrospective design, information
on confounders of interest has been incomplete [19,20].
Consequently, a number of epidemiological studies to
date in this field of research have been unable to fully
adjust for potential confounding. Interpretation of results
from these studies is, therefore, limited by the possibility
of residual confounding. The prospective cohort design
and comprehensive data collection of Born in Bradford
will address these methodological weaknesses and in time
help to inform the evidence base about the potential
effects of DBPs on birth outcomes.
This study has a number of limitations. The results in this
study are based on small numbers of women in one city
and may not therefore be generalisable to the wider pop-
ulation of pregnant women. Nonetheless, given that there
is very little information available on water use by preg-
nant women in the UK, we believe that these results are
useful as approximate estimates of water use in pregnancy
and indicate issues that should be considered in epidemi-
ological studies of DBPs, e.g. potential differences in water
use in relation to ethnicity.
There is potential for selection bias in this subset. Due to
the prohibitive cost of translation, recruitment to the sub-
set excluded the 12-15% of women who spoke no Eng-
lish. This may explain the greater proportion of women of
White British origin and lower proportion of women of
Pakistani origin compared to the main cohort. With
regards to age, marital status, parity and smoking the
nested subset was similar to the main cohort. However,
the nested subset appeared better educated and had a
greater proportion of women in higher income brackets
than the main cohort. Thus it is possible that our results
may not fully reflect water use in women with lower levels
of educational attainment or income.
Conclusion
This study provides estimates of water exposure in preg-
nant women in a multi-ethnic population in the north of
England. The findings are valuable to inform exposure
assessment in studies assessing the relationship between
DBPs and adverse birth outcomes. Future work will
involve further investigation of potential differences
between demographic subgroups on a larger dataset,
using regression-type analyses, and validation of ques-
tionnaire responses for water exposures. This will be
undertaken by comparing questionnaire responses with
records of water use kept by the 39 women in a 7-day
exposure diary.
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There appears to be very good epidemiological evidence for a relationship between chlorination
by-products, as measured by trihalomethanes (THMs), in drinking water and bladder cancer,
but the evidence for other cancers, including colorectal cancer appears to be inconclusive
and inconsistent. There appears to be some evidence for a relationship between chlorination
by-products, as measured by THMs, and small for gestational age (SGA)/intrauterine growth
retardation (IUGR) and preterm delivery, but evidence for other outcomes such as low birth
weight (LBW), stillbirth, congenital anomalies and semen quality appears to be inconclusive
and inconsistent.
The overall aim of the HIWATE study is to investigate potential human health risks (e.g. bladder
and colorectal cancer, premature births, SGA, semen quality, stillbirth, congenital anomalies)
associated with long-term exposure to low levels of disinfectants (such as chlorine) and DBPs
occurring in water for human consumption and use in the food industry. The study will comprise
risk–benefit analyses including quantitative assessments of risk associated with microbial
contamination of drinking water versus chemical risk and will compare alternative treatment
options. The outcome will be improved risk assessment and better information for risk
management. The work is divided into different topics (exposure assessment, epidemiology, risk
assessment and management) and studies.
Key words | cancer, chlorination, disinfection by-products, epidemiology, reproductive health, risk
assessment
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INTRODUCTION
It has been more than 30 years since trihalomethanes
(THMs) were first discovered in the Netherlands (Rooks
1974). Chlorination disinfection by-products (DBPs) are
formed when water is chlorinated and the organic matter
in the water reacts with chlorine to form these by-products.
The formation and occurrence depends on many factors,
including the chlorine dose, type of treatment, pH, tempera-
ture, residence time and bromine levels (Nieuwenhuijsen
et al. 2000a; IPCS 2000). Up to 600 DBPs have been
identified (Richardson 1998; Richardson et al. 2008).
Different mixtures of by-product may exist in different
locations depending on the various factors mentioned
above, making it more difficult to assess any health effects
of DBPs, particularly in epidemiological studies. In Europe
there is relatively little known about the occurrence of DBPs
other than THMs and their levels (Palacios et al. 2000), with
some exceptions in a fewplaces such as Poland (Dojlido et al.
1999), Finland (Nissinen et al. 2002), Spain (Villanueva et al.
2003), the UK (Malliarou et al. 2005), Greece (Golfinopoulos
& Nikolaou 2005) and Italy (Fantuzzi et al. 2007), while in
theUS extensive surveys have been conducted to assess DBP
occurrence under different water treatment methods (e.g.
Weinberg et al. 2002; Krasner et al. 2006).
In the USA and Canada there has been considerable
progress in the assessment of health risks and policy
development in relation to DBPs, including a research
programme on the occurrence and health risks relation to
the by-products by the USEPA’s office onWater andNational
Health and Environmental Effects Research Laboratory
(http://www.epa.gov/nheerl/research/drinking_water.html).
A considerable amount of work has been carried out
measuring a range of different DBPs, animal testing of a list
of high priority by-products and epidemiological studies.
However, results may not be extended to Europe because
mixtures of DBPs may be different as a result of different
determinants such as treatment, total organic content (TOC),
pH etc. In Europe there has been a much slower response to
the recent findings. Disinfection is used in many countries in
Europe and is therefore of European concern and requests a
European approach and solution. Relatively little research has
been carried out on DBPs in relation to adverse birth
outcomes and cancer in Europe. Where work has been
carried out, this has been carried out in isolation.
Safe drinking water has a high priority in Europe in
accordance with the Water Framework Directive and the
Directive on Quality of Water intended for Human
Consumption. Water treatment safety has become particu-
larly acute since the quality of water resources may be
declining because of water scarcity in some regions,
increasing the cost of drinking water production and the
likelihood of chemical interactions during the treatment
process. Water is an important part of the food chain.
Consumer health and well-being, quality, safety and con-
sumer concern, are highly important and should be
addressed where possible, particularly where environmental
health risks are concerned. Recently there has been
consumer concern about the quality of drinking water
from the tap and this may have led to an increase in the
consumption of expensive bottled water in developed
nations (Doria et al. 2005; Doria 2006), reducing the
money that can be spent on more beneficial items.
Ingestion of water may not be the only concern since an
individual can also be exposed to volatile DBPs (e.g. THMs)
through inhalation and absorption, during activities such as
showering, bathing and swimming (Nieuwenhuijsen et al.
2000a). Recent modelling has suggested that this route may
lead to the highest levels in the blood (Whitaker et al. 2003).
Uptake through showering, bathing and swimming showed
considerable increased risk in a recent bladder cancer study
(Villanueva et al. 2007). For non-volatile DBPs, such as
haloacetic acids (HAAs), ingestion is thought to be the main
route of exposure.
In this paper we briefly summarise the epidemiological
evidence and limitations regarding the two main areas of
health effects from exposure to DBPs, cancer and repro-
ductive effects. We then present the background and design
of a major research initiative in the EU (Health Impacts of
long-term exposure to disinfection by-products in drinking
WATEr, HIWATE project) that will provide an extensive
evaluation of exposure, hazard identification, risk assess-
ment and risk benefit analysis for these compounds in
the EU.
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EPIDEMIOLOGICAL STUDIES EXAMINING HEALTH
EFFECTS RELATED TO EXPOSURE TO
DISINFECTION BY-PRODUCTS
Cancer
The health effects of DBPs in drinking water have been a
concern since DBPs were first reported in the 1970s. Early
studies focused on cancer outcomes, while the more recent
studies have focused on reproductive outcomes (IPCS
2000). According to the recent review by IPCS (2000):
more studies have considered bladder cancer than any
other cancer. The authors of the most recently reported
results for bladder cancer risks caution against a simple
interpretation of the observed associations. The epide-
miological evidence for an increased relative risk for
bladder cancer is not consistent—different risks are
reported for smokers and non-smokers, for men and
women, and for low and high water consumption. Risk
may differ among various geographic areas because the
DBP mix may be different or because other water
contaminants are also present. More comprehensive
water quality data must be collected or simulated to
improve exposure assessments for epidemiological
studies.
The document also mentioned the difficulties in
exposure assessment for epidemiological studies of cancer
and DBPs, due to the long lag periods and the general lack
of detailed historical data.
A very important recent pooled analysis by Villanueva
et al. (2004), which provided quantitative information,
confirmed this. For men there was an exposure response
relationship between DBP intake and bladder cancer, but
there was no relationship in women (Table 1). Furthermore,
the latest Spanish study suggested that not only is exposure
through ingestion an important risk factor but also exposure
through swimming, showering and bathing (Villanueva et al.
2007). Furthermore in this study the authors identified
genetically susceptible groups such as those with gluta-
thione S-transferase theta 1 (GSTT1) and glutathione
S-transferase zeta 1 (GSTZ1) polymorphisms (Cantor et al.
2006). Some studies have suggested an association between
DBPs and colorectal cancers, while others have not (Young
et al. 1981, 1987;Wilkins & Comstock 1981; Doyle et al. 1997;
Koivusalo & Vartiainen 1997; Hildesheim et al. 1998; King
et al. 2000a; Bove et al. 2007). Studies on colorectal cancer
have relatively limited sample size and have used relatively
crude measures of exposure assessment focusing principally
on THMs levels in the water, without examining different
exposures or gene–environment interactions. There is little
evidence for an association between exposure to DBPs
and other cancers such as liver, kidney, brain, lung and
breast cancer, lymphomas or cancer of the pancreas, but
the number of studies is small (IPCS 2000) and very few of
these have involved populations in Europe. A recent
report suggested an association between THMs and skin
cancer, but further work needed to be conducted (Karagas
et al. 2008).
Reproductive outcomes
Reproductive health outcomes should be easier to study
from an exposure point of view, because of the shorter
relevant exposure period. Among others, birth weight,
prematurity, spontaneous abortion, congenital anomalies
and stillbirth have been the focus of these studies. Overall
there appears to be some evidence for a relationship
between chlorination by-products, as measured by THMs,
and small for gestational age (SGA)/intrauterine growth
retardation (IUGR) and preterm delivery, but evidence for
other outcomes such as low birth weight (LBW), stillbirth,
congenital anomalies and semen quality appears to
be inconclusive and inconsistent (Kramer et al. 1992;
Aschengrau et al. 1993; Bove et al. 1995, 2002; Savitz et al.
1995, 2006; Kanitz et al. 1996; Reif et al. 1996;Gallagher et al.
1998; Waller et al. 1998, 2001; Dodds et al. 1999, 2004;
Table 1 | Pooled analysis of bladder cancer and THM (after Villanueva et al. 2004)
THM exposure level (mg) Male ORs (95%CI) Female ORs (95%CI)
0–15 1.00 1.00
.15–50 1.22 (1.01–1.48) 0.92 (0.65–1.32)
.50–400 1.28 (1.08–1.51) 0.94 (0.70–1.27)
.400–1000 1.31 (1.09–1.58) 1.02 (0.74–1.41)
.1000 1.50 (1.22–1.85) 0.92 (0.65–1.30)
OR (95%CI) ¼ odds ratio (95% confidence interval).
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Klotz & Pyrch 1999; Magnus et al. 1999; King et al. 2000b,
2005; Kallen & Robert 2000; Yang et al. 2000, 2007;
Nieuwenhuijsen et al. 2000b, 2008; IPCS 2000; Gevecker
Graves et al. 2001; Jaakkola et al. 2001; Dodds & King 2001;
Cedergren et al. 2002; Hwang et al. 2002; Fenster et al. 2003;
Hwang & Jaakkola 2003; Shaw et al. 2003; Wright et al.
2003, 2004; Aggazzotti et al. 2004; Yang 2004; Hinckley
et al. 2005; Porter et al. 2005; Toledano et al. 2005;
Lewis et al. 2006, 2007; Tardiff et al. 2006; Luben et al. 2007).
Infante-Rivard (2004) found that the association
between THMs and intrauterine growth retardation was
modified by a metabolic polymorphism, with newborns
without the CYP2E1 (G1259C) variant at high risk, but
found no indication that MTHFR C677T modified the effect
of exposure to chloroform and risk to foetal growth in
humans. Neither did Shaw et al. (2003) for neural tube
defects (NTDs). This sheds some light on the possible
mechanism of action. However, the mechanisms through
which DBPs may cause adverse health effects, including
cancer and adverse reproductive effects are not well
investigated. Several mechanisms have been suggested
that involve genotoxicity (DeMarini et al. 1997; Pegram
et al. 1997; Ross & Pegram 2004; Richardson et al. 2008),
oxidative stress (Tomasi et al. 1985; Larson & Bull 1992;
Ni et al. 1996; Scholl & Stein 2001;Meek et al. 2002;Gemma
et al. 2003; Sciuto et al. 2003;Weber et al. 2003;Myatt & Cui
2004; Crider et al. 2005; Engel et al. 2005a,b; Min et al.
2006), disruption of folate metabolism (Kamen 1997; Ray &
Laskin 1999; Dow & Green 2000; Geter et al. 2005),
disruption of the synthesis and/or secretion of placental
syncytiotrophoblast-derived chorionic gonadotropin (Chen
et al. 2003, 2004) and lowering of testosterone levels (Potter
et al. 1996).
Limitations
The major limiting factor in these studies has generally been
crude exposure assessment. Use of ecologic water supply
zone estimates as an exposure index may result in exposure
misclassification. Furthermore, ingestion has generally been
the primary interest, while uptake through showering,
bathing and swimming is considerable (Whitaker et al.
2003). Combining information on individual water use with
water zone estimates would provide more detailed exposure
assessment, if done appropriately, taking into account
classical and Berkson error models (Nieuwenhuijsen et al.
2000b). Exposure estimates have been based primarily on
residence. This ignores any exposure which occurs outside
the home (e.g. in the workplace) and also ignores the
possibility that a mother has moved house during her
pregnancy. Exposure assessment based on residence there-
fore, results in exposure misclassification.
Most of the epidemiological studies have used THMs as
a proxy for total DBP load, but THMs are not necessarily a
good proxy measure. The metabolism of different DBP
species varies (IPCC 2000), so it is insufficient to analyse
DBPs as a whole, or to use TTHM (total THM) as a proxy.
Investigation of the relation between non-THM by-products
and reproductive outcomes is required in order to help
elucidate the specific DBPs driving the associations
observed.
In addition, when chlorine dioxide is used as disin-
fectant agent, chlorite and chlorate are the main DBPs;
the toxicological action due to chlorite and chlorate has
not yet been fully investigated. Only one study has been
carried out in Europe on the association between personal
exposure to these DBPs and pregnancy outcomes. This
study was carried out in nine Italian provinces and
evidenced a small increase in the risk of SGA at term
(term SGA) and high levels of chlorite in drinking water
(Aggazzotti et al. 2004).
Also, for reproductive epidemiological studies, in-depth
analyses comparing exposure metrics for the different
trimesters of pregnancy are required to discover the critical
window in which DBP exposure affects foetal growth.
The retrospective and registry based nature of many of
the reproductive epidemiological studies has meant that
information on potential confounders, and other risk
factors for foetal growth restriction, such as maternal
smoking and alcohol consumption have often been lacking.
Furthermore, for reproductive epidemiological studies,
there is also a need for better case identification for
outcomes such as foetal growth restriction and congenital
anomalies. Previous epidemiological studies have used a
variety of outcomes as proxies for foetal growth restriction:
term low birth weight (LBW), intrauterine growth retar-
dation (IUGR) and small for gestational age (SGA). There
are some limitations to these measures. LBW is rather
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crudely defined; the fixed criterion of birth weight below
2,500 g takes no account of population-specific birth weight
distributions (Wilcox 2001). Somewhat confusingly, the
terms IUGR and SGA have been used interchangeably in
the literature and criteria for IUGR/SGA diagnosis have
varied, some studies using the 5th and some the 10th
percentile of gestational specific weight according to a
standard population growth chart as a cut-off point. These
measures fail to distinguish between those babies which are
constitutionally small and those which are pathologically
small (i.e. growth restricted). Some small but normally
grown babies will fall below the cut-off point, and some
growth restricted babies will reach a weight above the cut-
off point. A proportion of infants therefore are misclassified,
and in epidemiological studies this may bias any association
towards the null. There is evidence to show that the use of
customised foetal growth charts, which take into account
factors such as maternal height and ethnicity, significantly
reduces the proportion of false-positive and false-negative
diagnoses of foetal growth restriction, compared with the
use of a standard population growth chart (Gelbaya &
Nardo 2005; Gardosi 2006).
Congenital malformations have often been classed into
main categories (e.g. neural tube, major heart and abdomi-
nal defects) as a result of the small number of cases in the
studies. These malformations, however, are generally
heterogeneous with respect to both phenotype and pre-
sumed aetiology. Nieuwenhuijsen et al. (2008) showed that
focusing on isolated subcategories may result in different
findings.
Even though there has been some good animal work
that suggests strong effects on semen quality (Smith et al.
1989; Toth et al. 1992; Linder et al. 1994a,b, 1995, 1997a,b),
only two small US epidemiological studies have been
conducted (Fenster et al. 2003; Luben et al. 2007).
The pooled bladder cancer analysis results have
provided good evidence for some risk related to DBPs;
however, the authors did not examine whether the results in
North America and Europe were consistent (Villanueva
et al. 2004). There may be differences because of different
water treatment practices. Further, the results for colon
cancer have been inconsistent and inconclusive and have
not examined the role of different exposure pathways and
routes, which may be important.
Very few studies have examined gene–environment
interaction and/or the presence of susceptible groups
(Shaw et al. 2003; Infante-Rivard 2004), which is important
for guideline setting and can elucidate potentialmechanisms.
THE HIWATE PROJECT
HIWATE is a major research initiative that has started in
Europe (www.hiwate.org) to address the shortcomings of
previous research on DBPs. The overall aim is to investigate
potential human health risks (e.g. cancer, premature births,
SGA, semen quality, stillbirth, congenital anomalies)
associated with long-term exposure to low levels of
disinfectants (such as chlorine) and DBPs occurring in
water for human consumption and use in the food industry.
The study will comprise risk–benefit analyses including
quantitative assessments of risk associated with microbial
contamination of drinking water versus chemical risk
and will compare alternative treatment options. The out-
come will be improved risk assessment/management. The
study will make use of existing studies/databases and newly
collected information. The project involves 16 teams in
eight European countries (Table 2). The work is divided
into different topics (exposure assessment, epidemiology,
risk assessment and management) and studies (Table 3).
The specific objectives of the proposed work are
outlined below.
Exposure assessment
(I) To determine the DBP composition and levels in
drinking water in various regions in Europe (see Table 4).
Representative water samples will be primarily collected
in the regions where the epidemiological studies are carried
out, to give a wider picture on their presence and levels.
Samples will be analysed for THMs (chloroform, bromodi-
chloromethane, chlorodibromomethane and bromoform),
haloacetonitriles (HANs) (including chloroacetonitrile, dich-
loroacetonitrile, trichloroacetonitrile, bromoacetonitrile,
dibromoacetonitrile, tribromoacetonitrile, chlorobromoace-
tonitrile, dichlorobromoacetonitrile and dibromochloroace-
tonitrile), HAAs (including chloroacetic acid, dichloroacetic
acid, trichloroacetic acid, dibromoacetic acid, tribromoacetic
189 M. J. Nieuwenhuijsen et al. | HIWATE Journal of Water and Health | 07.2 | 2009
285
acid, dibromochloroacetic acid, chlorobromoacetic acid,
bromoacetic acid, dichlorobromoacetic acid), haloketones
(HAKs) (including 1,1-dichloropropanone, 1,3-dichloropro-
panone, 1,1,1-trichloropropanone), 3-chloro-4-(dichloro-
methyl)-5-hydroxy-2(5H)-furanone (MX), chlorate hydrate
(CH), chloropicrin (CP), bromate, chlorite and chlorate,
depending on the type of water disinfectant treatment used.
The study will produce a database containing the levels of
these DBPs in the various regions in the UK, France, Spain,
Greece, Italy and Lithuania. The number of samples collected
in each region is given in Table 4. The samples will be
collected over a two year sampling period to provide
information on the temporal variability of the DBPs over
different seasons. Some work will be done to examine the
effects of filters and boiling water. Detailed sampling and
analyses protocols have been developed (see www.hiwate.
org). Furthermore, an interlaboratory comparison pro-
gramme will be set up to compare the performance of the
various laboratories within the HIWATE consortium with
laboratories outside the HIWATE consortium.
(II) To identify the determinants of DBPs and develop
predictive models.
In addition to the DBP analysis for a range of DBPs (see
objective 1), the study will obtain information regarding the
possible determinants of the DBPs including organic matter
content, water source, temperature, pH and (residual) disin-
fectant levels (e.g. chlorine and bromide level) (Table 5).
Statistical techniques will be employed to quantify the effect
of these determinants on the formation of DBPs and
use this to build a predictive model of DBP formation
(Golfinopoulos & Arhonditsis 2002; Nieuwenhuijsen 2003;
Nikolaou et al. 2004; Whitaker et al. 2005). Furthermore,
the correlation between THMs and other DBPs will be
assessed.
Initially a separate hierarchical model will be built to
describe the data originating from each of the region-
s/countries. These region-specific models will be of a similar
structure but the determinants included in the final models
of each region may differ. We will explore ways in which
these region-specific models might be combined, for
instance by including an extra level in the hierarchy of the
model structure. This extra level will allow us to explore the
variability between the regions.
Basic mixture model
For each DBP and each region we will build a separate
hierarchical model in order to describe the temporal and
Table 2 | Participants in HIWATE
Participant organisation name Short name organisation Country
Centre for Environmental Epidemiology CREAL Spain
Imperial College London Imperial United Kingdom
University of the Aegean UA Greece
National Public Health Institute KTL Finland
Vytautas Magnus University VMU Lithuania
University of Crete UC Greece
Universite´ de Rennes INSERM France
Municipal Institute of Medical Research Foundation FIMIM Spain
Centre for Genomic Regulation CRG Spain
University of Modena and Reggio UMR Italy
Istituto di Ricerche Farmacologiche ‘Mario Negri’ MN Italy
Swedish Institute for Infectious Disease Control SIIDC Sweden
Hylobates Consulting Srl HCS Italy
ICON Ltd ICON United Kingdom
Scarab Scarab Sweden
Catalan Institute of Cancer ICO Spain
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Table 3 | Studies by topic area in the HIWATE study
Exposure assessment studies Epidemiological studies Health risk assessment and management
DBP measurements in UK, France, Spain,
Greece, Italy and Lithuania (WP1)
A nation-wide study of congenital anomalies in
the UK (approx 20,000 cases and 2.5 million
births) (WP3)
A risk–benefit analysis study including
quantitative assessments of risk associated with
microbial contamination of drinking water
versus chemical risk, compare alternative
treatment options, and produce burden of
disease estimates in Barcelona, Bradford,
Rennes, Heraklion, Kaunas and Modena (WP8)
Modelling of various DBPs using data from
WP1 and information determinants of the
DBPs (WP2)
A study of congenital anomalies in the Emilia
Romagna region in Italy (approx 150,000 births)
(WP3)
A water treatment intervention study of stillbirth
and low birth weight in the UK (approx 360,000
births) (WP3)
A study of small for gestational age and
premature birth in five pregnancy cohorts in
the UK, Spain, Greece, France and Lithuania
(23,000 births) (WP4)
A review of the water and health policies in
Europe, USA and worldwide in relation to water
disinfection (WP9)
A case-control study of semen quality in the UK
(1,700 cases and controls (WP5)
A guide to best practice in terms of water
disinfection and a brief assessment of
disinfection alternatives (WP9)
A pooled analysis of European bladder cancer
studies with almost 6,000 cases and controls
(WP6)
Organise a workshop to bring together scientists
working on environmental, toxicological,
epidemiological and policy aspects of
chlorination DBPs, microbiologists, policy-
makers, and representatives from the water
industry and consumer organisations in Europe
to develop guidelines for policy across Europe
and the future research agenda (WP9)
A case-control study of colon cancer in Italy and
Spain (2,000 cases and controls) (WP7)
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Table 4 | Proposed number of samples to be collected in various regions in Europe
For which workpackage/study
Number of DBP samples
analysed by University
of Aegean, Greece
Number of samples
MX analysed by KTL,
Finland (first year)
Number of bromate
samples analysed
by KTL, Finland
Chlorite/chlorate,
analysed by University of
Modena and Reggio, Italy
WP3 congenital anomalies, Italy 20 (10 Emilia Romagna,
5 Milan, 5 Friuli)
20 (7) (10 Emilia
Romagna, 5 Milan,
5 Friuli)
20 (10 Emilia Romagna,
5 Milan, 5 Friuli)
100 chlorate Emilia
Romagna, 50 Milan,
50 Friuli
WP3 þ WP5 congenital anomalies,
low birth weight, stillbirth and semen
quality, United Kingdom
100 10 (3) 4
WP4 Birth weight and prematurity,
Bradford, United Kingdom
150 10 (1)
WP4 Birth weight and prematurity,
INMA study areas, Spain
200 10 (3) 4 Some chlorite/chlorate
WP4 Birth weight and prematurity,
Pelagie study area, Rennes, France
60 smaller network
40–80 bigger network
10 (3)
WP4 Birth weight and prematurity,
RHEA study, Crete, Greece, Evripidis,
stephanou@chemistry.uoc.gr
150 3 (3)
WP4 Birth weight and prematurity,
Kaunsas, Lithuania
144 8 (4) 4
WP6 bladder cancer areas No additional
(to be re-evaluated
for specific areas Spain)
WP7 Colon cancer, Barcelona, Spain 114 10 (3)
WP1 other, e.g. Athens 48
WP1 boiling/filter experiment To be defined
Total 1,066 81 (27) 32
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Table 5 | Sampling form
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spatial variability of the data in that region. We will follow
the basic hierarchical structure as used by Whitaker et al.
(2005) in modelling THMs. The data will be transformed so
that the values of each DBP that we model are approxi-
mately normally distributed.
In previous work modelling THMs it has been found
that a mixture model is necessary. This form of model is
particularly suited to non-normal distributions where the
underlying data may have arisen from a number of distinct
sources or populations. In Whitaker et al. 2005, the model
assigns a water source type, or some mixture of types (for
instance ground, lowland surface or upland surface), to each
water supply zone. For each DBP model we will explore the
different number of components needed in the mixture
model. It may be desirable to use jump Markov Chain
Monte Carlo techniques to allow the number of com-
ponents to be estimated in the model. For some DBPs a
mixture model may not be required at all. Seasonal variation
is then taken into account by adding a quarterly effect
common to all zones supplied by the same source type.
Furthermore, measurements under the detection limit
will be modelled to obtain an estimate between 0 and the
detection limit, rather than arbitrarily assigning a value of,
for example, half the detection limit. In this approach a
zone mean depends on measurements taken within that
particular zone and the DBP levels for water of the same
source type in other zones, taking into account seasonal
variability across the region. This model can then be used,
after it is back-transformed onto the original scale, to
predict quarterly zone specific estimates of the DBP of
interest. The model produces robust estimates for each zone
together with an estimate of the degree of uncertainty
around the estimates.
One of the main advantages of the model is that it
provides good estimates for zones where few or no measure-
ments are available. This hierarchical modelling approach
fits well into a Bayesian framework and the software
WinBUGS (Bayesian analysis using Gibbs sampling) will
be used for the estimation (Spiegelhalter 2003). These
techniques have already been successfully applied else-
where and provide a cost efficient way to provide exposure
estimates for current and past exposures for epidemio-
logical and risk assessment studies in areas where infor-
mation on potential determinants is available, but where
there is no or little information on DBP levels. In order to
visualise the modelled DBP estimates and check for any
unusual estimates or potential errors in the modelling, the
modelled quarterly zone mean DBP estimates will be
classified into exposure categories. The categorised DBP
estimate for each zone and quarter will then be mapped for
each water region, together with the raw annual mean DBP.
These will then be sent to the local water utilities for
checking.
Regression modelling
The basic model described above aims to explain geo-
graphical and seasonal variability. This model will then be
extended by incorporating factors affecting the creation of
the relevant DBP. There is a wide literature on the
determinants of DBP concentrations in water (see Sadiq
& Rodriguez 2004 for an overview).
By adding additional regression terms to the model
described above we will seek to further explain the
variability in the relevant modelled DBP. In determining
the form of these regression models we will follow the
regression mapping methodology used in this type of study
(Sadiq & Rodriguez 2004). Here, the fitted DBP levels at
each sampling point, as produced in the above hierarchical
model, are treated as fixed and become the dependent
variable in a regression analysis against possible DBP
formation determinants.
A simple statistical regression model can be expressed
in the form:
lnðCijÞ ¼ b0 þ b1vari þ b2varj þ E
where ln(Cij) denotes the log transformed exposure con-
centration, b0 the background level, varx the potential
determinant of exposure, bx the regression coefficient of
varx providing the magnitude of the effect, and E a random
variable with mean 0, often called the error term.
Further, levels can be added to take account of multi-
level effects.
Epidemiology
(III) To assess the risk of reproductive effects in relation to
disinfection practices and levels of disinfection by-products,
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epidemiological studies will be conducted to examine the
relationship between DBP exposure estimates and a
number of outcomes.
(a) Congenital anomalies, including neural tube, major
heart, major stomach wall, and urinary tract defects, cleft
palate/lip will be studied in a large, nation-wide, cross-
sectional study, using registry data in the UK, where mainly
chlorination is used as a disinfectant. The study included
over 2.5 million births and approximately 20,000 cases with
congenital anomalies. The study uses novel Bayesian
statistics for the exposure assessment modelling (Whitaker
et al. 2005). Initial results have been published and showed
no association between THMs and cleft palate/lip, abdomi-
nal wall, major cardiac, neural tube, urinary and respiratory
defects, except for a restricted set of anomalies with isolated
defects. There were excess risks in the highest exposure
categories of total THMs for ventricular septal defects, OR
(odds ratio) ¼ 1.43 (95% confidence interval (CI) 1.00–
2.04) and of bromoform for major cardiovascular defects
and gastroschisis, OR ¼ 1.18 (95% CI 1.00–1.39) and
OR ¼ 1.38 (95% CI 1.00–1.92), respectively (Nieuwen-
huijsen et al. 2008).
Congenital anomalies, including neural tube, major
heart and urinary tract defects will also be studied using
registry data in Italy in the Emilia Romagna region, where
mainly chlorine dioxide is used as a disinfectant. The study
includes around 150,000 births and will be analysed as a
case-control study (1:2 ratio). The main exposure variables
are the concentrations of some DBPs (THMs, chlorite and
bromate) in drinking water networks supplying the homes
of the mothers of cases and controls during the first
trimester of pregnancy. Moreover, other information on
determinants of DBPs will be collected. On the basis of each
subject’s home address the local water network supplying
drinking water during the period of interest will be
identified. The following data on waterworks will be
collected: type of water source, disinfection treatment and
supplied population The following analytical data will be
collected: total and individual THMs (chloroform, bromo-
form, bromodichloromethane (BDCM), chlorodibromo-
methane (CDBM)), chlorite, bromate, nitrate, residual
disinfectant, total organic carbon, oxidant power, pH and
hardness. Information on potential confounders will be
collected, such as: social and demographic variables of
mother and father (residence and address, age in years,
nationality, education, occupation, blood relationship);
reproductive history of the mother (parity, number of
previous live births, stillbirths, previous terminations);
present pregnancy (date of last menstrual period, obstetric
history, hospital admissions); termination (date…); delivery
(date, single/plural births, live birth, stillbirth, gender,
weight, length, cranial circumference); and stillbirth
(causes according to international classification of diseases
(ICD) 9).
(b/c) Stillbirth and LBW will be studied in an interven-
tion study in the North East of England in the UK, in areas
where enhanced coagulation in the water treatment plant
was installed in 2003. The rates of stillbirth and low birth
weight will be examined 3 years before and after the
intervention. In each year there are around 60,000 births.
Primary analysis will aim to determine whether there is
evidence for a reduction in the rates of stillbirth after
introduction of the new water treatment practices com-
pared with before the changes took place. Secondary
analysis will focus on specific THM species. Differences in
small-area rates of stillbirth before and after treatment
changes will be modelled against change in total and
individual mean annual THM concentrations using Poisson
regression. For each mg l21 decrease in THM concentration,
the increase/decrease in rates will be determined. In
addition, areas will be categorised into low, medium and
high change in THM concentrations and the change in rates
of stillbirth will be estimated in each category using Poisson
regression. Models will be adjusted for potential confoun-
ders such as maternal age and social deprivation (Carstairs’
deprivation score and/or index of multiple deprivation).
(d) SGA, FGR and premature birth will be studied
in five pregnancy cohorts in the UK, Spain, Greece, France
and Lithuania (Table 6), where a range of treatments
are used.
Cohort in France (Pelagie). The ongoing French epide-
miological PELAGIE study (Perturbateurs endocriniens:
E´tude Longitudinale sur les Anomalies de la Grossesse,
l’Infertilite´ et l’Enfance) is a follow up study conducted from
2002 onwards in three departments of Brittany (France):
Ille-et-Vilaine, Coˆtes d’Armor and Finiste`re. Recruitment of
study subjects finished at the end of 2005, with a population
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of 3,500 study subjects (80% participation rate). The general
objective of the study is the assessment of exposure during
pregnancy to environmental and occupational pollutants,
and evaluate the association with reproductive adverse
effects such as intrauterine growth retardation/small for
gestational age, low birth weight, prematurity and con-
genital malformations. Mothers are recruited in the first
trimester of pregnancy through a gynaecologist/obstetri-
cian, general practitioner or echographist. Then, they are
administered a questionnaire and urine samples are
collected. At birth, samples of placenta, mother hair and
cord blood are obtained. Six months after birth, a
neurological test is administered to the child. The existing
exposure assessment: 1) compares regulatory with ad hoc
measurements; 2) evaluates seasonal and geographical
variability of THM levels; and 3) evaluates the relevance
of personal habits (drinking water, showering, bathing, etc.)
in the assessment of THM exposure. In the study area, 150
tap water samples were collected: 100 during October–
November 2004 and 50 during April–May 2005. Individual
questionnaires to collect data on, for example, water
consumption, frequency and duration of showers, baths
and swimming pool attendance have been distributed.
Cohort in Spain (INMA study). The Spanish birth cohort,
called INMA—INfancia y Medio Ambiente (Environment
and Childhood), is a network of research groups in Spain
that have built up a project aiming to study the role of the
most important environmental pollutants in air, water and
diet, life-style and socioeconomic conditions during preg-
nancy and early in life and their effects on child growth and
development (Ramon et al. 2005). It is a prospective
population-based cohort study. Pregnant women are
assessed at 12, 20 and 32 weeks of gestation to collect
information about environmental exposures and foetal
growth, and to obtain maternal venous blood samples
(20ml). For the DBP analysis, the INMA project will follow
up a population sample of 2,500 pregnant mothers and
newborns recruited in four study areas: Basque country
(N ¼ 500, enrolment 2005–2007), Valencia (N ¼ 800,
2003–2005), Asturias (N ¼ 500, 2005–2007) and Saba-
dell/Barcelona (N ¼ 800, 2005–2007) (participation rate
approximately 80%). The main exposures of interest in the
study are environmental contaminants in air and water
(trihalomethanes), persistent and semi-persistent pollutants
in different biological samples, maternal occupation, diet
and dietary determinants such as antioxidants, folate and
fatty acids, genetic determinants, social determinants
including parental education, marital status, employment
status and paternal-to-child attachment and paternal
mental status. For the exposure assessment to disinfection
by-products, tap water samples will be taken from the study
areas to measure trihalomethanes. They will also collect
available data from water companies and local authorities.
The study population are administered a questionnaire
including data on water consumption and water-related
habits (e.g. showering, bathing, swimming pool use).
Cohort in Greece (Rhea study). The Greek birth cohort
was initiated on the island of Crete and will enrol all births
in one year within the prefecture of Heraklion, which
includes urban and rural areas with different water supply
sources (N ¼ 1,700). About one-third of the subjects live in
rural or semi-urban areas and about one-fifth of the
pregnant mother are recent immigrants. The existence of a
well-developed health care system in Crete provides an
Table 6 | Pregnancy cohorts included in the HIWATE study
Cohort
Total subjects with
questionnaire data
Subjects with questionnaire,
and cord and mother’s blood
Subjects with questionnaire
and only cord blood
Subjects with questionnaire
and only mother’s blood
France, Pelagie 3,500 1,500
Greece, Rhea 1,700 1,700
Lithuania, Kaunas, 4,000 4,000
Spain, INMA 2,500 2,500
UK, BiB 10,000 10,000
Total 23,000 15,500 1,500 4,000
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advantage for the identification and close follow-up of a
cohort in a relatively closed population. On the basis of
pilot studies, an 80% participation rate is expected for both
questionnaire and biological sample collection. The
majority of study subjects will be identified through four
main hospitals in Heraklion. Information will be collected
on life-style factors, occupational and environmental
exposures and nutrition, which are predominantly based
on a Mediterranean diet. Follow-up will combine compu-
terised archives with active contacts following procedures
applied in previous children cohorts in Crete. Sources of
water differ substantially in the areas of the study and will
provide a population with contrasted exposures. Analyses
of DBP levels in the past have indicated the presence of
DBPs at levels below those in other Mediterranean coastal
areas while relatively high levels of brominated compounds
have been identified. Subjects will be personally interviewed
with a computerised interview regarding sources of water,
and other habits related to use of water such as showers,
swimming pools or contact at work. Biological samples will
include blood samples from the mother, cord blood, and
child at age four, urine samples form the mother at
pregnancy, hair of the child, and toenail (mother).
Cohort in Lithuania. Kaunas is a second city of Lithuania
with 400,000 inhabitants and 4,000 births per year. The
Lithuanian epidemiological study is a population-based
cohort study that includes all pregnant Kaunas city women
in 2007–2008 (n ¼ 4,000). The main objective of the study
in Kaunas is to identify the environmental factors that are
associated with newborns’ development and early child-
hood allergy. Pregnant women will be recruited through
antenatal clinics in the city. Mothers will be identified in the
first trimester of pregnancy, mainly though a general
practitioner or gynaecologist and will be interviewed. The
health institutions in Kaunas that register mothers include
four clinical hospitals, 19 outpatient departments, nine
private treatment centres and 15 family health centres.
A second interview will take place in the four main Kaunas
hospitals’ maternity departments. Exposure assessment for
the critical trimester of pregnancy will be based on personal
information on water consumption and other THMs-related
activities obtained through questionnaire, and water work-
level information on water quality—both routinely collected
information and based on water quality analyses of THMs
and exposure modelling. There are four water utility
networks that supply underground water treated by sodium
hypochlorite. Blood samples of the mother will be collected
for genotyping. Information on potential confounders and
modifiers (health behaviour, job exposures, sociodemo-
graphic data) will be collected prospectively, during inter-
view by standardised questionnaire.
Cohort in the UK (Born in Bradford). The study popu-
lation is to be drawn from the metropolitan district of
Bradford in the UK. Bradford is the eighth most deprived
health community in the UK with an infant mortality rate
which is significantly higher than the UK average. A greater
proportion of babies born in Bradford are of low birth
weight (9.7%) compared with England and Wales as a
whole (7.5%). Nearly 50% of the 5,500 babies born each
year in Bradford are to parents of South Asian origin. The
high prevalence of low birth weight and ethnicity in the
Bradford community provides a unique setting in which to
investigate causes of foetal growth restriction and low birth
weight. Study families (mother, father and index child) will
be recruited by the Born in Bradford (BiB) prospective
cohort study. The study aims to investigate risk factors for
abnormal foetal growth and birth outcomes. Recruitment is
began in February 2007, and it is aimed to recruit 10,000
families over a 2-year period. Participants will be enrolled at
the antenatal glucose tolerance test (26–28 weeks ges-
tation).
Pooled analyses. We expect to be able to extract from the
existing cohort studies (France, Spain) and obtain from the
new cohort studies (Lithuania, Greece, UK) around 23,000
births for pooled analysis (Table 6). All subjects will have
complete questionnaire data and in most cases both cord
blood and mother’s blood will be available.
Exposure assessment. The five studies include question-
naires that cover several different areas such as socio-
demographic, life-style, nutrition, occupation, medical and
reproductive history, family history, environmental
exposures and other. The questionnaires used in the studies
in Crete and Spain are fairly similar. All studies have
information on water intake and sources of drinking water.
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In addition, all studies have information on showers, baths
and swimming pool use during pregnancy. The degree of
detail, however, of this information differs considerably
between studies, and an effort will have to be made to adapt
some of the questionnaires. One set of analyses will be
based on the average level of THMs during pregnancy based
on routinely collected THMs for regulatory purposes, and
indices based on the combination of THM measurements
and personal activities such as ingestion, showering, bath-
ing and swimming as an estimate of total dose. This analysis
will be completed with information from measured DBPs
under Work Package 1 that will include several other
compounds apart from THMs. This information will be
modelled (WP2) based on available water quality para-
meters, treatment and water source for the study regions.
Exposure categories will be formed (e.g. none, low, medium
and high) for initial analysis, followed by continuous
indices, if appropriate. The cohorts in Crete, Bradford and
Kaunas will measure many DBPs (through WP1) during the
subjects’ pregnancy, while INMA and PELAGIE have
measurements on THMs and will collect information on
many DBPs (through WP1) after the subjects’ pregnancy.
Modelling techniques will be used (through WP2) to obtain
estimates on various DBPs for all the subjects during the
whole length of pregnancy.
Various exposure indices will be used including average
exposure over the whole pregnancy and also average
exposure during the first, second and third trimesters. Use
of trimester-specific exposure estimates will allow evalu-
ation of the critical exposure window. The questionnaires of
all cohorts include information on the main confounders of
interest such as maternal age and education, socioeconomic
status, parity, smoking and alcohol consumption.
The outcomes that will be measured are:
† low birth weight (LBW)
† small for gestational age (SGA) including symmetrical
and asymmetrical SGA
† preterm delivery
† foetal growth restriction (FGR)! preferential measure
† parameters derived from the ultrasounds
In addition to DBP metabolising genes, a series of other
genes will be selected that may influence reproductive
outcomes through other mechanisms such as genes on
oxidative stress and related to the folate-mechanism (e.g
MTHFR). To interpret the function of some of these genes
information should be available through the nutritional
questionnaire on folate and multivitamin use during the
pregnancy since that may have a modifying effect. Candi-
date genes will be identified on the basis of their reported
involvement in the metabolism of DBPs (i.e. their potential
interaction with environmental exposures). The criteria
used for the selection of candidate genes will be based on
reported biological and genetic relevance (e.g. http://www.
cdc.gov/genomics): (i) evidence from epidemiologic studies
on disease association and gene–environment interaction;
and (ii) evidence of the involvement of the genes in any
reproductive outcome pathobiological pathway. Selection
of specific SNPs (single nucleotide polymorphisms) in the
genes or regions of interest will be based on established
criteria, including ethnicity, population frequency (e.g.
MAF—minor allele frequency—above 10% for most SNPs),
validation status, location and type of sequence (e.g. coding
sequences, promoter regions, 50UTR and 30UTR, splicing
regions, etc.) and reported or predicted function (e.g. SNPs
evolutionary conserved, SNPs in well-defined domains,
etc.). The final selection of genes and SNPs to be analysed
will be decided at a later stage. The genes to be analysed will
include CYPE1, GSTT1, GSTZ and others.
(e) Semen quality will be studied using an existing case-
control study (CHAPS-UK) (Clyma et al. 2008) in the UK,
where mainly chlorination is used for water disinfection.
Subjects were drawn from new patients attending fertility
clinics for investigation: sperm donors were specifically
excluded. Cases were new male patients seen at any of the
clinics over a 25 month period who had ,12 £ 106ml21
progressively motile sperm in their initial semen sample.
Around 1,700 cases and controls have been recruited. The
study uses novel Bayesian statistics for the exposure
assessment modelling (Whitaker et al. 2005) and the
exposure and health data will be linked in GIS (geographic
information system). Information on potential confounders
has been collected and the analyses of semen quality and
DBP levels will be adjusted for potential confounders in
logistic regression models. Unfortunately no information is
available on the various exposure pathways and routes and
only DBP concentrations in the water will be used as an
exposure index for the critical exposure windows.
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(IV) To assess the risk of cancer, particularly bladder
cancer and colon cancer, in relation to disinfection by-
product practices and DBP levels, including the examin-
ation of any gene–environment interactions (e.g. CYP2E1,
GSTT1).
The study will obtain risk estimates from existing case-
control bladder cancer studies in Spain, France (includes
ozonation as treatment) and Finland, and produce specific
risk estimates for Europe. The work will build on a pooled
analysis that has been conducted examining long-term
exposure to chlorination by-products by combining resi-
dential information from questionnaires with information
from water utilities gathered in six case-control studies from
the US, Canada and Europe (Villanueva et al. 2004).
It included 2,806 cases of bladder cancer and 5,254
controls. The Finnish case-control study contained 732
bladder cancer cases and 914 controls (Koivusalo et al.
1998). The French study was a hospital-based case-control
study of bladder cancer conducted between 1985 and 1987,
including 765 cases and 765 controls (Chevrier et al. 2004).
The Spanish study is the most recent and included 1,226
cases and 1,271 controls (Villanueva et al. 2007). The cases
and controls have been genotyped (e.g. CYP2E1, NAT2,
GSTM1 and GSTT1), funded by the National Cancer
Institute, and the results will be included in the current
study (Garcia-Closas et al. 2005). The current study will
compare and contract risk estimates from the above studies
and the recently conducted pooled analysis to obtain the
best or a range of risk estimates for various disinfectant
practices and DBPs for the risk–benefit analysis, including
genetically susceptible populations.
A case-control study will be conducted to examine the
relationship between DBPs and colorectal cancer in Spain
and Italy. The main aims are the evaluation of the long-term
exposure to various DBPs in the study subjects through
ingestion, inhalation and dermal absorption and the risk
of colorectal and rectal cancers associated, including
the examination of any gene–environment interactions.
There will be 500 cases and 500 controls in Italy (areas
of great Milan and the provinces of Pordenone and
Udine) and in Spain (Barcelone`s, Baix Llobregat, Valle`s
Occidental, Maresme, and Valle`s Oriental, in Barcelona
province), bringing the total study population to 1,000 cases
and 1,000 controls. Study subjects will be interviewed
face-to-face using a structured questionnaire administered
by trained interviewers. The questionnaire includes infor-
mation on socio-demographics, smoking habit, coffee and
alcohol consumption, diet, physical activity, occupational
exposures, medical history and drug use, family history of
cancer, and detailed information on water use and water-
related habits: drinking water source at each residence from
birth (municipal/private well/other); quantity and type
(bottled/tap) of water consumed, including water based
fluids (coffee, tea and herbal infusions); average frequency
and duration of showering and bathing; lifetime swimming
pool attendance; and dish washing habits. Main potential
confounders and covariates are included in both question-
naires. Each centre has included questions on other
potential risk factors that are not the main focus of this
proposal (e.g. drugs, medical history, etc.). A blood sample
will be collected from each subject. Retrospective infor-
mation on water source, treatment and quality in the study
municipalities will be obtained through a questionnaire
aimed at water companies and local authorities. Tap water
samples will be collected in the study areas to measure a
range of DBPs (as part of WP1). Retrospective DBP levels in
the study areas will be modelled on the basis of historical
data on water source and treatment (see Villanueva et al.
2006). Data on DBP levels will be combined with personal
information on water-related habits. Personal indices of
exposure to DBP through different routes (ingestion,
inhalation and dermal exposure) will be calculated. An
overall index combining different exposure routes will be
also calculated applying weighting factors obtained from
the literature (see Villanueva et al. 2006).
Polymorphisms analysed include several types of mar-
ker: SNPs (single nucleotide polymorphism), In/Del poly-
morphisms (polymorphisms of short deletions or insertions)
and large deletions (e.g. null GST alleles). The selected
study design is the ‘candidate gene approach’ based on the
analysis of those genes potentially involved in a functional
way; for the first phase of the study we will focus on those
involved in the DBP metabolism (e.g. GSTT1, CYP2E1,
GSTZ1) and in folate metabolism (e.g. MFTHR). A compre-
hensive review will be conducted to identify key genes that
may be involved in the interplay between DBP exposure
and colorectal cancer risk. Candidate genes will be selected
after discussion between partners.
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Risk assessment and management
(V) To conduct risk–benefit assessment including quanti-
tative assessments of risk associated with microbial contami-
nation of drinking water versus chemical risk, compare
alternative treatment options, and produce burden of
disease estimates (e.g. DALYs, disability-adjusted life years).
The study will build on and make use of expertise and
experience of EC-funded projects such as MICRORISK
(www.microrisk.com) and INTARESE (www.intarese.org).
The purpose of the assessment is defined as the following
research question: ‘What is the net human health impact
of microbial and disinfectant by-product contamination of
drinking water?’ The pyrkilo methodology, an open risk
assessment method, will be used to create an integrated
risk–benefit model (Tuomisto & Pohjola 2007).
We will develop an overall framework for the risk–
benefit analyses of microbial and chemical risks, specifically
for DBPs in drinking water. The framework will integrate
long-term chemical effects versus the short-term microbial
effects to make realistic comparisons. We will conduct risk–
benefit analyses, including quantitative assessments of risk
associated with microbial contamination of drinking water
versus chemical risk, compare treatment options (e.g.
chlorination, chlorine dioxide and ozonation), and produce
burden of disease estimates. The risk–benefit analyses will
be the result of integrated DPBs and microbial risk
assessments, from modelling of alternative treatment
options and from different risk–benefit metrics, including
burden of disease (e.g. DALYs). As far as we are aware only
one such study has been reported in the literature,
describing a risk–benefit model for Cryptosporidium par-
vum and bromate exposure and comparing the risks and
benefits of ozonation using disability-adjusted life years
(Havelaar et al. 2000).
The work will start with a review to identify the relevant
microbial and DBP exposures and related diseases (e.g.
infectious diarrhoea, gastrointestinal illness and reproduc-
tive and cancer outcomes, respectively). This will be
followed by an exact framing of the risk assessment (more
details in Merila¨inen et al. 2008). All DBPs from the
exposure assessment part of the HIWATE study (WP1
and 2) will be considered. Information on personal
habits including, for example, ingested amounts of water,
showering, use of filters and boiling water will be obtained
from the epidemiological studies and the EC-funded
projects MICRORISK and INTARESE, for which this
information was also collected, and from other available
studies (Barbone et al. 2002; Kaur et al. 2004; Westrell et al.
2006) and will be organised in a meaningful and coherent
framework.
DBP exposure and risk estimates, including exposure–
response relationships of DBPs will be provided by the
exposure assessment (WP1 and 2) and epidemiological
research areas (WP3, WP4, WP5, WP6, and WP7) of the
current proposal and from the literature, particularly where
pooled or meta-analyses are available (e.g. for bladder
cancer, Villanueva et al. 2004), or we have to rely on
toxicological data. The outcome data for the risk–benefit
analyses will be prioritised using set criteria. For outcomes
such as cancer, long-term exposure will be taken into
account. Where necessary, novel dose–response relation-
ships for DBPs will be derived combining data from the
epidemiological studies, from published toxicological and
other relevant studies (see e.g. Peters et al. 2005).
Exposure estimates for microbiological load will come
from routinely collected data (heterotrophic plate counts
and indicator bacteria including coliforms, Escherichia coli
and Clostridium perfringens as set out in Council Directive
98/83/EC) provided by water companies in the area, litera-
ture, or newly collected data, where necessary. The data will
be linked with failure frequency distributions by converting
indicator values into hypothetical input incidences in
the distribution network (see e.g. Westrell et al. 2003).
We will take into account the relationship with the raw
water quality and its potential content and variability of
microbial load (see e.g.Westrell et al. 2004). Dose–response
relationships will come from MICRORISK and the
literature.
The dose–response of and the barrier efficiency of
other treatment steps for several other specific microbes
causing waterborne diseases worldwide but not routinely
measured (including Campylobacteraceae, Mycobacteria,
Giardia, Cryptosporidium, protozoa and enteric viruses)
for disinfection methods will be assessed (see e.g. Persson
et al. 2005). Also, the indicator value of heterotrophic plate
counts for pathogenic waterborne bacteria will be
evaluated.
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Risk estimates for related infectious diseases will come
from the EC-funded MICRORISK, other sources or will be
derived where not available. For the risk assessment, a
combined or best dose–response will be selected based on
the ability to predict cases in an independent data set
(validation with one of the studies, see above). Before
entering the risk–benefit (or risk–risk) analysis, areas of
non-independence of the microbiological and chemical
risks will be examined (e.g. same susceptible or highly
exposed populations, correlation between high DBPs
exposure and higher microbial load). In all the above
work, variability and uncertainty will be incorporated in the
models and sensitivity analyses will be conducted on the
results.
As part of the study, the water consumption, water treat-
ment techniques, treatment performance in water works
and raw water quality will be evaluated in the case study
areas: Barcelona, Bradford, Rennes, Heraklion, Kaunas and
Modena. A few scenarios will be constructed for interven-
tion, and the difference in the outcome measures estimated:
a) change in treatment by water company; b) changes in
behaviour (e.g. change from tap to bottled water); and c) use
of point-of-use measures (e.g. filters) where they are needed
(specifically for food industry).
(VI) To review the water and health policies in Europe,
USA and worldwide in relation to water disinfection.
Best practice in terms of water disinfection and a brief
assessment of disinfection alternatives will complete the
study. A final workshop will be organised in 2010 as an
open conference that will aim to bring together scientists
working on environmental, toxicological, epidemiological
and policy aspects of chlorination DBPs, microbiologists,
policy-makers, and representatives from the water industry
and consumer organisations in Europe to provide infor-
mation for the development of guidelines for policy across
Europe and the future research agenda. Specific objectives
include: comparison of policies related to DBPs in drinking
water in Europe, North America and worldwide; review the
current literature on toxicological and epidemiological
findings of DBPs and adverse health outcomes, including
findings from the HIWATE epidemiological studies; assess-
ment of the findings of the HIWATE study in terms of
Exposure assessment
* DBP measurements
* DBP modelling
Reproductive epidemiological studies
* Birth defects and stillbirth
* Prematurity and SGA
* Semen quality
Risk/benefit analysis
Microbial vs. chemical risk
Different treatments
Susceptible populations
Policy implications
*Review of water and health
*Policy implications
Cancer epidemiological studies
* Bladder cancer
* Colon cancer
Data, models and expertise from
MICRORISK and INTARESE
Literature data on toxicology
and epidemiology
Concentration data from
water companies
Figure 1 | Linkage of work and the application of the risk assessment work into policy.
201 M. J. Nieuwenhuijsen et al. | HIWATE Journal of Water and Health | 07.2 | 2009
297
current guideline values and treatment practices in
Europe; and recommendations concerning EU legislation
regarding the Water Framework Directive, Directive
98/83/EC, and other related directives. A conceptual
model for application of the risk assessment work into
policy is given in Figure 1.
CONCLUSION
There appears to be very good epidemiological evidence for
a relationship between chlorination by-products, as
measured by THMs, in drinking water and bladder cancer,
but the evidence for other cancers, including colorectal
cancer appears to be inconclusive and inconsistent. There
appears to be some evidence for a relationship between
chlorination by-products, as measured by THMs, and small
for gestational age (SGA)/intrauterine growth retardation
(IUGR) and preterm delivery, but evidence for other
outcomes such as low birth weight (LBW), stillbirth,
congenital anomalies and semen quality appears to be
inconclusive and inconsistent. Major limitations in exposure
assessment may account for the inconclusive and incon-
sistent results in epidemiological studies, but there are
other issues such as outcome definition and bias and
confounding.
The HIWATE study brings together a number of leading
researchers in Europe to carry out the research. A concerted
European research effort has so far been lacking in this
area, resulting in a widening gap of knowledge compared
with North America. A larger number of people including
scientists, policy-makers, industry and consumer represen-
tatives will meet during the proposed open workshop
at the end of the project to produce European guidelines
and recommendations and set a research agenda for
further work.
Innovative aspects of the work include detailed
exposure assessment methods in many of the studies
taking into account not only the measurement of water
levels of many by-products but also water-related activi-
ties/pathways such as ingestion, showering, bathing and
swimming and routes (oral, skin absorption and inhala-
tion) producing integrated exposure indices, particularly
for THMs, but also other DBPs where relevant;
examination of gene–environment interaction and identi-
fication of genetically susceptible groups both in the
epidemiological and risk–benefit studies, and pooling of
studies across countries to increase the power of the
studies. It will provide new risk estimates for various
health outcomes in Europe, including not only cancer
(specifically colon cancer) but also reproductive outcomes
(specifically semen quality, foetal growth restriction,
IUGR) and improved risk estimates for various other
outcomes (congenital malformations, stillbirth, low birth
weight) in relation to DBPs in the risk–benefit study.
It will provide a framework and methodology to compare
the microbial and chemical risks, particularly DBPs, and
the risk–benefit study will include a range of DBPs rather
than using, for example, only ‘chlorinated water’ or THMs.
The gene-interaction studies may provide further insight
into the mechanisms of action. For the first time there
will be comparable data for a range of DBPs throughout
various regions in Europe. The work is expected to finish
in April 2010 and an international workshop is planned
in London a few months before the end of the project
(see www.hiwate.org for news).
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Appendix F.  
Sampling protocol for Bradford 
304
  
Water Sampling Protocol – BiB & HiWate 
Aim 
To determine chlorination disinfection by-product (DBP) levels in drinking water for Water Supply 
Zones (WSZs) which cover the Born in Bradford (BiB) study catchment area.  
 
Objectives 
1. Capture seasonal variation in DBPs for each WSZ. 
2. Capture spatial variation within each WSZ. 
 
Length of sampling programme:  2 years –to provide DBP exposure data for the whole BiB 
cohort. 
 
The Study Area 
 
 
Figure 1: The Study Area 
 
Figure 1 shows the BiB study area:  the area within the dashed black border denotes the extent of 
Bradford Metropolitan District Council, and Bradford & Airedale Primary Care Trust.  Residents of 
this area are eligible to participate in BiB.   
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The area is served by maternity services at two hospitals:  Bradford Royal Infirmary, which is 
located north-west of the city centre in the Girlington area, and the smaller Airedale General 
Hospital, which is located to the north-west of the District, at Steeton, near Keighley. 
 
On average, there are 7,100 births per annum within the Bradford & Airedale PCT, of which 5,470 
occur at Bradford Royal Infirmary and 1,630 occur at Airedale General Hospital. 
 
Mothers will be recruited to the BiB study at the antenatal clinic at Bradford Royal Infirmary only.  
It is therefore useful to know the likely catchment area of the Bradford Royal Infirmary antenatal 
clinic.  Birth data according to location of birth (either BRI or AGH) by LSOA (Lower Super 
Output Area), aggregated over calendar years 2003 to 2005 were provided by Bradford & Airedale 
PCT.  There are 307 LSOAs in the Bradford & Airedale PCT area.  Where counts of less than 5 
births per LSOA over the 3 years were observed, this information was suppressed.  Confidentiality 
meant that it was not possible for the PCT to release the mother’s residential postcode, and thus the 
births could not be mapped at postcode level. 
 
It was possible to identify the 236 LSOAs which ‘provided’ BRI with more than 5 births over 3 
years.  Overlaying these LSOAs onto a map of Bradford allowed identification of the area in which 
the majority of BiB mothers will reside. 
  
The area shaded green on Figure 1 denotes that area:  i.e that from which the majority of users of 
Bradford Royal Infirmary’s maternity services have been drawn for 2003 to 2005. 
 
The Sampling Area 
 
Figure 2:  Water Supply Zones in the region 
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Figure 2 shows water supply zone boundaries in the Bradford area.  Water to these zones is supplied 
by Yorkshire Water.  The boundaries were set in 2004, and have remained unchanged since then. 
 
 
Figure 3:  Water Sampling Area 
 
Figure 3 shows that the likely BiB catchment area (shaded light green) is covered by 9 water supply 
zones: Bradford City, Peel Park/Laisterdyke 2004, Bradford SE 2004, Bradford SW 2004, 
Shipley/Bingley 2004, Idle/Pudsey 2004, Airedale 2004, Keighley 2004, Graincliffe 2004.  These 
WSZs are edged in purple.  Sampling from these 9 WSZs will provide exposure estimates at WSZ 
level for virtually all potential BiB participants. 
 
To the south of the catchment area a very small area overlaps into Roils Head 2004 WSZ, but these 
areas contain very few residential properties, and appear to be mostly farm land.  As it is unlikely 
that any BiB mothers will reside in these areas, there is little reason to sample from this supply 
zone. 
 
It could be argued that the likely catchment area covers little of the Keighley 2004 WSZ, and that 
perhaps it is not worth sampling from this area given the small number of participants that will be 
drawn from this area.  However this WSZ does contain a residential area (Riddlesden) which 
provides a small number of births per year to BRI, but more than that, it would be useful to have 
exposures measures for this WSZ, as it is likely that people travel from surrounding areas to work in 
the town of Keighley itself, and thus measures from the Keighley WSZ will be useful to calculate 
work related exposure. 
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To the north of Graincliffe 2004 WSZ, part of the green “catchment” area falls outside the WSZs.  
This area is moorland, with only a few farm buildings.  Yorkshire Water does not supply water to 
this area. 
 
The 9 WSZs of interest are to be referred to by the following sampling site codes: 
 
Airedale 2004   ADL 
Bradford City   BCY 
Bradford SE 2004  BSE 
Bradford SW 2004  BWS 
Graincliffe 2004   GCF 
Idle/Pudsey 2004   IPY 
Keighley 2004   KLY 
Peel Park/Laisterdyke 2004 PPL 
Shipley/Bingley 2004  SBY 
 
The WSZs of interest are served by the following water treatment plants: 
 
Chellow Heights 
Graincliffe 
Embsay 
Sladen Valley 
Oldfield 
 
Table 1 shows which treatment plant supplies each of the WSZs of interest. 
 
Table 1: WSZs and their supplying Water Treatment Plant 
Supply Zone Water Treatment Plant 
Bradford City   Chellow Heights, Graincliffe 
Bradford SE 2004  Chellow Heights 
Bradford SW 2004  Chellow Heights 
Idle/Pudsey 2004  Chellow Heights 
Peel Park/Laisterdyke 2004  Chellow Heights 
Shipley/Bingley 2004  Chellow Heights 
Airedale 2004  Graincliffe 
Graincliffe 2004  Graincliffe 
Keighley 2004  Graincliffe, Embsay, Oldfield, Sladen Valley 
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Sampling Strategy – THMs, volatile DBPs and HAAs 
 
Number of samples available:  100 
 
Capturing seasonal variation in DBPs 
Tap water will be sampled quarterly in each WSZ over a period of 9 quarters, commencing June 
2007.   Proposed dates for sampling are set out in Table 2 below.  Samples will not be taken 
repeatedly from the same location in each WSZ, for each subsequent quarter.  It was decided not to 
sample repeatedly in case an anomalous sampling site was selected, which would skew all results 
for a particular WSZ. 
 
On this basis the number of samples collected would be: 
9 WSZs  x  9 quarters  =  81 samples 
 
Capturing spatial variation within WSZs: 
It is important to assess the extent of within WSZ variation in order to gauge how representative 
DBP estimates from a single sampling point are of DBP levels across the WSZ at any particular 
timepoint.   
  
By sampling at different locations within the WSZ for each subsequent quarter, spatial variation 
within the WSZ will be captured.  Modelling of the data will allow the spatial variation within each 
WSZ to be determined, independent of seasonal variation. 
 
Nonetheless, there remain 19 of the 100 available samples.  These can be used to further ascertain 
spatial variation within WSZs.  There are not sufficient to sample in two locations per quarter in 
each WSZ.  However, it will be possible to take a second sample from 2 of the WSZs for each 
quarter.  These extra samples are to be distributed as equally as possible between the 9 WSZs.  
Table 3 shows that the number of samples to be collected in each WSZ varies according to sampling 
date in order to achieve this.  On average each WSZ is to be sampled in one location for 6 quarters 
and in two locations for 2 quarters. 
 
Total number of samples:   81 + 19 = 100 
 
Table 2: Proposed sampling timetable 
Location 
No. of  
THM etc. 
samples 
No. of 
MX 
samples 
No. of 
bromate 
samples 
Sampling 
date 
Despatch 
date 
Analysis 
date 
       
Bradford 12 - - Jun-07   
Bradford 11 5 2 Sep-07   
Bradford 11 5 - Nov-07   
Bradford 11 5 - Feb-08   
Bradford 11 5 2 May-08   
Bradford 11 - - Aug-08   
Bradford 11 - - Nov-08   
Bradford 11 - - Feb-09   
Bradford 11 - - May-09   
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Table 3:  Distribution of samples by location and sampling date 
June 
2007
Sept 
2007
Nov 
2007
Feb 
2008
May 
2008
Aug 
2008
Nov 
2008
Feb 
2009
May 
2009
Total
Airedale 2 1 2 1 1 1 1 1 1 11
Bradford City 1 1 1 1 1 1 2 1 2 11
Bradford SE 2 1 1 1 1 2 1 1 1 11
Bradford SW 1 1 1 2 1 1 1 2 1 11
Graincliffe 1 2 1 1 2 1 1 1 1 11
Idle/Pudsey 2 1 2 1 1 1 1 1 1 11
Keighley 1 1 1 1 1 2 1 2 1 11
Peel Park/Laisterdyke 1 1 1 2 1 1 1 1 2 11
Shipley/Bingley 1 2 1 1 2 1 1 1 1 11
Blank for QC 1 1 1 1 1 1 1 1 1 9
Total 13 12 12 12 12 12 11 12 12 108
Sampling date
W
at
er
 S
up
pl
y 
Zo
ne
 
 
Alternative distribution strategies would be to give the extra samples to those WSZs which are 
either geographically larger and would therefore be expected to exhibit greater spatial variation in 
DBPs, or to those WSZs which have a higher population density, and thus would be expected to 
contribute more participants to the BiB project, and for whom it would be useful to have the best 
possible DBP exposure estimates. 
 
Choice of sample location 
This will be determined by Yorkshire Water’s random sample address generator.  Sample vials will 
be provided to Yorkshire Water when they are carrying out routine sampling in the water supply 
zones of interest. 
 
The sampling strategy used by Yorkshire Water for their routine monitoring is as follows: a random 
address generator is used to provide a sampling address for each WSZ.  On the whole, these are 
private residential addresses.  A Yorkshire Water Quality Control representative visits the address.  
If there is no-one in, or the resident is unwilling to let the representative collect samples, then a 
neighbouring house is used. 
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Sampling Strategy – MX and bromate  
 
Number of MX samples available:  20 
Number of bromate samples available:  4 
 
Capturing seasonal variation 
Tap water will be sampled quarterly in five WSZs over a period of 4 quarters, commencing 
September 2007.   This will capture one year’s worth of seasonal variation.  Proposed dates for 
sampling are set out in Table 1 above.  Samples will not be taken repeatedly from the same location 
in each of the five WSZs, for each subsequent quarter.  It was decided not to sample repeatedly in 
case an anomalous sampling site was selected, which would skew all results for a particular WSZ. 
 
On this basis the number of samples collected would be: 
 5 WSZs  x  4 quarters  =  20 samples 
 
Capturing spatial variation: 
With only 20 samples it is difficult to design a sampling strategy which will encompass both 
seasonal and spatial variation.  Spatial variation between five WSZs will be captured over the 4 
quarters.  Modelling of the data will allow the spatial variation within each WSZ to be determined, 
independent of seasonal variation. 
 
Choice of sample location  
 
MX 
After examining which treatment works supply each of the WSZs, five WSZs were selected to 
provide information on variation between treatment works.  Airedale and Graincliffe are both 
supplied solely by the Graincliffe works, Peel Park/Laisterdyke and Bradford South West are both 
supplied solely by the Chellow Heights works, and Keighley is supplied by 4 different works: 
Graincliffe, Embsay, Oldfield and Sladen Valley. 
 
Choice of sample location within selected WSZs same as for THMs, volatile DBPs and HAAs, i.e. 
determined by random address generator. 
 
Bromate 
Once the first set of sample results (June 07) have been received back from the lab, they will 
reviewed to identify the WSZs with the highest and lowest values for brominated DBPs, i.e. 
bromoform.  It is then these two WSZs that will be sampled from, over 2 quarters. 
 
Choice of sample location within selected WSZs same as for THMs, volatile DBPs and HAAs, i.e. 
determined by random address generator. 
 
Miscellaneous issues regarding sampling strategy 
Variation in DBP levels during week and weekend:  samples will only be collected on weekdays.  
Should there be some systematic variation in DBP levels between weekdays and weekends this will 
not be identified.  However, such variation is likely to be dwarfed by seasonal variation. 
 
Quality control 
A set of blank samples (containing RO water and the relevant preservative) will be sent with each 
set of samples to the laboratory for analysis. 
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Sample Collection method 
Samples to be collected in accordance with the HiWATE protocol: 
 
THMs, volatile DBPs and HAAs 
Samples are collected in 40 ml amber glass bottles with polypropylene screw caps and PTFE-faced 
silica septum (Supelco 23189 or SMI-Labhut 200911). 
 
Vials used for sampling is to be washed with detergent, rinsed with tap water, ultrapure water 
(Millipore: Milli-Ro 5 plus and Milli Q plus 185) and acetone (Acros Organics 177170025) and 
placed in an oven at 150 °C for 2 h. 
 
There are two categories of analysis: (i) THMs and volatile DBPs and (ii) HAAs. 
 
Samples are collected in duplicate at each sampling point for each category (so the total number of 
vials is 4). The vials are carefully filled (complete filling) so that trapping of air bubbles inside is 
prevented. 
 
Sodium sulfite (Acros Organics 424430010) (about 4 mg/40 ml sample) is used as a preservative for 
THMs and other volatile DBPs and ammonium chloride (Acros Organics 423280010)  is used as a 
preservative (about 4 mg/40 ml sample) for HAAs.  
 
After sampling, the vials are to be stored in the dark at temperatures between 0 and 4°C.   
 
MX 
The water sample is collected in normal 500 ml poly-ethylene bottles.  Airspace is left at the top of 
the bottle during sampling.  The pH of the sample is adjusted to 1.5 – 2.0 with concentrated 
hydrochloric acid as soon as possible after sampling. The amount of acid required typically varies 
between 0.6 – 0.75 ml / 500 ml depending on the original pH and buffer capacity of the sample. 
Also 6 - 7.5 ml of 1 M HCl can be used if concentrated HCl is considered too dangerous. pH has to 
be checked either with pH-meter or with pH-paper having sufficient resolution to ensure that pH is 
in the correct range. 
  
After pH adjustment the bottle is flattened slightly and capped to give space for freezing expansion, 
and frozen at -20ºC. Frozen samples can be sent in an insulated box with enough coolers (either dry 
ice or ice-packs to keep samples frozen for a few days). 
 
Bromate 
The water sample is collected in normal 50 ml poly-ethylene bottles.  Airspace is left at the top of 
the bottle during sampling.   50 µl of 5% ethylenediamine (EDA) solution is added to the 50 ml of 
water sample to quench the oxidants. 
 
After adding the quenching agent, the bottle is flattened slightly and capped to give space for 
freezing expansion, and frozen at -20ºC. Frozen samples can be sent in an insulated box with 
enough coolers (either dry ice or ice-packs to keep samples frozen for a few days). 
 
Frozen samples can be kept for at least a few weeks in the freezer allowing several samples to be 
sent together. 
 
TOC, bromide, UV-absorbance 
Water samples must also be collected for TOC, bromide and UV-absorbance analysis.  Two 500ml 
PET bottles will be filled for the bromide and UV-absorbance analyses.  One 100ml clear glass 
bottle will be filled for the TOC analysis.  Samples to be kept cool after collection.  The analysis is 
to be carried out by Alcontrol, in Rotherham, South Yorkshire.  Sample bottles to be provided by 
Alcontrol. 
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Measurements to be taken in the field 
At each sampling location, the following will also measured: 
 
Free residual chlorine will be measured with a portable colorimeter (Lovibond Comparator 2000+ 
Test Kit AF 112 A).  This kit has a range of 0.1-1.0 mg/l measured in 0.1 mg increments. Liquid 
reagents DPD No. 1 (Lovibond) are added to a vial of water, and the colour of the solution is 
inspected visually using the comparator.  According to Yorkshire Water protocol, if a sample falls 
between divisions in the range it will be assigned an intermediate value:  e.g. 0.15 mg/l if between 
0.1 and 0.2 mg/l. 
 
Water temperature will be measured with a temperature meter (Hanna HI-98128).   
 
pH for each sample will be acquired from Yorkshire Water, who have pH determined by laboratory 
analysis. 
 
Labelling 
Vials and containers are to be labelled with the following information: 
 
 EXAMPLE 
COUNTRY CODE UK 
WORK PACKAGE WP4 
CITY CODE BFD 
WATER COMPANY 
CODE YKW 
SAMPLING DATE CODE 20/04/2007 
SAMPLING SITE CODE ADL1 
PARAMETER CODE THM 
SAMPLE ID CODE A 
 
Example label: UK/ WP4/ BFD/YKW/20-04-2007/ADL1/THM/A 
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Transport of samples for analysis 
 
THMs, volatile DBPs and HAAs: 
Package will be collected by courier company from for transport by air to the Water and Air Quality 
Laboratory of the Department of Environmental Studies of the University of Aegean in Mytilene 
(Greece). 
 
University of the Aegean 
Dept. of Environmental Studies 
Laboratory of Air and Water Quality 
Theofrastou and Alkaiou 
81100 Mytilene 
Greece 
Attention to: Mr Andreas Petsas and Mrs Vicky Tsiouma 
tel. 0030 22510 36226-7 
 
MX and bromate: 
Samples for MX and bromate analysis can be stored in a freezer before sending.    Bottles will be 
packed into a cool box with ice packs.  Samples to be couriered to: 
 
Panu Rantakokko 
National Public Health Institute 
Laboratory of Chemistry 
P.O.Box 95 
70701 Kuopio 
FINLAND 
 
TOC, bromide and UV-absorbance 
Analyses for TOC, bromide and UV-absorbance are to be done by Alcontrol in Rotherham.  
Samples will be delivered to Alcontrol’s lab in Bradford.  Alcontrol’s internal courier will take 
samples to Alcontrol lab in Rotherham. 
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Appendix G.  
Analytical plan for exposure assessment and epidemiological analysis of 
fetal growth outcomes and DBP exposure in the BiB cohort 
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Analytical plan for exposure assessment and epidemiological analysis of fetal growth 
outcomes and DBP exposure in the BiB cohort 
 
 
1. Objectives 
 
1.1. To create exposure indices for epidemiological analysis (1.4) 
1.2. To describe water use patterns within the BiB cohort 
1.3. To assess which component of exposure, e.g. area-level DBP concentrations or individual-
level water use has greatest influence upon exposure. 
1.4. To assess the risk of adverse fetal growth outcomes in relation to DBP exposure in the BiB 
cohort (future work) 
 
2. Outcomes of interest for future epidemiological analysis 
 
2.1. Prematurity and gestational duration variables 
• Gestational age (GA) 
• Preterm delivery (PD): gestation length <37 completed gestational weeks 
• Very preterm delivery (VPD): gestation length <34 completed gestational weeks 
 
2.2. Fetal growth variables 
• Birth weight (BW) will be analysed as a continuous outcome 
• Low birth weight (LBW):  BW <2500g regardless of GA.  
• Very low birth weight (VLBW)- BW <1500g regardless of GA.  
• Term low birth weight (TLBW): BW <2500g after at least 37 completed weeks of 
gestation. 
• Small for gestational age (SGA) - defined as a liveborn infant below the 10th percentile 
of BW for GA by sex in a referent population. 
• Fetal growth restriction  (FGR)  ‐ FGR  is assessed by BW relative to growth potential.  
Growth potential depends on maternal characteristics (height, pre‐pregnancy weight, 
smoking),  newborn  baby  measures  (height,  weight  and  head  circumference)  and 
parental characteristics (age, height, weight). 
 
3. Data sources 
 
3.1. Routine sampling data from Yorkshire water - modelled in R to give monthly 
concentrations of TTHM, chloroform, BDCM, DBCM, and TBROM, for January 2006 to 
December 2008 inclusive.  
 
3.2. BiB baseline questionnaire data - from final questionnaire only as pilot not yet merged 
(n=4070 mothers and 4126 births (1 set of triplets, 54 sets of twins)). 
 
3.3. Matching data from eClipse - on selected outcomes/medical data for the 4126 BiB babies. 
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4. Creation of Exposure Indices 
 
4.1. Initial tasks 
 
4.1.1. Assign WSZs to each mother 
 
Home WSZ 
WSZ assigned to maternal residence given at BiB registration (~28 weeks gestation) (and 
current/most recent workplace where possible) via GIS linkage to postcodes.  
 
Work WSZs 
WSZ assigned to current/most recent workplace via GIS linkage to postcodes. 
Sensitivity analysis will exclude from epidemiological analysis women who have worked during 
pregnancy, but to whom a workplace WSZ and DBP concentrations cannot be assigned. 
 
4.1.2. Assign WSZ-specific DBP tap concentrations to each mother 
On the basis of home WSZ at registration (WSZ_H) a set of DBP concentrations (TTHM, CFM, 
DCBM, DBCM and TBROM) is assigned to each mother. This is repeated on the basis of work 
WSZ (WSZ_W), irrespective of current employment status. 
 
This assigns a set of modelled WSZ-specific monthly DBP values for 2007 and 2008 to each 
mother’s residence (and workplace). 
 
Where WSZ is outside the study area or unknown, NA values are assigned for DBP values. 
 
4.1.3. Calculate relevant exposure windows 
Pregnancy length in days is calculated from the estimated gestational age at birth, presented in 
format 39w 4d (representing 39 completed weeks and 4 days) by multiplying number of completed 
weeks by 7 and adding the extra days. 
 
Start of 1st trimester date then calculated by subtracting gestational age from delivery date: 
Delivery Date – Estimated GA at birth = Start of 1st trimester 
 
Start of 1st trimester is treated as the first complete day of exposure.  The day preceding delivery is  
treated as the last complete day of exposure.  Delivery date assumed not to be a full day of 
exposure, and therefore not included as part of the exposure window. 
 
The following variables are defined in Excel to allow the relevant time windows for each woman to 
be linked to DBP concentrations at the relevant time. 
 
Variable Calculation Meaning Coding 
T1S start of Trimester 1 = start of Trimester 1 As number of 
days since 
01/01/1900, 
where 01/01/1900 
= 1 
T1E start of Trimester 1+ 93 days = end of Trimester 1 
T2S start of Trimester 1+ 94 days = start of Trimester 2 
T2E 
start of Trimester 1+ 186 days = end of Trimester 2 
(except where GA =< 186) 
Delivery date - 1 
= last complete day of Trimester 2 
and of pregnancy 
T3S start of Trimester 1+ 187 days = start of Trimester 3 
T3E Delivery date - 1 = last complete day of Trimester 3 and of pregnancy 
DelivDate Delivery date  
 
If the pregnancy ends on or before 186 days gestation, T3S and T3E given the value NA, but 
DelivDate still represents the end of the pregnancy. 
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4.2. Calculate time-specific DBP concentrations during exposure windows 
 
For the following exposure windows: 
• Entire pregnancy 
• 1st trimester (days 1 - 93) 
• 2nd trimester (days 94 - 186) 
• 3rd trimester (days 187 – last complete day before delivery) (except where there is no 3rd 
trimester) 
At 
• Maternal residence 
• Maternal workplace (where appropriate/possible) 
 
4.2.1. Weighted average of monthly DBP concentrations: 
A weighted average DBP concentration at the tap is calculated based on the modelled monthly 
estimates.  Modelled DBP data available for each month in 2006, 2007 and 2008, thus it is possible 
to assign a full set of DBP concentrations (entire pregnancy and each trimester) to any mother who 
gave birth on or before 1st January 2009, i.e. any mother whose last complete day of pregnancy was 
on or before 31 December 2008. 
 
The weighting is based on the proportion of the trimester (or entire pregnancy, as appropriate) 
falling into each month.  Where gestation was less than or equal to 186 days (i.e. =< 2 trimesters), 
mothers were not assigned DBP values for the 3rd trimester. 
 
The basic calculation is as follows:  if date of conception is 12th Sept 2007, and 1st trimester length 
is 93 days, the weighted average TTHM concentration for 1st trimester is: 
 
= No.Days exposedSept07 / 93  x TTHMSept07 
+ No.Days exposedOct07 / 93 x TTHMOct07  
+ No.Days exposedNov07 / 93  x TTHMNov07  
+ No.Days exposedDec07 / 93   x TTHMDec07 
 
= 19/93  x TTHMSept07  
+ 31/93  x TTHMOct07   
+ 30/93  x TTHMNov07  
+ 13/93  x TTHMDec07 
 
Where No.Days exposedMonthYear represents the number of days in a given month in given year that 
fall into the relevant trimester/entire pregnancy, and TTHMMonthYear represents the modelled TTHM 
concentration in a given month in given year. 
 
The calculations are done in R. 
 
The proportion of trimester/entire pregnancy falling into each month in 2007 and 2008 is calculated 
based on completed days of pregnancy (i.e. Delivery Date is not counted).  Where Delivery Date is 
on or after 1st January 2009 the value given is NA, as it is not possible to assign DBP concentrations 
to the entire pregnancy.  Where none of the pregnancy/trimester falls into a particular month this is 
given value 0.  This gives a matrix of proportions in R. 
 
Due to varying number of days in months, and variations in trimester length (usually only for the 3rd 
trimester), it is possible for trimesters to fall across anything from 1 to 5 months.  The calculations 
allow for differing trimester lengths, and differing month lengths.   
 
This matrix is then multiplied with a matrix of DBP concentrations for each month in 2007 and 
2008.  These values are then summed to give the weighted average for each trimester and entire 
pregnancy, or NA for those delivering after 1st Jan 2009. 
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For each mother, there are 4 proportion matrices (one each for Trimesters 1, 2 and 3 and entire 
pregnancy), 5 matrices of DBP concentrations at Home (TTHM, CFM, DCBM, DBCM and 
TBROM) and 5 matrices of DBP concentrations at Work (TTHM, CFM, DCBM, DBCM and 
TBROM) (although for women to whom a Work WSZ is not assigned the DBP values are NA). In 
reality for each mother there is a 24x1 matrix of proportions multiplied by a 24x1 matrix of DBP 
concentrations.  For the most months the proportions are 0, and across the whole matrix the 
proportions always sum to 1. 
 
The above process allows calculation of the following time specific weighted average DBP 
concentrations at the tap at mother’s Home, and where appropriate at mother’s Workplace: 
 
  T1 T2 T3 Entire pregnancy 
Home 
TTHM × × × × 
CFM × × × × 
DCBM × × × × 
DBCM × × × × 
TBROM × × × × 
Work 
TTHM × × × × 
CFM × × × × 
DCBM × × × × 
DBCM × × × × 
TBROM × × × × 
 
 
 
4.3. Area-level exposure estimates: 
 
4.3.1. Based on annual average DBP concentrations (μg/l) 
 
From the modelled data, annual average concentrations (TTHM, CFM, DCBM, DBCM and 
TBROM) are calculated for each WSZ for each year (2006, 2007, and 2008), by calculating 
the arithmetic mean of monthly values for each year. 
  
For each mother, the last trimester of pregnancy is assigned an annual average 
concentration as follows: 
 
If Delivery Date fell on or before the 15th February then trimester assigned the annual 
average value from the previous year, if the Delivery date fell after the 15th February then 
trimester assigned the annual average value from the current year. 
 
Similarly for 1st and 2nd trimesters, if the trimester ended on or before the 15th February, the 
previous year’s value is assigned, and if the trimester ended after the 15th February the 
current year’s value is assigned. 
 
An entire pregnancy DBP concentration based on annual average values is calculated as the 
arithmetic mean of the three trimester-specific values. 
 
Each mother is assigned a set of annual average concentrations for each trimester for 
TTHM, CFM, DCBM, DBCM and TBROM, for home WSZ, and where appropriate, for 
workplace WSZ 
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Weighted average of home and work values according to proportion of time spent at home 
and work as per 4.3.4 below. 
 
(Annual averages are not calculated from the raw routine THM monitoring data provided by 
the water company because a) data was not available for the whole of 2008, and b) the 
distribution of samples throughout the year was sometimes uneven, any average would thus 
be skewed by over or under sampling in a particular season.  Using the modelled monthly 
estimates eliminates such problems, as the model includes a year effect, so can overcome 
problem of missing data at end of 2008, and estimates are evenly spaced throughout the 
year). 
 
4.3.2. Weighted average of monthly modelled DBP concentration over entire 
pregnancy (μg/l) 
 
• As per point 4.2.1 
• Weighted average of home and work values according to proportion of time spent 
at home and work as per 4.3.4 below. 
 
4.3.3. Weighted average of monthly modelled DBP concentration over individual 
trimesters (μg/l) 
• As per point 4.2.1  
• Weighted average of home and work values according to proportion of time spent 
at home and work as per 4.3.4 below. 
 
4.3.4. Weighting of area-level estimates for time spent at home and work: 
For women who report currently working, it is necessary to weight the area-level 
exposure indices according to time spent at Home and Work.  For those women 
with time-weighted average THM concentrations based on both home and 
workplace values, it is then necessary to take a weighted average according to time 
spent at home and work, to achieve an overall estimate of time-weighted average 
THM concentration to which these women were exposed.  It is assumed that during 
the 5 day working week, time was split equally between home and work, but the 
weekend was spent at home, thus giving a 5/14 weighting for work and a 9/14 
weighting for home.  For all other women the time-weighted average THM 
concentrations are based solely on the Home WSZ THM values. 
 
This weighting is applied to women: 
• who are currently working at the time of the BiB questionnaire AND 
• for whom a WSZ within the study area has been assigned to workplace 
AND therefore have been assigned weighted average DBP concentrations 
for the workplace. 
 
For all other women the weighting will be 100% of the home values. 
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4.4. Individual-level exposure estimates: 
 
4.4.1. Tap water ingestion (l/day) 
Calculate separately for home, work, elsewhere, then aggregate. 
 
4.4.2. Tap water exposure via showering/bathing (min/day) 
Calculate separately for showering and bathing, then aggregate. 
 
4.4.3. Swimming (min/day) 
 
 
 
4.5. Semi-individual exposure estimates: 
 
Aim:  combine weighted average DBP concentration with individual-level tap water exposure data 
to arrive at one number representing exposure during relevant exposure window 
 
4.5.1. THMs (using chloroform as an example) 
 
Ingestion of THMs - taking into account the effects of boiling and filtering 
 
Assumptions: 
 
• if woman has stated that she filters the water that she drinks, this is assumed to mean that 
she filters 100% of the cold tap water that she drinks.  All other drinks (including squash) 
are assumed to be unfiltered, as we do not have sufficient information to infer which other 
drinks may be made from filtered water, so would only introduce uncertainty, rather than 
improve accuracy of estimates. 
 
• THM concentrations are assumed to be zero for bottled water 
 
Ingestion (μg/day)  = ( 
Chloroform (μg/l) x {Cold Unfiltered Tap Water intake (l/day) + Squash (l/day)} + 
Chloroform (μg/l) x Filtering Factor x Cold Filtered Tap Water intake (l/day) + 
Chloroform (μg/l) x Boiling Factor x Hot Water-based drinks intake (l/day) 
) 
 
Ingestion is calculated separately for home, work, elsewhere, and summed to give a total daily 
ingestion estimate across all locations. 
 
Ingestion = ingestion at home + ingestion at work + ingestion elsewhere 
 
Ingestion at work is treated as zero for those women who not are currently working (i.e. not 
employed) at time of completing questionnaire.  Sick/maternity leave is ignored – assumed to have 
been working for most of pregnancy, and ingestion at work is calculated. 
 
Where work WSZ is known and has modelled THM estimates, this used to calculate ingestion at 
work, otherwise this is calculated based on home WSZ THM values. 
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Uptake of THMs from ingestion 
 
Uptake via ingestion  (μg/day)  = (Ingestion at home + Ingestion at work (μg/day)) x ingestion chloroform 
uptake factor (μg/μg/l) 
 
Calculated for chloroform, DCBM, DBCM and TBROM.   Values for chloroform and TBROM 
summed to give TTHM value.  This allows differences in uptake factors for chloroform and 
brominated THMs to be taken into account for the TTHM values. 
 
Uptake of THMs via inhalation/dermal absorption (during showering/bathing)  
 
Uptake during showering (μg/day) = Duration showering (min/day) x chloroform (μg/l) x showering 
chloroform uptake factor (μg/min /l) 
 
Uptake during bathing (μg/day)  = Duration bathing (min/day) x chloroform (μg/l) x bathing chloroform 
uptake factor (μg/min /l) 
 
Calculated for CHCl3, DCBM, DBCM and TBROM.   Values for chloroform and TBROM 
summed to give TTHM value.  This allows differences in uptake factors for chloroform and 
brominated THMs to be taken into account for the TTHM values. 
 
Uptake of THMs via inhalation/dermal absorption (during swimming)  
 
Uptake during swimming (μg/day) = Duration swimming (min/day) x chloroform (μg/l) x swimming 
chloroform uptake factor (μg/min /l) 
 
Note:  THM concentrations for swimming not based on WSZ, but take value from literature for UK 
swimming pools. 
 
Calculated for CHCl3, DCBM, DBCM and TBROM.   Values for chloroform and TBROM 
summed to give TTHM value.  This allows differences in uptake factors for chloroform and 
brominated THMs to be taken into account for the TTHM values. 
 
 
Integrated index of exposure 
 
Sum daily uptakes from ingestion, showering, bathing and swimming to give an integrated index of 
blood concentration (μg/day) 
 
Calculate the above for the: 
• Entire pregnancy 
• 1st trimester 
• 2nd trimester 
• 3rd trimester 
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Uptake factors 
Calculated from work by Backer et al.,1 Lynberg et al.2 and Aggazzotti et al.,3 using method 
described by Whitaker et al.4 
 
Activity DBP Units Uptake factor Reference 
Ingestion Chloroform  μg/(μg/l)l 0.00490196 Backer et al.1 
 BDCM μg/(μg/l)l 0.00108696 Backer et al.1 
 DBCM μg/(μg/l)l 0.00115 Backer et al.1 
 Brominated THM  μg/(μg/l)l 0.00111848 Average of BDCM and DBCM 
uptake factors (as used by 
Villanueva et al.5) 
     
Showering Chloroform  μg/(μg/l)min 0.001563091 Weighted average from Backer 
et al.1 and Lynberg et al.2 
 BDCM μg/(μg/l)min 0.001322253 Weighted average from Backer 
et al.1 and Lynberg et al.2 
 DBCM μg/(μg/l)min 0.001355042 Weighted average from Backer 
et al.1 and Lynberg et al.2 
 Brominated THM  μg/(μg/l)min 0.0013386475 Average of BDCM and DBCM 
uptake factors 
     
Bathing Chloroform  μg/(μg/l)min 0.001320755 Backer et al.1 
 BDCM μg/(μg/l)min 0.001189711 Backer et al.1 
 DBCM μg/(μg/l)min 0.001401709 Backer et al.1 
 Brominated THM  μg/(μg/l)min 0.00129571 Average of BDCM and DBCM 
uptake factors 
     
Swimming Chloroform  μg/(μg/l)min 0.002541407 Aggazzotti et al.3 – based on 
non-competitive swimmers 
Swimming Brominated THM  μg/(μg/l)min 0.0022367211 As used by Villanueva et al.6 – 
based on expert judgement 
 
Water handling parameters 
Parameter Value % reduction Reference 
Boiling 
factor 
0.08 92% Average from Krasner & Wright 2005, Weinberg et al 2006, Wu et al 
2001, Ma 2008 – average based on 2 and 5 min boiling tests.  7-10 
Filtering 
factor 
0.10 90% Average from Levesque et al 2006, Weinberg et al 2006, Eslinger & 
Weinberg 2003, Gibbons & Laha 1999, Egorov et al 2003, Ma 2008 – 
average based on all new and used, pitcher and tap-mounted tests8;10-14 
 
Although there are some differences in reduction between the 4 species of THM, they are of a 
similar magnitude, therefore for simplicity one value is applied to all THM species, for boiling and 
for filtering. 
 
Filter type is unknown in our study.  So have taken average of various filter types, e.g. tap mounted 
and pitcher filters, and at various stages of filter usage. 
 
Swimming pool trihalomethane concentrations 
 
Parameter Units Value 
Swimming pool chloroform concentration μg/l 121.1 
Swimming pool DCBM μg/l 8.3 
Swimming pool DBCM μg/l 2.7 
Swimming pool bromoform μg/l 0.9 
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Values for swimming pool concentrations taken from study by Chu & Nieuwenhuijsen15 which 
sampled from 8 swimming pools in London, UK.  The determinants of THM formation, pH, 
temperature and TOC, measured in the London swimming pools, are similar to the values for pH, 
temperature and TOC in swimming pools in the Bradford area. 
 
4.5.2. HAAs 
• Little sampling data so far, no modelling 
• Calculate exposure as per THMs, exclude non-ingestion route 
• Boiling/filtering factors  
• Uptake factors – should not be necessary as no need to integrate ingestion with other routes 
 
4.5.3. MX 
 
• Good sampling data so far, quarterly modelling should be possible 
• Calculate exposure as per THMs, exclude non-ingestion route? 
• Boiling/filtering factors  
• Uptake factors – not necessary if we can discount non-ingestion routes 
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5. Indices for use statistical analysis 
 
5.1. Exposure indices 
 
• Area-level – DBP concentrations at tap 
o Annual average DBP concentration (μg/l) 
o Weighted average of monthly modelled DBP concentration over each 
trimester/entire pregnancy (μg/l) 
 
• Individual-level – exposure to tap water 
o Tap water consumption (l/day) 
o Tap water exposure via showering/bathing (min/day) 
o Swimming (min/day) 
 
• Semi-individual DBP exposure estimates 
o THM ingestion (μg/day) 
 
o THM uptake via ingestion (μg/day) 
o THM uptake via showering/bathing (μg/day) 
o THM uptake via swimming (μg/day) 
 
o Integrated THM uptake from all sources (μg/day) 
 
 
For the following total and individual THMs: 
 
• TTHM 
• Chloroform 
• TBROM 
• BDCM 
• DBCM 
 
Exposures can be both: 
• Continuous 
• Categorical:  Low, Medium, High (cutpoints at tertiles of the exposure distribution)  
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5.2. Possible outcome measures 
 
• Continuous  (for linear regression models) 
o Birth weight 
o Term birth weight 
o Gestational age 
o Head circumference 
o Abdominal circumference 
o Ratio of head to abdomen circumference (i.e. identify those with asymmetric 
growth restriction) 
o Placental weight 
 
• Categorical (for logistic regression models) 
o Low birth weight 
o Very low birth weight 
o Term low birth weight 
o SGA based on weight 
o SGA based on head circumference 
o FGR based on weight 
o FGR based on head circumference 
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5.3. Confounders/Other variables 
• Continuous 
o Gestational age 
o Maternal age 
o Maternal height 
o Maternal weight (not pre-pregnancy, and not clear when during pregnancy this has 
been measured) 
o Maternal BMI (not pre-pregnancy, and not clear when during pregnancy this has 
been measured) 
 
• Categorical 
o Maternal age 
o Maternal active smoking during pregnancy 
 1st trimester 
 After 1st trimester 
 Average no. cigarettes per week 
o Maternal passive smoking during pregnancy 
o Maternal alcohol consumption during pregnancy  
 1st trimester 
 After 1st trimester 
o Maternal ethnicity 
o Maternal education level 
o Maternal household income (proxy for SES) 
o Maternal marital status 
o Maternal cohabiting status 
o Maternal parity 
o Sex of child 
o Maternal medical conditions, e.g. diabetes, hypertension, preeclampsia 
o Period of conception 
o Paternal height (not available for all) 
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Confounders/Other variables – coding and categorisation (continued on following pages) 
 
Variable Variable 
name 
Coding Definition n % Format 
Maternal age at 
recruitment 
(years) 
 
(DtRecruited,  
DOB) 
age age = <value> 
age = NA 
 
If age missing 
 
1 
 Continuous 
Maternal age cat_age cat_age = <20 
cat_age = 20-24 
cat_age = 25-29 
cat_age = 30-34 
cat_age = 35-39 
cat_age = ≥40 
cat_age = NA 
 
<20 
20-24 
25-29 
30-34 
35-39 
>40 
If cat_age missing 
302 
1088 
1317 
839 
450 
73 
1 
7.4 
26.7 
32.4 
20.6 
11.1 
1.8 
 
Categorical 
Maternal 
smoking 
(from G1, G2) 
smok smok =1 
smok =2 
smok =3 
smok = NA 
Current 
Previous 
Never 
If smok missing 
562 
612 
2896 
0 
13.8 
15.0 
71.2 
Categorical 
Maternal active 
smoking (G3) 
 
      
During 1st 
trimester 
asmok1 asmok1 = 1 
asmok1 = 2 
asmok1 = NA 
 
Yes 
No 
If asmok1 missing 
647 
3423 
0 
 Categorical 
After 1st  
trimester 
asmok2 asmok2 = 1 
asmok2 = 2 
asmok2 = NA 
 
Yes 
No 
If asmok2 missing 
587 
3483 
0 
 Categorical 
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Variable Variable 
name 
Coding Definition n % Format 
Average no. 
cigarettes per day 
 
During 1st 
trimester 
 
 
 
asmokcig1 
 
 
 
asmokcig1 = 1 
asmokcig1 = 2 
asmokcig1 = 3 
asmokcig1 = 4  
asmokcig1 = 5 
asmokcig1 = NA 
 
 
 
 
None 
1-5 
6-10 
11-20 
Over 20 per day 
If asmokcig1 missing 
 
 
 
3423 
255 
235 
133 
24 
0 
  
 
 
Categorical 
After 1st  
trimester 
asmokcig2 asmokcig2 = 1 
asmokcig2 = 2 
asmokcig2 = 3 
asmokcig2 = 4  
asmokcig2 = 5 
asmokcig2 = NA 
 
None 
1-5 
6-10 
11-20 
Over 20 per day 
If asmokcig2 missing 
3483 
267 
201 
101 
18 
0 
 Categorical 
Maternal passive 
smoking (G4) 
 
      
During 
pregnancy 
psmok psmok = 1 
psmok = 2 
psmok = 3 
psmok = NA 
 
Yes 
No 
Less than 1 hour per day/Occasionally 
If psmok missing 
516 
2769 
753 
32 
12.7 
68.0 
18.5 
0.8 
Categorical 
Hours per day 
passive smoking 
(G4Hrs_CLN), 
if psmok = 1 
 
psmok_hrs psmok_hrs = <value> 
psmok_hrs = NA 
 
If psmok_hrs missing or psmok ≠ 1 
509 
3561 
 Continuous 
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Variable Variable 
name 
Coding Definition n % Format 
Maternal alcohol 
consumption 
(G7_CLN, 
G7d_CLN, 
G7g_CLN) 
 
During 1st 
trimester 
 
 
 
 
 
 
alc1 
 
 
 
 
 
 
alc1 = 1 
alc1 = 2 
alc1 = 3 
alc1 = NA 
 
Set to 3 if G7_CLN = No, set to NA if G7_CLN 
or G7d/g_CLN= Don’t remember, set to NA if 
G7_CLN = NA. 
 
 
 
Yes, once per week or more 
Yes, occasionally 
No 
If alc1 missing or answered “Don’t remember” 
 
 
 
 
 
 
174 
485 
3386 
25 
 
  
 
 
 
 
 
Categorical 
After 1st trimester alc2 alc2 = 1 
alc2 = 2 
alc2 = 3 
alc2 = NA 
 
Yes, once per week or more 
Yes, occasionally 
No 
If alc2 missing or answered “Don’t remember” 
54 
444 
3539 
33 
 Categorical 
Maternal drug 
use during 
pregnancy or in 
the 3 months 
before pregnancy 
(G6) 
drug drug = 1 
drug = 2 
drug =NA 
Yes 
No 
If drug missing or answered “Don’t know” 
 
47 
4010 
13 
 Categorical 
Maternal 
education – 
Highest 
Qualification 
 
(E1) 
edum edum=1 
edum=2 
edum=3 
edum=4 
edum=5 
edum=6 
edum= NA 
 
No Qualifications 
GCSE / NVQ1-2 / Foundation/Int GNVQ 
A Level / NVQ3 / Advanced GNVQ 
First degree / NVQ4-5/ HNC/ HND 
Post-graduate qualification 
Other 
If edum missing or answered “Don’t know” 
 
See education table below for collapsed 
categories 
698 
1586 
565 
624 
271 
264 
62 
17.1 
39.0 
13.9 
15.3 
6.7 
6.5 
1.5 
Categorical 
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Variable Variable 
name 
Coding Definition n % Format 
Employment 
status 
 
(F1, F2_CLN, 
F3_CLN) 
emp emp=1 
emp=2 
emp=3 
emp=4 
emp= NA 
 
Employed – currently working 
Employed – maternity/sick leave 
Unemployed – not working 
Full-time student 
If emp missing 
 
1624 
184 
2178 
80 
4 
39.9 
4.5 
53.5 
2.0 
0.1 
Categorical 
Employment 
status 
 
(F1, F2_CLN, 
F3_CLN) 
emp2 emp2=1 
emp2=0 
emp2= NA 
 
Employed 
Not employed 
If emp2 missing 
 
1808 
2258 
4 
44.4 
 55.5 
0.1 
Categorical 
Household 
Income 
(F14) 
inc inc=1 
inc=2 
inc=3 
inc=NA 
<£11,000 
£11,000 - £24,999 
≥£25,000 
If inc missing or subject replied “Don’t know” or 
“Did not wish to answer” 
 
See income table below for how categories 
collapsed 
1017 
1180 
964 
909 
25.0 
29.0 
23.7 
22.3 
Categorical 
Gestational 
duration (weeks) 
gac gac = <value>  
 
No missing data 
  Continuous 
(decimals ok) 
Squared 
gestational 
duration (weeks) 
gacsq gacsq = <value>  
 
No missing data 
  Continuous 
(decimals ok) 
Maternal parity 
before index 
pregnancy 
parity parity = <value> 
parity = NA 
Number of previous registerable births 
If parity missing 
 
 
100 
 Continuous 
Maternal parity 
before index 
pregnancy 
cat_parity cat_parity = 0 
cat_parity = 1 
cat_parity = 2 
cat_parity = NA 
No previous registerable births 
1 previous registerable births 
2 or more previous registerable births 
If parity missing 
 
1587 
1198 
1185 
100 
39.0 
29.4 
29.1 
2.5 
Categorical 
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Variable Variable 
name 
Coding Definition n % Format 
Maternal race/ 
ethnicity 
 
(C10_CLN 
section, 
Ethnic_Category) 
ethnic ethnic = 1 
ethnic = 2 
ethnic = 3  
ethnic = 4  
ethnic = 5 
ethnic = 6 
ethnic = NA 
 
White British 
White Other 
Black or Black British 
Asian or Asian British, Pakistani 
Asian or Asian British, Other 
All others 
If ethnic missing or “Not Stated” 
 
See ethnicity table below for how these collapsed 
categories created 
1573 
96 
105 
1873 
293 
126 
4 
38.6 
2.4 
2.6 
46.0 
7.2 
3.1 
0.1 
Categorical 
Maternal marital 
status (B2) 
marital marital =1 
marital =2 
marital =3 
marital =NA 
Married or Re-married 
Never married (single) 
Separated/Divorced/Widowed 
If marital missing 
2828 
1153 
81 
8 
 
69.5 
28.3 
2.0 
0.2 
Categorical 
Maternal co-
habiting status 
(B3) 
cohab cohab=1 
cohab=2 
cohab=3 
cohab=NA 
 
Living with baby’s father 
Living with another partner 
Not living with a partner 
If cohab missing 
3428 
7 
624 
11 
84.2 
0.2 
15.3 
0.3 
Categorical 
Language in 
which 
questionnaire 
carried out 
lang lang=1 
lang=2 
lang=3 
lang=4 
lang=NA 
 
English  
Mirpuri/Punjabi 
Urdu 
Other 
If lang missing 
3305 
259 
473 
5 
28 
81.2 
6.4 
11.6 
0.1 
0.7 
Categorical 
Length at current 
address 
 
lca lca=<value> 
lca=NA 
Years at current address (decimals ok) 
If lca missing 
 
5 
 Continuous 
Length at current 
address 
 
Cat_lca cat_lca= 1 
cat_lca= 2 
cat_lca= 3 
cat_lca=NA 
Less than or equal 6 months 
Greater than 6 months, Less than or equal 1 year 
Greater than 1 year 
If cat_lca missing 
588 
587 
2890 
5 
14.4 
14.4 
71.0 
0.1 
Continuous 
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Variable Variable 
name 
Coding Definition n % Format 
Period of 
conception 
trimcon trimcon=1 
trimcon=2 
trimcon=3 
trimcon=4 
 
January-March 
April-June 
July-September 
October-December 
678 
1344 
1346 
702 
16.7 
33.0 
33.1 
17.2 
Categorical 
Sex of the child sex sex = M 
sex = F 
Male 
Female 
  Categorical 
Paternal 
education 
 
(E2) 
      
Maternal height 
(cm) 
 
height height = <value> 
height = NA 
 
If height missing 
  Continuous 
 
Maternal pre-
pregnancy 
weight 
weight weight = <value> 
weight = NA 
Not available   Continuous 
Maternal pre-
pregnancy BMI 
 
bmi bmi = <value> 
bmi = NA 
Not available   Continuous 
Paternal height 
 
fheight fheight = <value> 
fheight = NA 
Available for some but not all 
If fheight missing 
  Continuous 
 
333
  
Collapsed categories 
 
Ethnicity 
Ethnic Group as defined by BiB Qu. Code n Potential collapsed categories 
White (1669, 41.0%) 
British 
Irish 
Any other White background 
 
1 
2 
3 
 
1573 
5 
91 
 
1 
2 
2 
 
White British 
White Other 
White Other 
Mixed (67, 1.6%) 
White and Black Caribbean 
White and Black African 
White and Indian 
White and Pakistani 
White and Bangladeshi 
White and Indian Caribbean 
White and African-Indian 
Any other Mixed background 
 
4 
5 
6 
7 
8 
9 
10 
11 
 
28 
5 
2 
14 
3 
0 
0 
15 
 
6 
6 
6 
6 
6 
6 
6 
6 
 
All Others 
All Others 
All Others 
All Others 
All Others 
All Others 
All Others 
All Others 
Black or Black British (105, 2.6%) 
Caribbean 
African 
Any other Black background 
 
12 
13 
14 
 
17 
84 
4 
 
3 
3 
3 
 
Black or Black British 
Black or Black British 
Black or Black British 
Asian or Asian British (2166, 53.2%) 
Indian 
Pakistani 
Bangladeshi 
Indian Caribbean 
African-Indian 
Any other Asian background 
 
15 
16 
17 
18 
19 
20 
 
159 
1873 
94 
0 
2 
38 
 
5 
4 
5 
5 
5 
5 
 
Asian or Asian British, Other 
Asian or Asian British, Pakistani 
Asian or Asian British, Other 
Asian or Asian British, Other 
Asian or Asian British, Other      
Asian or Asian British, Other      
Chinese (23, 0.6%) 
Chinese 
Japanese 
Filipino 
Vietnamese 
Any Chinese or other background 
 
21 
22 
23 
24 
25 
 
 
4 
1 
18 
0 
0 
 
6 
6 
6 
6 
6 
 
All Others 
All Others 
All Others 
All Others 
All Others 
Other (36, 0.9%) 
Any other cultural background 
 
26 
 
36 
 
6 
 
All Others 
Not stated/missing (4, 0.1%) 27 4 NA Not stated 
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Income 
Income Group as defined by BiB Qu. Code n Potential collapsed categories 
[ 1 = less than £1,299 ] 
[ 2 = £1,300 - £2,099 ] 
[ 3 = £2,100 - £3,099 ] 
[ 4 = £3,100 - £4,199 ] 
[ 5 = £4,200 - £5,199 ] 
[ 6 = £5,200 - £6,499 ] 
[ 7 = £6,500 - £7,799 ] 
[ 8 = £7,800 - £9,299 ] 
[ 9 = £9,300 - £10,999 ] 
[ 10 = £11,000 - £13,499 ] 
[ 11 = £13,500 - £15,999 ] 
[ 12 = £16,000 - £19,999 ] 
[ 13 = £20,000 - £24,999 ] 
[ 14 = £25,000 – £29,999 ] 
[ 15 = £30,000 - £39,999 ] 
[ 16 = £40,000 - £49,999 ] 
[ 17 = £50,000 - £59,999 ] 
[ 18 = £60,000 - £69,999 ] 
[ 19 = £70,000 - £79,999 ] 
[ 20 = £80,000 or more ] 
[ 21 = Don’t know ] 
[ 22 = Does not wish to answer ] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
NA 
65 
39 
105 
54 
78 
155 
114 
163 
244 
261 
273 
325 
321 
306 
326 
167 
81 
37 
18 
29 
846 
57 
6 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3 
3 
NA 
NA 
NA 
<£11,000 
<£11,000 
<£11,000 
<£11,000 
<£11,000 
<£11,000 
<£11,000 
<£11,000 
<£11,000 
£11,000 - £24,999 
£11,000 - £24,999 
£11,000 - £24,999 
£11,000 - £24,999 
≥£25,000 
≥£25,000 
≥£25,000 
≥£25,000 
≥£25,000 
≥£25,000 
≥£25,000 
Missing 
Missing 
Missing 
 
Note:  this division of income categories give approximately equal numbers in the 3 categories (~1000), and represents Low, Medium and High incomes in 
the BiB cohort.  There may be some distortion due to the high number of women (n=846, 21%), who answered Don’t know to this question.  Those who 
answered “Don’t know” or “Did not want to answer” are classed as missing data. 
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Education 
Education as defined by BiB Qu. Code n Potential collapsed categories for variable “edum” 
E1. UK education or equivalent if overseas qualification 
[ 1 = 1 + 0 levels/CSEs/GCEs(any grades) ] 
[ 2 = 5 + 0 levels, 5+ CSEs (grade 1) 5 + GCSEs (grades A-C), School Certificate  
[ 3 = 1 + A levels/AS levels ] 
[ 4 = 2 + A levels, 4 + AS levels, Higher School Certificate ] 
[ 5 = NVQ Level 1, Foundation GNVQ ] 
[ 6 = NVQ Level 2,Intermediate GNVQ ] 
[ 7 = NVQ Level 3, Advanced GNVQ ] 
[ 8 = NVQ Levels 4-5, HNC, HND ] 
[ 9 = First Degree (e.g. BA, BSc) ] 
[ 10 = Higher Degree (e.g. MA, PhD, PGCE Post-graduate certificates/diplomas) ] 
[ 11 = Other qualifications e.g. City and Guilds, RSA/OCR, BTEC/Edexcel ] 
[ 12 = Overseas qualification ] 
[ 13 = No Qualifications ] 
[ 14 = Don’t know ] 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
NA 
 
178 
919 
50 
242 
70 
419 
273 
68 
556 
271 
264 
- 
698 
53 
9 
 
2 
2 
3 
3 
2 
2 
3 
4 
4 
5 
6 
- 
1 
7 
NA 
 
GCSE / NVQ1-2 / Foundation/Int GNVQ 
GCSE / NVQ1-2 / Foundation/Int GNVQ 
A Level / NVQ3 / Advanced GNVQ 
A Level / NVQ3 / Advanced GNVQ 
GCSE / NVQ1-2 / Foundation/Int GNVQ 
GCSE / NVQ1-2 / Foundation/Int GNVQ 
A Level / NVQ3 / Advanced GNVQ 
First degree / NVQ4-5/ HNC/ HND 
First degree / NVQ4-5/ HNC/ HND 
Post-graduate qualification 
Other, e.g. City & Guilds, RSA/OCR, 
BTEC 
No Qualifications 
Missing 
Missing 
 
Note:  Qualifications which are roughly equivalent (according to Qualifications and Curriculum Development Agency, www.qcda.gov.uk) were grouped 
together.  The only exception was for “NVQ Levels 4-5, HNC, HND” and “First Degree”, which are not strictly equivalent, but were grouped together 
because there were very few in the “NVQ Levels 4-5, HNC, HND” group, and this level of qualification represents specialised post-school education. 
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6. Statistical analysis 
 
Split into 3 sections:  descriptive analysis of water use, analysis of exposure indices, and 
regression analysis of association between DBP exposure and fetal growth measures 
 
 
6.1. Descriptive analysis of water use 
 
Aim: 
• Describe patterns of water use 
• Find any factors associated with water use, in particular, any which may confound 
association between DBP exposure and fetal growth (Maternal age, SES, ethnicity16-
18) 
 
Tasks 
 
• Stratified descriptive analysis by ethnicity, age, education, employment status, 
income. 
 
• Test of difference between strata. 
 
• Regression analysis of water use and the above demographic variables. 
 
 
6.2. Analysis of exposure indices 
 
Misclassification  
Misclassification according to various exposure indices to be assessed by comparing  
classification according to different exposure indices: 
 
Exposure Area-level Individual-level Semi-individual 
High    
Medium    
Low    
 
Also to examine correlation between various continuous indices 
 
Drivers of exposure - questions to address: 
 
• What is driving DBP exposure?  What is the most important component? 
• Area-level DBP concentrations – spatial variation 
• Temporal variation in DBP concentrations 
• Individual level variation in water use – consumption, showering, bathing 
• Between and within zone variation for area-level concentrations. 
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6.3. Future epidemiological analysis 
 
Aim: assess association between DBP exposure and fetal growth measures 
 
6.3.1. Exclusions 
• Births from residential postcodes with no matching WSZ 
• Mothers with workplaces outside the modelled area 
• Multiple births 
• Unknown values for GA, date of delivery  
 
 
6.3.2. Possible sensitivity analyses 
 
• For October-December 2008 no sampling data available, but THM values 
predicted for these months nonetheless.  Exclude those whose exposure estimates 
include these months. 
 
• Residential mobility during pregnancy: exclude those who are known to have 
moved house during pregnancy.  (The assumption is that we know they have 
moved, but either do not know when during pregnancy this has taken place, or do 
not know previous/later address to assign a WSZ). 
 
• Workplace exposure:  exclude those known to be working during pregnancy, but 
for whom workplace exposure could not be calculated (either because work 
address missing or incomplete, or workplace was outside WSZs which have been 
modelled, and thus work WSZ could not be assigned). 
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Participants’ Information Sheet: 
A study about tap water, air pollution 
and how babies grow and develop before 
birth. 
 
This information sheet gives details of a study which has been set up within the Born 
in Bradford project, which you are invited to join.  Please take some time to read the 
following information carefully. 
 
• What is this study about? 
This study is about chemicals in tap water and air, and how these might affect babies’ growth 
and development before they are born. 
 
In the BiB questionnaire you have just completed, you may recall that you were asked 
questions about how you travel, how much water you drink, and how often you shower and 
bathe.  Those questions were part of our research into this subject. 
 
This study looks at your water use in much greater detail and how and where you spend your 
time during the day, in order to investigate the possible effects of chemicals in tap water and 
of air pollution on babies’ growth during pregnancy. 
 
• Why is it important to do this research? 
We all use tap water and we all breathe in the air around us, therefore we are all exposed to 
the chemicals that exist in water and air.  With so many people potentially at risk from these 
chemicals, it is very important that we investigate any possible health effects that they may 
have. 
 
It is also really important to investigate babies’ growth and development, because we know 
that low birth-weight is associated with poorer health in later life.  If we can learn what factors 
contribute to low birth-weight then we can improve a baby’s chance of a healthy start to life. 
 
• What advantages are there to taking part? 
You get to be part of a very special group of mothers in the BiB study who will be studied in 
greater detail.  The main advantage of taking part is that you will be helping us to understand 
more about how the water we drink and use, and the air we breathe might affect babies 
during pregnancy.  You may also find that you enjoy taking part in research that could help 
mothers and babies in the future. 
 
• What will I have to do if I decide to take part? 
The study takes 8 days to complete, and the timetable on the next page shows what you 
would do on each day, if you decide to take part. 
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Day Activity required 
How long will this take 
me? 
1 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
• Place air pollution tubes inside and outside 
home 5 min 
2 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
3 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
4 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
5 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
• Researcher will visit you at home to collect 
tap water samples 15 min 
6 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
7 
• Fill in diary 5 min 
• Wear air pollution tube Just wear all day 
8 
• Complete final questions in diary 5 min 
• Collect urine sample 5 min 
• Put urine sample in post or store in your 
freezer 5-20 min 
• Put air pollution tubes in your fridge 5 min 
Pre-
arranged 
date 
• Researcher will visit you at home to collect 
diary and air pollution tubes 15 min 
 
 
Thank you for reading this Information Sheet. 
If you would like any more information about this study, or you think that you would like to 
take part, please speak with the main study researcher, Rachel Smith, or one of her 
colleagues, who are here in the clinic today. 
 
 
Miss Rachel Smith 
 
Contact Details 
 
  
 
 
 
 
 
 
Department of Epidemiology and Public Health, 
Imperial College London, 
St Mary's Campus, Norfolk Place, Paddington, 
London, W2 1PG. 
 
 Mobile: 07941 617476 
E-mail:  rachel.smith05@imperial.ac.uk 
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Recruitment Form 
 
Participant ID:  VSBIB-001 
 
 
BiB Study ID: 
 
 
Title of Project: BiB Nested Validation Study 
 
Name of Study Researcher: Rachel Smith 
 
Date of Recruitment __ __ / __ __ / __ __ 
Forenames  
Surname  
Date of Birth  
Address  
Postcode   
Preferred contact 
number 
(please tick below) 
Telephone number 
(incl. area code)   
Mobile number   
  
Agreed start date for diary __ __ / __ __ / __ __ 
Agreed date for Day 5 visit __ __ / __ __ / __ __ 
Agreed date for final visit __ __ / __ __ / __ __ 
        
345
  
 
 
Appendix J.  
Nested Validation Study protocol 
346
  
 
  
 
 
 
 
 
 
Nested Validation Study of Water and 
Air Exposures in the Born in Bradford 
Questionnaire 
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Abbreviations 
 
 
BiB  Born in Bradford 
CBPs  Chlorination By-Products 
ESRC  Economic & Social Research Council 
EXPOLIS Air Pollution Exposure Distributions within Adult Urban Populations in 
Europe 
FMU  First Morning Urine 
HiWATE Health Impacts of Long Term Exposure to Disinfection By-Products in 
Drinking Water 
LC-MS-MS Liquid Chromatography Mass Spectrometry 
NERC  Natural Enviroment Research Council 
NO2  Nitrogen Dioxide 
SPME  Solid Phase Micro-extraction 
TCAA  Trichloroacetic Acid 
US EPA United States Enviromental Protection Agency 
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Abstract 
 
This is a protocol for a nested validation study within the Born in Bradford (BiB) 
study. 
 
BiB and Imperial College London are collaborating to investigate the relationship 
between chlorination by-products (CBPs) in drinking water, air pollution and 
adverse fetal growth outcomes within the BiB study.  Information on each mother’s 
water exposure and travel patterns is currently recorded in the BiB questionnaire, 
from which her exposure to CBPs and air pollution during pregnancy can be 
calculated. 
 
Errors in exposure assessment are major source of uncertainty in epidemiological 
studies, and can reduce the power to detect associations with health, or bias the 
associations found.  It is important, therefore, to validate the BiB questionnaire to 
show that it provides reliable measures of personal exposure during pregnancy. 
 
We propose to use gold-standard methods of exposure assessment (exposure 
diaries, biomarkers and personal monitoring) in a small sub-sample of the BiB 
mothers, in order to assess the validity of responses given in the BiB questionnaire. 
 
This will allow us to quantify the uncertainty in the exposure estimates we 
calculate for each mother, and correct relative risk estimates for measurement 
error.  This will improve our relative risk estimates for adverse fetal growth 
outcomes associated with CBPs and air pollution, for the whole cohort. 
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Title: Nested Validation Study of Water and Air Exposures in the 
Born in Bradford Questionnaire 
 
 
1. Background 
 
Researchers from Imperial College London and Born in Bradford are collaborating to 
investigate the relationship between chlorination by-products (CBPs) in drinking 
water, air pollution (NO2, particles) and adverse fetal growth outcomes within the 
Born in Bradford (BiB) study.   
 
We are currently collecting data which will be used to calculate exposure measures 
to CBPs and air pollution for all mothers in the BiB study.  Information on each 
mother’s water exposure and travel patterns is being collected by the BiB team 
through the BiB Questionnaire (Sections I and F Mother’s questionnaire Version 38 
dt 3-09-2007).  This information will be combined with data on levels of CBPs and 
air pollution in the environment in the Bradford area currently being collected and 
modelled by Imperial College researchers.  This work will provide an estimate of 
each BiB mother’s exposure to CBPs and air pollution during her pregnancy. 
 
This protocol is for a validation study nested within this current work we are doing 
in the BiB study. 
 
 
 
2. Justification for this study 
 
The aim of this Nested Validation Study is to validate the questions on water and 
travel patterns in the main BiB Questionnaire, so that we can estimate the 
uncertainty in the exposure estimates we calculate for each mother. 
 
Errors in exposure assessment are inevitably a major source of uncertainty in 
epidemiological studies, and commonly act to reduce the power to detect 
associations with health, or bias the associations found. 
 
There are several ways to reduce error in exposure assessment, the most obvious 
being to use more accurate methods of assessment, such as personal monitoring, 
biomarkers and exposure diaries.  These methods are considered “gold standards” 
in exposure assessment.  However, in large studies such as BiB, especially, such 
methods are not feasible, due to high cost and burden on the participant, so 
alternatives must be used.  If these alternatives (in this case the questions on 
water and travel patterns in the BiB questionnaire) are to provide credible and 
reliable measures of personal exposure they need to be calibrated and validated 
against independent measures of exposure. 
 
This is usually done by measuring exposure using a “gold standard” method in a 
small subset of subjects from the main cohort, and comparing the measurements 
with estimates made by the study methodology.  This information can then be used 
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to improve the accuracy of exposure estimates and relative risk estimates for all 
participants in the study. 
 
This protocol is for such a validation study nested within the BiB study. 
 
We propose a personal monitoring campaign for a sample of mothers from the 
cohort, to include the following components: 
 
• a 7-day diary recording water exposure and travel-activity patterns; 
• biomarker assessment of CBP exposure; 
• tap water sampling at mothers’ homes; and 
• personal air pollution monitoring. 
 
The main BiB study will benefit from this validation study, because our relative risk 
estimates of the effects of CBPs and air pollution for the whole BiB cohort will be 
corrected for measurement error.  It will also quantify any residual uncertainties in 
the exposure estimates, and assess their possible implications for interpreting 
results from the full study. 
 
This will considerably improve our estimates of the relative risk of outcomes such 
as low birth-weight and intra-uterine growth retardation, associated with CBPs and 
air pollution.  Notwithstanding, the validation study will provide a unique database 
of exposure measurement in pregnant women.  Currently there is little information 
in this area. 
 
 
 
3. Aims & Objectives of this Validation Study 
 
Aims:  
 
a) To assess the validity of water and travel questions in the BiB 
questionnaire as measures of personal exposure to chlorination by-
products and air pollution; and 
 
b) To analyse errors in chlorination by-product and air pollution exposure 
assessment in order to correct relative risk estimates for all BiB cohort 
members. 
 
Objectives: 
 
- Detailed assessment of personal exposure to CBPs and air pollution for 50 
mothers over a 7 day period using an exposure diary, urine sampling, tap water 
sampling and air pollution monitoring. 
 
Specific to CBPs: 
 
- Validation of self-reported water use and consumption: comparison of 
questionnaire and exposure diary results. 
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- Assessment of within-subject variability in water related activities over a 7 day 
period. 
 
- Assessment of week-to-week variability in water use and consumption (if 
repeat measures are obtained). 
 
- Assessment of agreement between mother’s self-reported water use in the 
diary and corresponding biomarker levels of TCAA in urine. 
 
- Analysis of sources of error in the exposure estimates, in order to provide 
correction factors for use in the main cohort study. 
 
Specific to air pollution: 
 
- Validation of self-reported travel patterns: comparison of questionnaire and 
exposure diary results. 
 
- Validation of the exposure estimates by comparison with the personal 
monitoring and home measurements. 
 
- Analysis of sources of error in the exposure estimates, in order to provide 
correction factors for use in the main cohort study. 
 
 
 
4. Study Design & Materials 
 
At recruitment to the validation study, participants will be given a Study Pack 
containing: 
 
- Participants’ Information Sheet    (Appendix 1) 
- FAQs        (Appendix 2) 
- 7-day exposure diary     (Appendix 3) 
- 25ml universal Sterilin urine sample tube x 1 
- NO2 passive sampling tubes x 3 
 
Information/literature will be provided in English only. 
 
4.1. 7-day exposure diary 
 
7-day exposure diary (see Appendix 3) to be completed by each mother, as soon as 
possible after recruitment at Glucose Tolerance Test, for seven consecutive days.  
Participants to indicate when they will commence the diary, so that likely 
completion date is known and recorded by researcher. 
 
The diary will collect the same environmental exposure information as the BiB 
questionnaire (Sections F12-F13 (travel to work) and I1-I4 (water consumption)), 
and some additional information: 
 
4.1.1. Water/CBP related information collected in the exposure diary: 
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- Daily consumption of filtered, unfiltered and bottled water, and other 
beverages and food containing water. 
- Daily frequency and duration of showering and bathing. 
- Bathroom ventilation. 
- Duration of swimming. 
- Daily duration of washing dishes by hand 
- Daily duration of running a dishwasher 
- Daily duration of cooking involving boiling water 
- Daily duration of washing laundry by hand 
- Daily duration of bathing children 
- General habits regarding use of filtered water. 
 
This part of the diary is largely based on a diary used in a study by Kaur et al 1. 
 
4.1.2. Air pollution information: 
 
To be assessed by the time-microenvironment-activity component of the 7-day 
exposure diary which records the following information at 30 minute intervals 
throughout the day. 
 
- Travel 
- Location 
- Activities 
 
This section of the diary is based upon the EXPOLIS study diary 2. 
 
4.1.3. Confounders 
 
We are interested in subjects’ exposure to any chlorinated solvents that can be 
metabolised to TCAA (a chlorination by-product) in the body, as this may influence 
the results we get for the urine biomarker analysis. These include trichloroethylene 
and tetrachloroethylene which are used in dry cleaning and metal degreasing 
processes, and in some consumer products such as paint and varnish removers3.  At 
the end of the diary there are some closing questions which will cover exposure to 
the above chemicals over the previous week. 
 
Some medications (anxiolytics and hypnotics) contain chloral hydrate, which 
metabolises to TCAA in the body, and would thus influence TCAA biomarker in 
urine results.  However, it is recommended to avoid the prescribing of chloral 
hydrate during pregnancy4, so it is unlikely that any of the subjects in our study 
would be exposed to this potential confounder.  Thus, we conclude that it is not 
necessary to ask about current medications. 
 
The time-microenvironment-activity component of the seven-day diary collects 
information on exposure to cigarette smoke, which is known to have an adverse 
effect upon fetal growth5. 
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4.2. Air pollution monitoring 
 
Personal exposure to nitrogen dioxide (NO2) will be monitored as a marker for 
exposure to traffic-related particulates.  Participants will be instructed to 
commence wearing the NO2 tube, for 7 days, on the day they commence the 
exposure diary.  They will also be instructed to put one tube inside their house (in 
living room) and one tube outside their house (e.g. close to front door).  
Instructions will also be given for sealing and refrigerator storage of the tubes, 
pending collection, at the end of the monitoring period. 
 
4.3. Tap water samples 
 
The study researcher will visit participants at home to collect tap water samples 
from the cold tap at their kitchen sink.  These are to be taken on the 5th day of the 
diary, i.e 3 days before the urine sample is collected.  This means that comparison 
of tap and urine TCAA levels will take into account the approximate 3 day half-life 
of TCAA in the body.   
 
4.4. Urine sample for TCAA biomarker analysis 
 
Participants will provide a urine sample on the day after they complete the 
exposure diary, i.e. Day 8.  We will instruct participants to take the sample from 
first morning urine (FMU), for uniformity, and because urinary TCAA concentration 
collected in FMU samples has been validated as a biomarker for exposure to CBPs 6.  
The urine sample container will be a standard 25ml universal Sterilin container.  
Participants will be asked to record the time at which the sample is taken.  The 
sample will be refrigerated by participants, in order to minimise sample 
degradation. 
 
4.5. Collection of diary, samples and NO2 tubes at the end of the study 
 
The study researcher will visit participants on Day 8 to collect the completed diary, 
urine sample and NO2 tubes.  Urine samples will be frozen and stored at Bradford 
Royal Infirmary, until they are delivered to the Health & Safety Laboratory at 
Buxton for analysis.  NO2 tubes will be refrigerated until delivered to the AEAT lab 
for analysis. 
 
4.6. Repeated measures 
 
On the closing page of the diary, we ask subjects to indicate if they would be 
willing to repeat the study approximately 9 to 10 weeks later.  It would be 
informative to get some repeated measures on the same individuals, to allow 
assessment of week-to-week variation of water use, travel and activity patterns 
during the third trimester.  When participants repeat the study they will complete 
the diary and give a urine sample for TCAA biomarker analysis, but there will be no 
personal air pollution monitoring, nor will tap water samples be collected.  This is 
due to limitations on funding for air pollution monitoring and tap water analysis. 
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5. Laboratory Analysis 
 
5.1. Urine samples 
 
Urine samples will be transported to the Health & Safety Laboratory in Buxton, 
Derbyshire.  Samples will be transported in a cool box to keep them frozen until 
they arrive at the lab.  Samples to be analysed for trichloroacetic acid, a good 
biological marker of trichloroacetic acid in drinking water 7. The samples will be 
analysed according to a modified version of US EPA Method 552.28 that employed 
the use of solid phase microextraction (SPME) 8.  The method of analysis for TCAA is 
solid phase extraction followed by LC-MS-MS (Liquid Chromatography-Mass 
Spectrometry).  The minimum sample volume required for analysis is 5ml. 
 
A detailed description of the method of analysis is available in Appendix 4. 
 
Samples will also be analysed for creatinine.  Urinary TCAA concentration is 
affected by the rate of urine production.  TCAA concentration can be corrected for 
creatinine excretion (which is an indicator of rate of urine production)9. 
 
Once analysed, the urine sample will be destroyed. 
 
5.2. Tap water samples 
 
Tap water samples will be couriered to the HiWATE lab at the University of the 
Aegean, Greece, for analysis in accordance with HiWATE protocol.  Samples will be 
analysed for a range of CBPs, including trihalomethanes, and haloacetic acids.  
Samples will be analysed within 14 days of collection. 
 
A detailed description of the methods of analyses is given in Appendix 5. 
 
5.3. NO2 monitoring tubes 
 
NO2 monitoring tubes will be couriered to the analytical lab at AEAT Harwell for 
analysis.  Analysis will be in accordance with the procedures used in the national 
survey. 
 
 
 
6. Sample Size Calculation 
 
We are limited by the fact that we have funding for the analysis of only 150 
personal NO2 monitoring tubes (3 per study pack). 
 
This allows us to recruit a sample size of n = 50, which would enable us to: 
 
i) Detect a correlation of at least 0.45 between questionnaire and diary 
responses, with 90% power and a significance level of 0.05, against a null 
hypothesis of zero correlation 10. 
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ii) Detect a correlation of at least 0.65 to within 0.2 either way (i.e. if we 
observe a correlation of 0.65, then the true population correlation 
coefficient lies within 0.45 to 0.85, with 95% confidence).  As correlation 
increases from 0.65 the confidence interval would narrow.  If correlation 
was below 0.65, then the confidence interval would widen. 
 
Previous studies have demonstrated reasonably good correlation between 
questionnaire and diary responses in relation to water exposure, with correlation 
coefficients largely ranging between 0.5 to 0.8 11-14. 
 
Given that we would expect to achieve correlation coefficients in line with 
previous studies, a sample size of 50 should provide sufficient power to detect 
agreement between questionnaire and diary responses. 
 
 
 
7. Subject Selection & Recruitment 
 
We aim to have 50 subjects in the final analysis.  Given possible dropout/non-
compliance we will aim to recruit more than 50. 
 
7.1. Recruitment Process 
 
Recruitment will take place at the BiB antenatal clinic at Bradford Royal Infirmary.  
Every mother who attends the antenatal clinic for the Glucose Tolerance Test, and 
enrols in BiB, during our two, week-long, recruitment sessions, one in February and 
the other in May, will be offered the opportunity to take part in this Validation 
Study.  We will ask the BiB study administrator to hand the Participant Information 
Sheet about this study to each mother, on completion of the BiB questionnaire.  
The validation study researchers will be on hand in the waiting room to answer any 
questions and to see who is willing to take part.  Those who agree will be asked to 
complete a recruitment form (see Appendix 6), and the study researcher will then 
go through the study pack with the participant and explain how the study should be 
carried out. 
 
7.2. Inclusion Criteria 
 
Subjects must have already agreed to participate in the main BiB study, and thus 
will already meet all BiB eligibility criteria.   Subjects must also reside in the 
catchment area that has been defined for the environmental air pollution 
monitoring that we are carrying out in parallel with this study (see area shaded 
pink on map in Appendix 7). 
 
7.3. Exclusion Criteria 
 
Approximately 12 to 15% of those recruited to the BiB study do not speak or read 
English.  Individuals who have insufficient reading, writing and speaking ability in 
English will be excluded from the study.  This is due to lack of funds for translation 
services.  The validation study relies on self-administration of a 7-day exposure 
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diary and sample collection.  It is necessary that participants have adequate 
abilities in English, in order for the study to be carried out successfully. 
 
7.4. Withdrawal of Subjects 
 
The FAQ Sheet states that participants are free to withdraw from the study at any 
time. 
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8. Data collection 
 
The table below summarises the data to be collected: 
 
Data Source Data collected 
by whom? 
Data 
collected 
when? 
Why is this data required? 
BiB Identifier, 
Name, 
Date of Birth 
Recruitment 
form 
Researcher At 
recruitment 
To allow linkage between BiB 
outcomes and environmental 
exposure validation. 
 
Address Recruitment 
form 
Researcher At 
recruitment 
To allow GIS linkage to modelled 
area-level environmental data on 
CBPs and NO2.  
 
Water Use & 
Consumption 
7-day 
exposure 
diary 
Participant Day 1-7 To allow calculation of individual 
water exposure.  To be compared 
with responses supplied in the BiB 
questionnaire. 
 
CBP level in 
tap water 
Sample of 
tap water 
Sample collected 
by researcher. 
 
Data collected by 
HiWate lab. 
Day 5 To be combined with reported 
water exposure in diary – and then 
compared with exposure estimate 
calculated from BiB questionnaire 
and area-level modelled CBP 
levels. 
 
TCAA in urine Sample of 
urine. 
Sample collected 
by participant. 
 
Data collected by 
Health & Safety 
Laboratory 
 
Day 8 To be compared with exposure 
estimate calculated from BiB 
questionnaire and area-level 
modelled CBP levels.  
 
Personal NO2 Monitoring 
tube 
Sample collected 
by participant. 
 
Data collected by 
AEA lab. 
 
Day 1-7 To allow calculation of personal 
exposure to NO2. 
Home internal  
NO2 
Monitoring 
tube 
Sample collected 
by participant. 
 
Data collected by 
AEA lab. 
 
Day 1-7 To allow calculation of NO2 
exposure within home 
environment. 
Home external 
NO2 
Monitoring 
tube 
Sample collected 
by participant. 
 
Data collected by 
AEA lab. 
 
Day 1-7 To allow calculation of NO2 
exposure in external home 
environment. 
Time-micro-
environment-
activity 
patterns 
7-day 
exposure 
diary 
Participant Day 1-7 To allow calculation of individual 
exposure to air pollution, including 
NO2.    To be compared with 
responses supplied in the BiB 
questionnaire. 
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9. Data handling and record keeping 
 
9.1. Responsibility 
 
Responsibility for the data to be generated from this study will lie with the 
following researchers at Imperial College, London: 
 
• Professor David J Briggs 
• Professor Mark J Nieuwenhuijsen 
• Dr Mireille B Toledano 
 
9.2. Confidentiality 
 
Names and addresses of participants will be recorded on the recruitment form.  No 
names or addresses will be recorded on diaries or sampling tubes.  Each study pack 
will be given a unique identifier number, which will be printed on recruitment 
form, diary and sample tubes.  This will allow us to link diaries and sampling tubes 
with participant details. 
 
This means that diaries and samples will not be participant identifiable without 
access to recruitment form.  Recruitment forms will be stored separately from 
diaries and results of sample analysis. 
 
In order to calculate exposure estimates, CBP and NO2 measurements must be 
linked to participants’ address and postcode at some point – which does make that 
information potentially identifiable.  However, these potentially identifiable data 
do not relate to any personal or medical condition of the participant, merely to 
levels of environmental risk factors in that particular participant’s residence and 
close environment.  Once linkage has been carried out, address and postcode data 
will be removed in order to make the study results anonymous. 
 
Linkage of these validation study results to health outcomes recorded in the BiB 
study, will occur at a later stage, in collaboration with BiB. 
 
9.3. Computerised records 
 
Data from paper records will be put in to a computer database.  There will be two 
separate databases.  One will link unique participant identifier to name and 
address of subject, the other linking the unique participant identifier to validation 
study exposure data collected. 
 
9.4. Location 
 
Paper records will be kept in locked cabinets at the Department of Epidemiology 
and Public Health, Imperial College, London.  Recruitment forms will be kept in 
separate cabinet to all study results so that results are not participant identifiable.  
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9.5. Retention 
 
Data will be retained for 3 years after publication of study results.  All data will be 
stored and used in accordance with the Data Protection Act 1998. 
 
 
 
10. Data Analysis 
 
The statistical analysis of the validation study will have the following major 
strands: 
 
10.1. New variables will be aggregated from the data, e.g.  total tap water intake, 
total water consumed at home15.  Basic descriptive statistics will be 
generated. 
 
10.2. Calculation of day-to-day, weekday-to-weekend, and workday-to-non-
workday variation within the diary. 
 
10.3. Assessment of agreement between questionnaire and diary responses 
through the calculation of various measures, e.g. correlation coefficients 
and difference-mean plots 16. 
 
10.4. Calculation of agreement between tap water levels and biomarker levels of 
TCAA in the validation study participants using Pearson’s correlation 
coefficient. 
 
10.5. If we manage to collect sufficient repeated measures (participants who 
agree to complete the validation study twice), we will assess the 
reproducibility of the diary data.  Calculation of the intraclass correlation 
coefficient (ICC) indicates the within subject variance (i.e. the random 
error in diary responses). 
 
10.6. Correction of main cohort relative risks for measurement error using 
validation data. 
 
The analysis of agreement between questionnaire and diary responses gives 
an indication of the uncertainty involved in the risk estimates produced.  It 
is sometimes possible to correct relative risks for measurement error.  This 
involves establishing a relationship between the surrogate exposure 
(calculated from questionnaire data) and the “true” exposure (calculated 
from exposure diary data). 
 
Various methods exist for the correction of risk estimates for measurement 
error, e.g. linear imputation17, maximum likelihood approximation17, and 
Bayesian methods18.  Several methods will be used, in order to investigate 
the most suitable method, for this particular dataset. 
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Analyses will incorporate adjustment for confounders, such as smoking and 
ethnicity. 
 
Statistical packages to be used:  R and WinBUGS. 
 
Selection of subjects to be used in statistical analyses: all eligible subjects. 
 
 
 
11. Reporting of Results 
 
Results will be reported in a PhD thesis to be written by the study researcher, 
Rachel Smith, and in scientific papers submitted to peer-reviewed journals.  
Results may also be incorporated in the HiWate pooled study on CBPs and low birth 
weight/intra-uterine growth retardation. 
 
 
 
12. Study Completion 
 
The study will be regarded as complete when 50 study packs have been successfully 
completed, i.e. diaries filled in and required samples provided.  We also expect to 
get some repeat study packs (excluding NO2 tubes and tap water samples) from 
some of those participant recruited in the first batch in February. 
 
 
 
13. Limitations 
 
Lack of funding for language translation/transliteration for this study will mean 
that it is limited to those who are able to speak and read English, which may mean 
that our validation study population is not wholly representative of the main BiB 
cohort. 
 
We have funding for the analysis of 150 NO2 monitoring tubes.  This limits us to a 
sample size of 50 participants (each study pack contains 3 NO2 tubes). 
 
 
 
14. Personnel 
 
The researchers who will carry out the day-to-day running of this study are: 
 
Miss Rachel Smith and Mrs Sirinath Jamieson. 
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15. Funding 
 
Administration of the study, analysis of urine samples and NO2 tubes are funded by 
a grant from NERC (Natural Environment Research Council) for research into 
environment and health. 
 
One of the study researchers, Rachel Smith, is funded by an ESRC (Economic & 
Social Research Council) 3 year PhD studentship. 
 
The tap water sampling and analysis is funded by the HiWate (Health Impacts of 
Long-Term Exposure to Disinfection By-Products in Drinking Water) project, which 
is itself funded by the 6th Framework Programme of the European Union. 
 
 
 
16. Timescale 
 
16.1. Pilot of study pack:  December 2007 
 
16.2. Recruitment 
Recruitment is to be carried out in 2 sessions: likely dates are February and May 
2008.  It is envisaged that 5 days be spent recruiting at BiB clinic, each time aiming 
to recruit approximately 30 participants. 
 
16.3. Sample and diary collection 
The study researchers will spend the week immediately following each recruitment 
week following up/collecting samples and diaries from participants. 
 
16.4. Laboratory Analysis 
 
To be conducted immediately following collection of samples from participants. 
 
16.5. Statistical Analysis 
 
Steps 10.1 to 10.5 to be conducted upon receipt of the all completed exposure 
diaries and sample results, and receipt of BiB questionnaire data for the Validation 
Study participants. 
 
Step 10.6 - use of validation study results in the analysis of the main BiB study 
results on CBPs/air pollution and fetal growth; to be conducted after linkage of 
results to BiB health outcome data. 
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Appendix K.  
7-day exposure diary 
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Participant ID: «Sample_ID_No»   BiB Nested Validation Study 
 
 
 
 
 
Study Instructions and Diary Booklet 
 
 
Thank you for agreeing to take part in this study. 
 
 
 
HOW AND WHEN DO I FILL IN THE DIARY? 
 
Please complete this diary when you are in your normal routine (so not when you are 
on holiday, or feeling poorly, for example). 
 
There are two pages to complete each day – one page asks about liquid 
consumption and contact with water and the other about how you travel and where 
you spend most of your time. 
 
• Start filling in the diary on  ______________________________ 
• Put the date at the top of each diary page. 
• Give the required information on activities carried out EACH day. 
• Please try to be as accurate as possible. 
 
• Record your liquid consumption using the units below: 
 
GLASS MUG BOWL 
200 ml 200 ml 400 ml 
(cereal bowl size) 
 
If you think the glasses, mugs and bowls that you generally use are very differently 
sized to those shown above, please use a measuring jug to see how much water 
they hold, and make a note of their volumes here: 
 
Glass =…………………ml 
 
Mug =…………………ml 
 
Bowl =…………………ml 
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WHAT DO I DO WITH THE AIR POLLUTION TUBES I HAVE BEEN GIVEN? 
 
Detailed instructions can be found on the sheet provided with the tubes.  
Please follow those instructions and fill in the details requested. 
 
The air pollution tube instructions are summarised briefly below: 
 
1. When you get home, place the bag containing the tubes in your 
refrigerator. 
 
2. On the day you start the diary, would you please: 
 
• Wear one tube outside your clothes every day for 7 days – only take it off if 
you have a shower or bath, go swimming and when you go to bed.  (If you 
forget to wear the tube, just make a note of this on the relevant day in the 
diary) 
 
• Place one tube in your living room and stick one tube to the outside of a 
downstairs window at your home.  Leave them there for SEVEN days – try not 
to move them at all. 
 
 
 
WHAT DO I HAVE TO DO FOR THE REST OF THE WEEK? 
 
1. Leave the tubes inside and outside your house for 7 days.  Wear the tube 
outside your clothes for 7 days. 
 
2. One of the researchers (Rachel or one of her colleagues) will contact you to 
arrange the most convenient time to call in and see you for about 15 minutes 
to collect tap water samples. 
 
3. On DAY 5 - Please wait in for Rachel to collect some samples of water from 
your kitchen tap. 
 
4. On DAY 8 – Please collect a urine sample when you get up in the morning.   
Please put the urine sample in the freepost packaging provided and put in the 
post.  If you are unable to take it to the post on this day, please put the urine 
sample in your FREEZER. 
 
Please put all 3 air pollution tubes in your FRIDGE. 
 
5. On a pre-arranged date, after you have finished the study - Please wait in 
for Rachel to collect the air pollution tubes from your fridge, and the diary.  If 
you have stored the urine sample in the freezer, Rachel will collect this also. 
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There are a few one-off questions that we would like you to answer before you 
start the study: 
 
Filtered and Unfiltered Tap Water 
We need to know whether the tap water you drink and cook with is filtered.  Please 
circle the correct answers below. 
 
1. Do you have a water filter on your kitchen tap at home? Yes No Don’t know 
2. Do you use a freestanding filter (e.g. Brita filter jug) at home? Yes No Don’t know 
 
If you answered Yes to the Question 2, please answer questions 3 and 4. 
 
If you answered No or Don’t know, please go straight to question 5. 
 
3. 
When you make hot drinks such as tea, or 
when you make a glass of squash, do you take 
the water from the filter jug? 
Always More than ½ the time 
About ½ 
the time 
Less than 
½ the time Never 
4. When you cook with water do you take the water from the filter jug? Always 
More than 
½ the time 
About ½ 
the time 
Less than 
½ the time Never 
  
5. Do you have a water filter on your tap at work or college? Yes No Don’t know 
6. Do you use a freestanding filter (e.g. Brita filter jug) at work or college? Yes No Don’t know 
 
If you answered Yes to the Question 6, please answer questions 7 and 8. 
 
If you answered No or Don’t know, please go straight to question 9. 
 
7. 
When you make hot drinks such as tea, or 
when you make a glass of squash at work, do 
you take the water from the filter jug? 
Always More than ½ the time 
About ½ 
the time 
Less than 
½ the time Never 
8. If you cook with water at work do you take the water from the filter jug? Always 
More than 
½ the time 
About ½ 
the time 
Less than 
½ the time Never 
 
Cooking and Heating 
Please circle the correct answers below. 
 
9. Does your cooker at home use gas or electric? Gas Electric Both Don’t know 
10. Is the hot water boiler / central heating system in your home powered by gas or electric? Gas Electric Both Don’t know 
11. Do you have a gas fire at home? Yes No   
12. Do you have an open wood burning fireplace at home? Yes No   
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Day 1    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
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Day 1 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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Day 2    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
room is 
smokingbus train cooking
06
07
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09
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11
MIDDAY
12
16
17
18
19
LOCATION TRAVEL
05
HOME WORK OTHER
01
02
03
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Day 2 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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Day 3    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
room is 
smokingbus train cooking
06
07
08
09
10
11
MIDDAY
12
16
17
18
19
LOCATION TRAVEL
05
HOME WORK OTHER
01
02
03
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Day 3 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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Day 4    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
room is 
smokingbus train cooking
06
07
08
09
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MIDDAY
12
16
17
18
19
LOCATION TRAVEL
05
HOME WORK OTHER
01
02
03
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Day 4 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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Day 5 
 
 
 
 
REMEMBER:  THE RESEARCHER WILL VISIT 
TO COLLECT TAP WATER SAMPLES TODAY
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Day 5    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
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smokingbus train cooking
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Day 5 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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Day 6    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
room is 
smokingbus train cooking
06
07
08
09
10
11
MIDDAY
12
16
17
18
19
LOCATION TRAVEL
05
HOME WORK OTHER
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02
03
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Day 6 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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Day 7    Date: ………………………. 
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Tick the boxes that apply to you for each 30 minute time slot
TIME ACTIVITIES
I am currently at… I am travelling by… I am… Someone in 
the same 
room is 
smokingbus train cooking
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MIDDAY
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16
17
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19
LOCATION TRAVEL
05
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Day 7 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Duration (minutes) 
Did you wear gloves?
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
  
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Duration 
(minutes) 
Time spent in 
bathroom afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
     
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
 
 
DON’T FORGET – Tomorrow morning please collect a urine sample, the first time you 
go to the bathroom after you wake up.  Instructions are on the next page. 383
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Day 8    Date: ………………………. 
 
 
 URINE SAMPLE COLLECTION  
1. Please collect a sample of your urine in the clear plastic 
specimen tube provided, the first time you go to the 
bathroom after you wake up. 
 
It is not necessary to completely fill the specimen tube. 
 
Screw the lid on firmly. 
 
Please record here the time you collected this sample. 
Time of urine sample collection: 
 :
 
 
 
2. 
 
 
WHAT DO I DO WITH THE URINE SAMPLE NOW? 
 
 EITHER POST: 
 
Put urine specimen tube in orange tube provided and 
screw the lid on firmly. 
 
 
 
 
 
Place orange tube in plastic white and green freepost 
envelope.  The postage is already paid for, so you do not 
need to use a stamp.  Seal the envelope. 
 
 
 
 
 
Take this envelope to your local post office and put in the 
post today. 
 
PLEASE NOTE:  It is very important that if you 
choose to post this urine sample that you do so 
TODAY, i.e. the same day that you collect the 
sample. 
 
 
 
 
 
 
 
 
 
 
 
 OR STORE: 
 
Place the urine specimen tube inside the plastic bag provided and put in your FREEZER.  
(The urine specimen tube will withstand freezing). 
 
The researcher will collect this sample from your freezer on her final visit to you. 
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AIR POLLUTION TUBES 
 
Have you remembered to put the air pollution tubes in the refrigerator this 
morning?  If not, please do so now, and fill in the air pollution tube record 
sheet with the date and time. 
 
 
There are some final questions we would like you to answer to finish 
the study. 
Please circle the answers. 
 
13. Have you visited, or worked in, any of the following industries during the past week? If Yes, please indicate the date(s) and duration of activity. 
    Date(s) Duration (mins) 
a) Dry cleaners Yes No   
b) Metal manufacturers Yes No   
c) Auto parts Yes No   
d) Textile production Yes No   
e) Paint production Yes No   
f) Printers Yes No   
 
14. Does anyone living in your household currently work in the dry cleaning industry? Yes No 
 
15. Have you used, or come into contact with, any of the following during the past week? If Yes, please indicate the date(s) used and duration of use, and fill in the name and manufacturer of the product used. 
   
 
Date(s) Duration (mins) 
Product 
Name Manufacturer 
a) Correction Fluid (e.g. Liquid Paper, Tipp-Ex) Yes No     
b) Carpet/Rug Cleaner Yes No     
c) Stain Remover Yes No     
d) Paint or Varnish Yes No     
e) 
Paint / Varnish Thinners or 
Removers 
(excl. nail varnish remover) 
Yes No     
f) Glue or Adhesive Yes No     
g) Pesticides Yes No     
h) Disinfectants Yes No     
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16. If you have a gas fire at home, have you used it during the past week? Yes No 
17. If you have an open fireplace at home, have you had an open wood burning fire during the past week? Yes No 
 
We would like participants to repeat the questions about liquid consumption 
and water contact, and to give a further urine sample, at a later stage in 
pregnancy. 
 
18. Would you be willing to repeat this part of the study again in 8 to 9 weeks’ time? Yes No 
 
If you answered Yes, the researcher will contact you to arrange for a new study 
pack to be delivered to you at the beginning of May. 
 
 
COLLECTION OF THIS DIARY AND THE AIR POLLUTION TUBES 
The researcher will visit you on the date she has pre-arranged with you, to 
collect this diary and the air pollution tubes.  The researcher will also collect 
the urine sample if you have stored it in the freezer. 
 
 
 
Thank you for taking part in this study ☺ 
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Appendix L.  
Water diary page for Phase 2 
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Day 1 
 
 
LIQUID CONSUMPTION Units today At home At work/ college Elsewhere 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tap Water Glasses    
Filter Jug Tap Water Glasses    
Bottled Water 
(incl. from a water cooler) Glasses    
Tea  (any sort) Mugs    
Coffee Mugs    
Hot Chocolate made with water Mugs    
Hot Chocolate made with milk Mugs    
Plain milk Glasses    
Squash/cordial (e.g. drinks which you 
dilute with water) Glasses    
Fruit juice (not cordial) Glasses    
Soft drinks (e.g. Coca-Cola) Glasses/Cans*    
Beer Pints/ ½-pints/ Cans/ Bottles *    
Wine Wine glasses    
Spirits Measures    
Homemade soup Bowls / Mugs *    
Powdered soup to which you have 
added water (e.g. Cup-a-soup) Bowls / Mugs *    
Soup from can or carton 
(i.e. not powdered) Bowls / Mugs *    
Pot Noodle Pot    
*delete as appropriate    
IN THE KITCHEN / HOUSEWORK Total duration today (minutes) 
Did you wear gloves? 
(please circle) 
Cooking involving boiling water    
Washing dishes up by hand (excl. drying)  Yes No 
Running a dishwasher    
Washing clothes by hand  Yes No 
   
WASHING YOUR 
BODY AT HOME 
No. of 
times 
today 
Total duration 
today 
(minutes) 
Total time spent 
in bathroom 
afterwards 
(minutes)
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING YOUR 
BODY AWAY FROM 
HOME (e.g. at swimming 
pool, religious cleansing) 
No. of 
times 
today 
Total duration 
today 
(minutes) 
Total time spent 
in bathroom 
afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Shower    Open Shut On Off 
Bath    Open Shut On Off 
   
WASHING OTHERS 
AT HOME 
No. of 
times 
today 
Total duration 
today 
(minutes) 
Total time spent 
in bathroom 
afterwards 
(minutes) 
Bathroom window 
open or shut? 
(please circle) 
Extractor fan 
on or off? 
(please circle) 
Bathing children    Open Shut On Off 
   
SWIMMING Duration of session (minutes) 
  
Swimming in a pool    
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